{"resourceType":"MedicationAdministration","id":"6116bbac-d220-5798-1cf3-c5f22dda0512","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/5cb78701-0c04-fa36-34cd-3d1973911d24"},"context":{"reference":"Encounter/74205412-fb94-2eab-c25d-612077a2ef96"},"effectiveDateTime":"1970-08-26T15:10:42-04:00","reasonReference":[{"reference":"Condition/74723c5c-6c7a-a22c-7cc3-029955d3cec9","display":"Gingivitis (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"bbd03b4c-9e2f-9925-a1b7-8f5975ab528e","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/2bdf4682-3a73-ab77-f854-3dfe85d67d45"},"context":{"reference":"Encounter/fcf456a1-85a8-5259-464c-b6b2e5ebba1b"},"effectiveDateTime":"2017-02-15T11:53:29-05:00","reasonCode":[{"coding":[{"system":"http://snomed.info/sct","code":"103697008","display":"Patient referral for dental care (procedure)"}],"text":"Patient referral for dental care (procedure)"}]}
{"resourceType":"MedicationAdministration","id":"faab6308-9cce-3898-6301-911d8a6e40f1","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/2ba35f2d-fb96-aa44-cd54-5291c51f55a6"},"context":{"reference":"Encounter/7ad0d5de-18cf-428c-71a1-1bffa72e380b"},"effectiveDateTime":"2016-01-11T02:26:45-05:00","reasonCode":[{"coding":[{"system":"http://snomed.info/sct","code":"103697008","display":"Patient referral for dental care (procedure)"}],"text":"Patient referral for dental care (procedure)"}]}
{"resourceType":"MedicationAdministration","id":"efe8b95d-f3cf-7779-ee17-61582e51e315","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/07ae78c8-b4da-1c81-732f-77523c3c7b32"},"context":{"reference":"Encounter/a510833d-b346-3f1d-125d-b393aa4cb051"},"effectiveDateTime":"2016-12-04T20:55:48-05:00","reasonReference":[{"reference":"Condition/06c0f21f-5ca9-e089-5214-ff580a9916c8","display":"Gingivitis (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"e3f9da9c-3e33-c249-1142-fe9f7e1b2710","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/ff8913aa-ddd7-60df-fbd6-aaba0e3520ea"},"context":{"reference":"Encounter/d3112d34-59b1-b2be-7bb3-4d999c4779e8"},"effectiveDateTime":"2017-09-19T07:52:34-04:00","reasonReference":[{"reference":"Condition/25a452d6-5b52-fa06-37e0-e5273b1ac2cb","display":"Gingivitis (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"20b59b1c-57e6-783e-152a-a008f671f14e","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/07ae78c8-b4da-1c81-732f-77523c3c7b32"},"context":{"reference":"Encounter/af35dc73-84fa-84c6-d289-9d06b176d020"},"effectiveDateTime":"2017-04-16T21:25:19-04:00","reasonReference":[{"reference":"Condition/06c0f21f-5ca9-e089-5214-ff580a9916c8","display":"Gingivitis (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"99ad8095-1695-29ad-056b-6104d59dc2b4","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/2bdf4682-3a73-ab77-f854-3dfe85d67d45"},"context":{"reference":"Encounter/a7c994dd-4e7e-f747-05ec-b7f80569e605"},"effectiveDateTime":"2021-03-10T11:57:08-05:00","reasonCode":[{"coding":[{"system":"http://snomed.info/sct","code":"103697008","display":"Patient referral for dental care (procedure)"}],"text":"Patient referral for dental care (procedure)"}]}
{"resourceType":"MedicationAdministration","id":"f7de5d24-0c2a-b2e6-04e9-24bfd71ec362","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/2ba35f2d-fb96-aa44-cd54-5291c51f55a6"},"context":{"reference":"Encounter/2d72631b-abed-6978-48a1-9f6f836a8d9b"},"effectiveDateTime":"2020-01-20T05:03:44-05:00","reasonReference":[{"reference":"Condition/ba9e60d2-6ed4-5ea1-6b0a-d044f7bd1d93","display":"Gingivitis (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"e80e7149-f8cf-728f-be20-f381111bb7ec","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1605257","display":"Liletta 52 MG Intrauterine System"}],"text":"Liletta 52 MG Intrauterine System"},"subject":{"reference":"Patient/f9e3c1be-b5b9-e169-863d-c38ba25f2589"},"context":{"reference":"Encounter/35016a63-20c0-fcfd-3d6a-66b1cea9db2b"},"effectiveDateTime":"2015-10-15T02:06:43-04:00"}
{"resourceType":"MedicationAdministration","id":"737dca5a-a522-3bd8-7f4c-10f914197ea5","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/5cb78701-0c04-fa36-34cd-3d1973911d24"},"context":{"reference":"Encounter/1e367485-7464-5a2d-c67b-c2f0fd29c1a2"},"effectiveDateTime":"1972-09-06T15:20:52-04:00","reasonCode":[{"coding":[{"system":"http://snomed.info/sct","code":"103697008","display":"Patient referral for dental care (procedure)"}],"text":"Patient referral for dental care (procedure)"}]}
{"resourceType":"MedicationAdministration","id":"f6038128-d477-a9de-eae5-fcb007d598e9","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/2bdf4682-3a73-ab77-f854-3dfe85d67d45"},"context":{"reference":"Encounter/c0927877-a7ab-3a53-0ca1-9b9336c239d9"},"effectiveDateTime":"2022-03-16T14:27:40-04:00","reasonCode":[{"coding":[{"system":"http://snomed.info/sct","code":"103697008","display":"Patient referral for dental care (procedure)"}],"text":"Patient referral for dental care (procedure)"}]}
{"resourceType":"MedicationAdministration","id":"84e07899-1e84-0a77-890d-348118be8d29","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/07ae78c8-b4da-1c81-732f-77523c3c7b32"},"context":{"reference":"Encounter/f35c4ce0-32b4-9776-059b-d66c3b1b05cc"},"effectiveDateTime":"2019-04-28T21:37:26-04:00","reasonReference":[{"reference":"Condition/06c0f21f-5ca9-e089-5214-ff580a9916c8","display":"Gingivitis (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"42278554-6081-3221-fdee-0f598c8e9f7c","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"198039","display":"nitroglycerin 0.4 MG Sublingual Tablet"}],"text":"nitroglycerin 0.4 MG Sublingual Tablet"},"subject":{"reference":"Patient/909595bb-97d1-4641-1efc-43534a90f21d"},"context":{"reference":"Encounter/ffdbdc0e-8d88-3b65-428d-6d311f4bd7a3"},"effectiveDateTime":"2017-06-03T15:08:01-04:00"}
{"resourceType":"MedicationAdministration","id":"9eb22522-e4a6-0632-7c90-59730e06719d","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1728805","display":"2 ML morphine sulfate 1 MG/ML Injection"}],"text":"2 ML morphine sulfate 1 MG/ML Injection"},"subject":{"reference":"Patient/909595bb-97d1-4641-1efc-43534a90f21d"},"context":{"reference":"Encounter/ffdbdc0e-8d88-3b65-428d-6d311f4bd7a3"},"effectiveDateTime":"2017-06-03T15:08:01-04:00"}
{"resourceType":"MedicationAdministration","id":"2e007b98-b273-6a5a-84f0-62d633be6db5","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1361048","display":"heparin sodium, porcine 100 UNT/ML Injectable Solution"}],"text":"heparin sodium, porcine 100 UNT/ML Injectable Solution"},"subject":{"reference":"Patient/909595bb-97d1-4641-1efc-43534a90f21d"},"context":{"reference":"Encounter/6762a45c-8e13-c634-1624-02c051cbc3c6"},"effectiveDateTime":"2017-06-03T15:24:47-04:00"}
{"resourceType":"MedicationAdministration","id":"9795b213-489e-ac2e-a87f-b35e4bfa0322","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1116635","display":"ticagrelor 90 MG Oral Tablet"}],"text":"ticagrelor 90 MG Oral Tablet"},"subject":{"reference":"Patient/909595bb-97d1-4641-1efc-43534a90f21d"},"context":{"reference":"Encounter/6762a45c-8e13-c634-1624-02c051cbc3c6"},"effectiveDateTime":"2017-06-03T16:37:32-04:00"}
{"resourceType":"MedicationAdministration","id":"f8eabc72-9e6f-ec9a-d106-737ddc7a1e16","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/ce8e6341-34b2-25be-42c8-960ebe6e980d"},"context":{"reference":"Encounter/41748bfa-2a96-d156-42e7-8de8e89d2f90"},"effectiveDateTime":"2018-05-15T14:21:40-04:00","reasonCode":[{"coding":[{"system":"http://snomed.info/sct","code":"103697008","display":"Patient referral for dental care (procedure)"}],"text":"Patient referral for dental care (procedure)"}]}
{"resourceType":"MedicationAdministration","id":"c954be7b-eb6a-44b1-3eb4-16ae00ad8cd6","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/f1afac15-a9c0-d6dc-3efe-c9376f51dfc1"},"context":{"reference":"Encounter/5ba2420e-9aa7-1024-e16c-f34583828194"},"effectiveDateTime":"2021-12-18T12:38:40-05:00","reasonCode":[{"coding":[{"system":"http://snomed.info/sct","code":"103697008","display":"Patient referral for dental care (procedure)"}],"text":"Patient referral for dental care (procedure)"}]}
{"resourceType":"MedicationAdministration","id":"a211a23a-f687-b260-72be-40ffec9ae211","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/2ba35f2d-fb96-aa44-cd54-5291c51f55a6"},"context":{"reference":"Encounter/8f332533-9a5e-6930-901d-007cfa90dd79"},"effectiveDateTime":"2025-02-03T02:21:13-05:00","reasonCode":[{"coding":[{"system":"http://snomed.info/sct","code":"103697008","display":"Patient referral for dental care (procedure)"}],"text":"Patient referral for dental care (procedure)"}]}
{"resourceType":"MedicationAdministration","id":"dc2e5020-2641-9b8b-0d43-c3b7ba4272ad","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"212033","display":"aspirin 325 MG Oral Tablet"}],"text":"aspirin 325 MG Oral Tablet"},"subject":{"reference":"Patient/f9e3c1be-b5b9-e169-863d-c38ba25f2589"},"context":{"reference":"Encounter/f39eaa3a-3d48-ea6d-d320-ca7710b1026c"},"effectiveDateTime":"2017-12-09T13:46:25-05:00","dosage":{"dose":{"value":4.0}}}
{"resourceType":"MedicationAdministration","id":"005ca3b9-1c4e-118d-734f-23d400f4343b","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"198039","display":"nitroglycerin 0.4 MG Sublingual Tablet"}],"text":"nitroglycerin 0.4 MG Sublingual Tablet"},"subject":{"reference":"Patient/f9e3c1be-b5b9-e169-863d-c38ba25f2589"},"context":{"reference":"Encounter/f39eaa3a-3d48-ea6d-d320-ca7710b1026c"},"effectiveDateTime":"2017-12-09T13:46:25-05:00"}
{"resourceType":"MedicationAdministration","id":"013d7475-ddb4-9c89-a96c-50037aa71c2c","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/07ae78c8-b4da-1c81-732f-77523c3c7b32"},"context":{"reference":"Encounter/22ecf44f-8df7-fba3-cf15-b3b338034c13"},"effectiveDateTime":"2021-05-09T21:33:44-04:00","reasonReference":[{"reference":"Condition/06c0f21f-5ca9-e089-5214-ff580a9916c8","display":"Gingivitis (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"ad3d89ca-426c-9c9b-bc25-0a1687c98280","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1361048","display":"heparin sodium, porcine 100 UNT/ML Injectable Solution"}],"text":"heparin sodium, porcine 100 UNT/ML Injectable Solution"},"subject":{"reference":"Patient/f9e3c1be-b5b9-e169-863d-c38ba25f2589"},"context":{"reference":"Encounter/bcc95290-6032-474c-b50d-39fe86f19138"},"effectiveDateTime":"2017-12-09T14:02:28-05:00"}
{"resourceType":"MedicationAdministration","id":"dc8b7344-f0dd-e94e-a6ed-9e2c20080745","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"749196","display":"clopidogrel 300 MG Oral Tablet"}],"text":"clopidogrel 300 MG Oral Tablet"},"subject":{"reference":"Patient/f9e3c1be-b5b9-e169-863d-c38ba25f2589"},"context":{"reference":"Encounter/bcc95290-6032-474c-b50d-39fe86f19138"},"effectiveDateTime":"2017-12-09T15:00:11-05:00"}
{"resourceType":"MedicationAdministration","id":"9f903278-b033-5349-1958-acfcfdf020be","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/5ff15a2a-f35a-a535-bfec-624eeb56096f"},"context":{"reference":"Encounter/760a5e14-7d66-0c42-0d80-8ff8460562ee"},"effectiveDateTime":"2023-12-05T11:00:10-05:00","reasonReference":[{"reference":"Condition/67952988-24b2-e579-81f1-1aa798e74bf5","display":"Gingivitis (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"97aa87b5-1947-646a-1a54-c1a22f95273a","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/ce8e6341-34b2-25be-42c8-960ebe6e980d"},"context":{"reference":"Encounter/d9162679-cc8f-7022-1784-fbc47189fff6"},"effectiveDateTime":"2019-05-21T15:03:39-04:00","reasonCode":[{"coding":[{"system":"http://snomed.info/sct","code":"103697008","display":"Patient referral for dental care (procedure)"}],"text":"Patient referral for dental care (procedure)"}]}
{"resourceType":"MedicationAdministration","id":"e3b545dc-874e-d9cc-d178-155f4f626b33","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/ce8e6341-34b2-25be-42c8-960ebe6e980d"},"context":{"reference":"Encounter/1f91d1b0-9750-99b2-a599-d54bea5c3988"},"effectiveDateTime":"2020-05-26T14:13:08-04:00","reasonReference":[{"reference":"Condition/f9fbbf3c-74c3-114e-8e0d-19e399030c85","display":"Gingivitis (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"378b4de4-5ad5-18eb-d71e-009a870ad5c1","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/d419a6ea-cd05-142c-4ed5-cbf82b2045ef"},"context":{"reference":"Encounter/1319c5d3-2621-6bd4-b49b-1b87f0a78d00"},"effectiveDateTime":"2015-08-11T15:29:02-04:00","reasonCode":[{"coding":[{"system":"http://snomed.info/sct","code":"103697008","display":"Patient referral for dental care (procedure)"}],"text":"Patient referral for dental care (procedure)"}]}
{"resourceType":"MedicationAdministration","id":"b97ffe46-e2ab-894b-10bc-c3f423f5dc5d","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"389221","display":"Etonogestrel 68 MG Drug Implant"}],"text":"Etonogestrel 68 MG Drug Implant"},"subject":{"reference":"Patient/f9e3c1be-b5b9-e169-863d-c38ba25f2589"},"context":{"reference":"Encounter/48b244c3-3e44-0000-83b7-b546b1398ba2"},"effectiveDateTime":"2019-09-26T12:01:33-04:00"}
{"resourceType":"MedicationAdministration","id":"a972eb77-1dc1-7feb-cd27-4a075e3f16f4","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/0d612725-99cc-2054-4a25-ef2e5e6e30c8"},"context":{"reference":"Encounter/a4c6728e-981d-3540-7528-3108d04ce059"},"effectiveDateTime":"2021-08-28T06:45:30-04:00","reasonReference":[{"reference":"Condition/dd3a0432-e796-99dc-a953-2d7c33c1d562","display":"Gingivitis (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"482267a5-3e60-8c81-ed60-9315f24151d0","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/ce8e6341-34b2-25be-42c8-960ebe6e980d"},"context":{"reference":"Encounter/01780b80-4dae-7bd5-4634-53ab4276b10a"},"effectiveDateTime":"2023-01-10T13:28:42-05:00","reasonCode":[{"coding":[{"system":"http://snomed.info/sct","code":"103697008","display":"Patient referral for dental care (procedure)"}],"text":"Patient referral for dental care (procedure)"}]}
{"resourceType":"MedicationAdministration","id":"95c62315-c035-53ca-b874-a682387bf870","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/f9e3c1be-b5b9-e169-863d-c38ba25f2589"},"context":{"reference":"Encounter/05f726d9-ce1e-4cfa-0051-8c177c741a8a"},"effectiveDateTime":"2022-06-04T17:05:53-04:00","reasonCode":[{"coding":[{"system":"http://snomed.info/sct","code":"103697008","display":"Patient referral for dental care (procedure)"}],"text":"Patient referral for dental care (procedure)"}]}
{"resourceType":"MedicationAdministration","id":"4bd0f48e-4ffd-dbe8-a077-173cd7259939","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/f9e3c1be-b5b9-e169-863d-c38ba25f2589"},"context":{"reference":"Encounter/e1f1b405-3bc7-89d1-d756-e22883dc5ea8"},"effectiveDateTime":"2023-06-10T16:51:25-04:00","reasonReference":[{"reference":"Condition/871f1ca7-43f7-e3d2-ae02-c53152a0ee58","display":"Gingivitis (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"ec2fb83e-e525-3fd9-a3ea-0e30888b5676","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/8ee6beac-5203-c8a2-f0ba-946f13602ee8"},"context":{"reference":"Encounter/5999ab42-f197-e317-1893-e57a0b4b8ccc"},"effectiveDateTime":"2015-12-30T02:30:30-05:00","reasonCode":[{"coding":[{"system":"http://snomed.info/sct","code":"103697008","display":"Patient referral for dental care (procedure)"}],"text":"Patient referral for dental care (procedure)"}]}
{"resourceType":"MedicationAdministration","id":"7c376b08-62cb-b190-fc47-89590b9e9577","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/007696ef-07ea-6a33-d81c-bb6021f07acd"},"context":{"reference":"Encounter/13890d98-9d3e-a333-1049-bacd9f08a433"},"effectiveDateTime":"2017-01-15T01:31:17-05:00","reasonCode":[{"coding":[{"system":"http://snomed.info/sct","code":"103697008","display":"Patient referral for dental care (procedure)"}],"text":"Patient referral for dental care (procedure)"}]}
{"resourceType":"MedicationAdministration","id":"f78b66b6-e6be-b9ac-08fe-77d3f534a30f","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/c29ffe32-8cd3-2c33-5643-7bd899ee276c"},"context":{"reference":"Encounter/6b0a53a2-ab7f-9af9-a55a-8c5350305322"},"effectiveDateTime":"2015-10-10T13:44:14-04:00","reasonCode":[{"coding":[{"system":"http://snomed.info/sct","code":"103697008","display":"Patient referral for dental care (procedure)"}],"text":"Patient referral for dental care (procedure)"}]}
{"resourceType":"MedicationAdministration","id":"046621de-e076-9d1c-0ef3-502bfd1d7da1","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/007696ef-07ea-6a33-d81c-bb6021f07acd"},"context":{"reference":"Encounter/121c7911-598d-316c-b141-86e6e1c8c14b"},"effectiveDateTime":"2017-07-16T02:00:46-04:00","reasonCode":[{"coding":[{"system":"http://snomed.info/sct","code":"103697008","display":"Patient referral for dental care (procedure)"}],"text":"Patient referral for dental care (procedure)"}]}
{"resourceType":"MedicationAdministration","id":"f44142ba-ca9a-47a1-bf22-d1f9058ef8b9","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/c29ffe32-8cd3-2c33-5643-7bd899ee276c"},"context":{"reference":"Encounter/4b462586-2965-be64-4259-0f94806e4e43"},"effectiveDateTime":"2017-10-28T14:16:49-04:00","reasonCode":[{"coding":[{"system":"http://snomed.info/sct","code":"103697008","display":"Patient referral for dental care (procedure)"}],"text":"Patient referral for dental care (procedure)"}]}
{"resourceType":"MedicationAdministration","id":"d4e74093-beb5-d364-0b5a-34559ec6fe57","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1659131","display":"piperacillin 2000 MG / tazobactam 250 MG Injection"}],"text":"piperacillin 2000 MG / tazobactam 250 MG Injection"},"subject":{"reference":"Patient/9535e81d-8daa-f0f8-bdd6-870e38da96fe"},"context":{"reference":"Encounter/f1b82745-5981-1c0f-4730-4b1845b7b233"},"effectiveDateTime":"2016-09-11T10:41:55-04:00","reasonReference":[{"reference":"Condition/5d2717c4-0ec5-3ddb-270b-8110dd93cc6c","display":"Sepsis (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"fc87f620-c974-26f5-0db2-e8573c67e8d6","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1807510","display":"150 ML vancomycin 5 MG/ML Injection"}],"text":"150 ML vancomycin 5 MG/ML Injection"},"subject":{"reference":"Patient/9535e81d-8daa-f0f8-bdd6-870e38da96fe"},"context":{"reference":"Encounter/f1b82745-5981-1c0f-4730-4b1845b7b233"},"effectiveDateTime":"2016-09-11T10:41:55-04:00","reasonReference":[{"reference":"Condition/5d2717c4-0ec5-3ddb-270b-8110dd93cc6c","display":"Sepsis (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"e6b469a6-7fda-e541-0ff3-5f05c0c315f3","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"807283","display":"Mirena 52 MG Intrauterine System"}],"text":"Mirena 52 MG Intrauterine System"},"subject":{"reference":"Patient/b9197d40-f942-ad59-3606-581e2df546ab"},"context":{"reference":"Encounter/095ab7ef-b908-ec8f-2aa3-c9c04e476de5"},"effectiveDateTime":"2012-05-20T17:22:27-04:00"}
{"resourceType":"MedicationAdministration","id":"41e4be9b-59a2-eee4-198a-47d11a3bf99e","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/c29ffe32-8cd3-2c33-5643-7bd899ee276c"},"context":{"reference":"Encounter/f112c0f0-cda5-8148-317f-907dc7378806"},"effectiveDateTime":"2019-11-09T13:20:00-05:00","reasonReference":[{"reference":"Condition/c1aef582-4976-605e-5f97-c338e82b6d71","display":"Gingivitis (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"cd5be672-99d5-8df6-1bb7-c66c495e8b82","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/8ee6beac-5203-c8a2-f0ba-946f13602ee8"},"context":{"reference":"Encounter/a8245268-bf70-737e-fb4c-c2d1a4f8bb6d"},"effectiveDateTime":"2022-02-09T01:41:19-05:00","reasonCode":[{"coding":[{"system":"http://snomed.info/sct","code":"103697008","display":"Patient referral for dental care (procedure)"}],"text":"Patient referral for dental care (procedure)"}]}
{"resourceType":"MedicationAdministration","id":"e80b0ea2-ad8a-71c2-253e-afa2e9513a12","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/382199f7-e295-3387-96ff-58bf8270ed45"},"context":{"reference":"Encounter/236d15eb-463b-4d1c-bf69-43c397976c24"},"effectiveDateTime":"2016-07-28T04:13:52-04:00","reasonCode":[{"coding":[{"system":"http://snomed.info/sct","code":"103697008","display":"Patient referral for dental care (procedure)"}],"text":"Patient referral for dental care (procedure)"}]}
{"resourceType":"MedicationAdministration","id":"f5697b7a-5784-fc56-2abb-c9d4eb1dfc2c","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/defdd79b-e3a8-5371-2706-c8973efba9e8"},"context":{"reference":"Encounter/e227dda0-017b-9e86-4001-21b4a80c8ae2"},"effectiveDateTime":"2015-02-23T14:16:44-05:00","reasonCode":[{"coding":[{"system":"http://snomed.info/sct","code":"103697008","display":"Patient referral for dental care (procedure)"}],"text":"Patient referral for dental care (procedure)"}]}
{"resourceType":"MedicationAdministration","id":"3fc5ef91-5652-10ba-3e03-fbbda0aae0e7","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/b9197d40-f942-ad59-3606-581e2df546ab"},"context":{"reference":"Encounter/4893bbeb-4ca9-defa-46d3-8ce5d026247c"},"effectiveDateTime":"2014-11-08T18:44:40-05:00","reasonReference":[{"reference":"Condition/38165396-4a15-6048-216c-abb4b465b59b","display":"Gingivitis (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"5561fa22-52fa-569f-7a8f-4cafe2655cb5","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"389221","display":"Etonogestrel 68 MG Drug Implant"}],"text":"Etonogestrel 68 MG Drug Implant"},"subject":{"reference":"Patient/b9197d40-f942-ad59-3606-581e2df546ab"},"context":{"reference":"Encounter/899fa42b-f9db-8a2a-244c-84a48f4a7d07"},"effectiveDateTime":"2015-05-09T22:29:26-04:00"}
{"resourceType":"MedicationAdministration","id":"5d51e3b4-fe2d-a622-fea3-8996da264092","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/007696ef-07ea-6a33-d81c-bb6021f07acd"},"context":{"reference":"Encounter/a5e9f1dd-0d9b-dcae-975f-5546ff95b4a3"},"effectiveDateTime":"2024-02-18T00:49:58-05:00","reasonCode":[{"coding":[{"system":"http://snomed.info/sct","code":"103697008","display":"Patient referral for dental care (procedure)"}],"text":"Patient referral for dental care (procedure)"}]}
{"resourceType":"MedicationAdministration","id":"98a783f3-69b0-3e70-5d6c-12b1d84d2a43","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/c29ffe32-8cd3-2c33-5643-7bd899ee276c"},"context":{"reference":"Encounter/037d54fe-1b98-0365-2dba-40630c4930fa"},"effectiveDateTime":"2021-04-10T14:18:10-04:00","reasonReference":[{"reference":"Condition/c1aef582-4976-605e-5f97-c338e82b6d71","display":"Gingivitis (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"7948b50f-1470-f2f6-0a51-64d2977c058e","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"389221","display":"Etonogestrel 68 MG Drug Implant"}],"text":"Etonogestrel 68 MG Drug Implant"},"subject":{"reference":"Patient/b9197d40-f942-ad59-3606-581e2df546ab"},"context":{"reference":"Encounter/3f657d15-5388-5486-9ffa-eef5195977a8"},"effectiveDateTime":"2016-05-03T23:02:04-04:00"}
{"resourceType":"MedicationAdministration","id":"566d00d6-0e15-8f02-5c75-ec73886e2812","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/c29ffe32-8cd3-2c33-5643-7bd899ee276c"},"context":{"reference":"Encounter/dc85939c-dd27-94d9-5316-b76452a63cbb"},"effectiveDateTime":"2021-05-29T14:23:28-04:00","reasonReference":[{"reference":"Condition/c1aef582-4976-605e-5f97-c338e82b6d71","display":"Gingivitis (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"78aa4bbe-2c23-066e-37f7-33fe418461a0","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"807283","display":"Mirena 52 MG Intrauterine System"}],"text":"Mirena 52 MG Intrauterine System"},"subject":{"reference":"Patient/382199f7-e295-3387-96ff-58bf8270ed45"},"context":{"reference":"Encounter/d7b9905d-2a1a-a5d9-6c35-55fff511315c"},"effectiveDateTime":"2018-04-29T01:32:28-04:00"}
{"resourceType":"MedicationAdministration","id":"c08ae680-fc21-cf4d-e0fc-693cf76d21c0","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/defdd79b-e3a8-5371-2706-c8973efba9e8"},"context":{"reference":"Encounter/481d8a71-bcb1-9526-3d99-42ee59db82e3"},"effectiveDateTime":"2019-03-11T18:32:56-04:00","reasonCode":[{"coding":[{"system":"http://snomed.info/sct","code":"103697008","display":"Patient referral for dental care (procedure)"}],"text":"Patient referral for dental care (procedure)"}]}
{"resourceType":"MedicationAdministration","id":"0815094e-ec71-78b6-097b-8f724326473a","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/382199f7-e295-3387-96ff-58bf8270ed45"},"context":{"reference":"Encounter/8db0c2e4-72c3-6752-8c55-b455ba572a9e"},"effectiveDateTime":"2018-08-09T05:08:03-04:00","reasonCode":[{"coding":[{"system":"http://snomed.info/sct","code":"103697008","display":"Patient referral for dental care (procedure)"}],"text":"Patient referral for dental care (procedure)"}]}
{"resourceType":"MedicationAdministration","id":"f6c3c3fc-6c0d-cbbd-78dc-7714c4a28c4b","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/b9197d40-f942-ad59-3606-581e2df546ab"},"context":{"reference":"Encounter/f9de68ad-9da8-a9f3-328e-ccbe599913e2"},"effectiveDateTime":"2016-11-19T18:37:31-05:00","reasonCode":[{"coding":[{"system":"http://snomed.info/sct","code":"103697008","display":"Patient referral for dental care (procedure)"}],"text":"Patient referral for dental care (procedure)"}]}
{"resourceType":"MedicationAdministration","id":"529aee9c-664b-5e27-79e6-845ac16bc5d1","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/83fe615b-64ff-69f6-3346-0445fd9b3809"},"context":{"reference":"Encounter/98993729-1ae9-dbfc-eccc-1da492c30176"},"effectiveDateTime":"2024-10-19T15:47:59-04:00","reasonCode":[{"coding":[{"system":"http://snomed.info/sct","code":"103697008","display":"Patient referral for dental care (procedure)"}],"text":"Patient referral for dental care (procedure)"}]}
{"resourceType":"MedicationAdministration","id":"2a65def8-addd-975d-df8d-11073c6d6517","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/defdd79b-e3a8-5371-2706-c8973efba9e8"},"context":{"reference":"Encounter/e2ac3dd7-b5d4-072f-9600-5d9bc8e9fe2b"},"effectiveDateTime":"2023-04-03T14:48:55-04:00","reasonReference":[{"reference":"Condition/f9e860a7-896b-733a-c483-e4a5b5846977","display":"Gingivitis (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"9ef94f37-8bc6-f1cb-aa52-ec3f8f5b9b3f","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"389221","display":"Etonogestrel 68 MG Drug Implant"}],"text":"Etonogestrel 68 MG Drug Implant"},"subject":{"reference":"Patient/382199f7-e295-3387-96ff-58bf8270ed45"},"context":{"reference":"Encounter/92fba867-1b1f-6606-17ab-5ad1dae64d25"},"effectiveDateTime":"2020-04-20T09:25:51-04:00"}
{"resourceType":"MedicationAdministration","id":"89b2c0ec-02d8-e306-99ba-d201073cb640","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1000126","display":"1 ML medroxyprogesterone acetate 150 MG/ML Injection"}],"text":"1 ML medroxyprogesterone acetate 150 MG/ML Injection"},"subject":{"reference":"Patient/382199f7-e295-3387-96ff-58bf8270ed45"},"context":{"reference":"Encounter/94626c4e-9f20-48af-167e-6086307937dc"},"effectiveDateTime":"2021-04-15T10:00:16-04:00"}
{"resourceType":"MedicationAdministration","id":"54058233-e244-54fc-281d-dac8b1bef189","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/b9197d40-f942-ad59-3606-581e2df546ab"},"context":{"reference":"Encounter/0e65fc88-d85b-775f-6ba8-85fb943a720c"},"effectiveDateTime":"2018-12-01T18:15:27-05:00","reasonCode":[{"coding":[{"system":"http://snomed.info/sct","code":"103697008","display":"Patient referral for dental care (procedure)"}],"text":"Patient referral for dental care (procedure)"}]}
{"resourceType":"MedicationAdministration","id":"614f7d22-c927-911a-8c70-c014c474795a","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1856546","display":"Kyleena 19.5 MG Intrauterine System"}],"text":"Kyleena 19.5 MG Intrauterine System"},"subject":{"reference":"Patient/382199f7-e295-3387-96ff-58bf8270ed45"},"context":{"reference":"Encounter/47994f3e-db95-16d2-6272-d22367c2f379"},"effectiveDateTime":"2024-03-30T10:10:47-04:00"}
{"resourceType":"MedicationAdministration","id":"a8c0504a-6cf7-bdb5-fc43-bdce2cfa781e","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/7821bfb1-387c-200d-8dbb-2f1c683d3be5"},"context":{"reference":"Encounter/f201aa60-57ff-4c02-ad07-1e11e302b756"},"effectiveDateTime":"2017-08-15T12:14:18-04:00","reasonCode":[{"coding":[{"system":"http://snomed.info/sct","code":"103697008","display":"Patient referral for dental care (procedure)"}],"text":"Patient referral for dental care (procedure)"}]}
{"resourceType":"MedicationAdministration","id":"2bbcb169-416f-e1e5-b277-1abcce294de8","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/7821bfb1-387c-200d-8dbb-2f1c683d3be5"},"context":{"reference":"Encounter/f06d6774-3136-9a28-1488-a24030dcb1a1"},"effectiveDateTime":"2020-02-25T17:34:55-05:00","reasonCode":[{"coding":[{"system":"http://snomed.info/sct","code":"103697008","display":"Patient referral for dental care (procedure)"}],"text":"Patient referral for dental care (procedure)"}]}
{"resourceType":"MedicationAdministration","id":"e7ac4ee7-fbb8-c09c-0004-e3d11bff9320","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1605257","display":"Liletta 52 MG Intrauterine System"}],"text":"Liletta 52 MG Intrauterine System"},"subject":{"reference":"Patient/b9197d40-f942-ad59-3606-581e2df546ab"},"context":{"reference":"Encounter/faa91428-18a5-ad6d-6019-8d2ccd81adb2"},"effectiveDateTime":"2022-05-29T17:28:29-04:00"}
{"resourceType":"MedicationAdministration","id":"fd8c2735-b70a-414d-3aa9-e740d992de34","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/3890ec81-9726-52af-cbcf-7043a1400c67"},"context":{"reference":"Encounter/df0f047f-0d07-b52c-1108-46672b7b405e"},"effectiveDateTime":"2018-10-03T14:04:06-04:00","reasonCode":[{"coding":[{"system":"http://snomed.info/sct","code":"103697008","display":"Patient referral for dental care (procedure)"}],"text":"Patient referral for dental care (procedure)"}]}
{"resourceType":"MedicationAdministration","id":"bee6888e-3264-2c19-0d46-343c7c2f15bf","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/7821bfb1-387c-200d-8dbb-2f1c683d3be5"},"context":{"reference":"Encounter/0d055f2d-4960-f85f-9029-bafa5b09ed85"},"effectiveDateTime":"2023-03-14T14:57:42-04:00","reasonCode":[{"coding":[{"system":"http://snomed.info/sct","code":"103697008","display":"Patient referral for dental care (procedure)"}],"text":"Patient referral for dental care (procedure)"}]}
{"resourceType":"MedicationAdministration","id":"e838ee73-ccf3-299b-0091-835d87b0a9e7","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1719286","display":"10 ML Furosemide 10 MG/ML Injection"}],"text":"10 ML Furosemide 10 MG/ML Injection"},"subject":{"reference":"Patient/b9197d40-f942-ad59-3606-581e2df546ab"},"context":{"reference":"Encounter/42a9cd49-b07f-0e68-df90-35b90f79a0ab"},"effectiveDateTime":"2022-06-28T17:19:38-04:00","reasonReference":[{"reference":"Condition/043356e8-2c7b-cbea-eeca-e7cc804824ad","display":"Chronic congestive heart failure (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"b4d22f7a-d92c-b75c-2f73-8c1309dde130","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1719286","display":"10 ML Furosemide 10 MG/ML Injection"}],"text":"10 ML Furosemide 10 MG/ML Injection"},"subject":{"reference":"Patient/b9197d40-f942-ad59-3606-581e2df546ab"},"context":{"reference":"Encounter/42a9cd49-b07f-0e68-df90-35b90f79a0ab"},"effectiveDateTime":"2022-06-29T05:19:38-04:00","reasonReference":[{"reference":"Condition/043356e8-2c7b-cbea-eeca-e7cc804824ad","display":"Chronic congestive heart failure (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"df0bf623-c881-894b-bb57-0e7c5d6b492f","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1719286","display":"10 ML Furosemide 10 MG/ML Injection"}],"text":"10 ML Furosemide 10 MG/ML Injection"},"subject":{"reference":"Patient/b9197d40-f942-ad59-3606-581e2df546ab"},"context":{"reference":"Encounter/42a9cd49-b07f-0e68-df90-35b90f79a0ab"},"effectiveDateTime":"2022-06-29T17:19:38-04:00","reasonReference":[{"reference":"Condition/043356e8-2c7b-cbea-eeca-e7cc804824ad","display":"Chronic congestive heart failure (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"b78ab8f8-b55f-eb59-c166-e22916c23f00","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1719286","display":"10 ML Furosemide 10 MG/ML Injection"}],"text":"10 ML Furosemide 10 MG/ML Injection"},"subject":{"reference":"Patient/b9197d40-f942-ad59-3606-581e2df546ab"},"context":{"reference":"Encounter/42a9cd49-b07f-0e68-df90-35b90f79a0ab"},"effectiveDateTime":"2022-06-30T05:19:38-04:00","reasonReference":[{"reference":"Condition/043356e8-2c7b-cbea-eeca-e7cc804824ad","display":"Chronic congestive heart failure (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"551e3063-56b6-9b22-857f-92b6fdcac403","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1719286","display":"10 ML Furosemide 10 MG/ML Injection"}],"text":"10 ML Furosemide 10 MG/ML Injection"},"subject":{"reference":"Patient/b9197d40-f942-ad59-3606-581e2df546ab"},"context":{"reference":"Encounter/42a9cd49-b07f-0e68-df90-35b90f79a0ab"},"effectiveDateTime":"2022-06-30T17:19:38-04:00","reasonReference":[{"reference":"Condition/043356e8-2c7b-cbea-eeca-e7cc804824ad","display":"Chronic congestive heart failure (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"bf7168fd-7119-fda4-a340-1c237d464819","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1719286","display":"10 ML Furosemide 10 MG/ML Injection"}],"text":"10 ML Furosemide 10 MG/ML Injection"},"subject":{"reference":"Patient/b9197d40-f942-ad59-3606-581e2df546ab"},"context":{"reference":"Encounter/42a9cd49-b07f-0e68-df90-35b90f79a0ab"},"effectiveDateTime":"2022-07-01T05:19:38-04:00","reasonReference":[{"reference":"Condition/043356e8-2c7b-cbea-eeca-e7cc804824ad","display":"Chronic congestive heart failure (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"31653031-d720-96cd-7777-b9b4e2333406","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1719286","display":"10 ML Furosemide 10 MG/ML Injection"}],"text":"10 ML Furosemide 10 MG/ML Injection"},"subject":{"reference":"Patient/b9197d40-f942-ad59-3606-581e2df546ab"},"context":{"reference":"Encounter/42a9cd49-b07f-0e68-df90-35b90f79a0ab"},"effectiveDateTime":"2022-07-01T17:19:38-04:00","reasonReference":[{"reference":"Condition/043356e8-2c7b-cbea-eeca-e7cc804824ad","display":"Chronic congestive heart failure (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"0cc52f62-14d5-1301-1f62-68fa8d1e960c","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1719286","display":"10 ML Furosemide 10 MG/ML Injection"}],"text":"10 ML Furosemide 10 MG/ML Injection"},"subject":{"reference":"Patient/b9197d40-f942-ad59-3606-581e2df546ab"},"context":{"reference":"Encounter/42a9cd49-b07f-0e68-df90-35b90f79a0ab"},"effectiveDateTime":"2022-07-02T05:19:38-04:00","reasonReference":[{"reference":"Condition/043356e8-2c7b-cbea-eeca-e7cc804824ad","display":"Chronic congestive heart failure (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"4154db64-70e8-730f-b6bf-43c6572590d2","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/3890ec81-9726-52af-cbcf-7043a1400c67"},"context":{"reference":"Encounter/7042c25a-e6a7-7f40-3e9d-f077ca6bc90a"},"effectiveDateTime":"2022-06-22T17:37:03-04:00","reasonCode":[{"coding":[{"system":"http://snomed.info/sct","code":"103697008","display":"Patient referral for dental care (procedure)"}],"text":"Patient referral for dental care (procedure)"}]}
{"resourceType":"MedicationAdministration","id":"0bf5144f-a710-f72a-b13c-76d7d474be50","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/373692d9-ec04-1c90-c88e-f93b46bffd47"},"context":{"reference":"Encounter/bd1909d0-3e39-c323-eed1-0cf9d6efc102"},"effectiveDateTime":"2024-03-17T11:07:51-04:00","reasonReference":[{"reference":"Condition/99bda539-067c-0b42-aecc-6a4bc9cb4dd3","display":"Gingivitis (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"7ccb34be-82f5-9164-a915-a9c00de71770","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1719286","display":"10 ML Furosemide 10 MG/ML Injection"}],"text":"10 ML Furosemide 10 MG/ML Injection"},"subject":{"reference":"Patient/b9197d40-f942-ad59-3606-581e2df546ab"},"context":{"reference":"Encounter/34ebca12-7284-2b12-f0bf-ddc13b08905e"},"effectiveDateTime":"2022-07-12T18:28:50-04:00","reasonReference":[{"reference":"Condition/043356e8-2c7b-cbea-eeca-e7cc804824ad","display":"Chronic congestive heart failure (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"33449b39-be08-578c-8371-e3c21ecb1c33","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1719286","display":"10 ML Furosemide 10 MG/ML Injection"}],"text":"10 ML Furosemide 10 MG/ML Injection"},"subject":{"reference":"Patient/b9197d40-f942-ad59-3606-581e2df546ab"},"context":{"reference":"Encounter/34ebca12-7284-2b12-f0bf-ddc13b08905e"},"effectiveDateTime":"2022-07-13T06:28:50-04:00","reasonReference":[{"reference":"Condition/043356e8-2c7b-cbea-eeca-e7cc804824ad","display":"Chronic congestive heart failure (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"529035f1-a42c-1e44-3488-96b468d36e86","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1719286","display":"10 ML Furosemide 10 MG/ML Injection"}],"text":"10 ML Furosemide 10 MG/ML Injection"},"subject":{"reference":"Patient/b9197d40-f942-ad59-3606-581e2df546ab"},"context":{"reference":"Encounter/34ebca12-7284-2b12-f0bf-ddc13b08905e"},"effectiveDateTime":"2022-07-13T18:28:50-04:00","reasonReference":[{"reference":"Condition/043356e8-2c7b-cbea-eeca-e7cc804824ad","display":"Chronic congestive heart failure (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"0886ecc7-b21a-56e3-2dc1-6f7b8d5d5cf9","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1719286","display":"10 ML Furosemide 10 MG/ML Injection"}],"text":"10 ML Furosemide 10 MG/ML Injection"},"subject":{"reference":"Patient/b9197d40-f942-ad59-3606-581e2df546ab"},"context":{"reference":"Encounter/34ebca12-7284-2b12-f0bf-ddc13b08905e"},"effectiveDateTime":"2022-07-14T06:28:50-04:00","reasonReference":[{"reference":"Condition/043356e8-2c7b-cbea-eeca-e7cc804824ad","display":"Chronic congestive heart failure (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"7a328e60-ecff-996e-dbb5-99738a4145c1","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1719286","display":"10 ML Furosemide 10 MG/ML Injection"}],"text":"10 ML Furosemide 10 MG/ML Injection"},"subject":{"reference":"Patient/b9197d40-f942-ad59-3606-581e2df546ab"},"context":{"reference":"Encounter/34ebca12-7284-2b12-f0bf-ddc13b08905e"},"effectiveDateTime":"2022-07-14T18:28:50-04:00","reasonReference":[{"reference":"Condition/043356e8-2c7b-cbea-eeca-e7cc804824ad","display":"Chronic congestive heart failure (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"0aacbdde-98c4-7bcd-8eaa-30219edaa107","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1719286","display":"10 ML Furosemide 10 MG/ML Injection"}],"text":"10 ML Furosemide 10 MG/ML Injection"},"subject":{"reference":"Patient/b9197d40-f942-ad59-3606-581e2df546ab"},"context":{"reference":"Encounter/34ebca12-7284-2b12-f0bf-ddc13b08905e"},"effectiveDateTime":"2022-07-15T06:28:50-04:00","reasonReference":[{"reference":"Condition/043356e8-2c7b-cbea-eeca-e7cc804824ad","display":"Chronic congestive heart failure (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"14ba4fbd-b37f-4ea3-97c5-625af5d06d84","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1719286","display":"10 ML Furosemide 10 MG/ML Injection"}],"text":"10 ML Furosemide 10 MG/ML Injection"},"subject":{"reference":"Patient/b9197d40-f942-ad59-3606-581e2df546ab"},"context":{"reference":"Encounter/34ebca12-7284-2b12-f0bf-ddc13b08905e"},"effectiveDateTime":"2022-07-15T18:28:50-04:00","reasonReference":[{"reference":"Condition/043356e8-2c7b-cbea-eeca-e7cc804824ad","display":"Chronic congestive heart failure (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"a6147fb2-025a-e15c-cfe8-a9ea4c73120d","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1719286","display":"10 ML Furosemide 10 MG/ML Injection"}],"text":"10 ML Furosemide 10 MG/ML Injection"},"subject":{"reference":"Patient/b9197d40-f942-ad59-3606-581e2df546ab"},"context":{"reference":"Encounter/34ebca12-7284-2b12-f0bf-ddc13b08905e"},"effectiveDateTime":"2022-07-16T06:28:50-04:00","reasonReference":[{"reference":"Condition/043356e8-2c7b-cbea-eeca-e7cc804824ad","display":"Chronic congestive heart failure (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"fa58d053-3ad6-c0f1-e62d-935950fbfb77","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1719286","display":"10 ML Furosemide 10 MG/ML Injection"}],"text":"10 ML Furosemide 10 MG/ML Injection"},"subject":{"reference":"Patient/b9197d40-f942-ad59-3606-581e2df546ab"},"context":{"reference":"Encounter/34ebca12-7284-2b12-f0bf-ddc13b08905e"},"effectiveDateTime":"2022-07-16T18:28:50-04:00","reasonReference":[{"reference":"Condition/043356e8-2c7b-cbea-eeca-e7cc804824ad","display":"Chronic congestive heart failure (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"14ec3259-fbba-bfd3-97f7-44f73f030ff4","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1719286","display":"10 ML Furosemide 10 MG/ML Injection"}],"text":"10 ML Furosemide 10 MG/ML Injection"},"subject":{"reference":"Patient/b9197d40-f942-ad59-3606-581e2df546ab"},"context":{"reference":"Encounter/34ebca12-7284-2b12-f0bf-ddc13b08905e"},"effectiveDateTime":"2022-07-17T06:28:50-04:00","reasonReference":[{"reference":"Condition/043356e8-2c7b-cbea-eeca-e7cc804824ad","display":"Chronic congestive heart failure (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"51f99e28-dc54-ba13-8c80-d3949f5ad038","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1719286","display":"10 ML Furosemide 10 MG/ML Injection"}],"text":"10 ML Furosemide 10 MG/ML Injection"},"subject":{"reference":"Patient/b9197d40-f942-ad59-3606-581e2df546ab"},"context":{"reference":"Encounter/34ebca12-7284-2b12-f0bf-ddc13b08905e"},"effectiveDateTime":"2022-07-17T18:28:50-04:00","reasonReference":[{"reference":"Condition/043356e8-2c7b-cbea-eeca-e7cc804824ad","display":"Chronic congestive heart failure (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"51280400-1c7f-f1e5-7d72-790fd0ee77f1","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1719286","display":"10 ML Furosemide 10 MG/ML Injection"}],"text":"10 ML Furosemide 10 MG/ML Injection"},"subject":{"reference":"Patient/b9197d40-f942-ad59-3606-581e2df546ab"},"context":{"reference":"Encounter/34ebca12-7284-2b12-f0bf-ddc13b08905e"},"effectiveDateTime":"2022-07-18T06:28:50-04:00","reasonReference":[{"reference":"Condition/043356e8-2c7b-cbea-eeca-e7cc804824ad","display":"Chronic congestive heart failure (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"a96a7db2-6fe9-c8b5-2f76-a9fce4fac6bb","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1719286","display":"10 ML Furosemide 10 MG/ML Injection"}],"text":"10 ML Furosemide 10 MG/ML Injection"},"subject":{"reference":"Patient/b9197d40-f942-ad59-3606-581e2df546ab"},"context":{"reference":"Encounter/34ebca12-7284-2b12-f0bf-ddc13b08905e"},"effectiveDateTime":"2022-07-18T18:28:50-04:00","reasonReference":[{"reference":"Condition/043356e8-2c7b-cbea-eeca-e7cc804824ad","display":"Chronic congestive heart failure (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"c4ed2fe3-84fb-4af0-7617-042ca36d6321","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1719286","display":"10 ML Furosemide 10 MG/ML Injection"}],"text":"10 ML Furosemide 10 MG/ML Injection"},"subject":{"reference":"Patient/b9197d40-f942-ad59-3606-581e2df546ab"},"context":{"reference":"Encounter/34ebca12-7284-2b12-f0bf-ddc13b08905e"},"effectiveDateTime":"2022-07-19T06:28:50-04:00","reasonReference":[{"reference":"Condition/043356e8-2c7b-cbea-eeca-e7cc804824ad","display":"Chronic congestive heart failure (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"9c351fc0-a148-7280-2140-0f806f78363e","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/0d952ed6-dd0b-5bf2-7a48-3ab3ad6f971a"},"context":{"reference":"Encounter/efa99d62-30e0-47d2-7c00-e6e967620df3"},"effectiveDateTime":"2016-07-26T07:24:29-04:00","reasonReference":[{"reference":"Condition/e32135b4-9608-7932-0143-c9ff1dd3fb5c","display":"Gingivitis (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"b6a4b022-cb4e-692d-b9c5-535ef15abba4","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/57a7dcb7-8168-6b53-86b2-95f4012abf92"},"context":{"reference":"Encounter/dbc4e352-a944-6ef0-113c-5e47fdf9621f"},"effectiveDateTime":"2017-03-18T19:32:38-04:00","reasonCode":[{"coding":[{"system":"http://snomed.info/sct","code":"103697008","display":"Patient referral for dental care (procedure)"}],"text":"Patient referral for dental care (procedure)"}]}
{"resourceType":"MedicationAdministration","id":"7ddb7cd9-4cc1-9a3f-1051-f550fd6333ec","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/0d952ed6-dd0b-5bf2-7a48-3ab3ad6f971a"},"context":{"reference":"Encounter/aa7fbb4e-f200-0a34-e725-aec4ea406a16"},"effectiveDateTime":"2018-08-07T07:15:13-04:00","reasonReference":[{"reference":"Condition/e32135b4-9608-7932-0143-c9ff1dd3fb5c","display":"Gingivitis (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"19425d16-7215-19cd-08a3-a0c13a3d847e","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/0d952ed6-dd0b-5bf2-7a48-3ab3ad6f971a"},"context":{"reference":"Encounter/5c3d0be1-d9eb-bb39-f9f4-d72c8effcbd6"},"effectiveDateTime":"2020-08-18T10:29:24-04:00","reasonReference":[{"reference":"Condition/e32135b4-9608-7932-0143-c9ff1dd3fb5c","display":"Gingivitis (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"e198e765-633b-2428-6c31-18168d13455a","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/b9197d40-f942-ad59-3606-581e2df546ab"},"context":{"reference":"Encounter/5e79ec15-2d11-aa24-0558-e9076d19c387"},"effectiveDateTime":"2022-10-22T19:32:26-04:00","reasonReference":[{"reference":"Condition/38165396-4a15-6048-216c-abb4b465b59b","display":"Gingivitis (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"f47dbb17-5dbf-b383-eede-7ddc0523e730","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1719286","display":"10 ML Furosemide 10 MG/ML Injection"}],"text":"10 ML Furosemide 10 MG/ML Injection"},"subject":{"reference":"Patient/b9197d40-f942-ad59-3606-581e2df546ab"},"context":{"reference":"Encounter/de3be2a0-ed36-0c43-89a7-194a678bcbc5"},"effectiveDateTime":"2022-11-14T15:49:14-05:00","reasonReference":[{"reference":"Condition/043356e8-2c7b-cbea-eeca-e7cc804824ad","display":"Chronic congestive heart failure (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"024044f5-0bb8-c7b5-55f2-691840e92917","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1719286","display":"10 ML Furosemide 10 MG/ML Injection"}],"text":"10 ML Furosemide 10 MG/ML Injection"},"subject":{"reference":"Patient/b9197d40-f942-ad59-3606-581e2df546ab"},"context":{"reference":"Encounter/de3be2a0-ed36-0c43-89a7-194a678bcbc5"},"effectiveDateTime":"2022-11-15T03:49:14-05:00","reasonReference":[{"reference":"Condition/043356e8-2c7b-cbea-eeca-e7cc804824ad","display":"Chronic congestive heart failure (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"29b60e6c-5af5-ed28-742c-543a589bf954","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1719286","display":"10 ML Furosemide 10 MG/ML Injection"}],"text":"10 ML Furosemide 10 MG/ML Injection"},"subject":{"reference":"Patient/b9197d40-f942-ad59-3606-581e2df546ab"},"context":{"reference":"Encounter/de3be2a0-ed36-0c43-89a7-194a678bcbc5"},"effectiveDateTime":"2022-11-15T15:49:14-05:00","reasonReference":[{"reference":"Condition/043356e8-2c7b-cbea-eeca-e7cc804824ad","display":"Chronic congestive heart failure (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"be27c589-72d4-a15a-1eea-8a30d7461aa5","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1719286","display":"10 ML Furosemide 10 MG/ML Injection"}],"text":"10 ML Furosemide 10 MG/ML Injection"},"subject":{"reference":"Patient/b9197d40-f942-ad59-3606-581e2df546ab"},"context":{"reference":"Encounter/de3be2a0-ed36-0c43-89a7-194a678bcbc5"},"effectiveDateTime":"2022-11-16T03:49:14-05:00","reasonReference":[{"reference":"Condition/043356e8-2c7b-cbea-eeca-e7cc804824ad","display":"Chronic congestive heart failure (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"db42cad8-4548-7164-078d-4120a6741771","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1719286","display":"10 ML Furosemide 10 MG/ML Injection"}],"text":"10 ML Furosemide 10 MG/ML Injection"},"subject":{"reference":"Patient/b9197d40-f942-ad59-3606-581e2df546ab"},"context":{"reference":"Encounter/de3be2a0-ed36-0c43-89a7-194a678bcbc5"},"effectiveDateTime":"2022-11-16T15:49:14-05:00","reasonReference":[{"reference":"Condition/043356e8-2c7b-cbea-eeca-e7cc804824ad","display":"Chronic congestive heart failure (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"d94471d7-7491-972a-3199-335cfde06060","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1719286","display":"10 ML Furosemide 10 MG/ML Injection"}],"text":"10 ML Furosemide 10 MG/ML Injection"},"subject":{"reference":"Patient/b9197d40-f942-ad59-3606-581e2df546ab"},"context":{"reference":"Encounter/de3be2a0-ed36-0c43-89a7-194a678bcbc5"},"effectiveDateTime":"2022-11-17T03:49:14-05:00","reasonReference":[{"reference":"Condition/043356e8-2c7b-cbea-eeca-e7cc804824ad","display":"Chronic congestive heart failure (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"389ae190-8e08-25ea-fb17-28f26ccaaea5","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/0d952ed6-dd0b-5bf2-7a48-3ab3ad6f971a"},"context":{"reference":"Encounter/9a2921cc-f05a-17c8-1279-487b2c4d5e8b"},"effectiveDateTime":"2023-09-05T07:31:04-04:00","reasonReference":[{"reference":"Condition/e32135b4-9608-7932-0143-c9ff1dd3fb5c","display":"Gingivitis (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"826c37f3-66ab-9d99-43f1-c142300a28ce","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1719286","display":"10 ML Furosemide 10 MG/ML Injection"}],"text":"10 ML Furosemide 10 MG/ML Injection"},"subject":{"reference":"Patient/b9197d40-f942-ad59-3606-581e2df546ab"},"context":{"reference":"Encounter/de3be2a0-ed36-0c43-89a7-194a678bcbc5"},"effectiveDateTime":"2022-11-17T15:49:14-05:00","reasonReference":[{"reference":"Condition/043356e8-2c7b-cbea-eeca-e7cc804824ad","display":"Chronic congestive heart failure (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"b2396ad6-e92f-3165-de83-e123271fd771","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1719286","display":"10 ML Furosemide 10 MG/ML Injection"}],"text":"10 ML Furosemide 10 MG/ML Injection"},"subject":{"reference":"Patient/b9197d40-f942-ad59-3606-581e2df546ab"},"context":{"reference":"Encounter/de3be2a0-ed36-0c43-89a7-194a678bcbc5"},"effectiveDateTime":"2022-11-18T03:49:14-05:00","reasonReference":[{"reference":"Condition/043356e8-2c7b-cbea-eeca-e7cc804824ad","display":"Chronic congestive heart failure (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"10a4a4b9-d90d-656a-c310-e0f7096ec7bd","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1719286","display":"10 ML Furosemide 10 MG/ML Injection"}],"text":"10 ML Furosemide 10 MG/ML Injection"},"subject":{"reference":"Patient/b9197d40-f942-ad59-3606-581e2df546ab"},"context":{"reference":"Encounter/de3be2a0-ed36-0c43-89a7-194a678bcbc5"},"effectiveDateTime":"2022-11-18T15:49:14-05:00","reasonReference":[{"reference":"Condition/043356e8-2c7b-cbea-eeca-e7cc804824ad","display":"Chronic congestive heart failure (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"991f2f08-90d9-12f6-9f35-5443b841a249","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1719286","display":"10 ML Furosemide 10 MG/ML Injection"}],"text":"10 ML Furosemide 10 MG/ML Injection"},"subject":{"reference":"Patient/b9197d40-f942-ad59-3606-581e2df546ab"},"context":{"reference":"Encounter/de3be2a0-ed36-0c43-89a7-194a678bcbc5"},"effectiveDateTime":"2022-11-19T03:49:14-05:00","reasonReference":[{"reference":"Condition/043356e8-2c7b-cbea-eeca-e7cc804824ad","display":"Chronic congestive heart failure (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"190b0dbb-ca48-68c8-053b-feab2b8d025e","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/0d952ed6-dd0b-5bf2-7a48-3ab3ad6f971a"},"context":{"reference":"Encounter/c57545ac-ec9d-d808-b62c-d4f7fccacd11"},"effectiveDateTime":"2024-09-10T07:29:21-04:00","reasonCode":[{"coding":[{"system":"http://snomed.info/sct","code":"103697008","display":"Patient referral for dental care (procedure)"}],"text":"Patient referral for dental care (procedure)"}]}
{"resourceType":"MedicationAdministration","id":"540f6e41-030f-e8b3-d85f-a83674a3932e","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1000126","display":"1 ML medroxyPROGESTERone acetate 150 MG/ML Injection"}],"text":"1 ML medroxyPROGESTERone acetate 150 MG/ML Injection"},"subject":{"reference":"Patient/cec246bf-696c-5510-075a-49591386281b"},"context":{"reference":"Encounter/5985e0c0-9f23-301c-e7e1-4e4068718c15"},"effectiveDateTime":"2014-06-01T03:12:18-04:00"}
{"resourceType":"MedicationAdministration","id":"37c8b967-fd02-d813-f3a0-cd1278872917","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1000126","display":"1 ML medroxyPROGESTERone acetate 150 MG/ML Injection"}],"text":"1 ML medroxyPROGESTERone acetate 150 MG/ML Injection"},"subject":{"reference":"Patient/cec246bf-696c-5510-075a-49591386281b"},"context":{"reference":"Encounter/89286623-afa5-f456-5e31-58eceb7e875d"},"effectiveDateTime":"2016-02-21T02:12:18-05:00"}
{"resourceType":"MedicationAdministration","id":"f48173ab-c36a-8026-1c9a-74e16df38af1","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/08593cac-2773-f99a-8943-67a41323710d"},"context":{"reference":"Encounter/bd0fd41f-79f4-0baa-09de-8934cba20761"},"effectiveDateTime":"2016-04-15T04:35:13-04:00","reasonCode":[{"coding":[{"system":"http://snomed.info/sct","code":"103697008","display":"Patient referral for dental care (procedure)"}],"text":"Patient referral for dental care (procedure)"}]}
{"resourceType":"MedicationAdministration","id":"6d14b11a-7bfe-0167-5117-7b42950207be","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/08593cac-2773-f99a-8943-67a41323710d"},"context":{"reference":"Encounter/ba1d4500-47fb-420f-d2d3-558f3cb0fd5d"},"effectiveDateTime":"2017-01-20T00:44:55-05:00","reasonCode":[{"coding":[{"system":"http://snomed.info/sct","code":"103697008","display":"Patient referral for dental care (procedure)"}],"text":"Patient referral for dental care (procedure)"}]}
{"resourceType":"MedicationAdministration","id":"ed3a6c93-691f-9b17-e2e5-d92d06fb1768","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/70c04411-14fc-ba16-e580-3b3d88c18f50"},"context":{"reference":"Encounter/3c4b5e1d-1e1b-760b-ced4-7b3445122f75"},"effectiveDateTime":"2018-03-13T12:30:15-04:00","reasonCode":[{"coding":[{"system":"http://snomed.info/sct","code":"103697008","display":"Patient referral for dental care (procedure)"}],"text":"Patient referral for dental care (procedure)"}]}
{"resourceType":"MedicationAdministration","id":"06cff8c7-7a63-85bf-c41c-c7b54002787d","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/70c04411-14fc-ba16-e580-3b3d88c18f50"},"context":{"reference":"Encounter/b512c716-455d-2859-38a5-8b04b9efb62c"},"effectiveDateTime":"2019-03-19T11:55:56-04:00","reasonReference":[{"reference":"Condition/a6b29048-5539-226a-02cf-00a81e3b776c","display":"Gingivitis (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"479e8383-c307-816c-f349-b1b6297eefd4","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/70c04411-14fc-ba16-e580-3b3d88c18f50"},"context":{"reference":"Encounter/92f1fb5f-a5b9-94d4-993b-7303fb3b8b74"},"effectiveDateTime":"2020-03-24T11:33:21-04:00","reasonCode":[{"coding":[{"system":"http://snomed.info/sct","code":"103697008","display":"Patient referral for dental care (procedure)"}],"text":"Patient referral for dental care (procedure)"}]}
{"resourceType":"MedicationAdministration","id":"54b0283a-159e-becd-4284-b478dbe40b9c","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/70c04411-14fc-ba16-e580-3b3d88c18f50"},"context":{"reference":"Encounter/e21dae63-5e3b-2444-c9a7-c15631b562fe"},"effectiveDateTime":"2021-03-30T12:28:01-04:00","reasonReference":[{"reference":"Condition/a6b29048-5539-226a-02cf-00a81e3b776c","display":"Gingivitis (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"d7fffe28-c08f-d7c1-e035-3164780e8563","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1605257","display":"Liletta 52 MG Intrauterine System"}],"text":"Liletta 52 MG Intrauterine System"},"subject":{"reference":"Patient/70c04411-14fc-ba16-e580-3b3d88c18f50"},"context":{"reference":"Encounter/069f337b-1050-0530-d161-5dd4fa57675f"},"effectiveDateTime":"2022-10-04T09:12:30-04:00"}
{"resourceType":"MedicationAdministration","id":"aff4a460-8c21-218b-d998-b065bafe5f4d","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"389221","display":"Etonogestrel 68 MG Drug Implant"}],"text":"Etonogestrel 68 MG Drug Implant"},"subject":{"reference":"Patient/cec246bf-696c-5510-075a-49591386281b"},"context":{"reference":"Encounter/b8ff8387-1a83-614c-6b33-d344154279fe"},"effectiveDateTime":"2021-01-25T02:25:42-05:00"}
{"resourceType":"MedicationAdministration","id":"765692e9-8a46-be8d-8649-0dd62cc84f35","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/08593cac-2773-f99a-8943-67a41323710d"},"context":{"reference":"Encounter/86774028-189c-207d-28b8-c1e16dae4c34"},"effectiveDateTime":"2018-10-26T05:33:18-04:00","reasonCode":[{"coding":[{"system":"http://snomed.info/sct","code":"103697008","display":"Patient referral for dental care (procedure)"}],"text":"Patient referral for dental care (procedure)"}]}
{"resourceType":"MedicationAdministration","id":"2cf12778-1a7e-5033-40fd-adb4f072b958","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/08593cac-2773-f99a-8943-67a41323710d"},"context":{"reference":"Encounter/00eb015a-7e76-fdb4-e15b-d705b73f41a4"},"effectiveDateTime":"2019-05-10T05:27:55-04:00","reasonReference":[{"reference":"Condition/2d1ea6e2-4e2c-6203-55b1-e2daebbf84a9","display":"Gingivitis (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"429e53c2-69a5-3034-5190-e674f3ab7402","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/08593cac-2773-f99a-8943-67a41323710d"},"context":{"reference":"Encounter/a4d1fab3-c3ce-ff95-94eb-c9c21e09e490"},"effectiveDateTime":"2020-02-07T00:49:05-05:00","reasonReference":[{"reference":"Condition/2d1ea6e2-4e2c-6203-55b1-e2daebbf84a9","display":"Gingivitis (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"663e53a5-8465-576d-368c-6fe955ef37d2","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1000126","display":"1 ML medroxyprogesterone acetate 150 MG/ML Injection"}],"text":"1 ML medroxyprogesterone acetate 150 MG/ML Injection"},"subject":{"reference":"Patient/9dc17d79-272e-2928-c687-deddf31a7504"},"context":{"reference":"Encounter/375708ae-9dcb-0f98-8617-5865cc1912bb"},"effectiveDateTime":"2022-11-02T01:06:32-04:00"}
{"resourceType":"MedicationAdministration","id":"0e4f9372-12a6-4c7d-064c-640bd3dced49","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1665060","display":"cefazolin 2000 MG Injection"}],"text":"cefazolin 2000 MG Injection"},"subject":{"reference":"Patient/1d7c6417-1102-0d3c-7e35-47b6c086fc19"},"context":{"reference":"Encounter/daa2d1a6-1456-f705-3194-df558427aeae"},"effectiveDateTime":"2009-07-19T10:30:08-04:00"}
{"resourceType":"MedicationAdministration","id":"89034237-7c08-90df-8702-765dec563812","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1659263","display":"1 ML heparin sodium, porcine 5000 UNT/ML Injection"}],"text":"1 ML heparin sodium, porcine 5000 UNT/ML Injection"},"subject":{"reference":"Patient/1d7c6417-1102-0d3c-7e35-47b6c086fc19"},"context":{"reference":"Encounter/daa2d1a6-1456-f705-3194-df558427aeae"},"effectiveDateTime":"2009-07-19T10:30:08-04:00"}
{"resourceType":"MedicationAdministration","id":"1ce64f8c-7d62-1cfa-3526-eeb4d10afbf5","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/5f747051-36eb-3b8d-96a3-e332cbed8a7c"},"context":{"reference":"Encounter/f1cd6201-a0c8-b90e-6e29-c379deedf5ae"},"effectiveDateTime":"2016-06-16T04:06:21-04:00","reasonCode":[{"coding":[{"system":"http://snomed.info/sct","code":"103697008","display":"Patient referral for dental care (procedure)"}],"text":"Patient referral for dental care (procedure)"}]}
{"resourceType":"MedicationAdministration","id":"9859826a-c44d-c857-1759-1c7dfc749c71","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1796676","display":"25 ML protamine sulfate (USP) 10 MG/ML Injection"}],"text":"25 ML protamine sulfate (USP) 10 MG/ML Injection"},"subject":{"reference":"Patient/1d7c6417-1102-0d3c-7e35-47b6c086fc19"},"context":{"reference":"Encounter/daa2d1a6-1456-f705-3194-df558427aeae"},"effectiveDateTime":"2009-07-19T10:30:08-04:00"}
{"resourceType":"MedicationAdministration","id":"6fdfb003-55e7-bc7a-3c52-dfe3492a23ab","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"311034","display":"insulin, regular, human 100 UNT/ML Injectable Solution"}],"text":"insulin, regular, human 100 UNT/ML Injectable Solution"},"subject":{"reference":"Patient/1d7c6417-1102-0d3c-7e35-47b6c086fc19"},"context":{"reference":"Encounter/daa2d1a6-1456-f705-3194-df558427aeae"},"effectiveDateTime":"2009-07-19T10:33:08-04:00"}
{"resourceType":"MedicationAdministration","id":"6eccc600-61f1-138b-2e4c-930a119c1d98","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1740467","display":"2 ML Ondansetron 2 MG/ML Injection"}],"text":"2 ML Ondansetron 2 MG/ML Injection"},"subject":{"reference":"Patient/1d7c6417-1102-0d3c-7e35-47b6c086fc19"},"context":{"reference":"Encounter/daa2d1a6-1456-f705-3194-df558427aeae"},"effectiveDateTime":"2009-07-19T11:55:44-04:00"}
{"resourceType":"MedicationAdministration","id":"17118c1f-2189-5ff9-f704-ce8b0c4bd328","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"311700","display":"Midazolam 1 MG/ML Injectable Solution"}],"text":"Midazolam 1 MG/ML Injectable Solution"},"subject":{"reference":"Patient/1d7c6417-1102-0d3c-7e35-47b6c086fc19"},"context":{"reference":"Encounter/daa2d1a6-1456-f705-3194-df558427aeae"},"effectiveDateTime":"2009-07-19T11:55:44-04:00"}
{"resourceType":"MedicationAdministration","id":"c3cf2655-3bce-c87d-aa53-fe2ac0d5283d","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1808217","display":"100 ML Propofol 10 MG/ML Injection"}],"text":"100 ML Propofol 10 MG/ML Injection"},"subject":{"reference":"Patient/1d7c6417-1102-0d3c-7e35-47b6c086fc19"},"context":{"reference":"Encounter/daa2d1a6-1456-f705-3194-df558427aeae"},"effectiveDateTime":"2009-07-19T11:55:44-04:00"}
{"resourceType":"MedicationAdministration","id":"12ed525f-ce0c-6018-1287-65bf24207997","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1234995","display":"Rocuronium bromide 10 MG/ML Injectable Solution"}],"text":"Rocuronium bromide 10 MG/ML Injectable Solution"},"subject":{"reference":"Patient/1d7c6417-1102-0d3c-7e35-47b6c086fc19"},"context":{"reference":"Encounter/daa2d1a6-1456-f705-3194-df558427aeae"},"effectiveDateTime":"2009-07-19T11:55:44-04:00"}
{"resourceType":"MedicationAdministration","id":"3629504c-33e8-4881-2e26-20e72e98e94d","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"562366","display":"desflurane 1000 MG/ML Inhalation Solution"}],"text":"desflurane 1000 MG/ML Inhalation Solution"},"subject":{"reference":"Patient/1d7c6417-1102-0d3c-7e35-47b6c086fc19"},"context":{"reference":"Encounter/daa2d1a6-1456-f705-3194-df558427aeae"},"effectiveDateTime":"2009-07-19T11:55:44-04:00"}
{"resourceType":"MedicationAdministration","id":"ce4442ae-506c-294d-10b0-2d70d39c0941","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1735006","display":"10 ML Fentanyl 0.05 MG/ML Injection"}],"text":"10 ML Fentanyl 0.05 MG/ML Injection"},"subject":{"reference":"Patient/1d7c6417-1102-0d3c-7e35-47b6c086fc19"},"context":{"reference":"Encounter/daa2d1a6-1456-f705-3194-df558427aeae"},"effectiveDateTime":"2009-07-19T11:55:44-04:00"}
{"resourceType":"MedicationAdministration","id":"5d28d5dd-0df3-c7c3-ec49-c1bd5e9b1986","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/5f747051-36eb-3b8d-96a3-e332cbed8a7c"},"context":{"reference":"Encounter/deab8b0d-f869-96a2-f2c7-627938606f4d"},"effectiveDateTime":"2019-07-04T04:01:38-04:00","reasonCode":[{"coding":[{"system":"http://snomed.info/sct","code":"103697008","display":"Patient referral for dental care (procedure)"}],"text":"Patient referral for dental care (procedure)"}]}
{"resourceType":"MedicationAdministration","id":"1f14e999-b7de-d180-c195-374e4292bf69","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/33acd282-2b66-1eaf-7962-19ff2532ba4e"},"context":{"reference":"Encounter/364fbceb-feb7-0e7f-b078-0a39bf0cf82d"},"effectiveDateTime":"2008-08-05T14:22:51-04:00","reasonCode":[{"coding":[{"system":"http://snomed.info/sct","code":"103697008","display":"Patient referral for dental care (procedure)"}],"text":"Patient referral for dental care (procedure)"}]}
{"resourceType":"MedicationAdministration","id":"556f16dd-0def-edb2-5b2f-50bb5e973f7d","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/5f747051-36eb-3b8d-96a3-e332cbed8a7c"},"context":{"reference":"Encounter/85527cae-ba51-741f-f7fe-217951f9654a"},"effectiveDateTime":"2023-07-27T04:36:29-04:00","reasonReference":[{"reference":"Condition/522cc83f-e83c-549a-38db-1b5246894d4d","display":"Gingivitis (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"10f46446-1994-6de7-b9da-d5f7ca3d963a","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/5f747051-36eb-3b8d-96a3-e332cbed8a7c"},"context":{"reference":"Encounter/5452ce6a-c579-7a18-745e-59cda3cac8bb"},"effectiveDateTime":"2024-08-01T04:24:47-04:00","reasonCode":[{"coding":[{"system":"http://snomed.info/sct","code":"103697008","display":"Patient referral for dental care (procedure)"}],"text":"Patient referral for dental care (procedure)"}]}
{"resourceType":"MedicationAdministration","id":"577bce6c-2ca2-e65d-d0e1-a90e2397b7d5","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/33acd282-2b66-1eaf-7962-19ff2532ba4e"},"context":{"reference":"Encounter/e4c00a4d-8a33-92ba-f881-ccf77f650f78"},"effectiveDateTime":"2009-07-21T13:47:32-04:00","reasonReference":[{"reference":"Condition/bb65a54e-3b7e-ce30-0abc-21fa406b34d3","display":"Gingivitis (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"61df0a3d-eb7e-ab43-2d1d-e8d822b83344","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/33acd282-2b66-1eaf-7962-19ff2532ba4e"},"context":{"reference":"Encounter/1641123d-5704-eecf-795b-0748e23cfd57"},"effectiveDateTime":"2010-08-31T11:33:35-04:00","reasonReference":[{"reference":"Condition/bb65a54e-3b7e-ce30-0abc-21fa406b34d3","display":"Gingivitis (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"6e694480-cf68-1ee3-3feb-92655743f22b","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/33acd282-2b66-1eaf-7962-19ff2532ba4e"},"context":{"reference":"Encounter/9d13fa1f-f383-3447-1568-7439588d869c"},"effectiveDateTime":"2011-08-30T11:33:10-04:00","reasonCode":[{"coding":[{"system":"http://snomed.info/sct","code":"103697008","display":"Patient referral for dental care (procedure)"}],"text":"Patient referral for dental care (procedure)"}]}
{"resourceType":"MedicationAdministration","id":"689cf5c0-342d-d76c-c27d-ca4a5a5a82d9","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/acccb562-84ae-4722-eedd-247aacbcc938"},"context":{"reference":"Encounter/5adf36fb-c5a9-0213-a729-c5193b5860e1"},"effectiveDateTime":"2015-09-04T13:58:20-04:00","reasonCode":[{"coding":[{"system":"http://snomed.info/sct","code":"103697008","display":"Patient referral for dental care (procedure)"}],"text":"Patient referral for dental care (procedure)"}]}
{"resourceType":"MedicationAdministration","id":"eba09326-8ee1-6fe6-167b-e9d95afc8bf2","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/acccb562-84ae-4722-eedd-247aacbcc938"},"context":{"reference":"Encounter/b2debc82-5391-8f57-2826-6f04c0416728"},"effectiveDateTime":"2016-03-04T13:44:21-05:00","reasonCode":[{"coding":[{"system":"http://snomed.info/sct","code":"103697008","display":"Patient referral for dental care (procedure)"}],"text":"Patient referral for dental care (procedure)"}]}
{"resourceType":"MedicationAdministration","id":"89f1656c-402d-06c6-03ee-6885e7e3434f","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/7fcda815-a50a-0dda-0f24-a6d3585917ee"},"context":{"reference":"Encounter/447dced5-27c7-c282-1cbe-e4e2d7411d1b"},"effectiveDateTime":"2015-04-04T09:35:28-04:00","reasonReference":[{"reference":"Condition/fd31bc6d-56eb-1780-bfaa-074870ad7214","display":"Gingivitis (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"ed08d594-5020-b162-cef0-c9a169db3416","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/7fcda815-a50a-0dda-0f24-a6d3585917ee"},"context":{"reference":"Encounter/e4965a94-26a1-9833-b2f0-956e89a439dc"},"effectiveDateTime":"2018-04-21T08:07:15-04:00","reasonCode":[{"coding":[{"system":"http://snomed.info/sct","code":"103697008","display":"Patient referral for dental care (procedure)"}],"text":"Patient referral for dental care (procedure)"}]}
{"resourceType":"MedicationAdministration","id":"1c7fba05-234d-2e59-a8e1-6b179c9d69e2","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/4f727130-bf3c-4d54-bc6f-25487c6e554f"},"context":{"reference":"Encounter/e615dcb7-adfe-b3fb-64bd-cada886f9d07"},"effectiveDateTime":"2024-02-14T03:50:43-05:00","reasonReference":[{"reference":"Condition/f753b3c0-29b3-dc6c-6a26-f7e9d9707ee3","display":"Gingivitis (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"44c18d84-5ed8-35a3-6d3f-4ab917a4ff57","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/33acd282-2b66-1eaf-7962-19ff2532ba4e"},"context":{"reference":"Encounter/405493b2-784c-df76-fd8f-68cd74f7c9f4"},"effectiveDateTime":"2015-09-22T11:21:16-04:00","reasonCode":[{"coding":[{"system":"http://snomed.info/sct","code":"103697008","display":"Patient referral for dental care (procedure)"}],"text":"Patient referral for dental care (procedure)"}]}
{"resourceType":"MedicationAdministration","id":"c1f5c538-8bce-417d-c221-4fc284c89524","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/532653cc-0bd4-cd08-0a13-5a30bd59a1af"},"context":{"reference":"Encounter/6e0b39b1-351d-1394-7deb-1f0b0ccbb545"},"effectiveDateTime":"1985-07-18T03:20:56-04:00","reasonCode":[{"coding":[{"system":"http://snomed.info/sct","code":"103697008","display":"Patient referral for dental care (procedure)"}],"text":"Patient referral for dental care (procedure)"}]}
{"resourceType":"MedicationAdministration","id":"82d6be7e-4cb3-6fc3-e33c-ba7d2c5e3840","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/1d7c6417-1102-0d3c-7e35-47b6c086fc19"},"context":{"reference":"Encounter/22062431-eab8-4c0d-58b5-456ec0c20ee4"},"effectiveDateTime":"2017-09-02T07:35:01-04:00","reasonReference":[{"reference":"Condition/efa031cb-c6bd-1bfb-a39a-d17e7e03998b","display":"Gingivitis (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"4e8d0f73-e7f3-8cf9-013a-c50bdc2945d2","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/acccb562-84ae-4722-eedd-247aacbcc938"},"context":{"reference":"Encounter/b3e3b559-c820-b41c-91c9-590259b07386"},"effectiveDateTime":"2022-04-08T14:18:12-04:00","reasonCode":[{"coding":[{"system":"http://snomed.info/sct","code":"103697008","display":"Patient referral for dental care (procedure)"}],"text":"Patient referral for dental care (procedure)"}]}
{"resourceType":"MedicationAdministration","id":"0ee0b1b5-97fc-038c-02da-b89c04b38a7d","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/7fcda815-a50a-0dda-0f24-a6d3585917ee"},"context":{"reference":"Encounter/6280f124-454f-a645-56bf-fd8cd7196b97"},"effectiveDateTime":"2021-05-08T08:32:59-04:00","reasonCode":[{"coding":[{"system":"http://snomed.info/sct","code":"103697008","display":"Patient referral for dental care (procedure)"}],"text":"Patient referral for dental care (procedure)"}]}
{"resourceType":"MedicationAdministration","id":"b616a8d9-92b5-cfb1-35f2-be15d0cbdc71","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1719286","display":"10 ML Furosemide 10 MG/ML Injection"}],"text":"10 ML Furosemide 10 MG/ML Injection"},"subject":{"reference":"Patient/1d7c6417-1102-0d3c-7e35-47b6c086fc19"},"context":{"reference":"Encounter/4d986841-d858-a284-6d65-72ae35d26b20"},"effectiveDateTime":"2017-09-27T02:00:30-04:00","reasonReference":[{"reference":"Condition/4e18443a-255d-a6af-c97a-f6d64d5af93d","display":"Chronic congestive heart failure (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"925a316d-042f-a361-9f19-b1491a10acf7","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1719286","display":"10 ML Furosemide 10 MG/ML Injection"}],"text":"10 ML Furosemide 10 MG/ML Injection"},"subject":{"reference":"Patient/1d7c6417-1102-0d3c-7e35-47b6c086fc19"},"context":{"reference":"Encounter/4d986841-d858-a284-6d65-72ae35d26b20"},"effectiveDateTime":"2017-09-27T14:00:30-04:00","reasonReference":[{"reference":"Condition/4e18443a-255d-a6af-c97a-f6d64d5af93d","display":"Chronic congestive heart failure (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"03bf45e7-b4ac-40df-339f-3ced56218652","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1719286","display":"10 ML Furosemide 10 MG/ML Injection"}],"text":"10 ML Furosemide 10 MG/ML Injection"},"subject":{"reference":"Patient/1d7c6417-1102-0d3c-7e35-47b6c086fc19"},"context":{"reference":"Encounter/4d986841-d858-a284-6d65-72ae35d26b20"},"effectiveDateTime":"2017-09-28T02:00:30-04:00","reasonReference":[{"reference":"Condition/4e18443a-255d-a6af-c97a-f6d64d5af93d","display":"Chronic congestive heart failure (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"614cc893-5ae9-d038-0b56-295f52e791ab","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1719286","display":"10 ML Furosemide 10 MG/ML Injection"}],"text":"10 ML Furosemide 10 MG/ML Injection"},"subject":{"reference":"Patient/1d7c6417-1102-0d3c-7e35-47b6c086fc19"},"context":{"reference":"Encounter/4d986841-d858-a284-6d65-72ae35d26b20"},"effectiveDateTime":"2017-09-28T14:00:30-04:00","reasonReference":[{"reference":"Condition/4e18443a-255d-a6af-c97a-f6d64d5af93d","display":"Chronic congestive heart failure (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"3e24bb50-50c0-2228-0a1c-b911cdb6e389","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1719286","display":"10 ML Furosemide 10 MG/ML Injection"}],"text":"10 ML Furosemide 10 MG/ML Injection"},"subject":{"reference":"Patient/1d7c6417-1102-0d3c-7e35-47b6c086fc19"},"context":{"reference":"Encounter/4d986841-d858-a284-6d65-72ae35d26b20"},"effectiveDateTime":"2017-09-29T02:00:30-04:00","reasonReference":[{"reference":"Condition/4e18443a-255d-a6af-c97a-f6d64d5af93d","display":"Chronic congestive heart failure (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"3d3be0e6-4e1f-fbaa-ac67-fa654dd82c92","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1719286","display":"10 ML Furosemide 10 MG/ML Injection"}],"text":"10 ML Furosemide 10 MG/ML Injection"},"subject":{"reference":"Patient/1d7c6417-1102-0d3c-7e35-47b6c086fc19"},"context":{"reference":"Encounter/4d986841-d858-a284-6d65-72ae35d26b20"},"effectiveDateTime":"2017-09-29T14:00:30-04:00","reasonReference":[{"reference":"Condition/4e18443a-255d-a6af-c97a-f6d64d5af93d","display":"Chronic congestive heart failure (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"2af7c839-33e1-22bf-26f6-a901fbf9d325","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1719286","display":"10 ML Furosemide 10 MG/ML Injection"}],"text":"10 ML Furosemide 10 MG/ML Injection"},"subject":{"reference":"Patient/1d7c6417-1102-0d3c-7e35-47b6c086fc19"},"context":{"reference":"Encounter/4d986841-d858-a284-6d65-72ae35d26b20"},"effectiveDateTime":"2017-09-30T02:00:30-04:00","reasonReference":[{"reference":"Condition/4e18443a-255d-a6af-c97a-f6d64d5af93d","display":"Chronic congestive heart failure (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"b4deb060-0bd8-cb06-9c29-b6bfcbc6d7e5","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1719286","display":"10 ML Furosemide 10 MG/ML Injection"}],"text":"10 ML Furosemide 10 MG/ML Injection"},"subject":{"reference":"Patient/1d7c6417-1102-0d3c-7e35-47b6c086fc19"},"context":{"reference":"Encounter/4d986841-d858-a284-6d65-72ae35d26b20"},"effectiveDateTime":"2017-09-30T14:00:30-04:00","reasonReference":[{"reference":"Condition/4e18443a-255d-a6af-c97a-f6d64d5af93d","display":"Chronic congestive heart failure (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"0cb3e592-da01-085d-6d7f-dd909ba731fe","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1719286","display":"10 ML Furosemide 10 MG/ML Injection"}],"text":"10 ML Furosemide 10 MG/ML Injection"},"subject":{"reference":"Patient/1d7c6417-1102-0d3c-7e35-47b6c086fc19"},"context":{"reference":"Encounter/4d986841-d858-a284-6d65-72ae35d26b20"},"effectiveDateTime":"2017-10-01T02:00:30-04:00","reasonReference":[{"reference":"Condition/4e18443a-255d-a6af-c97a-f6d64d5af93d","display":"Chronic congestive heart failure (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"4657ac3c-60e5-aa8f-b6c3-c9d2b818a88e","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1719286","display":"10 ML Furosemide 10 MG/ML Injection"}],"text":"10 ML Furosemide 10 MG/ML Injection"},"subject":{"reference":"Patient/1d7c6417-1102-0d3c-7e35-47b6c086fc19"},"context":{"reference":"Encounter/4d986841-d858-a284-6d65-72ae35d26b20"},"effectiveDateTime":"2017-10-01T14:00:30-04:00","reasonReference":[{"reference":"Condition/4e18443a-255d-a6af-c97a-f6d64d5af93d","display":"Chronic congestive heart failure (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"effad005-42cf-ba6f-d0d8-318df335b66e","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1719286","display":"10 ML Furosemide 10 MG/ML Injection"}],"text":"10 ML Furosemide 10 MG/ML Injection"},"subject":{"reference":"Patient/1d7c6417-1102-0d3c-7e35-47b6c086fc19"},"context":{"reference":"Encounter/4d986841-d858-a284-6d65-72ae35d26b20"},"effectiveDateTime":"2017-10-02T02:00:30-04:00","reasonReference":[{"reference":"Condition/4e18443a-255d-a6af-c97a-f6d64d5af93d","display":"Chronic congestive heart failure (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"bec2f1fe-546a-c9ad-1e82-e00c7ce914b4","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1719286","display":"10 ML Furosemide 10 MG/ML Injection"}],"text":"10 ML Furosemide 10 MG/ML Injection"},"subject":{"reference":"Patient/1d7c6417-1102-0d3c-7e35-47b6c086fc19"},"context":{"reference":"Encounter/4d986841-d858-a284-6d65-72ae35d26b20"},"effectiveDateTime":"2017-10-02T14:00:30-04:00","reasonReference":[{"reference":"Condition/4e18443a-255d-a6af-c97a-f6d64d5af93d","display":"Chronic congestive heart failure (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"70bcff08-8c08-0675-1b48-48724c12ecd3","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/532653cc-0bd4-cd08-0a13-5a30bd59a1af"},"context":{"reference":"Encounter/813e3533-db58-729b-78dd-5d62e7f9bbb9"},"effectiveDateTime":"1986-07-24T02:12:25-04:00","reasonReference":[{"reference":"Condition/712bb810-c92f-30c2-32cc-fb9bc29f187e","display":"Gingivitis (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"5b802845-3da2-c6b1-0280-53eda16d0575","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/532653cc-0bd4-cd08-0a13-5a30bd59a1af"},"context":{"reference":"Encounter/8ee6539c-2a67-ca76-8bd9-e43c788eaac0"},"effectiveDateTime":"1987-07-30T02:04:27-04:00","reasonCode":[{"coding":[{"system":"http://snomed.info/sct","code":"103697008","display":"Patient referral for dental care (procedure)"}],"text":"Patient referral for dental care (procedure)"}]}
{"resourceType":"MedicationAdministration","id":"c14da72a-770a-5779-baee-0427dc741784","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1659131","display":"piperacillin 2000 MG / tazobactam 250 MG Injection"}],"text":"piperacillin 2000 MG / tazobactam 250 MG Injection"},"subject":{"reference":"Patient/532653cc-0bd4-cd08-0a13-5a30bd59a1af"},"context":{"reference":"Encounter/75fc6617-881a-a1e4-4878-5fd6723ee75b"},"effectiveDateTime":"1991-10-20T23:38:04-04:00","reasonReference":[{"reference":"Condition/e996614c-3fd5-521c-3324-1124f08b54b8","display":"Sepsis (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"588aafba-35e9-80a1-6fca-08f4a5ec3f09","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1807510","display":"150 ML vancomycin 5 MG/ML Injection"}],"text":"150 ML vancomycin 5 MG/ML Injection"},"subject":{"reference":"Patient/532653cc-0bd4-cd08-0a13-5a30bd59a1af"},"context":{"reference":"Encounter/75fc6617-881a-a1e4-4878-5fd6723ee75b"},"effectiveDateTime":"1991-10-20T23:38:04-04:00","reasonReference":[{"reference":"Condition/e996614c-3fd5-521c-3324-1124f08b54b8","display":"Sepsis (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"1859eaaf-6e4f-cb64-6b33-b1a92df41563","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/5837d1c0-4c29-e496-730f-012d38ff438b"},"context":{"reference":"Encounter/278ce343-dade-9363-98b7-aadc0b4bb309"},"effectiveDateTime":"2018-10-09T08:14:29-04:00","reasonReference":[{"reference":"Condition/4bc89019-5cbb-7d0f-cf01-2859de29e63a","display":"Gingivitis (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"1a622223-6d9a-382d-6a5c-e1824c5ab54f","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/5837d1c0-4c29-e496-730f-012d38ff438b"},"context":{"reference":"Encounter/7985ec1b-ed17-5260-4c0b-b5dc2e32ca11"},"effectiveDateTime":"2020-02-25T10:14:17-05:00","reasonReference":[{"reference":"Condition/4bc89019-5cbb-7d0f-cf01-2859de29e63a","display":"Gingivitis (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"37671384-f3e0-ae90-0feb-5ac4050ad79d","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"389221","display":"Etonogestrel 68 MG Drug Implant"}],"text":"Etonogestrel 68 MG Drug Implant"},"subject":{"reference":"Patient/31696126-5555-88d7-ffc7-24f3c4716dfa"},"context":{"reference":"Encounter/8c172738-8e78-9922-ea98-e17a6dfdc73d"},"effectiveDateTime":"2016-08-20T02:15:51-04:00"}
{"resourceType":"MedicationAdministration","id":"b1a8e064-0ec4-9160-0ca6-7b7497be8e71","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"389221","display":"Etonogestrel 68 MG Drug Implant"}],"text":"Etonogestrel 68 MG Drug Implant"},"subject":{"reference":"Patient/31696126-5555-88d7-ffc7-24f3c4716dfa"},"context":{"reference":"Encounter/64e44c05-7ebf-88d4-f89f-ab2b148b5ccc"},"effectiveDateTime":"2021-07-25T02:50:02-04:00"}
{"resourceType":"MedicationAdministration","id":"a90a64d1-0781-889a-9869-367672905e9d","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/1a3d3c22-f1e7-7d92-61cc-f5fe9a6f6d17"},"effectiveDateTime":"2016-11-12T19:01:53-05:00","reasonCode":[{"coding":[{"system":"http://snomed.info/sct","code":"103697008","display":"Patient referral for dental care (procedure)"}],"text":"Patient referral for dental care (procedure)"}]}
{"resourceType":"MedicationAdministration","id":"7df6c11e-1d4f-286f-751d-1a651ec6d813","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/b014f6d1-2bb7-0332-e2d6-0182f470a492"},"effectiveDateTime":"2018-11-17T18:55:24-05:00","reasonReference":[{"reference":"Condition/5413f81f-3dd2-0daa-bdd6-00fb3a3f3bfd","display":"Gingivitis (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"a65bac1c-bac4-6b28-bdd6-a79d0faae198","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/2d19865a-c5ca-601d-d054-45dac1f08949"},"effectiveDateTime":"2019-07-25T01:38:57-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"aac99ff3-9327-16fa-8988-8008ccc4b300","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/2d19865a-c5ca-601d-d054-45dac1f08949"},"effectiveDateTime":"2019-07-25T01:38:57-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"efdd7b2f-88ce-fb98-5ff4-f62b0aa9709f","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/2d19865a-c5ca-601d-d054-45dac1f08949"},"effectiveDateTime":"2019-07-26T06:00:57-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"8273a9ba-727b-a8d4-e975-216a2a995024","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/2d19865a-c5ca-601d-d054-45dac1f08949"},"effectiveDateTime":"2019-07-26T06:00:57-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"31a6ca64-9a48-a7c4-3142-d04359297a38","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/2d19865a-c5ca-601d-d054-45dac1f08949"},"effectiveDateTime":"2019-07-27T08:45:57-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"429307fe-279f-31a6-02f0-f3ec34c671a0","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/2d19865a-c5ca-601d-d054-45dac1f08949"},"effectiveDateTime":"2019-07-27T08:45:57-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"0fea80b7-ed1b-5ef0-7093-56badc7acf89","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/2d19865a-c5ca-601d-d054-45dac1f08949"},"effectiveDateTime":"2019-07-28T12:48:57-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"4185d122-4c2d-e9e6-01e3-bd105f59ff00","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/2d19865a-c5ca-601d-d054-45dac1f08949"},"effectiveDateTime":"2019-07-28T12:48:57-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"6eee9f22-190f-b0b2-d1fe-7d891a87606a","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/2d19865a-c5ca-601d-d054-45dac1f08949"},"effectiveDateTime":"2019-07-29T14:52:57-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"504a4d57-8616-69fd-1441-e717e4025816","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/2d19865a-c5ca-601d-d054-45dac1f08949"},"effectiveDateTime":"2019-07-29T14:52:57-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"c72b3318-101a-689d-459b-4a930ba200b9","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/2d19865a-c5ca-601d-d054-45dac1f08949"},"effectiveDateTime":"2019-07-30T17:01:57-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"8faa9b70-c45a-498f-c6a7-fb9fba5158bf","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/2d19865a-c5ca-601d-d054-45dac1f08949"},"effectiveDateTime":"2019-07-30T17:01:57-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"03cc79ac-131e-5e22-c14a-3e22c281962d","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/2d19865a-c5ca-601d-d054-45dac1f08949"},"effectiveDateTime":"2019-07-31T17:52:57-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"21d88612-89f2-a305-fc96-1372b8e89a16","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/2d19865a-c5ca-601d-d054-45dac1f08949"},"effectiveDateTime":"2019-07-31T17:52:57-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"46226049-01f2-757c-51df-de0e2eb52cb4","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/2d19865a-c5ca-601d-d054-45dac1f08949"},"effectiveDateTime":"2019-08-01T20:23:57-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"8d5f913d-e749-9c3f-ab82-f34f0812473c","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/31696126-5555-88d7-ffc7-24f3c4716dfa"},"context":{"reference":"Encounter/fd4e696d-1539-3b2d-0abf-4047c21d7447"},"effectiveDateTime":"2024-11-27T04:38:35-05:00","reasonCode":[{"coding":[{"system":"http://snomed.info/sct","code":"103697008","display":"Patient referral for dental care (procedure)"}],"text":"Patient referral for dental care (procedure)"}]}
{"resourceType":"MedicationAdministration","id":"68d5af79-20f9-be3f-e085-681eb950a540","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/2d19865a-c5ca-601d-d054-45dac1f08949"},"effectiveDateTime":"2019-08-01T20:23:57-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"6b5dd469-657b-7f94-fe95-e026e3415648","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/2d19865a-c5ca-601d-d054-45dac1f08949"},"effectiveDateTime":"2019-08-02T21:08:57-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"173132e9-79d1-7af7-c49a-5959914c7682","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/2d19865a-c5ca-601d-d054-45dac1f08949"},"effectiveDateTime":"2019-08-02T21:08:57-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"cab7701e-14ff-3ec7-1857-cfc51676ee85","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/07ab708d-5b07-f6c7-4770-69680ee96ecb"},"effectiveDateTime":"2019-09-28T17:12:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"43d64e27-0ecc-98ef-5bc0-0e84fabbec57","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/07ab708d-5b07-f6c7-4770-69680ee96ecb"},"effectiveDateTime":"2019-09-28T17:12:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"1a15fd51-2ebb-7d70-f072-98239ed2f86b","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/07ab708d-5b07-f6c7-4770-69680ee96ecb"},"effectiveDateTime":"2019-09-29T21:21:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"6107970f-886f-c39c-13ec-6da3092b9b7b","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/07ab708d-5b07-f6c7-4770-69680ee96ecb"},"effectiveDateTime":"2019-09-29T21:21:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"dd5de387-dfac-9ea4-a71e-4173cf0bdc37","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/07ab708d-5b07-f6c7-4770-69680ee96ecb"},"effectiveDateTime":"2019-10-01T00:21:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"47b9cdb9-fe5f-5366-0536-c4052560cb16","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/07ab708d-5b07-f6c7-4770-69680ee96ecb"},"effectiveDateTime":"2019-10-01T00:21:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"be6a5ed5-b95d-7b9f-d187-96e176db6834","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/07ab708d-5b07-f6c7-4770-69680ee96ecb"},"effectiveDateTime":"2019-10-02T01:36:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"14833a05-458a-e1f6-792b-d2ef05e8cde5","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/07ab708d-5b07-f6c7-4770-69680ee96ecb"},"effectiveDateTime":"2019-10-02T01:36:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"c47c03ad-4eea-bae4-c056-a1c2615ad25f","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/07ab708d-5b07-f6c7-4770-69680ee96ecb"},"effectiveDateTime":"2019-10-03T04:41:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"2fad87b2-9638-12d9-9fc5-02ae70d627eb","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/07ab708d-5b07-f6c7-4770-69680ee96ecb"},"effectiveDateTime":"2019-10-03T04:41:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"e485bed8-842c-be4a-5c35-7c99d05d654c","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/07ab708d-5b07-f6c7-4770-69680ee96ecb"},"effectiveDateTime":"2019-10-04T07:58:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"f6f830b9-ceea-b158-f2d4-457cd95ac8d3","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/07ab708d-5b07-f6c7-4770-69680ee96ecb"},"effectiveDateTime":"2019-10-04T07:58:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"07040f0f-cffc-3610-35fa-06ca9ae11b70","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/07ab708d-5b07-f6c7-4770-69680ee96ecb"},"effectiveDateTime":"2019-10-05T08:29:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"1d5dce18-6300-6d50-7b49-bd8df8ca3710","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/07ab708d-5b07-f6c7-4770-69680ee96ecb"},"effectiveDateTime":"2019-10-05T08:29:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"267fc93c-deea-0b50-225e-9a60c95a22cb","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/07ab708d-5b07-f6c7-4770-69680ee96ecb"},"effectiveDateTime":"2019-10-06T10:58:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"e48e9fd1-c5d3-172f-c34d-97860ecdb335","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/07ab708d-5b07-f6c7-4770-69680ee96ecb"},"effectiveDateTime":"2019-10-06T10:58:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"9e6164a3-1d0e-9392-fe90-5a9add98b917","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/07ab708d-5b07-f6c7-4770-69680ee96ecb"},"effectiveDateTime":"2019-10-07T14:03:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"df152dcf-41b7-2837-f1d7-9de6bcb3087c","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/07ab708d-5b07-f6c7-4770-69680ee96ecb"},"effectiveDateTime":"2019-10-07T14:03:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"b25164db-e259-8895-a1b0-e1109b50de98","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/07ab708d-5b07-f6c7-4770-69680ee96ecb"},"effectiveDateTime":"2019-10-08T15:44:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"34afea43-5abc-ec2d-afab-cbe922775c44","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/07ab708d-5b07-f6c7-4770-69680ee96ecb"},"effectiveDateTime":"2019-10-08T15:44:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"616a761c-a594-1696-5677-1a1847d00081","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1665060","display":"cefazolin 2000 MG Injection"}],"text":"cefazolin 2000 MG Injection"},"subject":{"reference":"Patient/f13f51ad-3c0e-9806-fac5-8a349a522083"},"context":{"reference":"Encounter/6fd7dd87-e944-3099-6d11-c4e7cfec8338"},"effectiveDateTime":"2015-06-22T16:54:17-04:00"}
{"resourceType":"MedicationAdministration","id":"d16649a7-7398-54f6-195d-8e1f476e3e10","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1659263","display":"1 ML heparin sodium, porcine 5000 UNT/ML Injection"}],"text":"1 ML heparin sodium, porcine 5000 UNT/ML Injection"},"subject":{"reference":"Patient/f13f51ad-3c0e-9806-fac5-8a349a522083"},"context":{"reference":"Encounter/6fd7dd87-e944-3099-6d11-c4e7cfec8338"},"effectiveDateTime":"2015-06-22T16:54:17-04:00"}
{"resourceType":"MedicationAdministration","id":"83036130-5187-9d95-6d1c-a92795ff716b","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1796676","display":"25 ML protamine sulfate (USP) 10 MG/ML Injection"}],"text":"25 ML protamine sulfate (USP) 10 MG/ML Injection"},"subject":{"reference":"Patient/f13f51ad-3c0e-9806-fac5-8a349a522083"},"context":{"reference":"Encounter/6fd7dd87-e944-3099-6d11-c4e7cfec8338"},"effectiveDateTime":"2015-06-22T16:54:17-04:00"}
{"resourceType":"MedicationAdministration","id":"362fe663-7a5b-e11a-46fa-261d9e1cabd1","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1740467","display":"2 ML Ondansetron 2 MG/ML Injection"}],"text":"2 ML Ondansetron 2 MG/ML Injection"},"subject":{"reference":"Patient/f13f51ad-3c0e-9806-fac5-8a349a522083"},"context":{"reference":"Encounter/6fd7dd87-e944-3099-6d11-c4e7cfec8338"},"effectiveDateTime":"2015-06-22T18:10:12-04:00"}
{"resourceType":"MedicationAdministration","id":"3931374d-638b-b27d-0370-f1712456698e","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"311700","display":"Midazolam 1 MG/ML Injectable Solution"}],"text":"Midazolam 1 MG/ML Injectable Solution"},"subject":{"reference":"Patient/f13f51ad-3c0e-9806-fac5-8a349a522083"},"context":{"reference":"Encounter/6fd7dd87-e944-3099-6d11-c4e7cfec8338"},"effectiveDateTime":"2015-06-22T18:10:12-04:00"}
{"resourceType":"MedicationAdministration","id":"890a68d5-f338-7e7d-4d3c-f8c47c28b12b","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1808217","display":"100 ML Propofol 10 MG/ML Injection"}],"text":"100 ML Propofol 10 MG/ML Injection"},"subject":{"reference":"Patient/f13f51ad-3c0e-9806-fac5-8a349a522083"},"context":{"reference":"Encounter/6fd7dd87-e944-3099-6d11-c4e7cfec8338"},"effectiveDateTime":"2015-06-22T18:10:12-04:00"}
{"resourceType":"MedicationAdministration","id":"56bbf522-e531-8a14-ad9d-0e6adc76022d","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1234995","display":"Rocuronium bromide 10 MG/ML Injectable Solution"}],"text":"Rocuronium bromide 10 MG/ML Injectable Solution"},"subject":{"reference":"Patient/f13f51ad-3c0e-9806-fac5-8a349a522083"},"context":{"reference":"Encounter/6fd7dd87-e944-3099-6d11-c4e7cfec8338"},"effectiveDateTime":"2015-06-22T18:10:12-04:00"}
{"resourceType":"MedicationAdministration","id":"8413c001-4c59-1d00-1893-3448cdee8b22","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"542347","display":"isoflurane 99.9 % Inhalation Solution"}],"text":"isoflurane 99.9 % Inhalation Solution"},"subject":{"reference":"Patient/f13f51ad-3c0e-9806-fac5-8a349a522083"},"context":{"reference":"Encounter/6fd7dd87-e944-3099-6d11-c4e7cfec8338"},"effectiveDateTime":"2015-06-22T18:10:12-04:00"}
{"resourceType":"MedicationAdministration","id":"41ee9766-05b4-6e1a-97a7-1db803858c20","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1735006","display":"10 ML Fentanyl 0.05 MG/ML Injection"}],"text":"10 ML Fentanyl 0.05 MG/ML Injection"},"subject":{"reference":"Patient/f13f51ad-3c0e-9806-fac5-8a349a522083"},"context":{"reference":"Encounter/6fd7dd87-e944-3099-6d11-c4e7cfec8338"},"effectiveDateTime":"2015-06-22T18:10:12-04:00"}
{"resourceType":"MedicationAdministration","id":"827e2e68-121d-c6e9-297f-a617d2cd76b6","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/cda60764-aaa1-07b1-45ba-6ace32b84457"},"effectiveDateTime":"2019-11-09T17:14:59-05:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"d4fd578d-69c0-579c-347e-b6ed03165a8c","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/cda60764-aaa1-07b1-45ba-6ace32b84457"},"effectiveDateTime":"2019-11-09T17:14:59-05:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"6e170a5a-ebe0-2ab8-c377-3950e3f914eb","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/cda60764-aaa1-07b1-45ba-6ace32b84457"},"effectiveDateTime":"2019-11-10T20:46:59-05:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"037da9b8-d692-5bbf-d8b5-b5765498964b","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/cda60764-aaa1-07b1-45ba-6ace32b84457"},"effectiveDateTime":"2019-11-10T20:46:59-05:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"a2920700-1f7d-23bf-2099-00e554b52f7d","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/cda60764-aaa1-07b1-45ba-6ace32b84457"},"effectiveDateTime":"2019-11-12T00:38:59-05:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"89fd5152-c5c0-5073-e97f-0fcc13165362","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/cda60764-aaa1-07b1-45ba-6ace32b84457"},"effectiveDateTime":"2019-11-12T00:38:59-05:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"2eee9a3e-9946-8ea9-9f06-153aa890fbeb","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/cda60764-aaa1-07b1-45ba-6ace32b84457"},"effectiveDateTime":"2019-11-13T01:35:59-05:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"1ac87513-fcd2-f531-c31e-78035c54de7e","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/cda60764-aaa1-07b1-45ba-6ace32b84457"},"effectiveDateTime":"2019-11-13T01:35:59-05:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"7115c663-d6be-7e2d-2e93-cecc2c8bb639","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/cda60764-aaa1-07b1-45ba-6ace32b84457"},"effectiveDateTime":"2019-11-14T06:00:59-05:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"7fa2abee-92bc-5e24-b7ae-696c9b24b3f1","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/cda60764-aaa1-07b1-45ba-6ace32b84457"},"effectiveDateTime":"2019-11-14T06:00:59-05:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"f4c25db8-ae87-e7cf-be06-2a2113a7c4e2","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/f13f51ad-3c0e-9806-fac5-8a349a522083"},"context":{"reference":"Encounter/79fdfcd7-13f3-4cc5-8588-13228c009cd9"},"effectiveDateTime":"2015-07-04T01:28:55-04:00","reasonReference":[{"reference":"Condition/a7c7a568-fe7b-1917-5bd5-32553fd3ce00","display":"Gingivitis (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"3db772db-a7a0-d615-5138-2eb3895f66de","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/0771e7f5-7f58-e7d3-f46b-52b14127f764"},"effectiveDateTime":"2019-12-14T13:07:59-05:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"901c9d85-62a6-eae8-a797-99bd34c00d58","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/0771e7f5-7f58-e7d3-f46b-52b14127f764"},"effectiveDateTime":"2019-12-14T13:07:59-05:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"8f33fefa-fe67-702b-52c9-49daa568e7db","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/0771e7f5-7f58-e7d3-f46b-52b14127f764"},"effectiveDateTime":"2019-12-15T17:16:59-05:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"9443b846-25c8-4f39-f3ca-e2dbe51e5228","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/0771e7f5-7f58-e7d3-f46b-52b14127f764"},"effectiveDateTime":"2019-12-15T17:16:59-05:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"5ca6fd3f-929c-a55c-6864-7b5cf7085a94","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/0771e7f5-7f58-e7d3-f46b-52b14127f764"},"effectiveDateTime":"2019-12-16T20:22:59-05:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"d6016692-d4f8-2e50-67b0-3bf303ee26c6","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/0771e7f5-7f58-e7d3-f46b-52b14127f764"},"effectiveDateTime":"2019-12-16T20:22:59-05:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"08e56c6b-1271-f799-5ee8-5bca99fbf04a","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/0771e7f5-7f58-e7d3-f46b-52b14127f764"},"effectiveDateTime":"2019-12-18T00:50:59-05:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"281888a5-4a2a-7192-20c9-dea83989f91c","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/0771e7f5-7f58-e7d3-f46b-52b14127f764"},"effectiveDateTime":"2019-12-18T00:50:59-05:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"1bea5edb-e411-3ee4-592b-96e7a18f5dbc","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/0771e7f5-7f58-e7d3-f46b-52b14127f764"},"effectiveDateTime":"2019-12-19T02:31:59-05:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"4c8f8648-30ac-c203-029e-d69e339c218b","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/0771e7f5-7f58-e7d3-f46b-52b14127f764"},"effectiveDateTime":"2019-12-19T02:31:59-05:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"3708b26e-17e4-c24c-aeb8-76602edee94d","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/0771e7f5-7f58-e7d3-f46b-52b14127f764"},"effectiveDateTime":"2019-12-20T05:23:59-05:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"8c81b00a-59e2-1f41-3c45-a221540920b9","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/0771e7f5-7f58-e7d3-f46b-52b14127f764"},"effectiveDateTime":"2019-12-20T05:23:59-05:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"df203488-00c8-c419-6730-ee4b56cbb379","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/0771e7f5-7f58-e7d3-f46b-52b14127f764"},"effectiveDateTime":"2019-12-21T07:20:59-05:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"3db79404-1f5f-100d-1138-4fdc01633e7e","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/0771e7f5-7f58-e7d3-f46b-52b14127f764"},"effectiveDateTime":"2019-12-21T07:20:59-05:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"8cfb935a-9504-8f7e-af8a-73537d69af5b","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/f13f51ad-3c0e-9806-fac5-8a349a522083"},"context":{"reference":"Encounter/fc5e7a94-ecb3-c11c-924f-ceb13a8c0eaf"},"effectiveDateTime":"2016-01-16T00:38:19-05:00","reasonCode":[{"coding":[{"system":"http://snomed.info/sct","code":"103697008","display":"Patient referral for dental care (procedure)"}],"text":"Patient referral for dental care (procedure)"}]}
{"resourceType":"MedicationAdministration","id":"93e9173d-ab13-e242-9429-b34389d2fcc7","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/48ce9cfc-e622-02e3-a258-dd66aa26be5b"},"effectiveDateTime":"2020-01-22T13:59:59-05:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"6a7cb26f-84ff-c245-e22c-7910c50fe946","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/48ce9cfc-e622-02e3-a258-dd66aa26be5b"},"effectiveDateTime":"2020-01-22T13:59:59-05:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"c8d1174f-84f0-bd7e-12e9-b35563afd85a","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/48ce9cfc-e622-02e3-a258-dd66aa26be5b"},"effectiveDateTime":"2020-01-23T15:07:59-05:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"47075ca5-87a6-80e7-0622-37efa04286c6","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/48ce9cfc-e622-02e3-a258-dd66aa26be5b"},"effectiveDateTime":"2020-01-23T15:07:59-05:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"2d8bdf22-9dbd-fc55-0716-a9e7fdecf24e","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/48ce9cfc-e622-02e3-a258-dd66aa26be5b"},"effectiveDateTime":"2020-01-24T16:11:59-05:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"9e0f1aa5-2d24-3052-fe3e-109e06aefb17","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/48ce9cfc-e622-02e3-a258-dd66aa26be5b"},"effectiveDateTime":"2020-01-24T16:11:59-05:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"27c6a3e4-0696-435a-c3cc-82a32223477e","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/48ce9cfc-e622-02e3-a258-dd66aa26be5b"},"effectiveDateTime":"2020-01-25T18:53:59-05:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"61151fa7-7038-a4a3-0199-b3282c108815","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/48ce9cfc-e622-02e3-a258-dd66aa26be5b"},"effectiveDateTime":"2020-01-25T18:53:59-05:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"cbd8dd84-fd58-e8c6-bd97-a88a471946b2","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/48ce9cfc-e622-02e3-a258-dd66aa26be5b"},"effectiveDateTime":"2020-01-26T22:45:59-05:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"5a1e4fd8-37c0-464b-b9ac-46306216493a","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/48ce9cfc-e622-02e3-a258-dd66aa26be5b"},"effectiveDateTime":"2020-01-26T22:45:59-05:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"6c8efe48-32fc-c312-8e5c-a59e35ec22a0","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/48ce9cfc-e622-02e3-a258-dd66aa26be5b"},"effectiveDateTime":"2020-01-28T00:04:59-05:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"2d7bc5e8-8f5c-fce2-abb4-4d1f2c95089f","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/48ce9cfc-e622-02e3-a258-dd66aa26be5b"},"effectiveDateTime":"2020-01-28T00:04:59-05:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"016a2dbe-1d98-c3e3-3a76-d1b9c3652e2f","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/f13f51ad-3c0e-9806-fac5-8a349a522083"},"context":{"reference":"Encounter/cd1b2cfe-ec63-c056-ecec-ab6fb15df36d"},"effectiveDateTime":"2016-06-11T02:02:06-04:00","reasonReference":[{"reference":"Condition/a7c7a568-fe7b-1917-5bd5-32553fd3ce00","display":"Gingivitis (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"a33071ee-215e-6ae8-baab-6e60afa15d58","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/48ce9cfc-e622-02e3-a258-dd66aa26be5b"},"effectiveDateTime":"2020-01-29T04:01:59-05:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"5fdae633-f551-19ec-97e6-a3b22e983b65","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/48ce9cfc-e622-02e3-a258-dd66aa26be5b"},"effectiveDateTime":"2020-01-29T04:01:59-05:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"82724d89-5246-0ac6-2973-c539198467c9","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/48ce9cfc-e622-02e3-a258-dd66aa26be5b"},"effectiveDateTime":"2020-01-30T05:02:59-05:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"c6efab08-f1fd-1611-f5e5-a3f0bd9d6b71","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/48ce9cfc-e622-02e3-a258-dd66aa26be5b"},"effectiveDateTime":"2020-01-30T05:02:59-05:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"73f5567e-475d-72bb-f22f-f5dcc0957e78","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/48ce9cfc-e622-02e3-a258-dd66aa26be5b"},"effectiveDateTime":"2020-01-31T06:09:59-05:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"827e03a0-f28e-6e79-a97f-7b50b9e25a48","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/48ce9cfc-e622-02e3-a258-dd66aa26be5b"},"effectiveDateTime":"2020-01-31T06:09:59-05:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"efb0e94d-8510-69d8-5fc8-6449fbab0d4b","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/48ce9cfc-e622-02e3-a258-dd66aa26be5b"},"effectiveDateTime":"2020-02-01T07:29:59-05:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"75ba0d86-4479-ac70-5024-9b5004d79862","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/48ce9cfc-e622-02e3-a258-dd66aa26be5b"},"effectiveDateTime":"2020-02-01T07:29:59-05:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"bc1b9dac-f38c-5c36-b0d3-712daf644148","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/297eb1ab-7bef-cbd0-3ba1-58a0b288e89b"},"effectiveDateTime":"2020-03-06T05:00:59-05:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"3db9302e-cc1b-a123-1139-ec06b12d95db","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/297eb1ab-7bef-cbd0-3ba1-58a0b288e89b"},"effectiveDateTime":"2020-03-06T05:00:59-05:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"2e96e9c6-4685-778e-bd96-1ad006e36380","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/297eb1ab-7bef-cbd0-3ba1-58a0b288e89b"},"effectiveDateTime":"2020-03-07T09:03:59-05:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"9f87d728-38b4-ecb2-ffb6-cd2180348537","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/297eb1ab-7bef-cbd0-3ba1-58a0b288e89b"},"effectiveDateTime":"2020-03-07T09:03:59-05:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"15499e8d-8dae-7f4c-3e13-10610e6a5731","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/297eb1ab-7bef-cbd0-3ba1-58a0b288e89b"},"effectiveDateTime":"2020-03-08T11:12:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"421b64b6-4342-c0a6-0279-50a8d7a77990","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/297eb1ab-7bef-cbd0-3ba1-58a0b288e89b"},"effectiveDateTime":"2020-03-08T11:12:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"a644f329-8c49-e61f-1566-3d99a3c4e2c6","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/297eb1ab-7bef-cbd0-3ba1-58a0b288e89b"},"effectiveDateTime":"2020-03-09T12:06:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"e4e19676-3b96-a24f-a40b-323e8e32a82e","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/297eb1ab-7bef-cbd0-3ba1-58a0b288e89b"},"effectiveDateTime":"2020-03-09T12:06:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"adff897c-e7c1-cc49-9575-7ab4f37f4a9d","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/297eb1ab-7bef-cbd0-3ba1-58a0b288e89b"},"effectiveDateTime":"2020-03-10T13:43:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"21684bdf-9693-d611-505e-452f346b9b71","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/297eb1ab-7bef-cbd0-3ba1-58a0b288e89b"},"effectiveDateTime":"2020-03-10T13:43:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"4f9eb26a-6ebd-c241-c74e-7cfde1a4e942","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/297eb1ab-7bef-cbd0-3ba1-58a0b288e89b"},"effectiveDateTime":"2020-03-11T15:57:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"4c1b77f8-7f4b-7cdb-a0b7-0f31b7573a59","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/297eb1ab-7bef-cbd0-3ba1-58a0b288e89b"},"effectiveDateTime":"2020-03-11T15:57:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"7f58b13f-5624-e4cd-0014-8925ec0fd961","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/a6c4a54b-40e2-eb85-0db4-a83b96683a5e"},"effectiveDateTime":"2020-04-12T22:01:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"3db4d7eb-8353-3ae8-552f-d4be40b1cd58","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/a6c4a54b-40e2-eb85-0db4-a83b96683a5e"},"effectiveDateTime":"2020-04-12T22:01:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"e56131dd-cbff-888a-d4c0-cc609cbdde8d","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/a6c4a54b-40e2-eb85-0db4-a83b96683a5e"},"effectiveDateTime":"2020-04-13T23:09:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"ec821e4d-77d5-808d-dbe1-b8d04893d690","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/a6c4a54b-40e2-eb85-0db4-a83b96683a5e"},"effectiveDateTime":"2020-04-13T23:09:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"e149017c-a8ce-5090-9bfc-16b4b48bcefb","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/a6c4a54b-40e2-eb85-0db4-a83b96683a5e"},"effectiveDateTime":"2020-04-15T00:42:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"a942d7c1-0502-ed50-072e-cb16da9b9711","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/a6c4a54b-40e2-eb85-0db4-a83b96683a5e"},"effectiveDateTime":"2020-04-15T00:42:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"ce163901-29e8-c40a-9376-67f723e2e63a","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/0575dc2b-b03c-3380-95e8-f0c358ecca32"},"effectiveDateTime":"2020-05-15T19:03:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"1f8fe3c1-2e36-435a-1ca0-fba39e4dbe57","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/0575dc2b-b03c-3380-95e8-f0c358ecca32"},"effectiveDateTime":"2020-05-15T19:03:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"0707b066-9905-435d-4261-5514016a633a","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/f13f51ad-3c0e-9806-fac5-8a349a522083"},"context":{"reference":"Encounter/f504561d-fa5d-1ac9-d50d-6a8e36d7e52e"},"effectiveDateTime":"2016-11-19T03:09:35-05:00","reasonReference":[{"reference":"Condition/a7c7a568-fe7b-1917-5bd5-32553fd3ce00","display":"Gingivitis (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"32bb95c3-667e-3d5c-3e79-14429ff72694","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/0575dc2b-b03c-3380-95e8-f0c358ecca32"},"effectiveDateTime":"2020-05-16T20:49:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"283889e1-2e10-97b7-26ab-7bb39e2812b4","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/0575dc2b-b03c-3380-95e8-f0c358ecca32"},"effectiveDateTime":"2020-05-16T20:49:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"6d7e7185-4f97-8885-5cde-1180c4c9de88","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/0575dc2b-b03c-3380-95e8-f0c358ecca32"},"effectiveDateTime":"2020-05-17T23:05:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"40696552-be59-aebe-3468-d3f9081a0caa","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/0575dc2b-b03c-3380-95e8-f0c358ecca32"},"effectiveDateTime":"2020-05-17T23:05:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"97f90248-17d1-ae52-f5e4-f64d5ac73812","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/0575dc2b-b03c-3380-95e8-f0c358ecca32"},"effectiveDateTime":"2020-05-19T02:15:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"37e31c55-2a7a-9877-2ddd-1ef6a53ff8a6","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/0575dc2b-b03c-3380-95e8-f0c358ecca32"},"effectiveDateTime":"2020-05-19T02:15:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"e6f280bb-fa32-b08a-1596-d6bee99250e2","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/0575dc2b-b03c-3380-95e8-f0c358ecca32"},"effectiveDateTime":"2020-05-20T04:31:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"351e1287-c241-82a6-3afc-d1c8709ecb42","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/0575dc2b-b03c-3380-95e8-f0c358ecca32"},"effectiveDateTime":"2020-05-20T04:31:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"b468a328-e8e5-a81a-a365-25990060a54b","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/2bb946af-0eff-e3f5-17a1-b20284e96395"},"effectiveDateTime":"2020-06-25T01:55:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"ab188e54-1170-648d-670a-98146f5c5951","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/2bb946af-0eff-e3f5-17a1-b20284e96395"},"effectiveDateTime":"2020-06-25T01:55:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"594688b0-1777-64e7-afb7-deb306d70b34","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/2bb946af-0eff-e3f5-17a1-b20284e96395"},"effectiveDateTime":"2020-06-26T05:34:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"63cc6b06-44b4-543a-2d77-39300512402f","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/2bb946af-0eff-e3f5-17a1-b20284e96395"},"effectiveDateTime":"2020-06-26T05:34:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"faba8860-1796-8301-47ab-7f1ab39c61c1","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/2bb946af-0eff-e3f5-17a1-b20284e96395"},"effectiveDateTime":"2020-06-27T06:42:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"ef38fcad-f0c2-e948-5f50-77ab2486c433","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/2bb946af-0eff-e3f5-17a1-b20284e96395"},"effectiveDateTime":"2020-06-27T06:42:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"98bd3e5b-4a02-87ac-f75b-655cc1b25afd","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/2bb946af-0eff-e3f5-17a1-b20284e96395"},"effectiveDateTime":"2020-06-28T07:19:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"d7c45b0c-275d-63c4-565e-e60118956f82","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/2bb946af-0eff-e3f5-17a1-b20284e96395"},"effectiveDateTime":"2020-06-28T07:19:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"83a9f5c2-08da-5c67-2a77-36c85edd4bc7","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/2bb946af-0eff-e3f5-17a1-b20284e96395"},"effectiveDateTime":"2020-06-29T08:05:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"98fa0c70-be14-4f94-9366-e08123747e8a","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/2bb946af-0eff-e3f5-17a1-b20284e96395"},"effectiveDateTime":"2020-06-29T08:05:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"07fa58a5-659d-d6a6-0dd9-17fe71201b42","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/eb53f960-1234-021c-f1db-88e07b1a7795"},"effectiveDateTime":"2020-08-03T21:13:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"07cd615c-9691-a340-1ed1-ea94a24f21f2","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/eb53f960-1234-021c-f1db-88e07b1a7795"},"effectiveDateTime":"2020-08-03T21:13:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"440d7132-2f7d-1316-c2c0-41d640b51ed3","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/eb53f960-1234-021c-f1db-88e07b1a7795"},"effectiveDateTime":"2020-08-05T00:15:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"15f91745-e9b8-606b-6801-b34bc877b9d3","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/eb53f960-1234-021c-f1db-88e07b1a7795"},"effectiveDateTime":"2020-08-05T00:15:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"d7dbe093-f575-486d-c3d1-7c6410ff08cb","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/eb53f960-1234-021c-f1db-88e07b1a7795"},"effectiveDateTime":"2020-08-06T00:55:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"3abb9e40-3167-affd-193c-7a9634570faa","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/eb53f960-1234-021c-f1db-88e07b1a7795"},"effectiveDateTime":"2020-08-06T00:55:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"571210c6-4619-988a-f823-ff900677847f","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/eb53f960-1234-021c-f1db-88e07b1a7795"},"effectiveDateTime":"2020-08-07T01:25:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"6e5e30f9-58c7-cd49-2985-3271089e5191","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/eb53f960-1234-021c-f1db-88e07b1a7795"},"effectiveDateTime":"2020-08-07T01:25:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"7fa6b71e-4aa2-bd84-b7b2-749cff86287d","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/eb53f960-1234-021c-f1db-88e07b1a7795"},"effectiveDateTime":"2020-08-08T05:33:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"a7e962d4-fe6b-ac96-7e85-d034256d2446","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/eb53f960-1234-021c-f1db-88e07b1a7795"},"effectiveDateTime":"2020-08-08T05:33:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"61ea8541-84d2-eba5-26f7-293d2e90ba7a","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/f13f51ad-3c0e-9806-fac5-8a349a522083"},"context":{"reference":"Encounter/f2b3aca8-5988-c794-6208-f878ad85dc67"},"effectiveDateTime":"2017-07-08T02:15:25-04:00","reasonReference":[{"reference":"Condition/a7c7a568-fe7b-1917-5bd5-32553fd3ce00","display":"Gingivitis (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"7d802eea-00d7-fe18-2ae3-702656daed78","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/eb53f960-1234-021c-f1db-88e07b1a7795"},"effectiveDateTime":"2020-08-09T06:15:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"b3aa1b62-5a57-0da4-c76f-7b915051e3d8","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/eb53f960-1234-021c-f1db-88e07b1a7795"},"effectiveDateTime":"2020-08-09T06:15:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"0656ed93-03ef-2298-76e2-8074b60fcc40","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/00cf5952-6839-f0f4-3dfd-31c6cd082a6e"},"context":{"reference":"Encounter/b94e7d9e-43fe-f1b6-ca3f-51399df55ba7"},"effectiveDateTime":"1993-11-30T10:11:12-05:00","reasonCode":[{"coding":[{"system":"http://snomed.info/sct","code":"103697008","display":"Patient referral for dental care (procedure)"}],"text":"Patient referral for dental care (procedure)"}]}
{"resourceType":"MedicationAdministration","id":"d253408f-0268-885b-abab-7155a96a000b","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/ab1ab8c1-1309-ba79-57f8-c942d1862abb"},"effectiveDateTime":"2020-09-11T04:50:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"01bf8e54-5ba2-fe28-0df1-3814b98ef47e","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/ab1ab8c1-1309-ba79-57f8-c942d1862abb"},"effectiveDateTime":"2020-09-11T04:50:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"bd53ec92-d05c-ec26-3851-8366c6c75c3e","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/ab1ab8c1-1309-ba79-57f8-c942d1862abb"},"effectiveDateTime":"2020-09-12T05:22:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"cc5af820-4a1e-5e22-89d9-c38a4553962e","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/ab1ab8c1-1309-ba79-57f8-c942d1862abb"},"effectiveDateTime":"2020-09-12T05:22:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"0cd44cf8-903d-b09e-0e4b-fcd2143bd845","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/ab1ab8c1-1309-ba79-57f8-c942d1862abb"},"effectiveDateTime":"2020-09-13T07:52:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"9ead93a2-00d9-62e3-51b5-8ff156dc5243","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/ab1ab8c1-1309-ba79-57f8-c942d1862abb"},"effectiveDateTime":"2020-09-13T07:52:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"1d3d1762-f9af-a04f-855d-b368d86f06b8","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/ab1ab8c1-1309-ba79-57f8-c942d1862abb"},"effectiveDateTime":"2020-09-14T09:55:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"c17aaf8d-8c9d-97b7-8ea7-b3a10d596fa4","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/ab1ab8c1-1309-ba79-57f8-c942d1862abb"},"effectiveDateTime":"2020-09-14T09:55:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"96601b22-1727-e1e9-4699-80c9189f91c3","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/ab1ab8c1-1309-ba79-57f8-c942d1862abb"},"effectiveDateTime":"2020-09-15T11:24:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"d0251046-00d0-4cff-8385-831156d33c5f","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/ab1ab8c1-1309-ba79-57f8-c942d1862abb"},"effectiveDateTime":"2020-09-15T11:24:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"1d5d21fb-7be5-f821-071d-7fe772582233","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/ab1ab8c1-1309-ba79-57f8-c942d1862abb"},"effectiveDateTime":"2020-09-16T15:52:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"843a5ed4-3da6-f887-c677-96dffb25c6cc","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/ab1ab8c1-1309-ba79-57f8-c942d1862abb"},"effectiveDateTime":"2020-09-16T15:52:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"ca25c385-8ade-5e19-87a4-928bdcef9625","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/ab1ab8c1-1309-ba79-57f8-c942d1862abb"},"effectiveDateTime":"2020-09-17T19:59:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"4f591746-d3a6-60d7-7861-b34cb265c85a","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/ab1ab8c1-1309-ba79-57f8-c942d1862abb"},"effectiveDateTime":"2020-09-17T19:59:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"cd2a9bc8-7320-34ad-e96f-fbf7691b7368","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/ab1ab8c1-1309-ba79-57f8-c942d1862abb"},"effectiveDateTime":"2020-09-18T20:31:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"85c05f67-464d-dda1-4198-4c6232bef122","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/ab1ab8c1-1309-ba79-57f8-c942d1862abb"},"effectiveDateTime":"2020-09-18T20:31:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"b596eb68-977c-61e4-3e32-f14756e4912c","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/ab1ab8c1-1309-ba79-57f8-c942d1862abb"},"effectiveDateTime":"2020-09-19T22:07:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"ab4dd448-1ddd-7383-c2f1-989e20ccd337","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/ab1ab8c1-1309-ba79-57f8-c942d1862abb"},"effectiveDateTime":"2020-09-19T22:07:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"255d017e-127a-1871-1b58-45ab87df78a0","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/ab1ab8c1-1309-ba79-57f8-c942d1862abb"},"effectiveDateTime":"2020-09-20T23:17:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"a72ec8c2-9c86-7e64-64ad-99cdf9dfb670","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/ab1ab8c1-1309-ba79-57f8-c942d1862abb"},"effectiveDateTime":"2020-09-20T23:17:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"8277209b-a1f3-621b-a978-984b7c2ca2d9","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/ab1ab8c1-1309-ba79-57f8-c942d1862abb"},"effectiveDateTime":"2020-09-22T03:03:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"9f4d2c39-2ac9-20f2-ff7c-223471f138b7","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/ab1ab8c1-1309-ba79-57f8-c942d1862abb"},"effectiveDateTime":"2020-09-22T03:03:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"5a1280bc-d7aa-1e52-8ba3-d6bfc709d2f0","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/ab1ab8c1-1309-ba79-57f8-c942d1862abb"},"effectiveDateTime":"2020-09-23T04:30:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"b869f590-2687-cb28-cfe4-f33518145598","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/ab1ab8c1-1309-ba79-57f8-c942d1862abb"},"effectiveDateTime":"2020-09-23T04:30:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"b646b386-3c43-cae8-cdc1-b12c9e8add58","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/ab1ab8c1-1309-ba79-57f8-c942d1862abb"},"effectiveDateTime":"2020-09-24T07:21:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"9e289582-43fc-8bd2-fe57-8b7d90c119f7","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/ab1ab8c1-1309-ba79-57f8-c942d1862abb"},"effectiveDateTime":"2020-09-24T07:21:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"bcc86276-dd83-959a-a41e-65663d388fdd","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/ab1ab8c1-1309-ba79-57f8-c942d1862abb"},"effectiveDateTime":"2020-09-25T10:08:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"1d7080ab-9f15-df18-6057-d6ae8e759412","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/ab1ab8c1-1309-ba79-57f8-c942d1862abb"},"effectiveDateTime":"2020-09-25T10:08:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"7778eb29-e14e-bd40-8b7d-1db9d005334b","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/f13f51ad-3c0e-9806-fac5-8a349a522083"},"context":{"reference":"Encounter/885e315a-fa06-1c4a-8d3b-a398b3a23b0f"},"effectiveDateTime":"2018-07-28T05:35:52-04:00","reasonReference":[{"reference":"Condition/a7c7a568-fe7b-1917-5bd5-32553fd3ce00","display":"Gingivitis (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"eccfdf70-ee9f-432b-be51-cedb5eb6be29","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/984dfb66-72a4-8be8-02e8-2f82a841dcc8"},"effectiveDateTime":"2020-10-27T19:14:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"42b4c9ea-5c7d-6b26-0312-b5e1a28528d0","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/984dfb66-72a4-8be8-02e8-2f82a841dcc8"},"effectiveDateTime":"2020-10-27T19:14:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"08e73165-64d9-c229-5eea-20c51f379391","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/984dfb66-72a4-8be8-02e8-2f82a841dcc8"},"effectiveDateTime":"2020-10-28T21:47:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"e1426096-5623-963c-9ce5-31325c0255b1","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/984dfb66-72a4-8be8-02e8-2f82a841dcc8"},"effectiveDateTime":"2020-10-28T21:47:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"a985ab93-edd7-20cc-18e7-46749586b32d","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/1e12b0d4-3020-33c4-7e5e-1bec02535996"},"context":{"reference":"Encounter/343508da-6a53-ca66-1c0d-60e635531346"},"effectiveDateTime":"2019-12-17T11:05:01-05:00","reasonCode":[{"coding":[{"system":"http://snomed.info/sct","code":"103697008","display":"Patient referral for dental care (procedure)"}],"text":"Patient referral for dental care (procedure)"}]}
{"resourceType":"MedicationAdministration","id":"5abb81d8-d3d6-9ac0-8393-a36d534c6dee","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/f13f51ad-3c0e-9806-fac5-8a349a522083"},"context":{"reference":"Encounter/88408a05-1aa1-1477-0905-e383e8718488"},"effectiveDateTime":"2018-11-03T01:46:16-04:00","reasonReference":[{"reference":"Condition/a7c7a568-fe7b-1917-5bd5-32553fd3ce00","display":"Gingivitis (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"2e154d72-304b-d9a8-195f-0dd01c432ae6","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/984dfb66-72a4-8be8-02e8-2f82a841dcc8"},"effectiveDateTime":"2020-10-29T23:29:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"6a799fab-f577-94b1-e650-332cb14f8353","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/984dfb66-72a4-8be8-02e8-2f82a841dcc8"},"effectiveDateTime":"2020-10-29T23:29:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"8cae1b3e-5375-482e-78a6-1003a5ff088c","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/b092479a-7d6e-1cef-3ac6-fa202f28e981"},"effectiveDateTime":"2020-11-30T16:35:59-05:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"f702eae8-5f59-df20-f59b-953997659c9f","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/b092479a-7d6e-1cef-3ac6-fa202f28e981"},"effectiveDateTime":"2020-11-30T16:35:59-05:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"019a0475-026c-0486-e185-555c296d7c35","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/b092479a-7d6e-1cef-3ac6-fa202f28e981"},"effectiveDateTime":"2020-12-01T20:49:59-05:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"b300d2e9-aa7c-e181-680f-4559c1f7df80","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/b092479a-7d6e-1cef-3ac6-fa202f28e981"},"effectiveDateTime":"2020-12-01T20:49:59-05:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"ec89b3a0-ffb0-2f4d-dc8a-1a531330eb25","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/b092479a-7d6e-1cef-3ac6-fa202f28e981"},"effectiveDateTime":"2020-12-02T21:51:59-05:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"26778612-6aaa-a70d-4024-0b7299a0a30d","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/b092479a-7d6e-1cef-3ac6-fa202f28e981"},"effectiveDateTime":"2020-12-02T21:51:59-05:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"ebce597c-b590-c20d-a117-1ab4c14e410e","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/b092479a-7d6e-1cef-3ac6-fa202f28e981"},"effectiveDateTime":"2020-12-03T23:19:59-05:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"7e7196d6-fea1-5796-a573-0e86deb800ae","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/b092479a-7d6e-1cef-3ac6-fa202f28e981"},"effectiveDateTime":"2020-12-03T23:19:59-05:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"416dd463-cdcd-f5e5-01cb-c05bd919462f","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/b092479a-7d6e-1cef-3ac6-fa202f28e981"},"effectiveDateTime":"2020-12-05T01:33:59-05:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"bfbba87f-3c55-48dd-533c-64572c6bdf7e","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/b092479a-7d6e-1cef-3ac6-fa202f28e981"},"effectiveDateTime":"2020-12-05T01:33:59-05:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"d7b314ac-e768-df9f-938b-05fd25727320","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/71b573b7-d4ff-0afc-4244-f70b50308c33"},"effectiveDateTime":"2021-01-04T12:25:59-05:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"bdbb55ee-6c27-ae65-513c-11c65d77ec6f","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/71b573b7-d4ff-0afc-4244-f70b50308c33"},"effectiveDateTime":"2021-01-04T12:25:59-05:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"d6c27ead-7127-1083-4f37-b6b92ea62640","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/71b573b7-d4ff-0afc-4244-f70b50308c33"},"effectiveDateTime":"2021-01-05T15:18:59-05:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"08e13cbe-43c4-8e1d-5ee4-2c1e0933ac3a","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/71b573b7-d4ff-0afc-4244-f70b50308c33"},"effectiveDateTime":"2021-01-05T15:18:59-05:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"af614fab-e796-7db6-6eec-8ca9f2328395","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/71b573b7-d4ff-0afc-4244-f70b50308c33"},"effectiveDateTime":"2021-01-06T18:54:59-05:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"00e82b67-70e9-d749-56eb-1ac73688564e","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/71b573b7-d4ff-0afc-4244-f70b50308c33"},"effectiveDateTime":"2021-01-06T18:54:59-05:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"60564f5e-d920-6c13-1840-0fbcc519d804","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/935ac8e9-0daa-5fac-87cf-10b63f8487ee"},"effectiveDateTime":"2021-02-11T13:00:59-05:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"bdbc922f-f7c9-220f-913d-4e07eaa1037f","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/935ac8e9-0daa-5fac-87cf-10b63f8487ee"},"effectiveDateTime":"2021-02-11T13:00:59-05:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"8da6e0b5-9ce3-072b-ca42-e6945c7a220d","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/935ac8e9-0daa-5fac-87cf-10b63f8487ee"},"effectiveDateTime":"2021-02-12T15:45:59-05:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"17e718ab-a02f-f15e-b3ec-f76b374ad39a","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/935ac8e9-0daa-5fac-87cf-10b63f8487ee"},"effectiveDateTime":"2021-02-12T15:45:59-05:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"56c86dad-bee5-04af-401e-709d1eb0c2e8","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/935ac8e9-0daa-5fac-87cf-10b63f8487ee"},"effectiveDateTime":"2021-02-13T20:10:59-05:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"d634dad4-7c40-c1d5-0020-c05b6a6ebb8e","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/1e12b0d4-3020-33c4-7e5e-1bec02535996"},"context":{"reference":"Encounter/282e0f29-8917-d69f-326e-31ec6cd6c0e7"},"effectiveDateTime":"2024-01-09T10:44:41-05:00","reasonCode":[{"coding":[{"system":"http://snomed.info/sct","code":"103697008","display":"Patient referral for dental care (procedure)"}],"text":"Patient referral for dental care (procedure)"}]}
{"resourceType":"MedicationAdministration","id":"d97cf516-b77c-ec5f-547b-53087ec75c77","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/935ac8e9-0daa-5fac-87cf-10b63f8487ee"},"effectiveDateTime":"2021-02-13T20:10:59-05:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"1f5f65be-7db5-beb8-125a-602a91367a90","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/935ac8e9-0daa-5fac-87cf-10b63f8487ee"},"effectiveDateTime":"2021-02-14T22:47:59-05:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"a17080ab-91ea-70d1-8b20-d6ae814a3cbd","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/935ac8e9-0daa-5fac-87cf-10b63f8487ee"},"effectiveDateTime":"2021-02-14T22:47:59-05:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"063b73da-f65e-6682-9f62-faa37925e6d5","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"212033","display":"aspirin 325 MG Oral Tablet"}],"text":"aspirin 325 MG Oral Tablet"},"subject":{"reference":"Patient/00cf5952-6839-f0f4-3dfd-31c6cd082a6e"},"context":{"reference":"Encounter/aaf5fe1a-6ea9-a5a3-b196-33af9c255466"},"effectiveDateTime":"2002-11-11T07:38:43-05:00","dosage":{"dose":{"value":4.0}}}
{"resourceType":"MedicationAdministration","id":"0e77c42c-52b6-31d8-06e4-4c58cabdabd5","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1361048","display":"heparin sodium, porcine 100 UNT/ML Injectable Solution"}],"text":"heparin sodium, porcine 100 UNT/ML Injectable Solution"},"subject":{"reference":"Patient/00cf5952-6839-f0f4-3dfd-31c6cd082a6e"},"context":{"reference":"Encounter/35eba86e-1f0e-7e74-6f3e-b08c3e862011"},"effectiveDateTime":"2002-11-11T08:57:25-05:00"}
{"resourceType":"MedicationAdministration","id":"57a2048c-2fa5-c584-ea12-dd9c8896218f","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1116635","display":"ticagrelor 90 MG Oral Tablet"}],"text":"ticagrelor 90 MG Oral Tablet"},"subject":{"reference":"Patient/00cf5952-6839-f0f4-3dfd-31c6cd082a6e"},"context":{"reference":"Encounter/35eba86e-1f0e-7e74-6f3e-b08c3e862011"},"effectiveDateTime":"2002-11-12T07:24:42-05:00"}
{"resourceType":"MedicationAdministration","id":"7301e17c-9b3f-0794-d6ff-9eb4a6fc86da","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/51b0c8c2-0da6-cdb6-d4e7-068859619f44"},"effectiveDateTime":"2021-03-22T06:16:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"544d18e8-3dc3-c244-cbfd-01b4bd7b6945","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/51b0c8c2-0da6-cdb6-d4e7-068859619f44"},"effectiveDateTime":"2021-03-22T06:16:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"4b3073fc-8936-4b08-372a-ac9ab7200b66","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/51b0c8c2-0da6-cdb6-d4e7-068859619f44"},"effectiveDateTime":"2021-03-23T07:52:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"22c00e24-d27b-3aa6-289e-cdc85c5e1942","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/51b0c8c2-0da6-cdb6-d4e7-068859619f44"},"effectiveDateTime":"2021-03-23T07:52:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"b67bf325-337f-53cd-06bd-0c6d2ae20478","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/f13f51ad-3c0e-9806-fac5-8a349a522083"},"context":{"reference":"Encounter/e206b321-06fa-1c17-8f57-445693dae9a1"},"effectiveDateTime":"2019-08-03T01:10:56-04:00","reasonReference":[{"reference":"Condition/a7c7a568-fe7b-1917-5bd5-32553fd3ce00","display":"Gingivitis (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"827c14c0-523e-a3a5-a97d-8c703b37ed6d","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/51b0c8c2-0da6-cdb6-d4e7-068859619f44"},"effectiveDateTime":"2021-03-24T10:27:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"5f76a35e-c29e-1d54-9782-60de0a686b95","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/51b0c8c2-0da6-cdb6-d4e7-068859619f44"},"effectiveDateTime":"2021-03-24T10:27:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"98a1bb8a-25d8-13f5-1900-906ea94590e6","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/c1c38fed-6d8a-1937-3897-9bf237344c7c"},"context":{"reference":"Encounter/830a947f-c50c-fb17-936e-2330c196b2d6"},"effectiveDateTime":"2016-07-14T02:38:23-04:00","reasonReference":[{"reference":"Condition/c724361c-33de-d59b-b868-8bb397c0d360","display":"Gingivitis (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"87d8f014-27b1-d926-36d8-dc3ac3b7b7e6","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/087c8524-d6f9-097c-066e-a1d9ade0b859"},"effectiveDateTime":"2021-04-27T22:28:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"bc952de5-62ec-1caf-6d2f-9dfcddead8af","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/087c8524-d6f9-097c-066e-a1d9ade0b859"},"effectiveDateTime":"2021-04-27T22:28:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"08fc4bcf-92a3-b853-5eff-3b2f6a53bf16","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/087c8524-d6f9-097c-066e-a1d9ade0b859"},"effectiveDateTime":"2021-04-29T02:28:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"886dbb46-46bb-cdc4-7e6e-93b00719b9bf","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/087c8524-d6f9-097c-066e-a1d9ade0b859"},"effectiveDateTime":"2021-04-29T02:28:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"eea1eadb-98e2-2d95-9e8d-d85424892f0d","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/087c8524-d6f9-097c-066e-a1d9ade0b859"},"effectiveDateTime":"2021-04-30T03:28:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"e4a8a7de-ffb0-abab-da9f-6424d3316783","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/087c8524-d6f9-097c-066e-a1d9ade0b859"},"effectiveDateTime":"2021-04-30T03:28:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"81ca9a14-c2a7-1923-418f-fa43b8a49986","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/087c8524-d6f9-097c-066e-a1d9ade0b859"},"effectiveDateTime":"2021-05-01T04:39:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"a87946e9-475d-70df-27d9-5f9938957c9d","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/087c8524-d6f9-097c-066e-a1d9ade0b859"},"effectiveDateTime":"2021-05-01T04:39:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"54f29346-5ab9-c3be-6ae1-ecafdebcba67","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"389221","display":"Etonogestrel 68 MG Drug Implant"}],"text":"Etonogestrel 68 MG Drug Implant"},"subject":{"reference":"Patient/c1c38fed-6d8a-1937-3897-9bf237344c7c"},"context":{"reference":"Encounter/909dc558-9ae5-d239-73be-191b4f6c3b6d"},"effectiveDateTime":"2017-08-04T18:49:24-04:00"}
{"resourceType":"MedicationAdministration","id":"a9954c83-e76f-b5db-a01f-0ce1d36abc7e","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/087c8524-d6f9-097c-066e-a1d9ade0b859"},"effectiveDateTime":"2021-05-02T07:59:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"1e69eae4-fc29-d792-7e98-e0e27f7b52d7","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/087c8524-d6f9-097c-066e-a1d9ade0b859"},"effectiveDateTime":"2021-05-02T07:59:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"9281b95e-08d1-97e8-6ae3-a61f5ed48748","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/087c8524-d6f9-097c-066e-a1d9ade0b859"},"effectiveDateTime":"2021-05-03T10:06:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"e77b1823-902b-be42-5f2b-0454868c6544","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/087c8524-d6f9-097c-066e-a1d9ade0b859"},"effectiveDateTime":"2021-05-03T10:06:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"a09a539e-8a01-0cf0-16e0-6a1af922a170","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/f13f51ad-3c0e-9806-fac5-8a349a522083"},"context":{"reference":"Encounter/ac1e451b-aeb3-ab37-dab5-3a268fe90dcc"},"effectiveDateTime":"2019-10-26T01:53:50-04:00","reasonCode":[{"coding":[{"system":"http://snomed.info/sct","code":"103697008","display":"Patient referral for dental care (procedure)"}],"text":"Patient referral for dental care (procedure)"}]}
{"resourceType":"MedicationAdministration","id":"b101b077-ffb2-744d-a85a-781e13333025","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/d59287c5-978f-a0fc-140e-5b3ff3de8a82"},"effectiveDateTime":"2021-06-03T12:27:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"3ff44879-303b-955c-4bb1-c7eebcb5f694","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/d59287c5-978f-a0fc-140e-5b3ff3de8a82"},"effectiveDateTime":"2021-06-03T12:27:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"21caa15c-9dd2-583d-64ea-d294a98fd7b3","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/d59287c5-978f-a0fc-140e-5b3ff3de8a82"},"effectiveDateTime":"2021-06-04T15:03:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"a9d52db0-dee0-91ad-ea37-9dc859df7e33","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/d59287c5-978f-a0fc-140e-5b3ff3de8a82"},"effectiveDateTime":"2021-06-04T15:03:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"91dab52f-24d1-f690-c0d0-b30b3b857bf0","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/d59287c5-978f-a0fc-140e-5b3ff3de8a82"},"effectiveDateTime":"2021-06-05T19:23:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"61787329-a7f0-9923-6cd2-3599bf6b9811","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/d59287c5-978f-a0fc-140e-5b3ff3de8a82"},"effectiveDateTime":"2021-06-05T19:23:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"6a8234fe-e3b7-9611-9978-32ddb6cbfb71","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/d59287c5-978f-a0fc-140e-5b3ff3de8a82"},"effectiveDateTime":"2021-06-06T20:53:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"64e24e46-08d0-3da9-42cf-7f8c5ed32d09","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/d59287c5-978f-a0fc-140e-5b3ff3de8a82"},"effectiveDateTime":"2021-06-06T20:53:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"58da5eb8-ec51-7ae0-9a9f-96c4a9d0f33e","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/d59287c5-978f-a0fc-140e-5b3ff3de8a82"},"effectiveDateTime":"2021-06-07T21:34:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"14aa0442-66aa-2339-57d3-032f04d9ff4c","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/f13f51ad-3c0e-9806-fac5-8a349a522083"},"context":{"reference":"Encounter/d3747581-845c-ca00-cfa5-28e637befc64"},"effectiveDateTime":"2019-11-23T00:24:23-05:00","reasonReference":[{"reference":"Condition/a7c7a568-fe7b-1917-5bd5-32553fd3ce00","display":"Gingivitis (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"0d9e4251-138b-38c4-d5d6-e9528b3b27cf","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/d59287c5-978f-a0fc-140e-5b3ff3de8a82"},"effectiveDateTime":"2021-06-07T21:34:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"59faef86-9a7d-d0b0-7871-e0941e80c75b","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/c1c38fed-6d8a-1937-3897-9bf237344c7c"},"context":{"reference":"Encounter/771ca3a9-2d32-4d2d-77d9-f0b294f2d675"},"effectiveDateTime":"2018-09-13T02:11:58-04:00","reasonReference":[{"reference":"Condition/c724361c-33de-d59b-b868-8bb397c0d360","display":"Gingivitis (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"935d8039-83f5-77c3-bc95-8bf703814e7e","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/7bc2b7cc-3a9f-3178-18de-55d587287f2d"},"effectiveDateTime":"2021-07-08T03:29:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"f72b95be-0c1c-e5d3-499b-ad390b34934a","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/7bc2b7cc-3a9f-3178-18de-55d587287f2d"},"effectiveDateTime":"2021-07-08T03:29:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"edaf9b9b-d364-a4f7-5c03-1c57ab5d6e36","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/7bc2b7cc-3a9f-3178-18de-55d587287f2d"},"effectiveDateTime":"2021-07-09T07:02:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"c74c1587-096d-93d1-9f44-dec577c1148d","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/7bc2b7cc-3a9f-3178-18de-55d587287f2d"},"effectiveDateTime":"2021-07-09T07:02:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"362f9982-7c24-9eca-1b43-1a3e541d73a8","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/7bc2b7cc-3a9f-3178-18de-55d587287f2d"},"effectiveDateTime":"2021-07-10T10:07:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"17c968de-bdc6-e51a-b3cf-479e846dd442","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/7bc2b7cc-3a9f-3178-18de-55d587287f2d"},"effectiveDateTime":"2021-07-10T10:07:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"9b3374b4-5bfa-263e-1f36-6b5f9eb42b12","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/c1c38fed-6d8a-1937-3897-9bf237344c7c"},"context":{"reference":"Encounter/5be533ce-38bd-9eed-f82f-2d9c17b39e45"},"effectiveDateTime":"2018-10-11T06:10:21-04:00","reasonReference":[{"reference":"Condition/c724361c-33de-d59b-b868-8bb397c0d360","display":"Gingivitis (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"0641c2f1-1266-5e56-c3c1-629d860b9661","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/c3739c83-17e6-6e5b-e2c4-ff63fbbb0a0d"},"effectiveDateTime":"2021-08-07T22:59:47-04:00","reasonReference":[{"reference":"Condition/5413f81f-3dd2-0daa-bdd6-00fb3a3f3bfd","display":"Gingivitis (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"fe01573d-e7c4-d347-00f0-b725fedc8696","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/5255133e-1547-45f9-6e35-f6691e79c72d"},"effectiveDateTime":"2021-08-09T00:36:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"0a2f99d2-69dc-6a92-f703-1a8e41d67057","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/5255133e-1547-45f9-6e35-f6691e79c72d"},"effectiveDateTime":"2021-08-09T00:36:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"07615ae6-9396-b049-c731-e2b16e32b627","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/5255133e-1547-45f9-6e35-f6691e79c72d"},"effectiveDateTime":"2021-08-10T02:42:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"d8f95758-7e14-89c7-d77d-95af5374b8bd","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/5255133e-1547-45f9-6e35-f6691e79c72d"},"effectiveDateTime":"2021-08-10T02:42:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"14afcbe1-7fb4-2b7e-0ecb-ba69d334e756","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/5255133e-1547-45f9-6e35-f6691e79c72d"},"effectiveDateTime":"2021-08-11T04:14:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"c3a6d00a-5491-809c-b306-b87a0eb2d69f","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/5255133e-1547-45f9-6e35-f6691e79c72d"},"effectiveDateTime":"2021-08-11T04:14:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"0c79b528-175d-4356-8c1c-2ad3b8954f13","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/5255133e-1547-45f9-6e35-f6691e79c72d"},"effectiveDateTime":"2021-08-12T06:51:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"16164d71-51a4-8a8d-7320-0dcf3da19e3a","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/5255133e-1547-45f9-6e35-f6691e79c72d"},"effectiveDateTime":"2021-08-12T06:51:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"6e254e56-e28d-b882-b44f-38174079b59b","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/5255133e-1547-45f9-6e35-f6691e79c72d"},"effectiveDateTime":"2021-08-13T08:56:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"0f63b8c0-7f2c-f915-b28c-7dfdb738b694","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/5255133e-1547-45f9-6e35-f6691e79c72d"},"effectiveDateTime":"2021-08-13T08:56:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"ce5e8d53-de93-d1f0-9cda-97143c7fcf0f","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/5255133e-1547-45f9-6e35-f6691e79c72d"},"effectiveDateTime":"2021-08-14T10:43:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"8a121c0d-8de2-2093-3a06-97477e09220b","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/5255133e-1547-45f9-6e35-f6691e79c72d"},"effectiveDateTime":"2021-08-14T10:43:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"827e39be-523a-a969-a97f-b16e46cc343d","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/5255133e-1547-45f9-6e35-f6691e79c72d"},"effectiveDateTime":"2021-08-15T12:43:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"53b370f6-d640-355c-5f70-f09b6296d694","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/5255133e-1547-45f9-6e35-f6691e79c72d"},"effectiveDateTime":"2021-08-15T12:43:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"c40818e8-5f58-e4a3-694e-49a99764a223","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/5255133e-1547-45f9-6e35-f6691e79c72d"},"effectiveDateTime":"2021-08-16T15:47:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"361cab42-9be7-5690-cb35-6e47fc164c8e","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/5255133e-1547-45f9-6e35-f6691e79c72d"},"effectiveDateTime":"2021-08-16T15:47:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"b9464d0d-8785-bfd7-19de-f561084197d2","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/5255133e-1547-45f9-6e35-f6691e79c72d"},"effectiveDateTime":"2021-08-17T20:14:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"08f6df0b-31f1-1dfb-5ef9-ce6b1b73809c","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/5255133e-1547-45f9-6e35-f6691e79c72d"},"effectiveDateTime":"2021-08-17T20:14:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"377aa307-3248-a2ef-90ea-91173e23540f","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/c1c38fed-6d8a-1937-3897-9bf237344c7c"},"context":{"reference":"Encounter/db96b157-f981-d45b-18cd-a1d40c3ce62d"},"effectiveDateTime":"2019-05-02T06:17:21-04:00","reasonReference":[{"reference":"Condition/c724361c-33de-d59b-b868-8bb397c0d360","display":"Gingivitis (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"f71e673e-81c0-5abf-5708-19cf1f165daf","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/5255133e-1547-45f9-6e35-f6691e79c72d"},"effectiveDateTime":"2021-08-19T00:18:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"1090e3a6-a77d-5d59-9037-ade91cb56916","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/5255133e-1547-45f9-6e35-f6691e79c72d"},"effectiveDateTime":"2021-08-19T00:18:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"08a1f2c1-ccda-0ea2-0a19-a2b6be913f49","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/5255133e-1547-45f9-6e35-f6691e79c72d"},"effectiveDateTime":"2021-08-20T04:46:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"010a9ace-e20a-47e3-e71f-fafdd808e619","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/5255133e-1547-45f9-6e35-f6691e79c72d"},"effectiveDateTime":"2021-08-20T04:46:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"8591ae7c-47a7-0e4d-064d-8676cbcc0e21","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/5255133e-1547-45f9-6e35-f6691e79c72d"},"effectiveDateTime":"2021-08-21T07:04:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"e39be1ee-e35a-18e3-d99a-82f8234f7912","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/5255133e-1547-45f9-6e35-f6691e79c72d"},"effectiveDateTime":"2021-08-21T07:04:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"0f316062-1d0d-aecf-b32f-c4777d3ca4cd","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/5255133e-1547-45f9-6e35-f6691e79c72d"},"effectiveDateTime":"2021-08-22T10:38:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"1cdc3d9b-7216-5e43-da5b-e69b0b1b964e","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/5255133e-1547-45f9-6e35-f6691e79c72d"},"effectiveDateTime":"2021-08-22T10:38:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"e80d3a97-3f7d-3166-67b6-f060e4b53d24","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/5255133e-1547-45f9-6e35-f6691e79c72d"},"effectiveDateTime":"2021-08-23T13:10:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"7912fb42-ecfb-1725-57d2-d01dd1cdb32b","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/5255133e-1547-45f9-6e35-f6691e79c72d"},"effectiveDateTime":"2021-08-23T13:10:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"4a693ced-96cf-170f-2929-1229d09fb315","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/5255133e-1547-45f9-6e35-f6691e79c72d"},"effectiveDateTime":"2021-08-24T17:31:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"222224b8-028f-2710-00e1-f9f43c5fc316","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/5255133e-1547-45f9-6e35-f6691e79c72d"},"effectiveDateTime":"2021-08-24T17:31:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"877b9300-2795-2ac0-5d16-c938c39b0980","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/5255133e-1547-45f9-6e35-f6691e79c72d"},"effectiveDateTime":"2021-08-25T21:11:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"8232d5f0-9a5e-3ae8-a3c7-5567240b9bde","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/f13f51ad-3c0e-9806-fac5-8a349a522083"},"context":{"reference":"Encounter/fc6cf0e2-a241-f76c-3087-6aea3b9b54b3"},"effectiveDateTime":"2020-05-23T01:43:48-04:00","reasonCode":[{"coding":[{"system":"http://snomed.info/sct","code":"103697008","display":"Patient referral for dental care (procedure)"}],"text":"Patient referral for dental care (procedure)"}]}
{"resourceType":"MedicationAdministration","id":"81b33f47-9544-1dcd-026f-174248aae4e1","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/5255133e-1547-45f9-6e35-f6691e79c72d"},"effectiveDateTime":"2021-08-25T21:11:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"1c3026ce-7db5-89b2-16ef-a4111136458a","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/5255133e-1547-45f9-6e35-f6691e79c72d"},"effectiveDateTime":"2021-08-27T01:21:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"42c3be02-4765-a726-0321-a9ffa7244870","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/5255133e-1547-45f9-6e35-f6691e79c72d"},"effectiveDateTime":"2021-08-27T01:21:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"069275e7-ef7d-0b62-863f-1688fcb5171f","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/5255133e-1547-45f9-6e35-f6691e79c72d"},"effectiveDateTime":"2021-08-28T01:56:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"1d5cdeba-29fb-755f-871d-3ca627607a67","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/5255133e-1547-45f9-6e35-f6691e79c72d"},"effectiveDateTime":"2021-08-28T01:56:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"9be3f048-2be2-5183-f16c-699e2ed1b16e","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/5255133e-1547-45f9-6e35-f6691e79c72d"},"effectiveDateTime":"2021-08-29T04:22:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"08c06910-6a4f-d201-8216-6bffca3b2789","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/5255133e-1547-45f9-6e35-f6691e79c72d"},"effectiveDateTime":"2021-08-29T04:22:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"12138ab9-a5c9-f054-150a-37b5d6a885d8","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/c1c38fed-6d8a-1937-3897-9bf237344c7c"},"context":{"reference":"Encounter/463cfa1e-992f-8f19-67ba-2846407c9370"},"effectiveDateTime":"2019-09-19T03:39:46-04:00","reasonReference":[{"reference":"Condition/c724361c-33de-d59b-b868-8bb397c0d360","display":"Gingivitis (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"1c374259-e609-f296-7fca-e95b5db9eade","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/325aa5f8-2e01-1299-946d-06f4d82e40a9"},"effectiveDateTime":"2021-09-30T16:32:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"0c347809-1d83-e4a2-0dac-280165e77849","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/325aa5f8-2e01-1299-946d-06f4d82e40a9"},"effectiveDateTime":"2021-09-30T16:32:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"2931cc51-2ec4-c0ff-af2c-2efb9edc3bfe","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/325aa5f8-2e01-1299-946d-06f4d82e40a9"},"effectiveDateTime":"2021-10-01T19:38:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"6996bc74-8b7c-31cc-1432-c2534b5db065","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/325aa5f8-2e01-1299-946d-06f4d82e40a9"},"effectiveDateTime":"2021-10-01T19:38:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"9f09c5a8-38ff-5872-ff38-bba747c16e97","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/325aa5f8-2e01-1299-946d-06f4d82e40a9"},"effectiveDateTime":"2021-10-02T21:45:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"fd547922-00d9-188c-ee40-9a8456dc07ec","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/325aa5f8-2e01-1299-946d-06f4d82e40a9"},"effectiveDateTime":"2021-10-02T21:45:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"3e092741-fdae-e34f-41eb-c347dc6ec584","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/325aa5f8-2e01-1299-946d-06f4d82e40a9"},"effectiveDateTime":"2021-10-04T00:46:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"d4f5176d-6ced-a00e-d8d7-b3734bad8243","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/325aa5f8-2e01-1299-946d-06f4d82e40a9"},"effectiveDateTime":"2021-10-04T00:46:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"5ea982bd-be4c-ecc3-d9a9-0ce626bf5cda","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/325aa5f8-2e01-1299-946d-06f4d82e40a9"},"effectiveDateTime":"2021-10-05T01:33:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"784d1f14-6c3b-1722-570d-019e8657b328","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/325aa5f8-2e01-1299-946d-06f4d82e40a9"},"effectiveDateTime":"2021-10-05T01:33:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"70454329-3c49-1f29-0bec-c59953c41eb5","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/325aa5f8-2e01-1299-946d-06f4d82e40a9"},"effectiveDateTime":"2021-10-06T04:35:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"d316c222-08d9-3135-c48a-37125edc2095","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/325aa5f8-2e01-1299-946d-06f4d82e40a9"},"effectiveDateTime":"2021-10-06T04:35:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"73b9ec3d-bdc0-455c-7f77-6c043b5c0694","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/325aa5f8-2e01-1299-946d-06f4d82e40a9"},"effectiveDateTime":"2021-10-07T06:11:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"0b165b42-1be5-a8bb-250c-ca477c149eba","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/325aa5f8-2e01-1299-946d-06f4d82e40a9"},"effectiveDateTime":"2021-10-07T06:11:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"f3ef28ab-6dad-2c72-6eee-b726f0179c8a","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/325aa5f8-2e01-1299-946d-06f4d82e40a9"},"effectiveDateTime":"2021-10-08T10:10:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"f3b0ab0c-fdc0-5304-53a2-7a7d4b1655f4","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/325aa5f8-2e01-1299-946d-06f4d82e40a9"},"effectiveDateTime":"2021-10-08T10:10:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"f17d340d-8263-8f3c-0189-0ec8e982c3c2","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/c1c38fed-6d8a-1937-3897-9bf237344c7c"},"context":{"reference":"Encounter/1237621e-e2a3-bb1d-91cc-cd137fba7e7e"},"effectiveDateTime":"2020-09-24T02:34:40-04:00","reasonReference":[{"reference":"Condition/c724361c-33de-d59b-b868-8bb397c0d360","display":"Gingivitis (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"301268e2-6fae-793e-6055-91e15d00e54d","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/f13f51ad-3c0e-9806-fac5-8a349a522083"},"context":{"reference":"Encounter/ad7a152f-7f3f-51a7-0897-71b3aa303cde"},"effectiveDateTime":"2020-08-29T01:03:36-04:00","reasonCode":[{"coding":[{"system":"http://snomed.info/sct","code":"103697008","display":"Patient referral for dental care (procedure)"}],"text":"Patient referral for dental care (procedure)"}]}
{"resourceType":"MedicationAdministration","id":"89625e96-c883-3ff8-bfd3-96a286031d05","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/fa208ef8-c158-6a5f-c4f3-e2baa45d597e"},"effectiveDateTime":"2021-11-11T06:19:59-05:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"356de20d-2a2b-171a-142d-d093c563b320","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/fa208ef8-c158-6a5f-c4f3-e2baa45d597e"},"effectiveDateTime":"2021-11-11T06:19:59-05:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"4464ed26-5519-8373-db6f-5d3dd0193eee","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/fa208ef8-c158-6a5f-c4f3-e2baa45d597e"},"effectiveDateTime":"2021-11-12T08:02:59-05:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"013dc8c7-2d81-0d7c-0cfb-48a4eb4c92b4","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/fa208ef8-c158-6a5f-c4f3-e2baa45d597e"},"effectiveDateTime":"2021-11-12T08:02:59-05:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"2e91e92a-39a0-dfa0-ea69-e71188093320","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/fa208ef8-c158-6a5f-c4f3-e2baa45d597e"},"effectiveDateTime":"2021-11-13T10:42:59-05:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"7be34258-3617-e991-18b3-e959adc7e560","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/fa208ef8-c158-6a5f-c4f3-e2baa45d597e"},"effectiveDateTime":"2021-11-13T10:42:59-05:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"1f11c9ce-be14-406c-1e8e-86a613746f62","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/fa208ef8-c158-6a5f-c4f3-e2baa45d597e"},"effectiveDateTime":"2021-11-14T13:50:59-05:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"d7318e48-3493-f543-a2ff-039e3783553b","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/fa208ef8-c158-6a5f-c4f3-e2baa45d597e"},"effectiveDateTime":"2021-11-14T13:50:59-05:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"852e258f-721e-a34d-05e9-fd8d700558e1","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/fa208ef8-c158-6a5f-c4f3-e2baa45d597e"},"effectiveDateTime":"2021-11-15T15:21:59-05:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"08ed155e-2445-c917-5ef0-04be1c3d63ed","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/fa208ef8-c158-6a5f-c4f3-e2baa45d597e"},"effectiveDateTime":"2021-11-15T15:21:59-05:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"fe3415fa-e24a-4695-0412-d5eb326e6732","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/fa208ef8-c158-6a5f-c4f3-e2baa45d597e"},"effectiveDateTime":"2021-11-16T19:35:59-05:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"abb5243a-526d-2ca1-26b4-e57ae2ef9cb9","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/fa208ef8-c158-6a5f-c4f3-e2baa45d597e"},"effectiveDateTime":"2021-11-16T19:35:59-05:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"40058d4e-323e-e866-0063-794d3d442ad0","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/fa208ef8-c158-6a5f-c4f3-e2baa45d597e"},"effectiveDateTime":"2021-11-17T23:36:59-05:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"af964c53-c018-7fa5-f200-0cb1ac178aaa","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/fa208ef8-c158-6a5f-c4f3-e2baa45d597e"},"effectiveDateTime":"2021-11-17T23:36:59-05:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"0c5dadc3-c764-ad5c-181b-2db9875a2a94","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/f448b781-b790-8cdb-ee47-e56bb3c7455f"},"effectiveDateTime":"2021-12-19T15:08:59-05:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"e5be61e4-9b5b-360f-14b4-61bb9b312b70","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/f448b781-b790-8cdb-ee47-e56bb3c7455f"},"effectiveDateTime":"2021-12-19T15:08:59-05:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"a0a880a7-8eb0-8f7a-f743-d6aa7e108d18","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/f448b781-b790-8cdb-ee47-e56bb3c7455f"},"effectiveDateTime":"2021-12-20T18:08:59-05:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"08f17aef-c423-169f-5ef4-6a4fc1c16d3a","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/f448b781-b790-8cdb-ee47-e56bb3c7455f"},"effectiveDateTime":"2021-12-20T18:08:59-05:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"3dba3483-ff4f-0882-913a-f05bfec1f636","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/f448b781-b790-8cdb-ee47-e56bb3c7455f"},"effectiveDateTime":"2021-12-21T20:34:59-05:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"9fa27e9f-a89d-0fa8-7ae7-b6ab661d06d7","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/f448b781-b790-8cdb-ee47-e56bb3c7455f"},"effectiveDateTime":"2021-12-21T20:34:59-05:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"0164e1cf-5654-3d9e-02dc-91d0b24894c5","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/db9a00d0-7ff3-0f1d-62f4-de972d930126"},"effectiveDateTime":"2022-01-21T10:41:59-05:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"48a27e9c-cdbc-498d-eb5b-b6a88b3c546c","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/db9a00d0-7ff3-0f1d-62f4-de972d930126"},"effectiveDateTime":"2022-01-21T10:41:59-05:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"47692580-95ef-916c-1f69-def3c4831228","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/db9a00d0-7ff3-0f1d-62f4-de972d930126"},"effectiveDateTime":"2022-01-22T13:25:59-05:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"8520b3bf-58e5-334d-05dc-8bc0125861e1","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/db9a00d0-7ff3-0f1d-62f4-de972d930126"},"effectiveDateTime":"2022-01-22T13:25:59-05:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"c6631ee4-484e-be48-3e13-206d7493654a","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/db9a00d0-7ff3-0f1d-62f4-de972d930126"},"effectiveDateTime":"2022-01-23T15:22:59-05:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"07ac218e-66ed-9056-dfac-e62489411111","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/db9a00d0-7ff3-0f1d-62f4-de972d930126"},"effectiveDateTime":"2022-01-23T15:22:59-05:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"e3a636cf-17a6-8954-a3ac-b64f3c428f33","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/db9a00d0-7ff3-0f1d-62f4-de972d930126"},"effectiveDateTime":"2022-01-24T17:49:59-05:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"5b937ca6-64aa-c6e3-db13-a1426a8986e9","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/db9a00d0-7ff3-0f1d-62f4-de972d930126"},"effectiveDateTime":"2022-01-24T17:49:59-05:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"c9c85770-278c-cc1e-d09f-4664c392aade","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/db9a00d0-7ff3-0f1d-62f4-de972d930126"},"effectiveDateTime":"2022-01-25T19:17:59-05:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"a8bc439a-7a6d-95f5-80bd-1e78590116b1","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/db9a00d0-7ff3-0f1d-62f4-de972d930126"},"effectiveDateTime":"2022-01-25T19:17:59-05:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"7d2ddd05-8293-f7b9-4361-83806394b565","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"854235","display":"0.4 ML Enoxaparin sodium 100 MG/ML Prefilled Syringe"}],"text":"0.4 ML Enoxaparin sodium 100 MG/ML Prefilled Syringe"},"subject":{"reference":"Patient/c1c38fed-6d8a-1937-3897-9bf237344c7c"},"context":{"reference":"Encounter/e4ad2d5a-5200-f1fd-a064-f59170ac1317"},"effectiveDateTime":"2020-11-12T00:28:41-05:00"}
{"resourceType":"MedicationAdministration","id":"9b756813-f054-615e-1f78-5ec30922fb4a","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"198440","display":"Acetaminophen 500 MG Oral Tablet"}],"text":"Acetaminophen 500 MG Oral Tablet"},"subject":{"reference":"Patient/c1c38fed-6d8a-1937-3897-9bf237344c7c"},"context":{"reference":"Encounter/e4ad2d5a-5200-f1fd-a064-f59170ac1317"},"effectiveDateTime":"2020-11-12T00:28:41-05:00"}
{"resourceType":"MedicationAdministration","id":"857116ec-696c-67c2-e3a5-474e40746daf","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"854235","display":"0.4 ML Enoxaparin sodium 100 MG/ML Prefilled Syringe"}],"text":"0.4 ML Enoxaparin sodium 100 MG/ML Prefilled Syringe"},"subject":{"reference":"Patient/c1c38fed-6d8a-1937-3897-9bf237344c7c"},"context":{"reference":"Encounter/e4ad2d5a-5200-f1fd-a064-f59170ac1317"},"effectiveDateTime":"2020-11-13T00:28:41-05:00"}
{"resourceType":"MedicationAdministration","id":"daae724a-97bc-2e85-e6e9-534b5567f50b","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"198440","display":"Acetaminophen 500 MG Oral Tablet"}],"text":"Acetaminophen 500 MG Oral Tablet"},"subject":{"reference":"Patient/c1c38fed-6d8a-1937-3897-9bf237344c7c"},"context":{"reference":"Encounter/e4ad2d5a-5200-f1fd-a064-f59170ac1317"},"effectiveDateTime":"2020-11-13T00:28:41-05:00"}
{"resourceType":"MedicationAdministration","id":"0ba6afef-9d56-0bf1-0c64-5bb675c806d2","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"854235","display":"0.4 ML Enoxaparin sodium 100 MG/ML Prefilled Syringe"}],"text":"0.4 ML Enoxaparin sodium 100 MG/ML Prefilled Syringe"},"subject":{"reference":"Patient/c1c38fed-6d8a-1937-3897-9bf237344c7c"},"context":{"reference":"Encounter/e4ad2d5a-5200-f1fd-a064-f59170ac1317"},"effectiveDateTime":"2020-11-14T00:28:41-05:00"}
{"resourceType":"MedicationAdministration","id":"88ea726f-dcdb-5371-fae5-53709a871a49","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"198440","display":"Acetaminophen 500 MG Oral Tablet"}],"text":"Acetaminophen 500 MG Oral Tablet"},"subject":{"reference":"Patient/c1c38fed-6d8a-1937-3897-9bf237344c7c"},"context":{"reference":"Encounter/e4ad2d5a-5200-f1fd-a064-f59170ac1317"},"effectiveDateTime":"2020-11-14T00:28:41-05:00"}
{"resourceType":"MedicationAdministration","id":"c5889e52-940b-1efd-81fb-4bce421b2ad8","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"854235","display":"0.4 ML Enoxaparin sodium 100 MG/ML Prefilled Syringe"}],"text":"0.4 ML Enoxaparin sodium 100 MG/ML Prefilled Syringe"},"subject":{"reference":"Patient/c1c38fed-6d8a-1937-3897-9bf237344c7c"},"context":{"reference":"Encounter/e4ad2d5a-5200-f1fd-a064-f59170ac1317"},"effectiveDateTime":"2020-11-15T00:28:41-05:00"}
{"resourceType":"MedicationAdministration","id":"9b5e9811-6253-d7de-1f61-8ec07eff36ca","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"198440","display":"Acetaminophen 500 MG Oral Tablet"}],"text":"Acetaminophen 500 MG Oral Tablet"},"subject":{"reference":"Patient/c1c38fed-6d8a-1937-3897-9bf237344c7c"},"context":{"reference":"Encounter/e4ad2d5a-5200-f1fd-a064-f59170ac1317"},"effectiveDateTime":"2020-11-15T00:28:41-05:00"}
{"resourceType":"MedicationAdministration","id":"661b03c8-ad9a-f11d-1b93-f3705cf71135","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"854235","display":"0.4 ML Enoxaparin sodium 100 MG/ML Prefilled Syringe"}],"text":"0.4 ML Enoxaparin sodium 100 MG/ML Prefilled Syringe"},"subject":{"reference":"Patient/c1c38fed-6d8a-1937-3897-9bf237344c7c"},"context":{"reference":"Encounter/e4ad2d5a-5200-f1fd-a064-f59170ac1317"},"effectiveDateTime":"2020-11-16T00:28:41-05:00"}
{"resourceType":"MedicationAdministration","id":"ddf52f6f-8496-7ddd-8d13-2465701a80d4","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"198440","display":"Acetaminophen 500 MG Oral Tablet"}],"text":"Acetaminophen 500 MG Oral Tablet"},"subject":{"reference":"Patient/c1c38fed-6d8a-1937-3897-9bf237344c7c"},"context":{"reference":"Encounter/e4ad2d5a-5200-f1fd-a064-f59170ac1317"},"effectiveDateTime":"2020-11-16T00:28:41-05:00"}
{"resourceType":"MedicationAdministration","id":"afefa881-d99a-f1d7-6568-a27640f711ef","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"854235","display":"0.4 ML Enoxaparin sodium 100 MG/ML Prefilled Syringe"}],"text":"0.4 ML Enoxaparin sodium 100 MG/ML Prefilled Syringe"},"subject":{"reference":"Patient/c1c38fed-6d8a-1937-3897-9bf237344c7c"},"context":{"reference":"Encounter/e4ad2d5a-5200-f1fd-a064-f59170ac1317"},"effectiveDateTime":"2020-11-17T00:28:41-05:00"}
{"resourceType":"MedicationAdministration","id":"c66dcc8b-b797-8cf4-069d-377dab805bad","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"198440","display":"Acetaminophen 500 MG Oral Tablet"}],"text":"Acetaminophen 500 MG Oral Tablet"},"subject":{"reference":"Patient/c1c38fed-6d8a-1937-3897-9bf237344c7c"},"context":{"reference":"Encounter/e4ad2d5a-5200-f1fd-a064-f59170ac1317"},"effectiveDateTime":"2020-11-17T00:28:41-05:00"}
{"resourceType":"MedicationAdministration","id":"22ca513b-2311-a001-2387-fd03451a9ae2","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"854235","display":"0.4 ML Enoxaparin sodium 100 MG/ML Prefilled Syringe"}],"text":"0.4 ML Enoxaparin sodium 100 MG/ML Prefilled Syringe"},"subject":{"reference":"Patient/c1c38fed-6d8a-1937-3897-9bf237344c7c"},"context":{"reference":"Encounter/e4ad2d5a-5200-f1fd-a064-f59170ac1317"},"effectiveDateTime":"2020-11-18T00:28:41-05:00"}
{"resourceType":"MedicationAdministration","id":"f37d89b1-db94-1dde-a0b5-956f5bb527d4","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/c8307591-58a9-f478-133d-8792188ee945"},"effectiveDateTime":"2022-02-24T21:04:59-05:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"6e6fb3c4-592b-0f0b-6078-3603116b3e76","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"198440","display":"Acetaminophen 500 MG Oral Tablet"}],"text":"Acetaminophen 500 MG Oral Tablet"},"subject":{"reference":"Patient/c1c38fed-6d8a-1937-3897-9bf237344c7c"},"context":{"reference":"Encounter/e4ad2d5a-5200-f1fd-a064-f59170ac1317"},"effectiveDateTime":"2020-11-18T00:28:41-05:00"}
{"resourceType":"MedicationAdministration","id":"7c6089e6-7b96-a448-3c71-0ee15232aa27","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/c8307591-58a9-f478-133d-8792188ee945"},"effectiveDateTime":"2022-02-24T21:04:59-05:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"59ef8592-f9da-5933-30f7-8b80581dfca9","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"854235","display":"0.4 ML Enoxaparin sodium 100 MG/ML Prefilled Syringe"}],"text":"0.4 ML Enoxaparin sodium 100 MG/ML Prefilled Syringe"},"subject":{"reference":"Patient/c1c38fed-6d8a-1937-3897-9bf237344c7c"},"context":{"reference":"Encounter/e4ad2d5a-5200-f1fd-a064-f59170ac1317"},"effectiveDateTime":"2020-11-19T00:28:41-05:00"}
{"resourceType":"MedicationAdministration","id":"ef97d7b6-9a1e-9707-1169-92a21e218db7","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"198440","display":"Acetaminophen 500 MG Oral Tablet"}],"text":"Acetaminophen 500 MG Oral Tablet"},"subject":{"reference":"Patient/c1c38fed-6d8a-1937-3897-9bf237344c7c"},"context":{"reference":"Encounter/e4ad2d5a-5200-f1fd-a064-f59170ac1317"},"effectiveDateTime":"2020-11-19T00:28:41-05:00"}
{"resourceType":"MedicationAdministration","id":"670fcb08-8a4f-e2e8-419f-2728a2055c01","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"854235","display":"0.4 ML Enoxaparin sodium 100 MG/ML Prefilled Syringe"}],"text":"0.4 ML Enoxaparin sodium 100 MG/ML Prefilled Syringe"},"subject":{"reference":"Patient/c1c38fed-6d8a-1937-3897-9bf237344c7c"},"context":{"reference":"Encounter/e4ad2d5a-5200-f1fd-a064-f59170ac1317"},"effectiveDateTime":"2020-11-20T00:28:41-05:00"}
{"resourceType":"MedicationAdministration","id":"17ceca4f-d0a0-6940-1abe-2a584117d996","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/c8307591-58a9-f478-133d-8792188ee945"},"effectiveDateTime":"2022-02-25T23:51:59-05:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"280e80b4-e9f7-4fe7-9f7e-d6b7d9575857","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/c8307591-58a9-f478-133d-8792188ee945"},"effectiveDateTime":"2022-02-25T23:51:59-05:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"d4915cc5-7f7d-264f-54b3-df3de4b5320d","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/c8307591-58a9-f478-133d-8792188ee945"},"effectiveDateTime":"2022-02-27T03:54:59-05:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"a1f92e80-d0f2-6ae8-b974-2ec5d5e33558","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/c8307591-58a9-f478-133d-8792188ee945"},"effectiveDateTime":"2022-02-27T03:54:59-05:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"77216258-a3b6-381d-7f27-4fb6e9ecdbf4","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"198440","display":"Acetaminophen 500 MG Oral Tablet"}],"text":"Acetaminophen 500 MG Oral Tablet"},"subject":{"reference":"Patient/c1c38fed-6d8a-1937-3897-9bf237344c7c"},"context":{"reference":"Encounter/e4ad2d5a-5200-f1fd-a064-f59170ac1317"},"effectiveDateTime":"2020-11-20T00:28:41-05:00"}
{"resourceType":"MedicationAdministration","id":"27d2453c-a58c-c642-c3d8-23fcb724205a","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/c8307591-58a9-f478-133d-8792188ee945"},"effectiveDateTime":"2022-02-28T04:59:59-05:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"f40c5927-0961-b3a3-a21c-6501c5f34747","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"854235","display":"0.4 ML Enoxaparin sodium 100 MG/ML Prefilled Syringe"}],"text":"0.4 ML Enoxaparin sodium 100 MG/ML Prefilled Syringe"},"subject":{"reference":"Patient/c1c38fed-6d8a-1937-3897-9bf237344c7c"},"context":{"reference":"Encounter/e4ad2d5a-5200-f1fd-a064-f59170ac1317"},"effectiveDateTime":"2020-11-21T00:28:41-05:00"}
{"resourceType":"MedicationAdministration","id":"40ed0408-77c7-74e6-014a-f009913d1670","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/c8307591-58a9-f478-133d-8792188ee945"},"effectiveDateTime":"2022-02-28T04:59:59-05:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"ea685a23-a910-3909-638b-816b053050bf","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"198440","display":"Acetaminophen 500 MG Oral Tablet"}],"text":"Acetaminophen 500 MG Oral Tablet"},"subject":{"reference":"Patient/c1c38fed-6d8a-1937-3897-9bf237344c7c"},"context":{"reference":"Encounter/e4ad2d5a-5200-f1fd-a064-f59170ac1317"},"effectiveDateTime":"2020-11-21T00:28:41-05:00"}
{"resourceType":"MedicationAdministration","id":"f31caf85-2ac4-127b-0328-8a41c17e1229","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"854235","display":"0.4 ML Enoxaparin sodium 100 MG/ML Prefilled Syringe"}],"text":"0.4 ML Enoxaparin sodium 100 MG/ML Prefilled Syringe"},"subject":{"reference":"Patient/c1c38fed-6d8a-1937-3897-9bf237344c7c"},"context":{"reference":"Encounter/e4ad2d5a-5200-f1fd-a064-f59170ac1317"},"effectiveDateTime":"2020-11-22T00:28:41-05:00"}
{"resourceType":"MedicationAdministration","id":"8f7d2406-f262-3d79-497c-d216fe3cfa10","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"198440","display":"Acetaminophen 500 MG Oral Tablet"}],"text":"Acetaminophen 500 MG Oral Tablet"},"subject":{"reference":"Patient/c1c38fed-6d8a-1937-3897-9bf237344c7c"},"context":{"reference":"Encounter/e4ad2d5a-5200-f1fd-a064-f59170ac1317"},"effectiveDateTime":"2020-11-22T00:28:41-05:00"}
{"resourceType":"MedicationAdministration","id":"267cd88a-1901-bb9d-d246-968fd3e2bc5a","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"854235","display":"0.4 ML Enoxaparin sodium 100 MG/ML Prefilled Syringe"}],"text":"0.4 ML Enoxaparin sodium 100 MG/ML Prefilled Syringe"},"subject":{"reference":"Patient/c1c38fed-6d8a-1937-3897-9bf237344c7c"},"context":{"reference":"Encounter/e4ad2d5a-5200-f1fd-a064-f59170ac1317"},"effectiveDateTime":"2020-11-23T00:28:41-05:00"}
{"resourceType":"MedicationAdministration","id":"00dd1c0e-b38b-fba2-db99-b7ef0f390bad","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"198440","display":"Acetaminophen 500 MG Oral Tablet"}],"text":"Acetaminophen 500 MG Oral Tablet"},"subject":{"reference":"Patient/c1c38fed-6d8a-1937-3897-9bf237344c7c"},"context":{"reference":"Encounter/e4ad2d5a-5200-f1fd-a064-f59170ac1317"},"effectiveDateTime":"2020-11-23T00:28:41-05:00"}
{"resourceType":"MedicationAdministration","id":"e501654e-08d4-1a88-f2ac-ad8f5ed709e8","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/39d3b4a3-7b9f-1385-1668-0742d364ae82"},"effectiveDateTime":"2022-03-30T12:46:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"2f669ed6-fe69-b001-363c-42f7a56b27b1","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/39d3b4a3-7b9f-1385-1668-0742d364ae82"},"effectiveDateTime":"2022-03-30T12:46:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"0d3bd070-7f05-10e8-4493-1de9b710ce68","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/39d3b4a3-7b9f-1385-1668-0742d364ae82"},"effectiveDateTime":"2022-03-31T13:33:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"28cd615c-9690-9af8-801a-da94a24e1b2f","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/39d3b4a3-7b9f-1385-1668-0742d364ae82"},"effectiveDateTime":"2022-03-31T13:33:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"9e0c68c4-3b46-c852-fe3b-5ec51b9503a7","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/39d3b4a3-7b9f-1385-1668-0742d364ae82"},"effectiveDateTime":"2022-04-01T16:58:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"e8623629-c8d9-0e28-c309-37a178e0109a","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/39d3b4a3-7b9f-1385-1668-0742d364ae82"},"effectiveDateTime":"2022-04-01T16:58:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"78c3f494-c58d-ee51-d6af-f65b155e5811","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/39d3b4a3-7b9f-1385-1668-0742d364ae82"},"effectiveDateTime":"2022-04-02T19:32:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"bee9b685-43cb-ae97-8539-86ef04299a99","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/39d3b4a3-7b9f-1385-1668-0742d364ae82"},"effectiveDateTime":"2022-04-02T19:32:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"1eb2c6f0-178d-450a-3b70-57beb39323ca","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/39d3b4a3-7b9f-1385-1668-0742d364ae82"},"effectiveDateTime":"2022-04-03T21:20:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"0782ea58-fbd6-7aa2-08fa-9a602b3aae49","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/39d3b4a3-7b9f-1385-1668-0742d364ae82"},"effectiveDateTime":"2022-04-03T21:20:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"ae177e6b-a3dc-e9be-3377-ad61a4c5a914","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/39d3b4a3-7b9f-1385-1668-0742d364ae82"},"effectiveDateTime":"2022-04-04T23:39:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"bfbeeefd-d0f9-cd9c-d33f-aad5d49ccaf2","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/39d3b4a3-7b9f-1385-1668-0742d364ae82"},"effectiveDateTime":"2022-04-04T23:39:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"2e3a153d-221a-5296-3418-d55a9a350932","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/39d3b4a3-7b9f-1385-1668-0742d364ae82"},"effectiveDateTime":"2022-04-06T03:40:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"2b7de275-2b94-4336-98b5-ee32abcf336b","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/39d3b4a3-7b9f-1385-1668-0742d364ae82"},"effectiveDateTime":"2022-04-06T03:40:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"21ba7ecf-237e-4a96-ceef-b6dae0fe8636","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/39d3b4a3-7b9f-1385-1668-0742d364ae82"},"effectiveDateTime":"2022-04-07T05:22:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"bf5a0385-4429-a617-9c5f-6d2f04879219","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/39d3b4a3-7b9f-1385-1668-0742d364ae82"},"effectiveDateTime":"2022-04-07T05:22:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"08eaef19-64e0-2001-5eed-de7978e4f465","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/76cb048d-b1b6-2540-cf40-dd55bbe7434a"},"effectiveDateTime":"2022-05-08T23:43:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"f29b0a21-e1da-1913-e89c-4a6f281f7942","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/76cb048d-b1b6-2540-cf40-dd55bbe7434a"},"effectiveDateTime":"2022-05-08T23:43:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"525e2fbc-d5cf-5923-4485-313485d9735b","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/76cb048d-b1b6-2540-cf40-dd55bbe7434a"},"effectiveDateTime":"2022-05-10T03:27:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"982d9a6f-2517-ae1d-9141-1b2afd1cbb39","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/76cb048d-b1b6-2540-cf40-dd55bbe7434a"},"effectiveDateTime":"2022-05-10T03:27:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"41a6d25d-68a5-6d3e-5c42-d83c28ce366b","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/76cb048d-b1b6-2540-cf40-dd55bbe7434a"},"effectiveDateTime":"2022-05-11T07:30:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"8df4946e-2d36-4af2-79f7-2100fee00b50","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/76cb048d-b1b6-2540-cf40-dd55bbe7434a"},"effectiveDateTime":"2022-05-11T07:30:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"222f0040-2afe-29f1-b4e4-31962ded8a05","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/76cb048d-b1b6-2540-cf40-dd55bbe7434a"},"effectiveDateTime":"2022-05-12T10:22:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"0ac1cc12-58e2-2dc1-bacc-156cf1892f38","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/76cb048d-b1b6-2540-cf40-dd55bbe7434a"},"effectiveDateTime":"2022-05-12T10:22:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"a5641783-17a6-8922-6597-6907de428f01","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/27cbde3a-3fb2-0467-b5ab-0fec4d54d486"},"effectiveDateTime":"2022-06-13T00:52:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"a7117896-4511-9a3c-f896-3f324af05a6f","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/27cbde3a-3fb2-0467-b5ab-0fec4d54d486"},"effectiveDateTime":"2022-06-13T00:52:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"27ded0d7-e266-f74e-c3e4-af98160ff98a","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/27cbde3a-3fb2-0467-b5ab-0fec4d54d486"},"effectiveDateTime":"2022-06-14T02:21:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"8c660f49-f8a7-8087-7bc6-291e79c5d68a","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/27cbde3a-3fb2-0467-b5ab-0fec4d54d486"},"effectiveDateTime":"2022-06-14T02:21:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"8276098b-6984-08a8-a977-813b7685f258","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/27cbde3a-3fb2-0467-b5ab-0fec4d54d486"},"effectiveDateTime":"2022-06-15T05:55:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"bef52d8f-5d6c-1c95-59f7-9da6d86cecb4","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/27cbde3a-3fb2-0467-b5ab-0fec4d54d486"},"effectiveDateTime":"2022-06-15T05:55:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"ecb18722-1dbc-af25-8fb9-4ed77deba527","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/27cbde3a-3fb2-0467-b5ab-0fec4d54d486"},"effectiveDateTime":"2022-06-16T07:56:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"7290081a-e90d-ab28-8a0b-08ec6cf18598","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/27cbde3a-3fb2-0467-b5ab-0fec4d54d486"},"effectiveDateTime":"2022-06-16T07:56:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"d2e92c36-696f-93d5-aaef-c3e659031491","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/27cbde3a-3fb2-0467-b5ab-0fec4d54d486"},"effectiveDateTime":"2022-06-17T10:53:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"cca5d17c-7a57-b2c7-47a4-cab486153331","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/27cbde3a-3fb2-0467-b5ab-0fec4d54d486"},"effectiveDateTime":"2022-06-17T10:53:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"f36cd9d2-f080-1c7b-0378-b495aa09cf91","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/c1c38fed-6d8a-1937-3897-9bf237344c7c"},"context":{"reference":"Encounter/1490231c-546f-168d-0ace-350461c46294"},"effectiveDateTime":"2021-09-23T01:59:22-04:00","reasonCode":[{"coding":[{"system":"http://snomed.info/sct","code":"103697008","display":"Patient referral for dental care (procedure)"}],"text":"Patient referral for dental care (procedure)"}]}
{"resourceType":"MedicationAdministration","id":"f3a1384f-013b-b37b-03ad-13124b29f841","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/c1c38fed-6d8a-1937-3897-9bf237344c7c"},"context":{"reference":"Encounter/aa3ab3f7-e02b-5f42-c7dd-f51331e72aa1"},"effectiveDateTime":"2021-10-21T02:54:32-04:00","reasonCode":[{"coding":[{"system":"http://snomed.info/sct","code":"103697008","display":"Patient referral for dental care (procedure)"}],"text":"Patient referral for dental care (procedure)"}]}
{"resourceType":"MedicationAdministration","id":"fb0fbe22-af3d-2d52-58fb-c219be141713","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/77a7341a-b1fb-18d6-6d65-f161fba20f0b"},"effectiveDateTime":"2022-07-20T16:48:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"3eb97e5d-fe61-4416-4e95-b9b9a562bbc6","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/77a7341a-b1fb-18d6-6d65-f161fba20f0b"},"effectiveDateTime":"2022-07-20T16:48:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"272a1bbb-23d7-d94e-09bf-7bea19d9d7d2","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/77a7341a-b1fb-18d6-6d65-f161fba20f0b"},"effectiveDateTime":"2022-07-21T20:38:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"0b81295e-e204-af40-0e70-897eca42d896","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/77a7341a-b1fb-18d6-6d65-f161fba20f0b"},"effectiveDateTime":"2022-07-21T20:38:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"947776f1-2e8f-f1d4-951e-b1139ea76cd5","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/77a7341a-b1fb-18d6-6d65-f161fba20f0b"},"effectiveDateTime":"2022-07-22T22:39:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"58c49b74-2cef-8fa3-30cc-a0adfe03105f","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/77a7341a-b1fb-18d6-6d65-f161fba20f0b"},"effectiveDateTime":"2022-07-22T22:39:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"27f76f10-bebb-7d7c-33b4-efa6b339f6b4","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/cfb8cd4d-1748-ad6f-4bd8-de26b785df53"},"effectiveDateTime":"2022-08-25T13:01:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"34b1c98d-8bca-4b5c-93f9-b1210c862365","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/cfb8cd4d-1748-ad6f-4bd8-de26b785df53"},"effectiveDateTime":"2022-08-25T13:01:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"76eba51b-8079-da9c-315b-bc9681a7327f","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/cfb8cd4d-1748-ad6f-4bd8-de26b785df53"},"effectiveDateTime":"2022-08-26T15:44:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"132b048c-a411-dfa2-cf03-0df76327b322","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/cfb8cd4d-1748-ad6f-4bd8-de26b785df53"},"effectiveDateTime":"2022-08-26T15:44:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"10a5003c-7ac3-8e96-1683-c0882f8cb332","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/cfb8cd4d-1748-ad6f-4bd8-de26b785df53"},"effectiveDateTime":"2022-08-27T19:21:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"733a9939-dd3d-f509-016c-1d3cd3ef33ad","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/c1c38fed-6d8a-1937-3897-9bf237344c7c"},"context":{"reference":"Encounter/a2087762-26d0-3e3e-74cd-bbe5f71e0bcd"},"effectiveDateTime":"2022-01-13T02:05:12-05:00","reasonReference":[{"reference":"Condition/c724361c-33de-d59b-b868-8bb397c0d360","display":"Gingivitis (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"f0406e48-33d0-1b31-caa5-009e36bf7b57","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/cfb8cd4d-1748-ad6f-4bd8-de26b785df53"},"effectiveDateTime":"2022-08-27T19:21:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"bdbe7a3e-5f67-c1f8-513f-36166a39a07b","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/57c26507-3c44-d44f-ecd3-0bb1cb0ab745"},"effectiveDateTime":"2022-09-30T12:33:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"dac075d6-6db0-9369-e516-78c5cddbdae3","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/57c26507-3c44-d44f-ecd3-0bb1cb0ab745"},"effectiveDateTime":"2022-09-30T12:33:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"5d5eb639-660e-144b-271f-14256b7d094c","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/57c26507-3c44-d44f-ecd3-0bb1cb0ab745"},"effectiveDateTime":"2022-10-01T16:37:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"00df727a-8f8f-62a5-56e2-61dabb070aab","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/57c26507-3c44-d44f-ecd3-0bb1cb0ab745"},"effectiveDateTime":"2022-10-01T16:37:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"12f7d912-5fba-fd48-15e7-393e07650d9e","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/57c26507-3c44-d44f-ecd3-0bb1cb0ab745"},"effectiveDateTime":"2022-10-02T20:35:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"68927e7c-dbae-92c6-10d3-b688992f4165","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/57c26507-3c44-d44f-ecd3-0bb1cb0ab745"},"effectiveDateTime":"2022-10-02T20:35:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"9b5dbfb0-b43d-4bdf-8c95-cb6e34eca5c1","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/57c26507-3c44-d44f-ecd3-0bb1cb0ab745"},"effectiveDateTime":"2022-10-03T23:51:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"bd96e420-9d7c-0801-b632-e9ff5dd3b4f2","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/57c26507-3c44-d44f-ecd3-0bb1cb0ab745"},"effectiveDateTime":"2022-10-03T23:51:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"86eb661a-e6f7-aea4-f95b-7d95e857d1fd","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/57c26507-3c44-d44f-ecd3-0bb1cb0ab745"},"effectiveDateTime":"2022-10-05T02:37:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"cf7ae0a6-573f-ade2-d851-3d425d1e6e3a","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/57c26507-3c44-d44f-ecd3-0bb1cb0ab745"},"effectiveDateTime":"2022-10-05T02:37:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"c6d7af88-ac4c-74cc-77ed-47752a954198","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1665060","display":"cefazolin 2000 MG Injection"}],"text":"cefazolin 2000 MG Injection"},"subject":{"reference":"Patient/7c31d354-ec90-25ae-5fb4-5268c6d29116"},"context":{"reference":"Encounter/eff318fe-b219-1013-f2fc-be91831c8795"},"effectiveDateTime":"2016-01-02T00:43:06-05:00"}
{"resourceType":"MedicationAdministration","id":"f10fefde-9c94-35bd-bddb-a0f43480b406","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1361226","display":"heparin sodium, porcine 1000 UNT/ML Injectable Solution"}],"text":"heparin sodium, porcine 1000 UNT/ML Injectable Solution"},"subject":{"reference":"Patient/7c31d354-ec90-25ae-5fb4-5268c6d29116"},"context":{"reference":"Encounter/eff318fe-b219-1013-f2fc-be91831c8795"},"effectiveDateTime":"2016-01-02T00:43:06-05:00"}
{"resourceType":"MedicationAdministration","id":"862bfe05-d2c1-37e8-b3c9-0e11ad879acc","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/c1c38fed-6d8a-1937-3897-9bf237344c7c"},"context":{"reference":"Encounter/d75c790b-dfcd-4e30-a567-c0d97151bf75"},"effectiveDateTime":"2022-03-24T02:22:23-04:00","reasonReference":[{"reference":"Condition/c724361c-33de-d59b-b868-8bb397c0d360","display":"Gingivitis (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"9e5bf46a-b252-fa6c-101c-5256b852dbe8","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/6751dc7c-7dbe-191b-5a3e-257ef8f68a31"},"effectiveDateTime":"2022-10-29T20:01:36-04:00","reasonCode":[{"coding":[{"system":"http://snomed.info/sct","code":"103697008","display":"Patient referral for dental care (procedure)"}],"text":"Patient referral for dental care (procedure)"}]}
{"resourceType":"MedicationAdministration","id":"865cde43-d7d4-a84d-0718-b65029ad81e1","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/f3a1ed27-0f02-ea4b-618c-841ebc6b48de"},"effectiveDateTime":"2022-11-06T18:17:59-05:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"b54b4b72-8f7c-fe1c-3610-690028b509da","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/f3a1ed27-0f02-ea4b-618c-841ebc6b48de"},"effectiveDateTime":"2022-11-06T18:17:59-05:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"219303ee-0f7d-02a1-a258-d719ccb50e5e","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/f3a1ed27-0f02-ea4b-618c-841ebc6b48de"},"effectiveDateTime":"2022-11-07T20:44:59-05:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"8f091a0d-89f0-8407-ec3b-d5e10aac5c13","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/f3a1ed27-0f02-ea4b-618c-841ebc6b48de"},"effectiveDateTime":"2022-11-07T20:44:59-05:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"14a52ceb-8f10-926d-b177-9d030a121f83","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/f3a1ed27-0f02-ea4b-618c-841ebc6b48de"},"effectiveDateTime":"2022-11-08T23:33:59-05:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"ee6d9500-ee4b-9f11-7b84-31d35e631a13","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/f3a1ed27-0f02-ea4b-618c-841ebc6b48de"},"effectiveDateTime":"2022-11-08T23:33:59-05:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"45071c65-77a6-84e8-056a-be9332428ac7","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/f3a1ed27-0f02-ea4b-618c-841ebc6b48de"},"effectiveDateTime":"2022-11-10T02:30:59-05:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"63b080ab-627d-1e55-7a8d-d6ae51dd5026","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/f3a1ed27-0f02-ea4b-618c-841ebc6b48de"},"effectiveDateTime":"2022-11-10T02:30:59-05:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"7027bbaa-3fb5-4a5a-5c2d-fb146cdf0ab8","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/f3a1ed27-0f02-ea4b-618c-841ebc6b48de"},"effectiveDateTime":"2022-11-11T03:06:59-05:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"5b5db806-9ef8-a913-0095-c3c41fc09659","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/f3a1ed27-0f02-ea4b-618c-841ebc6b48de"},"effectiveDateTime":"2022-11-11T03:06:59-05:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"3c00fdf1-31f5-3ae8-537b-ff8264485558","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/f3a1ed27-0f02-ea4b-618c-841ebc6b48de"},"effectiveDateTime":"2022-11-12T04:08:59-05:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"c32d993e-3ee7-abc1-5c01-19fa16f43554","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/f3a1ed27-0f02-ea4b-618c-841ebc6b48de"},"effectiveDateTime":"2022-11-12T04:08:59-05:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"8a5e2e91-9a9e-eb69-0285-30094ab816ce","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/f3a1ed27-0f02-ea4b-618c-841ebc6b48de"},"effectiveDateTime":"2022-11-13T08:23:59-05:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"0e96bd7c-983a-0b9f-13f6-ec729b5f782e","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/f3a1ed27-0f02-ea4b-618c-841ebc6b48de"},"effectiveDateTime":"2022-11-13T08:23:59-05:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"fef6a1c3-0939-8d5b-0ab4-228d2674ce94","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/f3a1ed27-0f02-ea4b-618c-841ebc6b48de"},"effectiveDateTime":"2022-11-14T12:39:59-05:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"ad3533c5-462a-bcdf-fe1f-0dcf0688a8e5","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/f3a1ed27-0f02-ea4b-618c-841ebc6b48de"},"effectiveDateTime":"2022-11-14T12:39:59-05:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"83952770-a2a8-a56f-74cf-c37681690adb","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/f3a1ed27-0f02-ea4b-618c-841ebc6b48de"},"effectiveDateTime":"2022-11-15T15:50:59-05:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"9e104d27-18b8-d052-fe3f-432a44185a27","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/f3a1ed27-0f02-ea4b-618c-841ebc6b48de"},"effectiveDateTime":"2022-11-15T15:50:59-05:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"9b2d98f0-214f-765f-5b01-19abf95c2e8d","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/f3a1ed27-0f02-ea4b-618c-841ebc6b48de"},"effectiveDateTime":"2022-11-16T16:44:59-05:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"0b75176c-b22b-6130-7973-b37290ebc6f1","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/f3a1ed27-0f02-ea4b-618c-841ebc6b48de"},"effectiveDateTime":"2022-11-16T16:44:59-05:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"85410080-ee67-78bd-1da4-e8eb5e7ef3bf","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/f3a1ed27-0f02-ea4b-618c-841ebc6b48de"},"effectiveDateTime":"2022-11-17T18:14:59-05:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"4a7a657c-a3b6-4a23-3680-c70c45600a81","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/f3a1ed27-0f02-ea4b-618c-841ebc6b48de"},"effectiveDateTime":"2022-11-17T18:14:59-05:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"de099611-9d5e-f164-f8fe-6454c65de21c","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/f13f51ad-3c0e-9806-fac5-8a349a522083"},"context":{"reference":"Encounter/e1834f4d-eaa5-3773-cc01-9045dc953159"},"effectiveDateTime":"2024-05-11T01:11:58-04:00","reasonReference":[{"reference":"Condition/a7c7a568-fe7b-1917-5bd5-32553fd3ce00","display":"Gingivitis (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"f246a693-7c1f-a64c-1e48-6bf3ab15a9da","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/04da3638-2010-064b-5dc1-7cd797cd6cd5"},"effectiveDateTime":"2022-12-23T15:23:59-05:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"5c0d8ce6-9ae8-39f4-2ad1-e6321eeb30a6","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/c1c38fed-6d8a-1937-3897-9bf237344c7c"},"context":{"reference":"Encounter/137cb171-33a6-a224-1d8e-188e12cd5b05"},"effectiveDateTime":"2022-05-05T01:49:45-04:00","reasonReference":[{"reference":"Condition/c724361c-33de-d59b-b868-8bb397c0d360","display":"Gingivitis (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"4f6c4252-ff61-b8d6-af7a-69547711d53f","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/04da3638-2010-064b-5dc1-7cd797cd6cd5"},"effectiveDateTime":"2022-12-23T15:23:59-05:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"a78ab9de-5f2a-233f-a952-b821d19a3aba","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/04da3638-2010-064b-5dc1-7cd797cd6cd5"},"effectiveDateTime":"2022-12-24T17:37:59-05:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"605e3543-1fbe-d276-9785-36bacfdb525a","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/04da3638-2010-064b-5dc1-7cd797cd6cd5"},"effectiveDateTime":"2022-12-24T17:37:59-05:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"7f87bba9-9346-7f74-b793-792a77f10fe5","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/04da3638-2010-064b-5dc1-7cd797cd6cd5"},"effectiveDateTime":"2022-12-25T18:35:59-05:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"00c06aec-ab0f-7278-1d16-6ddc0b489d1c","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/04da3638-2010-064b-5dc1-7cd797cd6cd5"},"effectiveDateTime":"2022-12-25T18:35:59-05:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"aef3828d-8e37-5417-0545-28210ef32c26","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/04da3638-2010-064b-5dc1-7cd797cd6cd5"},"effectiveDateTime":"2022-12-26T21:45:59-05:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"345e33dc-54a7-f13d-7f85-355404c49de0","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/04da3638-2010-064b-5dc1-7cd797cd6cd5"},"effectiveDateTime":"2022-12-26T21:45:59-05:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"1cca1a45-4423-04cf-c2cf-7a743a26e649","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/a686d8e6-50d1-0f9d-75e7-3c9f62b4c1f3"},"effectiveDateTime":"2023-01-25T09:11:59-05:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"7668b883-1a4e-2e53-d454-c0460f9a3813","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/a686d8e6-50d1-0f9d-75e7-3c9f62b4c1f3"},"effectiveDateTime":"2023-01-25T09:11:59-05:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"2e17a5ed-e7d8-59dc-0377-d4e3ebbcb7cc","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/a686d8e6-50d1-0f9d-75e7-3c9f62b4c1f3"},"effectiveDateTime":"2023-01-26T12:06:59-05:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"272ba091-ba60-5b28-3ea6-a283e9584598","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/a686d8e6-50d1-0f9d-75e7-3c9f62b4c1f3"},"effectiveDateTime":"2023-01-26T12:06:59-05:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"c0a2159f-34b4-a6f8-00d1-80bf82bdf9b1","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/c1c38fed-6d8a-1937-3897-9bf237344c7c"},"context":{"reference":"Encounter/d56abeb1-75fb-bb25-e7d9-6e5d05b88171"},"effectiveDateTime":"2022-06-16T02:31:05-04:00","reasonReference":[{"reference":"Condition/c724361c-33de-d59b-b868-8bb397c0d360","display":"Gingivitis (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"ee973e10-6d30-903e-e3f7-6d0671179a14","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/a686d8e6-50d1-0f9d-75e7-3c9f62b4c1f3"},"effectiveDateTime":"2023-01-27T13:00:59-05:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"0d6fb7eb-397a-dae8-24ea-b9debe65d558","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/a686d8e6-50d1-0f9d-75e7-3c9f62b4c1f3"},"effectiveDateTime":"2023-01-27T13:00:59-05:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"8f3de056-64b6-1280-0838-0f1abb1bd3ce","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/7c31d354-ec90-25ae-5fb4-5268c6d29116"},"context":{"reference":"Encounter/dfea8e33-1631-bb3a-e21c-ddc73373418e"},"effectiveDateTime":"2016-10-29T07:26:15-04:00","reasonReference":[{"reference":"Condition/550e6be8-3f0a-2a10-20d7-ad363d8b12a2","display":"Gingivitis (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"e67a7b81-cf5c-fb3c-6774-ea50649506fa","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/a686d8e6-50d1-0f9d-75e7-3c9f62b4c1f3"},"effectiveDateTime":"2023-01-28T14:06:59-05:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"b791be01-6b7f-1714-9652-3b38d2c9b31a","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/a686d8e6-50d1-0f9d-75e7-3c9f62b4c1f3"},"effectiveDateTime":"2023-01-28T14:06:59-05:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"5fa0097b-34ef-a55c-6b5d-8a765d407694","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/a686d8e6-50d1-0f9d-75e7-3c9f62b4c1f3"},"effectiveDateTime":"2023-01-29T17:07:59-05:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"972bdcf6-da97-7ceb-399b-f471dc8dcd8d","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/a686d8e6-50d1-0f9d-75e7-3c9f62b4c1f3"},"effectiveDateTime":"2023-01-29T17:07:59-05:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"aa436922-1e3c-5e81-f51b-db491fb40ea3","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/6edf8bc3-cd90-d6c8-91fd-b372f3a98b94"},"effectiveDateTime":"2023-03-06T17:23:59-05:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"30ea1b4f-38eb-e045-3f2f-7b7e2ef029a0","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/6edf8bc3-cd90-d6c8-91fd-b372f3a98b94"},"effectiveDateTime":"2023-03-06T17:23:59-05:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"c5f0f1e6-41dd-1611-f4e6-f6326ab15b71","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/6edf8bc3-cd90-d6c8-91fd-b372f3a98b94"},"effectiveDateTime":"2023-03-07T19:31:59-05:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"9e5c97c4-fa65-45d1-281c-f5b102fd977a","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/6edf8bc3-cd90-d6c8-91fd-b372f3a98b94"},"effectiveDateTime":"2023-03-07T19:31:59-05:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"5e5f4470-4639-aa68-a81f-a25c4ed7a0c4","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/6edf8bc3-cd90-d6c8-91fd-b372f3a98b94"},"effectiveDateTime":"2023-03-08T21:49:59-05:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"3697d070-914b-ae52-9483-d90e87a7f812","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/6edf8bc3-cd90-d6c8-91fd-b372f3a98b94"},"effectiveDateTime":"2023-03-08T21:49:59-05:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"3db89241-8c12-420f-9139-4e199ea71611","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/f5d93b3a-40a2-26f1-c1b1-44bba844f76b"},"effectiveDateTime":"2023-04-11T10:30:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"5ff14205-7b76-014c-97fc-ff86a4c34171","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/f5d93b3a-40a2-26f1-c1b1-44bba844f76b"},"effectiveDateTime":"2023-04-11T10:30:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"2d761da9-76f1-df6a-0026-312a32c9f20b","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/f5d93b3a-40a2-26f1-c1b1-44bba844f76b"},"effectiveDateTime":"2023-04-12T14:27:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"42f45e60-6d62-6d26-0352-4a69bdcbc530","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/f5d93b3a-40a2-26f1-c1b1-44bba844f76b"},"effectiveDateTime":"2023-04-12T14:27:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"edd4edb2-fc19-836a-2fe7-5dca771bd8f1","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/f5d93b3a-40a2-26f1-c1b1-44bba844f76b"},"effectiveDateTime":"2023-04-13T16:57:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"5d2930fe-9ca5-5fa3-1901-43aaceb5f324","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/f5d93b3a-40a2-26f1-c1b1-44bba844f76b"},"effectiveDateTime":"2023-04-13T16:57:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"d0e61fb1-354d-2cbb-4be8-76af4a4f9cd3","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/f5d93b3a-40a2-26f1-c1b1-44bba844f76b"},"effectiveDateTime":"2023-04-14T20:19:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"6ec07396-fbd0-2f19-0f16-76865c1b0edc","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/f5d93b3a-40a2-26f1-c1b1-44bba844f76b"},"effectiveDateTime":"2023-04-14T20:19:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"aa2d275a-3724-2498-b757-c36015e4bab8","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/f5d93b3a-40a2-26f1-c1b1-44bba844f76b"},"effectiveDateTime":"2023-04-16T00:26:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"bc5e334a-3118-26f8-0705-34c1e13daefc","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/f5d93b3a-40a2-26f1-c1b1-44bba844f76b"},"effectiveDateTime":"2023-04-16T00:26:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"eb410d55-1aef-0e17-37f9-171578db177f","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/f5d93b3a-40a2-26f1-c1b1-44bba844f76b"},"effectiveDateTime":"2023-04-17T01:07:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"77350329-4bd1-dd25-4a63-0599634cdf7f","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/f5d93b3a-40a2-26f1-c1b1-44bba844f76b"},"effectiveDateTime":"2023-04-17T01:07:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"51893731-7de2-2179-01ae-eac03e8922f1","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/f5d93b3a-40a2-26f1-c1b1-44bba844f76b"},"effectiveDateTime":"2023-04-18T03:10:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"02d9f23d-d5aa-0d5c-0e97-736b72201294","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/f5d93b3a-40a2-26f1-c1b1-44bba844f76b"},"effectiveDateTime":"2023-04-18T03:10:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"7a3a0376-a175-48a0-6643-75a8f61f08fe","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/f5d93b3a-40a2-26f1-c1b1-44bba844f76b"},"effectiveDateTime":"2023-04-19T03:54:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"787b2295-d01a-99b0-6e7f-dbaefa6ff9df","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/f5d93b3a-40a2-26f1-c1b1-44bba844f76b"},"effectiveDateTime":"2023-04-19T03:54:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"08332648-282d-2c88-8335-8431c8cf9c9f","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/f5d93b3a-40a2-26f1-c1b1-44bba844f76b"},"effectiveDateTime":"2023-04-20T05:19:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"d80488a0-eb3b-e52e-0c18-dea3da9c30ec","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/f5d93b3a-40a2-26f1-c1b1-44bba844f76b"},"effectiveDateTime":"2023-04-20T05:19:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"b7c3ebad-7db3-9f76-cabe-43d891345b4e","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/f5d93b3a-40a2-26f1-c1b1-44bba844f76b"},"effectiveDateTime":"2023-04-21T07:03:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"ac15be18-377f-808a-9b76-0a01982bd68d","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/f5d93b3a-40a2-26f1-c1b1-44bba844f76b"},"effectiveDateTime":"2023-04-21T07:03:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"16d8c770-e885-f940-19c8-27bd020d4e96","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/f5d93b3a-40a2-26f1-c1b1-44bba844f76b"},"effectiveDateTime":"2023-04-22T11:06:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"e0c8c973-ffe3-2737-bf89-61a70e8dc33d","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/f5d93b3a-40a2-26f1-c1b1-44bba844f76b"},"effectiveDateTime":"2023-04-22T11:06:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"077a5ec7-43b2-f7cc-434f-96d3013428de","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/f5d93b3a-40a2-26f1-c1b1-44bba844f76b"},"effectiveDateTime":"2023-04-23T12:10:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"90796fb6-1699-ad52-ee65-793ea8785712","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/f5d93b3a-40a2-26f1-c1b1-44bba844f76b"},"effectiveDateTime":"2023-04-23T12:10:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"c66816f0-b39b-ef99-2bc5-d912481b6837","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/f13f51ad-3c0e-9806-fac5-8a349a522083"},"context":{"reference":"Encounter/67883ea2-b2ed-251b-d78d-e767e80fe58e"},"effectiveDateTime":"2024-11-30T00:33:00-05:00","reasonReference":[{"reference":"Condition/a7c7a568-fe7b-1917-5bd5-32553fd3ce00","display":"Gingivitis (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"a17f0611-d4ea-bfae-e1a2-8354fde9b0ef","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/f13f51ad-3c0e-9806-fac5-8a349a522083"},"context":{"reference":"Encounter/1645a904-b725-9902-6105-2b21af802d64"},"effectiveDateTime":"2024-12-10T01:20:41-05:00","reasonReference":[{"reference":"Condition/99f3a74f-cfdf-01fc-c0e9-f8cd4fce9ea4","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"3e2fadde-2016-35ea-8ef9-ed9a70e7a63a","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/f13f51ad-3c0e-9806-fac5-8a349a522083"},"context":{"reference":"Encounter/8234af8e-9c9d-fbfe-2fa9-f0942b6ea7c9"},"effectiveDateTime":"2024-12-13T04:43:41-05:00","reasonReference":[{"reference":"Condition/99f3a74f-cfdf-01fc-c0e9-f8cd4fce9ea4","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"aeaf28f5-c900-2dc8-c303-69b61d32bdb7","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/f13f51ad-3c0e-9806-fac5-8a349a522083"},"context":{"reference":"Encounter/fd88c9ad-5dd5-45da-b968-b19b3186269d"},"effectiveDateTime":"2024-12-16T07:02:41-05:00","reasonReference":[{"reference":"Condition/99f3a74f-cfdf-01fc-c0e9-f8cd4fce9ea4","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"f992be0c-46df-8089-e8f3-0f123aa9d68c","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/a7f31c06-7802-47d4-cff6-f954086561e6"},"effectiveDateTime":"2023-05-23T01:21:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"f5686ed1-f527-7943-fa96-852f7dd4718c","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/7c31d354-ec90-25ae-5fb4-5268c6d29116"},"context":{"reference":"Encounter/f9b10b87-6436-bde3-154a-e5fc3fd7c45e"},"effectiveDateTime":"2019-11-16T03:48:01-05:00","reasonReference":[{"reference":"Condition/550e6be8-3f0a-2a10-20d7-ad363d8b12a2","display":"Gingivitis (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"9762398e-e238-bc56-7c89-3b0692613f50","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/a7f31c06-7802-47d4-cff6-f954086561e6"},"effectiveDateTime":"2023-05-23T01:21:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"0bc5b2fc-177d-43ff-8d0a-7f446cb54fbc","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/a7f31c06-7802-47d4-cff6-f954086561e6"},"effectiveDateTime":"2023-05-24T03:38:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"372b851e-5f29-859c-e19b-9c9961b31e2c","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/a7f31c06-7802-47d4-cff6-f954086561e6"},"effectiveDateTime":"2023-05-24T03:38:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"0c960e31-58bb-d9b9-58e1-ab7481bacb00","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/f13f51ad-3c0e-9806-fac5-8a349a522083"},"context":{"reference":"Encounter/4fa173cd-095d-348e-109d-a4d93a99e7f1"},"effectiveDateTime":"2024-12-19T10:48:41-05:00","reasonReference":[{"reference":"Condition/99f3a74f-cfdf-01fc-c0e9-f8cd4fce9ea4","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"dd5e37bb-0faf-f5cb-871e-95a719dc0240","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/a7f31c06-7802-47d4-cff6-f954086561e6"},"effectiveDateTime":"2023-05-25T06:02:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"ea1e518c-dfc0-4a04-4a6f-b1f085164cf4","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/a7f31c06-7802-47d4-cff6-f954086561e6"},"effectiveDateTime":"2023-05-25T06:02:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"aa843c26-8afa-98b8-a089-54e2bd8ff8e7","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/a7f31c06-7802-47d4-cff6-f954086561e6"},"effectiveDateTime":"2023-05-26T07:18:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"a7da7965-f2b9-08c2-fcc6-6e7296b4cde7","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/f13f51ad-3c0e-9806-fac5-8a349a522083"},"context":{"reference":"Encounter/8b9cd367-04e9-de4e-3fe2-e63ee9536784"},"effectiveDateTime":"2024-12-22T14:40:41-05:00","reasonReference":[{"reference":"Condition/99f3a74f-cfdf-01fc-c0e9-f8cd4fce9ea4","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"dec91bd6-cf6f-9489-b6dd-7ec799c31545","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/a7f31c06-7802-47d4-cff6-f954086561e6"},"effectiveDateTime":"2023-05-26T07:18:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"8005b29f-6426-50cd-00c1-8ab3d2ba3b61","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/a7f31c06-7802-47d4-cff6-f954086561e6"},"effectiveDateTime":"2023-05-27T10:25:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"bed54ddb-4f5e-21ec-b41f-0e393b685936","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/a7f31c06-7802-47d4-cff6-f954086561e6"},"effectiveDateTime":"2023-05-27T10:25:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"bfbd2672-ac84-2963-d33d-e24ac0fd7439","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/a7f31c06-7802-47d4-cff6-f954086561e6"},"effectiveDateTime":"2023-05-28T11:23:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"5da5c2c6-81ee-cceb-034f-c03f23834c64","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/f13f51ad-3c0e-9806-fac5-8a349a522083"},"context":{"reference":"Encounter/4cf2c197-7817-779d-dcd4-a011811668da"},"effectiveDateTime":"2024-12-25T17:03:41-05:00","reasonReference":[{"reference":"Condition/99f3a74f-cfdf-01fc-c0e9-f8cd4fce9ea4","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"a5d455bc-27a3-ec4e-499e-ac6cc3a9cb0f","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/a7f31c06-7802-47d4-cff6-f954086561e6"},"effectiveDateTime":"2023-05-28T11:23:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"b97e2676-13b6-4a31-a588-68f377800a8f","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/a7f31c06-7802-47d4-cff6-f954086561e6"},"effectiveDateTime":"2023-05-29T14:37:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"843c04ba-7e94-7659-895d-436c63f4a54f","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/a7f31c06-7802-47d4-cff6-f954086561e6"},"effectiveDateTime":"2023-05-29T14:37:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"46e06c6a-ff78-c2d6-250a-17d8ae2127f6","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/f13f51ad-3c0e-9806-fac5-8a349a522083"},"context":{"reference":"Encounter/2e840807-eac2-5135-3658-f825645ccbb3"},"effectiveDateTime":"2024-12-28T20:42:41-05:00","reasonReference":[{"reference":"Condition/99f3a74f-cfdf-01fc-c0e9-f8cd4fce9ea4","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"8af8d3f3-bec0-2b80-9ca1-39139cea1696","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/f13f51ad-3c0e-9806-fac5-8a349a522083"},"context":{"reference":"Encounter/5a3934a5-3fe5-1e08-3c89-cf2118830f14"},"effectiveDateTime":"2024-12-31T22:52:41-05:00","reasonReference":[{"reference":"Condition/99f3a74f-cfdf-01fc-c0e9-f8cd4fce9ea4","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"ac97c1b5-b45b-f011-101b-c4ac68c5a5b5","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/c1c38fed-6d8a-1937-3897-9bf237344c7c"},"context":{"reference":"Encounter/969e7333-f506-7e03-7e55-8600a98a2aaf"},"effectiveDateTime":"2023-10-05T02:32:21-04:00","reasonCode":[{"coding":[{"system":"http://snomed.info/sct","code":"103697008","display":"Patient referral for dental care (procedure)"}],"text":"Patient referral for dental care (procedure)"}]}
{"resourceType":"MedicationAdministration","id":"4e15ed04-7fd4-1007-3376-1bfa85475542","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/d684f54d-c2c3-f40f-b7a2-17b8579fb17b"},"effectiveDateTime":"2023-06-30T11:09:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"c37c80a2-a154-70b7-172a-d6a590b4c7ec","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/d684f54d-c2c3-f40f-b7a2-17b8579fb17b"},"effectiveDateTime":"2023-06-30T11:09:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"1350c8f7-40a1-b610-4246-ce6d63a82b70","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/d684f54d-c2c3-f40f-b7a2-17b8579fb17b"},"effectiveDateTime":"2023-07-01T13:52:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"1ee29b9d-f1ea-7372-7f11-91a3680d79e7","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/d684f54d-c2c3-f40f-b7a2-17b8579fb17b"},"effectiveDateTime":"2023-07-01T13:52:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"e0b29645-4770-5bdb-d285-892f07ce47e6","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/d684f54d-c2c3-f40f-b7a2-17b8579fb17b"},"effectiveDateTime":"2023-07-02T15:44:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"1a9c4c76-d9f3-5fa5-d674-625a7fd93325","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/d684f54d-c2c3-f40f-b7a2-17b8579fb17b"},"effectiveDateTime":"2023-07-02T15:44:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"5be15bf8-3d5b-4de6-66d8-e8ad871babd2","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/d684f54d-c2c3-f40f-b7a2-17b8579fb17b"},"effectiveDateTime":"2023-07-03T18:25:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"3a3d1762-3e0d-7c12-0591-b3681cce2b8b","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/d684f54d-c2c3-f40f-b7a2-17b8579fb17b"},"effectiveDateTime":"2023-07-03T18:25:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"047d1764-61c8-faf3-3ea1-b36a4089aac3","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/d684f54d-c2c3-f40f-b7a2-17b8579fb17b"},"effectiveDateTime":"2023-07-04T19:53:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"a996bbb6-f761-5eab-ce32-c195b8112ee5","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/d684f54d-c2c3-f40f-b7a2-17b8579fb17b"},"effectiveDateTime":"2023-07-04T19:53:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"67298ecd-13e4-da46-c182-a372570dd937","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/f13f51ad-3c0e-9806-fac5-8a349a522083"},"context":{"reference":"Encounter/ecd11d27-3ee8-dae6-a9a6-7c30fc1fa023"},"effectiveDateTime":"2025-01-18T01:02:41-05:00","reasonReference":[{"reference":"Condition/99f3a74f-cfdf-01fc-c0e9-f8cd4fce9ea4","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"8e1656d7-abe0-f4f9-d376-85cdb162649b","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/d684f54d-c2c3-f40f-b7a2-17b8579fb17b"},"effectiveDateTime":"2023-07-05T23:11:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"1e9765df-115e-aa12-7ec6-5be492ce4c57","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/d684f54d-c2c3-f40f-b7a2-17b8579fb17b"},"effectiveDateTime":"2023-07-05T23:11:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"20ccba7f-422a-5ae8-3847-bd41535d7558","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/d684f54d-c2c3-f40f-b7a2-17b8579fb17b"},"effectiveDateTime":"2023-07-07T00:20:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"437787ea-5c9e-ce26-03d5-73f564e39a90","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/d684f54d-c2c3-f40f-b7a2-17b8579fb17b"},"effectiveDateTime":"2023-07-07T00:20:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"324fcad4-cdc0-5483-92a8-384c0f165772","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/d684f54d-c2c3-f40f-b7a2-17b8579fb17b"},"effectiveDateTime":"2023-07-08T01:34:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"1ad6c543-d89a-0148-1dc6-259c4611429e","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/d684f54d-c2c3-f40f-b7a2-17b8579fb17b"},"effectiveDateTime":"2023-07-08T01:34:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"187f338f-7fe6-013d-1b20-76b87ed75d9b","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/f13f51ad-3c0e-9806-fac5-8a349a522083"},"context":{"reference":"Encounter/66a88669-6c9c-8a5e-aed8-e6f6d85d5a7c"},"effectiveDateTime":"2025-01-21T04:19:41-05:00","reasonReference":[{"reference":"Condition/99f3a74f-cfdf-01fc-c0e9-f8cd4fce9ea4","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"7e151046-73c0-aaed-0e04-262c281c3f20","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/f13f51ad-3c0e-9806-fac5-8a349a522083"},"context":{"reference":"Encounter/7d06e3d7-9af7-fe85-0c12-767a7592383c"},"effectiveDateTime":"2025-01-24T06:29:41-05:00","reasonReference":[{"reference":"Condition/99f3a74f-cfdf-01fc-c0e9-f8cd4fce9ea4","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"25bcf55c-bad0-0846-41a6-0ea4b25b0b4d","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/f13f51ad-3c0e-9806-fac5-8a349a522083"},"context":{"reference":"Encounter/3f8fba3e-e6f9-dc50-19bc-cebcad1b3892"},"effectiveDateTime":"2025-01-27T09:52:41-05:00","reasonReference":[{"reference":"Condition/99f3a74f-cfdf-01fc-c0e9-f8cd4fce9ea4","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"cc25b6da-57e4-f136-90e2-7934de36ef19","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/f13f51ad-3c0e-9806-fac5-8a349a522083"},"context":{"reference":"Encounter/85b4e7ec-5288-6909-05a5-3ddac18e9870"},"effectiveDateTime":"2025-01-30T12:04:41-05:00","reasonReference":[{"reference":"Condition/99f3a74f-cfdf-01fc-c0e9-f8cd4fce9ea4","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"b6d9b99b-2c7f-d3f8-fed1-44be52dffd11","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/f13f51ad-3c0e-9806-fac5-8a349a522083"},"context":{"reference":"Encounter/a4a27097-ee2d-6fe6-9c48-079b98d93d97"},"effectiveDateTime":"2025-02-02T15:34:41-05:00","reasonReference":[{"reference":"Condition/99f3a74f-cfdf-01fc-c0e9-f8cd4fce9ea4","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"a4e05e95-70fa-f597-3e7d-347a7d9ef15d","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/f13f51ad-3c0e-9806-fac5-8a349a522083"},"context":{"reference":"Encounter/49f2ed74-7a01-823d-e458-8f59cb036de1"},"effectiveDateTime":"2025-02-05T18:29:41-05:00","reasonReference":[{"reference":"Condition/99f3a74f-cfdf-01fc-c0e9-f8cd4fce9ea4","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"76964beb-5d01-811f-23c5-00439ae281dd","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/c1c38fed-6d8a-1937-3897-9bf237344c7c"},"context":{"reference":"Encounter/ed742f0f-db16-497a-90ba-28bfb2e801e7"},"effectiveDateTime":"2023-12-07T01:30:31-05:00","reasonCode":[{"coding":[{"system":"http://snomed.info/sct","code":"103697008","display":"Patient referral for dental care (procedure)"}],"text":"Patient referral for dental care (procedure)"}]}
{"resourceType":"MedicationAdministration","id":"0b05869e-17cb-b7a1-9f38-168d2e523d6b","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/f13f51ad-3c0e-9806-fac5-8a349a522083"},"context":{"reference":"Encounter/2f3b7cb5-4db4-f04e-8ce8-87a0672d8857"},"effectiveDateTime":"2025-02-08T21:13:41-05:00","reasonReference":[{"reference":"Condition/99f3a74f-cfdf-01fc-c0e9-f8cd4fce9ea4","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"6c73f43a-97f0-dcce-4140-934d1e42dab1","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/f13f51ad-3c0e-9806-fac5-8a349a522083"},"context":{"reference":"Encounter/8601647c-7213-0210-14be-8ea342b1a97f"},"effectiveDateTime":"2025-02-11T23:29:41-05:00","reasonReference":[{"reference":"Condition/99f3a74f-cfdf-01fc-c0e9-f8cd4fce9ea4","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"e4a94ae6-ffb0-597f-fc35-098693311557","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/380f3dab-6cbc-51f7-3642-8a96a3e7e0b8"},"effectiveDateTime":"2023-08-12T19:57:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"65f69dad-7ab9-3f56-2496-312e369156e2","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/380f3dab-6cbc-51f7-3642-8a96a3e7e0b8"},"effectiveDateTime":"2023-08-12T19:57:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"3914edc9-509d-8561-d9af-5de0cba07853","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/380f3dab-6cbc-51f7-3642-8a96a3e7e0b8"},"effectiveDateTime":"2023-08-13T23:32:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"ac40eb8c-fe94-c8bb-b226-d0ce33f4f7b1","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/380f3dab-6cbc-51f7-3642-8a96a3e7e0b8"},"effectiveDateTime":"2023-08-13T23:32:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"98e9173d-8b44-609c-5265-b3436a051db5","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/380f3dab-6cbc-51f7-3642-8a96a3e7e0b8"},"effectiveDateTime":"2023-08-15T02:21:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"bdbd2980-078f-4ae3-513d-e5581f326213","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/380f3dab-6cbc-51f7-3642-8a96a3e7e0b8"},"effectiveDateTime":"2023-08-15T02:21:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"a48afe18-fe59-11ca-b062-4f5a08196fb6","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/380f3dab-6cbc-51f7-3642-8a96a3e7e0b8"},"effectiveDateTime":"2023-08-16T05:15:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"babdab17-6396-b6c9-7b7b-202b7432bca8","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/380f3dab-6cbc-51f7-3642-8a96a3e7e0b8"},"effectiveDateTime":"2023-08-16T05:15:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"42f3d3ca-58cd-ad26-0351-bfd6cc3a9d50","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/230cf4d9-01db-2ad8-e018-95c36977fb12"},"effectiveDateTime":"2023-09-15T12:46:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"60b225ec-179d-e60a-27e8-f4eeb3a3c4cb","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/230cf4d9-01db-2ad8-e018-95c36977fb12"},"effectiveDateTime":"2023-09-15T12:46:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"56ebbdee-7386-1d73-b95b-d56976a452fb","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/230cf4d9-01db-2ad8-e018-95c36977fb12"},"effectiveDateTime":"2023-09-16T13:59:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"fc4e0bed-ffb1-9b84-153f-b8311332575d","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/230cf4d9-01db-2ad8-e018-95c36977fb12"},"effectiveDateTime":"2023-09-16T13:59:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"d3086b5a-08d5-a696-36fd-f9785ed895f7","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/230cf4d9-01db-2ad8-e018-95c36977fb12"},"effectiveDateTime":"2023-09-17T17:17:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"5d6d9293-4da9-8897-4ccd-f688dbc7de9a","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/230cf4d9-01db-2ad8-e018-95c36977fb12"},"effectiveDateTime":"2023-09-17T17:17:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"c3af9d3c-ad74-c5a4-fc83-1df8858dcefb","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/230cf4d9-01db-2ad8-e018-95c36977fb12"},"effectiveDateTime":"2023-09-18T21:08:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"9252a631-2e84-1d30-b37d-8d4b9e9b9833","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/230cf4d9-01db-2ad8-e018-95c36977fb12"},"effectiveDateTime":"2023-09-18T21:08:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"337d93a2-83c5-79f0-b0b5-9f60056fb42d","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/279de697-b58e-4cc4-8ce0-deb56332eb84"},"effectiveDateTime":"2023-10-28T17:12:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"db2c88a3-2754-52b7-6a8b-dea616b4bd46","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/279de697-b58e-4cc4-8ce0-deb56332eb84"},"effectiveDateTime":"2023-10-28T17:12:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"995e0b41-2e3c-8a9e-ef33-eafb9e5405a1","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/279de697-b58e-4cc4-8ce0-deb56332eb84"},"effectiveDateTime":"2023-10-29T18:56:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"38b626f8-853c-d55c-4473-a8a3702cb294","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/279de697-b58e-4cc4-8ce0-deb56332eb84"},"effectiveDateTime":"2023-10-29T18:56:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"2bc07c53-47e2-dfa1-e798-970d21277321","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/279de697-b58e-4cc4-8ce0-deb56332eb84"},"effectiveDateTime":"2023-10-30T20:57:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"08dec1b6-2446-a475-5ee1-b1168f2e0987","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/279de697-b58e-4cc4-8ce0-deb56332eb84"},"effectiveDateTime":"2023-10-30T20:57:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"e3370b7c-27a4-b1a2-b95d-c846c3aa9063","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/279de697-b58e-4cc4-8ce0-deb56332eb84"},"effectiveDateTime":"2023-10-31T22:34:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"375e39dc-3d5f-07bd-6a05-3b53ed94916c","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/279de697-b58e-4cc4-8ce0-deb56332eb84"},"effectiveDateTime":"2023-10-31T22:34:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"7e77d893-df15-0133-a579-504414b5e0ad","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/279de697-b58e-4cc4-8ce0-deb56332eb84"},"effectiveDateTime":"2023-11-02T01:35:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"1dd64e81-b99e-2a76-fc60-0edfa5ab92ad","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/279de697-b58e-4cc4-8ce0-deb56332eb84"},"effectiveDateTime":"2023-11-02T01:35:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"08f2e2ff-0365-13ff-5ef5-d25f741f26d6","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/afc806fa-f5ef-4373-a84f-cc697686ebd7"},"effectiveDateTime":"2023-12-06T00:20:59-05:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"61fab56e-e396-b757-22dc-29949232bd36","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/afc806fa-f5ef-4373-a84f-cc697686ebd7"},"effectiveDateTime":"2023-12-06T00:20:59-05:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"fa064a75-bbf6-7e4b-b788-0e2143cbb657","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/afc806fa-f5ef-4373-a84f-cc697686ebd7"},"effectiveDateTime":"2023-12-07T04:46:59-05:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"bd58c5eb-449e-f610-ec4e-ccf9f2be4b70","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/afc806fa-f5ef-4373-a84f-cc697686ebd7"},"effectiveDateTime":"2023-12-07T04:46:59-05:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"27e13d0b-8832-db0e-c3e7-1bcc6a5e2a62","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/afc806fa-f5ef-4373-a84f-cc697686ebd7"},"effectiveDateTime":"2023-12-08T05:41:59-05:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"89564f08-906a-5dae-7ea0-0f667c788063","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/afc806fa-f5ef-4373-a84f-cc697686ebd7"},"effectiveDateTime":"2023-12-08T05:41:59-05:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"f95e3df7-aa6f-7bef-de05-3f6f5aa81ea3","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/afc806fa-f5ef-4373-a84f-cc697686ebd7"},"effectiveDateTime":"2023-12-09T09:30:59-05:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"6bb7c2ba-c4b5-49e7-57c5-eb67bddf0a45","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/afc806fa-f5ef-4373-a84f-cc697686ebd7"},"effectiveDateTime":"2023-12-09T09:30:59-05:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"63848d1c-27a9-7350-466c-2c72c3af5211","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/afc806fa-f5ef-4373-a84f-cc697686ebd7"},"effectiveDateTime":"2023-12-10T12:32:59-05:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"6e67f409-9198-5da6-2a40-106685833127","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/afc806fa-f5ef-4373-a84f-cc697686ebd7"},"effectiveDateTime":"2023-12-10T12:32:59-05:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"3bce92ac-8056-7e35-f950-593a0fb7b640","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/afc806fa-f5ef-4373-a84f-cc697686ebd7"},"effectiveDateTime":"2023-12-11T16:15:59-05:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"5e651776-5c26-9fd8-2615-b37c3ae7831f","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/afc806fa-f5ef-4373-a84f-cc697686ebd7"},"effectiveDateTime":"2023-12-11T16:15:59-05:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"d3d064f6-bd59-cd3d-e20a-7450c71a2b29","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/afc806fa-f5ef-4373-a84f-cc697686ebd7"},"effectiveDateTime":"2023-12-12T18:31:59-05:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"f28953d7-0269-b4d6-2b71-913f296b2c87","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/afc806fa-f5ef-4373-a84f-cc697686ebd7"},"effectiveDateTime":"2023-12-12T18:31:59-05:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"5fa28435-f650-0e24-97ae-41b7d377dcd1","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/75069aa0-7141-0262-70ee-b36f09ec90be"},"effectiveDateTime":"2024-01-15T18:56:59-05:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"35e9173d-ee25-e218-1d3f-b343cce6d0ac","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/75069aa0-7141-0262-70ee-b36f09ec90be"},"effectiveDateTime":"2024-01-15T18:56:59-05:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"dce306f0-1fa6-99d8-9dd1-efdf0a429fb7","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/75069aa0-7141-0262-70ee-b36f09ec90be"},"effectiveDateTime":"2024-01-16T19:42:59-05:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"3fd39c64-fe14-c396-474a-e3dc5374f28c","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/75069aa0-7141-0262-70ee-b36f09ec90be"},"effectiveDateTime":"2024-01-16T19:42:59-05:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"fa7d8f2a-01c0-5ad5-5af5-2f259a165dc5","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/75069aa0-7141-0262-70ee-b36f09ec90be"},"effectiveDateTime":"2024-01-17T21:03:59-05:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"b86235d3-2021-de75-8489-374ad05dae73","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/75069aa0-7141-0262-70ee-b36f09ec90be"},"effectiveDateTime":"2024-01-17T21:03:59-05:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"03453f52-e4cc-2b48-0634-9fcab2c1c89e","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/75069aa0-7141-0262-70ee-b36f09ec90be"},"effectiveDateTime":"2024-01-18T23:50:59-05:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"73fe88b2-e480-927d-699b-deb5d3e10a4b","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/75069aa0-7141-0262-70ee-b36f09ec90be"},"effectiveDateTime":"2024-01-18T23:50:59-05:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"82714843-18e4-c05e-a972-bff354e13b53","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/75069aa0-7141-0262-70ee-b36f09ec90be"},"effectiveDateTime":"2024-01-20T00:53:59-05:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"c985f677-8bce-5dfb-8707-d65b63779607","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/75069aa0-7141-0262-70ee-b36f09ec90be"},"effectiveDateTime":"2024-01-20T00:53:59-05:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"e21722f5-cca2-8ae8-f992-26b70affd558","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/75069aa0-7141-0262-70ee-b36f09ec90be"},"effectiveDateTime":"2024-01-21T04:10:59-05:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"7a152467-085d-2c28-f518-e5a565a79c3f","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/75069aa0-7141-0262-70ee-b36f09ec90be"},"effectiveDateTime":"2024-01-21T04:10:59-05:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"d6ad38c7-e7af-c244-4e5d-74f36f526946","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/75069aa0-7141-0262-70ee-b36f09ec90be"},"effectiveDateTime":"2024-01-22T07:42:59-05:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"3fd38472-be14-3299-4758-f5671374618f","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/75069aa0-7141-0262-70ee-b36f09ec90be"},"effectiveDateTime":"2024-01-22T07:42:59-05:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"a9d9d329-b13f-ee20-937d-a599c8baf20d","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/b8145ec1-22da-0403-9e5b-152c1ed25139"},"effectiveDateTime":"2024-02-24T02:13:59-05:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"835da5e4-a6c2-881a-6c95-b1a228b8fcec","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/b8145ec1-22da-0403-9e5b-152c1ed25139"},"effectiveDateTime":"2024-02-24T02:13:59-05:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"f0fc450a-00d9-0190-6ec8-9fd456dbf0f1","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/b8145ec1-22da-0403-9e5b-152c1ed25139"},"effectiveDateTime":"2024-02-25T05:41:59-05:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"fe97f2e9-979a-c27d-616e-4559af15c66c","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/b8145ec1-22da-0403-9e5b-152c1ed25139"},"effectiveDateTime":"2024-02-25T05:41:59-05:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"e4d54de5-d956-1213-d8bf-0e43c565d14f","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/b8145ec1-22da-0403-9e5b-152c1ed25139"},"effectiveDateTime":"2024-02-26T08:12:59-05:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"b4c96612-d857-15ed-52c3-5b73074d1dcd","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/b8145ec1-22da-0403-9e5b-152c1ed25139"},"effectiveDateTime":"2024-02-26T08:12:59-05:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"5e1effd3-b23d-7610-8d15-080b0670ab70","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/29aaed4a-ecee-b40d-462e-22c662fa0e07"},"effectiveDateTime":"2024-03-31T10:44:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"ea5a49a6-de5a-98fd-e062-80fb118ff92c","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/29aaed4a-ecee-b40d-462e-22c662fa0e07"},"effectiveDateTime":"2024-03-31T10:44:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"7e755567-87b1-cbc0-a576-cd17c9819cef","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/29aaed4a-ecee-b40d-462e-22c662fa0e07"},"effectiveDateTime":"2024-04-01T11:25:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"5faba369-7b3e-2004-97b7-60eb89bca97d","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/29aaed4a-ecee-b40d-462e-22c662fa0e07"},"effectiveDateTime":"2024-04-01T11:25:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"ed3dd332-95c0-4d73-4dc1-a12e30165063","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/29aaed4a-ecee-b40d-462e-22c662fa0e07"},"effectiveDateTime":"2024-04-02T14:25:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"90ad9e8f-401c-2f43-7741-1f4b183d22c2","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/29aaed4a-ecee-b40d-462e-22c662fa0e07"},"effectiveDateTime":"2024-04-02T14:25:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"e310717c-13f3-887e-d270-f5766f6ade81","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/29aaed4a-ecee-b40d-462e-22c662fa0e07"},"effectiveDateTime":"2024-04-03T16:16:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"ceb963eb-b7cb-271f-ad7a-6be06eb9c325","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/29aaed4a-ecee-b40d-462e-22c662fa0e07"},"effectiveDateTime":"2024-04-03T16:16:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"55164cef-043c-a3c7-a260-0d4cf04d2874","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/29aaed4a-ecee-b40d-462e-22c662fa0e07"},"effectiveDateTime":"2024-04-04T17:21:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"acdee613-3dd3-19e9-0385-8b736cc9222c","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/29aaed4a-ecee-b40d-462e-22c662fa0e07"},"effectiveDateTime":"2024-04-04T17:21:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"4e60d4b7-3796-82cf-0f69-763c6e3288ae","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/29aaed4a-ecee-b40d-462e-22c662fa0e07"},"effectiveDateTime":"2024-04-05T18:36:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"8db1ed0d-879a-4d07-a1e2-93e108562528","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/29aaed4a-ecee-b40d-462e-22c662fa0e07"},"effectiveDateTime":"2024-04-05T18:36:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"b6eb69dd-f87b-25b0-b95b-8158fc9f318e","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/29aaed4a-ecee-b40d-462e-22c662fa0e07"},"effectiveDateTime":"2024-04-06T22:59:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"1f9f5610-f5dc-ae32-7fce-4c193df46a37","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/29aaed4a-ecee-b40d-462e-22c662fa0e07"},"effectiveDateTime":"2024-04-06T22:59:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"53570248-3afb-6d03-0232-f89e3deacd88","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/29aaed4a-ecee-b40d-462e-22c662fa0e07"},"effectiveDateTime":"2024-04-08T01:25:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"ef7a9c1d-f16a-8d38-5f92-172216e16ceb","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/29aaed4a-ecee-b40d-462e-22c662fa0e07"},"effectiveDateTime":"2024-04-08T01:25:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"fd2313be-2c13-1347-0012-7443086c8b96","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/29aaed4a-ecee-b40d-462e-22c662fa0e07"},"effectiveDateTime":"2024-04-09T03:55:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"9dd7cf79-76ad-5da3-59af-f0b08d0b7124","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/29aaed4a-ecee-b40d-462e-22c662fa0e07"},"effectiveDateTime":"2024-04-09T03:55:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"46623263-5aa9-6b4e-f709-33db0aebf0a3","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/29aaed4a-ecee-b40d-462e-22c662fa0e07"},"effectiveDateTime":"2024-04-10T06:54:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"cff2ffb8-00c6-702c-54fd-ab1956c95f8d","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/29aaed4a-ecee-b40d-462e-22c662fa0e07"},"effectiveDateTime":"2024-04-10T06:54:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"3a7f4982-3eea-4270-3ed3-9152795a59eb","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/d5b3ae87-e912-7c55-143b-483e6c78c47c"},"effectiveDateTime":"2024-05-14T10:08:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"b306f79e-1e15-9d87-bbaf-873e9375cc7d","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/d5b3ae87-e912-7c55-143b-483e6c78c47c"},"effectiveDateTime":"2024-05-14T10:08:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"9cd2f648-d5c8-4e09-fd5d-ab94141e50f8","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/d5b3ae87-e912-7c55-143b-483e6c78c47c"},"effectiveDateTime":"2024-05-15T11:57:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"4e9608b8-d31d-458c-33f6-37aedbc89a40","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/d5b3ae87-e912-7c55-143b-483e6c78c47c"},"effectiveDateTime":"2024-05-15T11:57:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"2d93517c-7809-c993-b8b6-52b483c74bbe","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/d5b3ae87-e912-7c55-143b-483e6c78c47c"},"effectiveDateTime":"2024-05-16T14:27:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"d405b640-2e59-0d5e-b6ce-769631486de9","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/d5b3ae87-e912-7c55-143b-483e6c78c47c"},"effectiveDateTime":"2024-05-16T14:27:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"727d302b-0266-e7d2-b804-bd26a9685f82","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/d5b3ae87-e912-7c55-143b-483e6c78c47c"},"effectiveDateTime":"2024-05-17T16:16:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"37c79d22-1b16-6d89-bf54-98c91c8e1dce","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/d5b3ae87-e912-7c55-143b-483e6c78c47c"},"effectiveDateTime":"2024-05-17T16:16:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"31e12758-161d-ca08-fbad-c35df4dee084","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/d5b3ae87-e912-7c55-143b-483e6c78c47c"},"effectiveDateTime":"2024-05-18T19:49:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"c262304b-ac29-5fec-3589-31c35c6eff1f","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/d5b3ae87-e912-7c55-143b-483e6c78c47c"},"effectiveDateTime":"2024-05-18T19:49:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"1e98c7b1-2e78-576a-a53c-224b9e8fd26e","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/f21be86d-9a32-5f92-8f29-7a0c7b6f28e4"},"effectiveDateTime":"2024-06-22T12:52:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"4f4341ec-fe6a-f05b-97ad-7796a56c680b","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/f21be86d-9a32-5f92-8f29-7a0c7b6f28e4"},"effectiveDateTime":"2024-06-22T12:52:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"d7fc4692-0708-352e-cf2b-7bf235fe3e3e","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/f21be86d-9a32-5f92-8f29-7a0c7b6f28e4"},"effectiveDateTime":"2024-06-23T13:56:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"02678b86-d882-1ae8-19e2-900ed419b558","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/f21be86d-9a32-5f92-8f29-7a0c7b6f28e4"},"effectiveDateTime":"2024-06-23T13:56:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"dd92958f-41c8-5a2c-3e23-c471c31e5d1c","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/f21be86d-9a32-5f92-8f29-7a0c7b6f28e4"},"effectiveDateTime":"2024-06-24T17:34:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"3b649a1e-0f0a-9a58-d2d5-dac510824aa0","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/f21be86d-9a32-5f92-8f29-7a0c7b6f28e4"},"effectiveDateTime":"2024-06-24T17:34:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"d99dddf1-7591-8ae8-f118-e27c6cf07d58","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/f21be86d-9a32-5f92-8f29-7a0c7b6f28e4"},"effectiveDateTime":"2024-06-25T21:33:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"8810a980-ee58-d947-1308-08735e70544c","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/f21be86d-9a32-5f92-8f29-7a0c7b6f28e4"},"effectiveDateTime":"2024-06-25T21:33:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"d99df156-b0cc-eca9-54a2-7dca3bf75cc1","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/f21be86d-9a32-5f92-8f29-7a0c7b6f28e4"},"effectiveDateTime":"2024-06-27T01:14:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"686a1b0b-8d98-f9f8-7ebf-7b3a83a212df","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/f21be86d-9a32-5f92-8f29-7a0c7b6f28e4"},"effectiveDateTime":"2024-06-27T01:14:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"f8138668-ea0c-ecd0-7318-143c05375ce8","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/f21be86d-9a32-5f92-8f29-7a0c7b6f28e4"},"effectiveDateTime":"2024-06-28T02:50:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"fd96e52a-d37c-4392-c832-eb09949fb859","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/f21be86d-9a32-5f92-8f29-7a0c7b6f28e4"},"effectiveDateTime":"2024-06-28T02:50:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"d8c865d9-0964-e105-231e-68c869f6c6a4","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/f21be86d-9a32-5f92-8f29-7a0c7b6f28e4"},"effectiveDateTime":"2024-06-29T04:01:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"4dda006c-f635-4b6d-39ec-3d20bf7f0bcb","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/f21be86d-9a32-5f92-8f29-7a0c7b6f28e4"},"effectiveDateTime":"2024-06-29T04:01:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"ec079fdd-2fde-24db-9c50-a81682852653","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/f21be86d-9a32-5f92-8f29-7a0c7b6f28e4"},"effectiveDateTime":"2024-06-30T04:58:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"19269dad-60a3-af81-35cf-f12e1c7bd405","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/f21be86d-9a32-5f92-8f29-7a0c7b6f28e4"},"effectiveDateTime":"2024-06-30T04:58:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"fec52d2f-7b51-228e-8fd7-9d46f655dc41","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/9a84f82f-f882-f635-63f1-1ce0125d4601"},"effectiveDateTime":"2024-08-01T04:41:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"03497ba2-08d9-6886-9a7f-cdc45edc57e6","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/9a84f82f-f882-f635-63f1-1ce0125d4601"},"effectiveDateTime":"2024-08-01T04:41:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"b1bbe329-1560-e091-e3e8-15992cdbe54c","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/9a84f82f-f882-f635-63f1-1ce0125d4601"},"effectiveDateTime":"2024-08-02T08:37:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"41f1ea92-4efc-14a6-024f-d6a53bc4c570","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/9a84f82f-f882-f635-63f1-1ce0125d4601"},"effectiveDateTime":"2024-08-02T08:37:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"df1a2c22-00d9-4625-76b0-fedb56dc3586","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/9a84f82f-f882-f635-63f1-1ce0125d4601"},"effectiveDateTime":"2024-08-03T12:54:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"7fba447c-4998-05dc-b7c6-01fea7f350c1","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/9a84f82f-f882-f635-63f1-1ce0125d4601"},"effectiveDateTime":"2024-08-03T12:54:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"6e7e2840-2740-a30f-2f5f-7b962a3003a7","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/9a84f82f-f882-f635-63f1-1ce0125d4601"},"effectiveDateTime":"2024-08-04T13:24:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"dca0ccef-7e58-5553-ef98-e919e818b33f","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/9a84f82f-f882-f635-63f1-1ce0125d4601"},"effectiveDateTime":"2024-08-04T13:24:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"0e16a389-b7db-07a4-6376-d27fc159d045","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/9a84f82f-f882-f635-63f1-1ce0125d4601"},"effectiveDateTime":"2024-08-05T14:50:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"9f8a4f20-34b0-b8b2-ffb9-4529b3795a07","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/9a84f82f-f882-f635-63f1-1ce0125d4601"},"effectiveDateTime":"2024-08-05T14:50:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"8d96e0f5-f19f-fe2d-5032-e6d4b2db2be0","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/0708fbf0-0929-71ec-e897-e76ee22f470a"},"effectiveDateTime":"2024-09-09T19:42:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"89ef3806-454b-0f44-3cca-643005a8fb58","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/0708fbf0-0929-71ec-e897-e76ee22f470a"},"effectiveDateTime":"2024-09-09T19:42:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"f61d1e30-5f12-a5d9-6d2d-8f5d971e635c","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/0708fbf0-0929-71ec-e897-e76ee22f470a"},"effectiveDateTime":"2024-09-10T22:04:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"7b156848-279a-f0a4-3f31-b39e2a8a5142","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/0708fbf0-0929-71ec-e897-e76ee22f470a"},"effectiveDateTime":"2024-09-10T22:04:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"801e79f5-1796-8970-415a-578d26328f4f","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/0708fbf0-0929-71ec-e897-e76ee22f470a"},"effectiveDateTime":"2024-09-11T22:56:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"4f13c896-3fa9-afbe-2cab-d732458870fa","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/0708fbf0-0929-71ec-e897-e76ee22f470a"},"effectiveDateTime":"2024-09-11T22:56:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"b8d55ff8-0265-f7d9-07e2-f240a9676f8a","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/0708fbf0-0929-71ec-e897-e76ee22f470a"},"effectiveDateTime":"2024-09-13T00:46:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"08e7ab57-64e7-d769-5eea-9ab80302fbfa","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/0708fbf0-0929-71ec-e897-e76ee22f470a"},"effectiveDateTime":"2024-09-13T00:46:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"4fe68424-00bf-40b7-ee30-946d56c23017","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/0708fbf0-0929-71ec-e897-e76ee22f470a"},"effectiveDateTime":"2024-09-14T04:06:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"7a824425-a73a-97eb-708c-28c6abcff81a","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/0708fbf0-0929-71ec-e897-e76ee22f470a"},"effectiveDateTime":"2024-09-14T04:06:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"d729173a-cd21-1ef8-270f-b340abe25beb","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/0708fbf0-0929-71ec-e897-e76ee22f470a"},"effectiveDateTime":"2024-09-15T07:32:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"0d2493d2-27fd-2c58-8829-879b67979c6f","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/0708fbf0-0929-71ec-e897-e76ee22f470a"},"effectiveDateTime":"2024-09-15T07:32:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"372b86d8-0727-e8b0-719b-9e530c438ba8","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/c739332a-f87b-f89f-7286-763620ac2139"},"effectiveDateTime":"2024-10-16T06:24:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"1a1f7265-8f2a-dc2d-1f3b-155dc99af3a8","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/c739332a-f87b-f89f-7286-763620ac2139"},"effectiveDateTime":"2024-10-16T06:24:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"5e5f2ebd-1250-3554-881f-8ca926c4ba23","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/c739332a-f87b-f89f-7286-763620ac2139"},"effectiveDateTime":"2024-10-17T10:14:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"1600153d-d83e-d940-18ef-75e17c655296","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/c739332a-f87b-f89f-7286-763620ac2139"},"effectiveDateTime":"2024-10-17T10:14:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"f16eafd0-08cc-6dba-953f-11875ecf5d1b","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/c739332a-f87b-f89f-7286-763620ac2139"},"effectiveDateTime":"2024-10-18T12:00:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"1e81706d-0eea-cae9-239f-f37ac95ae264","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/c739332a-f87b-f89f-7286-763620ac2139"},"effectiveDateTime":"2024-10-18T12:00:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"b4794b25-f75d-4a54-3709-37e0f4955612","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/c739332a-f87b-f89f-7286-763620ac2139"},"effectiveDateTime":"2024-10-19T12:56:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"335d9412-4a7a-31d4-3095-9fcfcd0a1e8f","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/c739332a-f87b-f89f-7286-763620ac2139"},"effectiveDateTime":"2024-10-19T12:56:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"51d6a3e3-f707-dda2-0dae-ccee8323f123","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/c739332a-f87b-f89f-7286-763620ac2139"},"effectiveDateTime":"2024-10-20T16:19:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"7fdb55a4-4987-27ec-b7e7-1326da2fe9ad","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/c739332a-f87b-f89f-7286-763620ac2139"},"effectiveDateTime":"2024-10-20T16:19:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"78ae4f44-0264-5f60-cad9-ef4ea965d710","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/c739332a-f87b-f89f-7286-763620ac2139"},"effectiveDateTime":"2024-10-21T18:34:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"c7ca3f2b-fe62-e046-19f5-df36a56457f7","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/c739332a-f87b-f89f-7286-763620ac2139"},"effectiveDateTime":"2024-10-21T18:34:59-04:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"63c3f12c-b3b9-8096-5324-9ae9cc3fd699","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/8b0e3fa9-d54c-4085-c729-833722d2ad08"},"effectiveDateTime":"2024-11-24T06:33:59-05:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"6317040d-8b39-e49f-d25d-25a10bf5bcc9","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/8b0e3fa9-d54c-4085-c729-833722d2ad08"},"effectiveDateTime":"2024-11-24T06:33:59-05:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"ea5478b1-38f3-c243-6204-cda7dc34e945","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/8b0e3fa9-d54c-4085-c729-833722d2ad08"},"effectiveDateTime":"2024-11-25T10:37:59-05:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"42ed23dc-b9f4-d611-71e3-2e7b8e5cfb71","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/8b0e3fa9-d54c-4085-c729-833722d2ad08"},"effectiveDateTime":"2024-11-25T10:37:59-05:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"90548ae1-2e0c-9595-e11c-3f9b9e24109a","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/8b0e3fa9-d54c-4085-c729-833722d2ad08"},"effectiveDateTime":"2024-11-26T12:04:59-05:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"1151be04-f9cf-1710-f013-1236e6fdb315","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/8b0e3fa9-d54c-4085-c729-833722d2ad08"},"effectiveDateTime":"2024-11-26T12:04:59-05:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"7663ddb9-bfa6-940e-37b8-70ed464299ed","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/8b0e3fa9-d54c-4085-c729-833722d2ad08"},"effectiveDateTime":"2024-11-27T16:24:59-05:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"b70123dc-c3fa-f610-e5f7-2e815d972b70","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/8b0e3fa9-d54c-4085-c729-833722d2ad08"},"effectiveDateTime":"2024-11-27T16:24:59-05:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"f0606dab-b6f6-48cb-dc75-bcd9b2600929","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/8b0e3fa9-d54c-4085-c729-833722d2ad08"},"effectiveDateTime":"2024-11-28T20:16:59-05:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"496a6858-7f34-dac4-f350-27c5b7409846","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"583214","display":"PACLitaxel 100 MG Injection"}],"text":"PACLitaxel 100 MG Injection"},"subject":{"reference":"Patient/e5e40026-e984-cfb5-cb67-0fefcad77ce2"},"context":{"reference":"Encounter/8b0e3fa9-d54c-4085-c729-833722d2ad08"},"effectiveDateTime":"2024-11-28T20:16:59-05:00","reasonReference":[{"reference":"Condition/19aa4413-ccf7-eb85-a929-c757797d1784","display":"Non-small cell carcinoma of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"60b9598a-04d5-935b-e15c-f6750b49e344","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/0b3dbc9a-a883-d4ea-ba72-1ac8cf1fd73c"},"effectiveDateTime":"2013-05-15T19:56:08-04:00","reasonCode":[{"coding":[{"system":"http://snomed.info/sct","code":"103697008","display":"Patient referral for dental care (procedure)"}],"text":"Patient referral for dental care (procedure)"}]}
{"resourceType":"MedicationAdministration","id":"814992db-ff62-eb05-668e-c165716fd3a5","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/3ba46e20-4fd8-e02f-b2d9-f5b37de99c6d"},"effectiveDateTime":"2013-12-28T18:45:29-05:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"8baa4626-2a50-c4dd-b9a1-f68d6f4ff108","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/ffef3a7e-f3f1-a5c6-cb66-5a522603c21c"},"effectiveDateTime":"2013-12-31T21:34:29-05:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"5df1949a-10f6-3205-763a-26624498b19c","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/159bb737-9e94-dff3-1f5d-333412a0fe13"},"effectiveDateTime":"2014-01-04T00:55:29-05:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"000fab84-111a-13cc-0683-fb771447e887","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/401a65d6-4434-505b-b135-c0f56d025d64"},"effectiveDateTime":"2014-01-07T03:49:29-05:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"02cd839d-1025-36f3-eee7-54dcdcb388fb","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/e8de17b5-651c-0809-0d6e-639ec9c9d931"},"effectiveDateTime":"2014-01-10T07:19:29-05:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"78826fad-bbc2-368f-b84f-7df1acae5060","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/0383835a-4884-dfa0-9902-e6383ef3d90c"},"effectiveDateTime":"2014-01-13T09:51:29-05:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"5294b6a5-87cf-0b07-f514-51c6c1f8d33a","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/8ff12f39-7e8c-f8a9-becc-79aa6cf11edb"},"effectiveDateTime":"2014-01-16T13:47:29-05:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"0ce6ab70-46de-3811-4531-0777f7457d10","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/aed2512a-6aad-3b8f-8b3f-7566dc6bf2b8"},"effectiveDateTime":"2014-01-19T17:30:29-05:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"b9f8fbcd-bd96-284e-b3cb-90aaba196276","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/cf6fbe87-d542-39ba-835c-346392a1eaf5"},"effectiveDateTime":"2014-01-22T21:16:29-05:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"315f25a5-a818-9d5d-a051-328e48002793","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/fb6238c5-4dcc-0203-327c-0ad4bd57d85d"},"effectiveDateTime":"2014-01-25T23:42:29-05:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"05c11b3f-1237-85ea-55c8-e372b4b72513","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/744289a7-bec5-b967-0e5d-348e151042e1"},"effectiveDateTime":"2014-01-29T02:24:29-05:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"c2d92070-02c1-3a22-92ee-801ceedb0b62","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/30c5db47-09cb-bea2-2111-7c99e23baa95"},"effectiveDateTime":"2014-02-01T05:23:29-05:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"3b292f20-270a-b718-7d87-ba7fd771fc17","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/1dcef963-e2c3-1cad-923f-b8cdf1c67041"},"effectiveDateTime":"2014-02-04T09:16:29-05:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"99b5c051-65f4-8841-c1af-e359f6f10b7b","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/351369fa-90df-752b-b165-60669d451cc8"},"effectiveDateTime":"2014-02-07T12:12:29-05:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"ed1edca6-f879-b82d-011b-f61e789879cb","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/94bc22dd-968d-f1b2-2e7a-7cdc80e7bdbb"},"effectiveDateTime":"2014-02-10T14:18:29-05:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"3e5f2b60-5eb0-c327-4f51-3848fe99ce84","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/154fe720-eea1-1d04-21f4-fa0f5b5927a8"},"effectiveDateTime":"2014-02-13T16:26:29-05:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"b6ba4d91-926f-e623-b917-ea14cc97e076","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/6f17aa43-9383-895b-68da-6df5f3f4ce7e"},"effectiveDateTime":"2014-02-16T19:47:29-05:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"ba33e915-16d9-b5f7-f53a-5d650b9ff1c4","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/b7daeb87-72bc-236a-080f-ad8aa1900a7a"},"effectiveDateTime":"2014-02-19T22:51:29-05:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"7a021a18-0b71-e04f-2133-846dd3a582cf","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/08f24ea5-16f2-94e1-9763-036a30ac4fd6"},"effectiveDateTime":"2014-02-23T01:17:29-05:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"83efd49a-1346-9062-b704-146246e9100a","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/3f28562a-7ac7-6db1-32aa-1033aab0781b"},"effectiveDateTime":"2014-02-26T04:20:29-05:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"bead591b-e3c7-dfb8-df7b-e31a8893fa8f","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/9ce14dba-a399-2cb1-45cf-dddbe250ef17"},"effectiveDateTime":"2014-03-01T06:53:29-05:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"218e30b2-7b2b-bf42-0a2e-1b401c83b14f","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/1f4a3563-8ceb-0847-2394-a1764c5c3c3e"},"effectiveDateTime":"2014-03-04T10:28:29-05:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"944ebc25-7f4e-dc1d-089e-b18c46f69724","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/2013dee8-a228-b06f-bf87-f24e58d17b1f"},"effectiveDateTime":"2014-03-07T12:57:29-05:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"140b846e-fdec-fb75-9e0a-3545e7fc1c43","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/538e6c9c-d0df-e600-fcfe-c979e8be218d"},"effectiveDateTime":"2014-03-10T16:22:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"e6bab44b-2971-4615-dddb-82d528262925","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/12a9ec6e-2f9d-afa3-56f2-908ef3d6db40"},"effectiveDateTime":"2014-03-13T19:49:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"beb18db6-7701-e1e8-df80-17b52fe5a617","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/74019296-b504-a62b-4d35-503bc66d575c"},"effectiveDateTime":"2014-03-16T22:26:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"2f2a159d-0db6-e805-6625-1c115daccf4f","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/2a614877-8696-2b88-79d8-5f4fa03b8e47"},"effectiveDateTime":"2014-03-20T01:24:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"a4ec8632-280c-4f0a-9459-f4f3c5204c8c","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/c011c685-5696-b528-d02a-d999bc998dd9"},"effectiveDateTime":"2014-03-23T05:01:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"d9f42256-bd96-b904-d507-fcaf7a19f32c","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/12f4c458-b903-65ef-74bf-53313c1017e2"},"effectiveDateTime":"2014-03-26T07:30:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"23306176-7320-bf35-0bd0-4e06100fb142","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/0dad9eed-c0a2-69a7-4623-2747f374e828"},"effectiveDateTime":"2014-03-29T10:18:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"3d8aa011-e09e-7706-2d52-d3b46051b95f","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/bb754169-4530-d630-8713-3665dff4edb0"},"effectiveDateTime":"2014-04-01T14:00:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"ef251fae-621f-1b01-91a4-d3ef5c9ae335","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/acc5b32f-861f-832f-3cc1-b68c18226653"},"effectiveDateTime":"2014-04-04T16:10:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"3d3eb803-fabb-2358-17de-b1f9e6d4f498","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/3d09b0a5-7217-c8f4-a405-5f80c173781f"},"effectiveDateTime":"2014-04-07T18:26:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"1581148a-1172-a31d-5567-7652451522d3","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/b30fda05-bdc2-bf18-6f68-bbd97ae9c73e"},"effectiveDateTime":"2014-04-10T20:59:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"5f948ae1-ad79-de79-e991-0e1bd5755281","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/7c9b9209-87d6-e797-9b45-d21d8f1c819f"},"effectiveDateTime":"2014-04-13T23:44:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"67a2f574-3c95-7dbe-6327-0cb5f918b7e6","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/7ca8cb1a-0a0b-f228-bbd4-15e5e3270877"},"effectiveDateTime":"2014-04-17T02:34:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"dcc785f1-d74b-1ae7-7f47-3f36f602e31b","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/5c5f565d-bc5d-d518-48e7-e14a0511d0f2"},"effectiveDateTime":"2014-04-20T06:12:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"77e1ff30-6beb-5a1c-ec31-f6794c529522","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/cb8a7ad8-dd7d-bb1c-77e2-1f95c1c27069"},"effectiveDateTime":"2014-04-23T09:19:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"4b7c12b8-56f8-256f-6a11-f1d92582245c","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/4316a80b-db92-05fd-fec2-c35b24d892ab"},"effectiveDateTime":"2014-04-26T12:04:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"2c525924-52d0-46b8-c4e4-8cd4ba154630","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/d1be3997-a47f-6563-690d-8191ee2f2d89"},"effectiveDateTime":"2014-04-29T15:59:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"3c400c1b-1290-71be-9082-8e0d1f7911ad","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/30099b03-4cd3-e925-865f-6f179f18f4ac"},"effectiveDateTime":"2014-05-02T19:56:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"0381088a-3573-0ef9-554a-9a5269158eb7","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/9e1dfafd-42ce-4e46-b97b-2d77afe3dd4d"},"effectiveDateTime":"2014-05-05T22:43:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"359a9053-1cc2-b688-5562-c3f59c820c28","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/9ec12a50-bcd0-b496-8d0e-1701f018fcc3"},"effectiveDateTime":"2014-05-09T02:24:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"b0fbef0a-05a7-cb83-bbb3-c0050c1c1b7b","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/29a33171-3c9e-fa80-bc46-8314c3190d95"},"effectiveDateTime":"2014-05-12T05:00:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"30158bdb-6400-579f-c5d2-0f158bfc6d2a","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/14c52f41-a17a-d2ab-b9f1-d1f84e16d93b"},"effectiveDateTime":"2014-05-15T08:26:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"dddca1e4-a987-8282-af1c-83122bbb6e9c","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/a304a9f8-7ede-125d-49ef-d0643af7cc80"},"effectiveDateTime":"2014-05-18T11:40:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"f67543a9-a867-da1f-6ac5-3c15a1129526","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/6d6a7d5d-a0a6-89a8-eb38-8117078a3dd7"},"effectiveDateTime":"2014-05-21T15:37:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"d4ba5c90-f92e-2f7d-52a6-766239105f94","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/1675702a-6bf7-b513-c12f-a8d3e5075f77"},"effectiveDateTime":"2014-05-24T18:18:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"fdd34a2c-3c42-96cd-0447-9a24e818be47","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/e507f6f3-4896-bf6f-88a8-d95dd9402ee2"},"effectiveDateTime":"2014-05-27T20:26:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"c98ab6d4-1db7-3646-ad52-ea769d7d9341","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/beb4aae7-5ddf-568d-afd6-8808d31c9602"},"effectiveDateTime":"2014-05-30T22:30:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"501686e4-eef9-7d93-4f34-0227ee1a4c1d","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/d3e3ce90-adab-cae6-ec0a-a6d6ae04a5a5"},"effectiveDateTime":"2014-06-03T01:36:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"bd550b13-84ec-b6bf-d0c2-d347276c7f1d","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/bff338e1-df77-e115-58db-868757502f9b"},"effectiveDateTime":"2014-06-06T03:57:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"ee350610-0706-d7f4-1cf6-a3240551c5da","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/2049d11f-fd7e-62dc-fd9d-246861fdc10d"},"effectiveDateTime":"2014-06-09T06:25:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"ab2a1672-ca33-bc3e-6a65-1ce71a2d07e0","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/7eb1acae-6ac5-0dd2-b297-f2e5fb621a0d"},"effectiveDateTime":"2014-06-12T08:47:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"be4b831f-0981-efa7-95a8-eb11166a8f9a","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/347f03d1-3c49-57d2-181e-d8e8229851bf"},"effectiveDateTime":"2014-06-15T11:28:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"2717dbbe-f41f-7a80-f857-c1ee6deb6699","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/b77698dc-546b-be39-3767-ff309c370f2f"},"effectiveDateTime":"2014-06-18T14:28:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"8e2c1984-b433-ea9d-0967-1ff9042e0964","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/742a4677-40c2-aa9a-63f8-ecc3cfaf53f1"},"effectiveDateTime":"2014-07-02T20:47:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"f9333f49-a397-586d-4fdb-31568c374cec","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/eaf7544b-497e-4af7-74ef-07e9aa5c3b0d"},"effectiveDateTime":"2014-07-06T00:16:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"ff169c27-a006-199a-0bff-3c1c5ef6d78d","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/44970fdb-cfed-bc78-8e27-4ee670857a4d"},"effectiveDateTime":"2014-07-09T03:32:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"9d9ad22b-b200-97b7-a21e-0c53af580c6f","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/772cdb89-4e5d-d613-7478-575cba6a1656"},"effectiveDateTime":"2014-07-16T20:39:14-04:00","reasonReference":[{"reference":"Condition/02a45867-628c-cf2b-d03a-9418bc51d591","display":"Gingivitis (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"2c9e8e13-00ab-bb42-153e-8400f7e02d4f","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/6754ca9f-6b11-cd1b-ef76-46f27fe22072"},"effectiveDateTime":"2014-07-23T20:35:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"4f6c86a2-02ab-c4e0-3bc9-0814eec59620","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/2436ec63-c261-1165-2a3d-a4723ee9b7de"},"effectiveDateTime":"2014-07-26T23:29:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"03d3bec0-9db2-92e7-02a1-85811c742ffb","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/8a12910f-d61e-1862-30e0-17a8d4ee6139"},"effectiveDateTime":"2014-07-30T02:00:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"9d9ac848-fe18-43c7-1a1e-0270fbc3d32f","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/e187bbaa-8aaf-3ac7-89c2-724397e4ab32"},"effectiveDateTime":"2014-08-02T04:36:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"b582883b-19c2-280b-f570-648af1ae41dc","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/acae83aa-2761-600c-d31a-914b181b8ea6"},"effectiveDateTime":"2014-08-05T07:04:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"35d450f8-9da8-bf36-1e74-4827f5d03143","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/3f3a868e-d086-59ac-1744-fc8ea901c5d2"},"effectiveDateTime":"2014-08-08T11:01:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"4b5b2a5e-f3de-8054-014d-374793d5f0e4","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/1f36de4e-b968-2825-5abe-174b319968b0"},"effectiveDateTime":"2014-08-11T15:00:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"2e0a39f8-80da-2031-90b8-fb9594d91639","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/a5615e9c-80e5-a6c7-c237-9950780ee555"},"effectiveDateTime":"2014-08-14T17:13:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"56ba4720-ed70-28bc-05db-15aaecef290e","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/7b30318e-1165-947c-c5ed-97bd11c1ad53"},"effectiveDateTime":"2014-08-17T19:30:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"7ebaabee-0f98-b6a5-01f4-d3ec1bda2562","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/abb75e47-925d-285a-c354-efb6d286be27"},"effectiveDateTime":"2014-08-20T23:14:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"239e5863-fab5-dc21-97ee-549c606ad727","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/8755bb6a-9389-bca4-2585-2a32e40d3c5f"},"effectiveDateTime":"2014-08-24T01:32:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"e7e7008a-3dce-571c-aa65-fc527170d6ff","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/a1946206-2fa4-4fbe-7c25-d4a6e5c0628f"},"effectiveDateTime":"2014-08-27T03:54:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"969ff305-1e66-259f-db9f-ba8a1e95d606","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/4772a789-a021-f7be-1b59-6f59905a62a1"},"effectiveDateTime":"2014-08-30T06:28:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"3115d0b8-02c5-b87b-2378-2050eedf89bb","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/1a9e3b34-ad99-aa94-5c04-70930e789179"},"effectiveDateTime":"2014-09-02T09:39:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"3c3890a1-90d2-7792-373f-04f18d8addd5","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/99a759a9-f2b6-975f-1a99-5de1892940b5"},"effectiveDateTime":"2014-09-05T11:48:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"87701944-4cb2-1b3e-0c3c-58f4b3f71b0c","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/c3af3466-63bb-69d1-3e63-195ce621922d"},"effectiveDateTime":"2014-09-08T14:08:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"f4f6008a-3e15-9eb6-b9c4-785271b81e9e","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/1962f4b7-f62c-e4e9-7ffb-2bc8aa2ab4be"},"effectiveDateTime":"2014-09-11T17:24:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"fbbeddfd-752c-bb9d-85be-81133803dc6c","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/62ab9c87-54c6-4257-491f-95c0ce93dca7"},"effectiveDateTime":"2014-09-14T20:09:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"1c35c176-bd96-bda8-1ad2-389efa19f7d0","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/9ece6777-ba16-e0e2-225f-56aa61969501"},"effectiveDateTime":"2014-09-17T23:18:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"d65504a7-f71b-1ae1-78d4-ef6ebaf2e315","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/ae5aa482-d8b5-0e84-3468-181db7de578c"},"effectiveDateTime":"2014-09-21T01:40:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"54c25c63-174f-7ef7-18ae-763457456495","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/266db975-1adb-db4a-5ec5-e117760ebb3d"},"effectiveDateTime":"2014-09-24T05:32:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"53257345-9a6f-82f6-f6d5-da8a9a491e95","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/c59e1b57-1f23-65e6-f163-b36827dd001a"},"effectiveDateTime":"2014-09-27T08:51:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"8e3654e0-5f0c-9aa7-0cf7-f1f45e7b2431","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/f5916ac2-178c-7b5b-92c6-00e138867e8a"},"effectiveDateTime":"2014-09-30T12:24:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"c9b4bcaf-df2c-7444-5ddb-dd7e692c2f99","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/ec00d418-c855-e7a9-4501-69e35bf67856"},"effectiveDateTime":"2014-10-03T16:07:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"88d7f320-7f1e-260a-cdd7-d2cff1c5d671","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/61529323-dd49-201d-02ee-b0074d83787f"},"effectiveDateTime":"2014-10-06T19:26:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"3c37807d-6c41-e7cd-373d-f4cd6a5cc1cf","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/38993ffa-28b0-2116-5767-68a7b3086299"},"effectiveDateTime":"2014-10-09T21:44:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"af9f7dd1-f79a-6dfc-2f91-58df1f62a19f","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/af163e2f-1bd7-63cb-6b85-435fe8f9be18"},"effectiveDateTime":"2014-10-13T01:32:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"0c14712f-5ef9-ccb2-0bdf-e396761a9b3c","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/4b0b63aa-d771-b455-ec32-3a58eee75286"},"effectiveDateTime":"2014-10-16T04:33:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"6216d8d2-6899-b68c-7616-77b0d7087829","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/baeabeeb-59e3-1fef-219e-d6ce5c87dedc"},"effectiveDateTime":"2014-10-19T06:53:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"fe180c9e-bd96-aed6-fd66-0a8dfa19e8fe","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/ce8bf1ed-d46c-4977-eb0c-7378f320978b"},"effectiveDateTime":"2014-10-22T10:38:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"ca2f82f9-0cad-1412-43f6-ea19db3713ea","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/0d3e075c-66cb-414f-600c-ef10586e9512"},"effectiveDateTime":"2014-10-25T12:47:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"e0433c6f-5fc2-3f5e-203e-ab9a34ae5930","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/39da6dde-f0fc-e3e6-1d1d-958f24ac54eb"},"effectiveDateTime":"2014-10-28T15:19:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"a50a3a04-b14e-1a6f-9c18-fba1c54dd95f","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/df289605-76fe-70f2-6386-b72b32fe465c"},"effectiveDateTime":"2014-10-31T17:47:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"eb6962f8-cf77-fa7b-5ba1-2a199e01fa5f","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/507a6150-3689-3d36-349e-01bb112f1cb3"},"effectiveDateTime":"2014-11-03T18:47:29-05:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"faca3145-6d89-fc42-e6e4-02856a77abe5","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/320765d0-04ac-b40a-199a-93d71aabad42"},"effectiveDateTime":"2014-11-06T21:09:29-05:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"3353381b-10a2-ea3e-eb3a-4f8d1d8b8a3c","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/c58b3039-0c8b-7b7c-f44b-a3e6b1e16d9b"},"effectiveDateTime":"2014-11-10T00:57:29-05:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"2b5f2a23-4227-b4f3-9351-370be226adc8","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/b1ddcd64-03a8-c76e-f281-24957fb8c03a"},"effectiveDateTime":"2014-11-13T04:36:29-05:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"bbf045b1-b017-14f2-d287-74734d2b14d9","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/b9fc6694-07bd-8196-6253-b4bea97637e8"},"effectiveDateTime":"2014-11-16T07:01:29-05:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"8c7985cc-4d6b-1aeb-2ef9-83b104d2e31f","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/c13adf40-f981-93c5-e08e-38317616b145"},"effectiveDateTime":"2014-11-19T10:08:29-05:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"f16bc5b1-6841-a1c4-0a5e-a4730555a1bc","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/0653f63f-b155-b01b-3adb-d690bec2bf28"},"effectiveDateTime":"2014-11-22T12:14:29-05:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"666a240c-082f-80b8-62b9-eec70ea3d0b8","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/65f062a8-4388-5f46-720f-e4ee4e746444"},"effectiveDateTime":"2014-11-25T14:37:29-05:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"1ae15c32-5e31-ad8e-5509-5c4093e46a11","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/97c203d5-439f-a176-1a27-e44cc00efc90"},"effectiveDateTime":"2014-11-28T17:26:29-05:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"f71a609e-7815-c689-2abc-e0a05cc2f852","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/71b55ad2-1f19-bbbd-4e4c-c15e2bdfd2ff"},"effectiveDateTime":"2014-12-01T20:23:29-05:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"fbaa146a-7fa3-9768-52e5-1adecfa3f45a","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/8df8640e-aad4-9f9d-6c93-7b9984ea29a5"},"effectiveDateTime":"2014-12-04T23:47:29-05:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"058765d7-cef9-385b-0597-0d2ee61a06e5","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/b378e330-791a-3ebc-7a20-ce6c4d85f27c"},"effectiveDateTime":"2014-12-08T03:01:29-05:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"9347872a-1d9e-460d-d847-90fdae15f674","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/73994777-afa1-744e-778c-76f9f8f57189"},"effectiveDateTime":"2014-12-11T05:34:29-05:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"a1c13842-25f9-86f0-98b5-3c2e3fcac6f3","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/f5bd47a3-b295-5e8d-a80e-a9dcba5f28a6"},"effectiveDateTime":"2014-12-14T09:20:29-05:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"29e9976c-c043-bab8-f873-9788743ec9d8","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/97414b71-063c-28fb-8d86-b97d32595998"},"effectiveDateTime":"2014-12-17T11:38:29-05:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"013cf716-a724-a756-014c-d953c6d50e9b","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/a455d088-fc1b-edc2-3d86-d079abab66e7"},"effectiveDateTime":"2014-12-20T15:24:29-05:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"ad8aa90e-1a1d-45e5-4f52-dcb09a263a48","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/333bc108-fd98-689c-7031-18a3044516b3"},"effectiveDateTime":"2014-12-23T18:55:29-05:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"93c7f32e-20be-2608-d8c8-0716caedd66f","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/45185152-fe96-66cb-f3bd-5759e9a84832"},"effectiveDateTime":"2014-12-26T21:28:29-05:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"0bca547b-1d0c-4832-d3fd-f6fb28013f87","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/30f9bd6c-3df7-3b45-cea7-92be6fa11989"},"effectiveDateTime":"2014-12-30T00:13:29-05:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"8a1efc84-fe34-03d7-8a7e-a3d35cf5a0eb","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/e11d47b2-f19e-ca62-d2db-ac7cf8b7ce4f"},"effectiveDateTime":"2015-01-02T02:46:29-05:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"cf9330a2-02ab-b78a-d60d-04f3eec588ca","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/6dbf5140-900a-5481-4a83-ae0047a95f34"},"effectiveDateTime":"2015-01-05T04:58:29-05:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"808882a2-b8fb-4f75-2a28-6ebc8a3b5671","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/9322ebb5-8c97-7286-aa49-09287b56ef08"},"effectiveDateTime":"2015-01-08T08:36:29-05:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"13256c47-1ef4-08f8-aed5-d38c1f11ff4b","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/4857ff85-0fe3-879f-ae7d-035cc158771b"},"effectiveDateTime":"2015-01-11T12:17:29-05:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"200b495c-1b63-6bfb-3006-7445e3970e7b","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/335f9465-32ef-c198-daf7-8a64619764ab"},"effectiveDateTime":"2015-01-14T14:51:29-05:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"11b1161e-3959-6d8f-4bd9-172dec19ca12","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/249ae9ca-7e4b-1506-a7d7-0fe1dd8cc00d"},"effectiveDateTime":"2015-01-17T17:25:29-05:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"7df7fe57-9af1-d3a4-0132-2658bab9b461","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/ab7b11cb-2bb9-2a8e-f8dc-fed873325b9f"},"effectiveDateTime":"2015-01-20T20:22:29-05:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"ad3d9c25-5cd2-bc24-9c59-972bd122be84","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/8e6bd86b-df84-574a-1665-558c91421630"},"effectiveDateTime":"2015-01-23T23:48:29-05:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"459a97d8-5bc3-8837-f362-cb7adbd789b1","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/f802e267-1a7c-f5b9-ef2a-c133452e44e4"},"effectiveDateTime":"2015-01-27T02:57:29-05:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"26b848e7-3f25-026f-26e2-4c5402d569b4","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/35278691-0e23-d4ab-cb49-01b92c49972f"},"effectiveDateTime":"2015-01-30T05:35:29-05:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"7fd6e36b-6e9e-0fe4-0311-0b6ccec0dac1","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/46b98b32-6181-9f09-ce5f-f6b3b818c75c"},"effectiveDateTime":"2015-02-02T08:17:29-05:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"25948b3f-a14f-8a61-5cd1-0e79c950fab6","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/bd28405d-bc2a-5668-43a3-57644ce96e8c"},"effectiveDateTime":"2015-02-05T11:46:29-05:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"7ed525ac-3080-7765-020f-4dadb0e63b22","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/c3cb1bb6-2462-8381-7943-69ee74721087"},"effectiveDateTime":"2015-02-08T14:38:29-05:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"f0ba61ad-2cce-e40b-a9a6-7b7e6cdb681d","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/e2a31831-832d-35ac-b15b-424eebe83eca"},"effectiveDateTime":"2015-02-11T17:43:29-05:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"5c98ebd4-1db5-ad2b-791c-25fc1f562d9f","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/1eb638ce-c47f-14a9-c857-60c12b995c98"},"effectiveDateTime":"2015-02-14T20:15:29-05:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"ceca3996-ff86-16f8-d2e8-fb341386ef56","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/a518564a-2752-eb79-a8d4-58f66368eb1b"},"effectiveDateTime":"2015-02-17T23:54:29-05:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"23fd2924-2184-976f-4206-54d488c997a7","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/a7fe955a-ba43-7e56-930a-84dcc18f66fa"},"effectiveDateTime":"2015-02-21T03:25:29-05:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"5b4a39dd-6a67-0616-9af8-fb7a7e67ee98","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/44f7f31d-4885-c92a-0577-da955763f5a7"},"effectiveDateTime":"2015-02-24T06:21:29-05:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"7fdcd120-563c-efe5-0316-f922374aa8c2","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/660ab9af-62e7-703b-d44e-aba0e8d9a95a"},"effectiveDateTime":"2015-02-27T09:05:29-05:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"440f8184-1b54-f2eb-631e-9813e388956b","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/75955aad-9c6d-f598-d607-f13e227196af"},"effectiveDateTime":"2015-03-02T11:08:29-05:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"47205fdf-0bfe-486c-f787-a4df4c21bb6b","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/08bd4d79-7071-aaa8-aa7c-4698af03216b"},"effectiveDateTime":"2015-03-05T14:28:29-05:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"86dd3f43-480d-b0ba-d13e-315030adb8ff","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/a723421b-ccfe-3329-5dee-515b9bc52b15"},"effectiveDateTime":"2015-03-08T19:02:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"360bf042-21ad-3c31-420f-762e3b7e7c42","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/1673c854-e0e5-d5d5-b3b2-282474ae8893"},"effectiveDateTime":"2015-03-11T22:26:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"2ca0ce8a-019a-32ff-8f9f-fec5080e8303","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/a4b0520d-1818-8719-45ea-29b9297b8d6b"},"effectiveDateTime":"2015-03-15T00:59:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"e7948acc-ce81-d6fc-4571-0e06f684185f","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/4063f341-73a7-4f9a-57c9-8acfd806e938"},"effectiveDateTime":"2015-03-18T03:01:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"7cd6e78c-03fb-22e8-2025-1b070a6f72ed","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/6370f7a0-a177-5503-53ec-910cea559007"},"effectiveDateTime":"2015-03-21T06:50:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"7b6e5e89-d6fb-844a-6d7b-4729e082543d","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/a0253001-4043-8801-7eb2-3173d3641b49"},"effectiveDateTime":"2015-03-24T09:38:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"a15b2534-c43e-38e1-83cd-321d644800c4","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/6a98558f-ece0-093e-d2f2-3761079af8b6"},"effectiveDateTime":"2015-03-27T13:27:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"3ed48ab3-27f5-bfc0-1b51-0ded4ff841c3","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/b071e38e-80ab-583f-aef3-7a792f16c715"},"effectiveDateTime":"2015-03-30T16:12:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"02264642-1246-47a2-938e-a22e2c1787b6","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/bec4602a-9c04-09c3-4bef-9e5aaf7e9299"},"effectiveDateTime":"2015-04-02T19:32:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"8e10434f-3fc2-3e60-ce25-53cdc9ae5831","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/d90835d4-1875-5624-7b83-c046a5108e40"},"effectiveDateTime":"2015-04-05T21:34:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"9f46402a-4e46-45b3-e446-9668668df61a","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/7d035fab-acde-9a74-8388-86161213241b"},"effectiveDateTime":"2015-04-08T23:34:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"b7624692-3d8a-3f62-d829-f6f9828a979d","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/0f12b05e-70bf-70b4-c61a-a154b1c747b5"},"effectiveDateTime":"2015-04-12T01:42:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"1bb130a9-c34d-a39a-e3e4-d329f06e955b","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/7cbe62c2-da11-b916-c271-259ba854010b"},"effectiveDateTime":"2015-04-15T05:15:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"88967c58-46d4-07f4-e4d5-685bf73b4cf4","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/de40cb25-d662-2e3d-a2e4-f4a907b2b76d"},"effectiveDateTime":"2015-04-18T07:23:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"f81cc387-50e0-269a-0505-639318ab9e8d","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/4ec520cd-8ad7-72a4-1a9b-9e230bc5c41d"},"effectiveDateTime":"2015-04-21T09:52:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"76c7bfe0-bdb9-1916-3747-0057de87a317","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/d97c9cc1-a87a-a312-ab3f-3bbd8f660fb8"},"effectiveDateTime":"2015-04-24T12:37:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"b83a4078-26c0-7f66-1a7e-9417d727c467","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/d32a9220-932b-53cd-9e86-1acfffbdf64a"},"effectiveDateTime":"2015-04-27T15:52:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"fae09aa2-7c59-61d0-e6fa-6be2956ae523","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/14325775-c0a0-505c-f77b-999d4258b200"},"effectiveDateTime":"2015-04-30T18:41:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"c4e68e60-86b3-7a7d-9626-a7f127876697","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/ef501206-ad41-5b6d-6c8a-41724b58c6bb"},"effectiveDateTime":"2015-05-03T20:44:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"7f671cf6-d101-d01f-7174-0596de09ba46","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/50b19113-47bd-30b8-430f-1ae53a46b9c4"},"effectiveDateTime":"2015-05-06T22:50:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"02c95956-ec2e-fb9b-0fb1-f9643516190d","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/78f6917b-d566-3851-c28a-4c0d2d651e0b"},"effectiveDateTime":"2015-05-10T02:33:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"0bcc07f3-7a1f-2e72-d3ff-aa73b045d461","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/d1f18743-77e3-ac7e-b494-0e870fe1aff2"},"effectiveDateTime":"2015-05-13T06:00:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"1d41c0cc-0b66-74ce-5467-602bd39a174e","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/b6e4658c-4b17-a572-d7fa-fd8ce9846917"},"effectiveDateTime":"2015-05-16T08:16:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"ceb411b5-a62f-9523-35f9-1225ef0950d4","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/c86ef829-890a-9741-3838-8a8db2fcd89c"},"effectiveDateTime":"2015-05-19T10:29:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"78e6c804-83c8-72bb-0b38-a42107029abf","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/0ed87a17-cfc6-e38d-2699-3241828b19d6"},"effectiveDateTime":"2015-05-22T13:15:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"774a2d1f-0399-ec58-018a-ea9110828c67","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/f8091be4-24af-e61d-be25-82055eaeba45"},"effectiveDateTime":"2015-05-25T16:57:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"27245329-3d49-582c-d78b-9829b3a23e1f","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/796ad3ad-fe05-3ee5-b310-d7d3762d79b2"},"effectiveDateTime":"2015-05-28T20:31:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"5f8a462e-90f0-c4d8-f299-f695d5f13d38","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/cb1ae178-d99a-6fae-b655-71048e9dbe36"},"effectiveDateTime":"2015-06-01T00:12:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"9ee67d24-a22c-fb91-28e7-71e4a7c41c60","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/bb290282-7858-d7ae-cc2e-69a4e2b76ab9"},"effectiveDateTime":"2015-06-04T02:41:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"be7bcd91-f4e7-b440-cd49-ea152f0fb823","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/99a86220-02a3-3de4-94a2-ec644362c199"},"effectiveDateTime":"2015-06-07T05:31:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"abfd1b1e-293e-c2fa-e286-e351cbbf0229","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/1084a997-3682-fb55-814b-cd21a057f0a1"},"effectiveDateTime":"2015-06-10T07:35:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"eca1c2f9-313f-f880-b098-c219ffc9f981","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/05cfb495-dfff-b6f5-bd80-27903b50e82a"},"effectiveDateTime":"2015-06-13T10:40:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"0af51027-7b2d-8272-dc35-30bf60cc6e8b","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/7f3ea641-0c30-ae83-1fdb-89aba4eadcf4"},"effectiveDateTime":"2015-06-16T12:53:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"3c37cba2-f0bc-db00-373e-3ff2f902cf0d","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/9d3d0138-6eb6-28d2-44e9-5b2c1acf9a8d"},"effectiveDateTime":"2015-06-19T15:24:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"f19acb27-53e1-a26b-6b62-fec9d424d550","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/bda00e58-6cb6-2f66-4c88-030fdd9002e7"},"effectiveDateTime":"2015-06-22T18:55:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"477c7a96-e5bf-edbe-c425-66b0b70011ed","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/8e9d0de5-31d5-0fa0-c78f-f8463ac8244d"},"effectiveDateTime":"2015-07-08T20:35:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"6fe8ea1f-0e4c-3b58-c8c8-d4111b34db6a","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/72188576-86ba-7912-39bb-8d10038ce1a5"},"effectiveDateTime":"2015-07-12T00:28:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"67a2556b-3c94-edb9-6c48-8ab8591827e1","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/fe690eda-e186-22e4-d545-adfd25f48344"},"effectiveDateTime":"2015-07-15T02:59:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"68752227-1eb9-dbad-69b1-a54a91daaa37","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/413aed49-07ab-a655-5a43-c26cdb85c03d"},"effectiveDateTime":"2015-07-29T20:26:07-04:00","reasonCode":[{"coding":[{"system":"http://snomed.info/sct","code":"103697008","display":"Patient referral for dental care (procedure)"}],"text":"Patient referral for dental care (procedure)"}]}
{"resourceType":"MedicationAdministration","id":"854b3fb0-46e6-8129-2813-eae7f74dc62a","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/e110a49a-6eb9-79d7-423e-39226fada1f0"},"effectiveDateTime":"2015-08-05T21:14:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"ff40d990-d22d-c4cd-05b5-299b1e7a5a47","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/048ec3de-9d86-9d41-1d4b-754bfd001429"},"effectiveDateTime":"2015-08-08T23:14:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"bc3400b5-8c51-9dc7-f73a-750596bdd2b2","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/ea5dfa3b-140f-d44a-23d5-ea9722aacaeb"},"effectiveDateTime":"2015-08-12T01:35:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"3c366464-8c52-cf7b-773c-d8b496df935c","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/a2ba906c-cc3e-fc23-4fc4-48d5c8aa6bec"},"effectiveDateTime":"2015-08-15T05:27:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"4165dd10-3674-74dd-bc4d-9d6bb37ab4aa","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/c10ba501-f610-f9af-78b8-8bb96523dba4"},"context":{"reference":"Encounter/26e9b0e6-1ac1-b5f0-f1bc-c799501a4d78"},"effectiveDateTime":"2016-04-30T19:18:38-04:00","reasonCode":[{"coding":[{"system":"http://snomed.info/sct","code":"103697008","display":"Patient referral for dental care (procedure)"}],"text":"Patient referral for dental care (procedure)"}]}
{"resourceType":"MedicationAdministration","id":"2b34fc9a-b31c-13c7-bb24-1d693d1d6961","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/0e6bdffb-68a1-4c22-99fe-1799bb553619"},"effectiveDateTime":"2015-08-18T08:10:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"7f44b0e9-eebd-826e-5084-dc1cbd736e88","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/9b6caa51-bf30-1184-3c9d-cf7a64806571"},"effectiveDateTime":"2015-08-21T10:26:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"ba1f61c1-1e32-d2c3-bcda-ad60ecf46fd7","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/3da667c1-5fc8-8e1f-9aa8-0840a77f07ef"},"effectiveDateTime":"2015-08-24T14:07:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"d4b49112-5b2e-1af7-a33e-927409b50218","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/a1b77b8a-5d56-5f92-2740-ace76ea38842"},"effectiveDateTime":"2015-08-27T17:19:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"edb5107e-dbd0-3930-bc76-ad92de9b8a60","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/06d9b469-93d3-534f-5613-3c3c65ff28ac"},"effectiveDateTime":"2015-08-30T19:27:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"eae9ab9e-0d09-ea89-1e8c-2bf87af7cc52","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/361d74e0-b44c-ffe1-4722-cdea89fe53b6"},"effectiveDateTime":"2015-09-02T23:07:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"e074d168-5888-a2b6-19f8-b2b652757be2","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/e129a0ea-4c90-1471-d0b4-c32272eefb6e"},"context":{"reference":"Encounter/29eb4579-55e1-52a0-b97b-99125f0d1a24"},"effectiveDateTime":"2020-10-27T11:19:40-04:00","reasonCode":[{"coding":[{"system":"http://snomed.info/sct","code":"103697008","display":"Patient referral for dental care (procedure)"}],"text":"Patient referral for dental care (procedure)"}]}
{"resourceType":"MedicationAdministration","id":"74d1cc27-67b4-85cd-9cd7-834eab310907","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/9e1e0a29-338b-fcb7-685c-3aedbd085b1f"},"effectiveDateTime":"2015-09-06T03:00:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"fad0f78e-cedb-310e-e6ea-c8cefd157ab7","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/320bf7ec-c923-c765-0a5f-22239c5d9efd"},"effectiveDateTime":"2015-09-09T06:11:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"55948b38-fd99-dc72-d651-0e73259fb3ce","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/9d9b1176-2cec-31f4-45a5-fe4c920fc053"},"effectiveDateTime":"2015-09-12T09:06:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"0540d280-1b7c-bd6e-63b7-ddebe3b05fee","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/ee673b48-dafc-498b-0ceb-715a60e056d8"},"effectiveDateTime":"2015-09-15T12:02:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"8ed6cd92-b85b-8866-243e-4a15f2838e5e","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/66dfee21-7f92-1060-4329-24bad2c5c19b"},"effectiveDateTime":"2015-09-18T15:16:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"b70a9f94-da16-ec90-f132-a59cbb8d4913","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/a9d9d8fb-9813-298b-22b8-f30206717fe5"},"effectiveDateTime":"2015-09-21T19:13:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"61a7bd2d-73df-21c6-01c0-1ca4ee512eaf","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/4f0aef59-9c79-8d5e-1888-38745c05b46f"},"effectiveDateTime":"2015-09-24T21:43:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"1d9c5e81-29f2-32a1-fa1f-98a9301a4ed2","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/b30848bd-b165-b932-a062-75db23121f93"},"effectiveDateTime":"2015-09-28T01:25:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"03457c05-5e09-fafc-caf5-e34a5ed0fd7c","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/5cee0da3-639b-044f-0de2-0f69fedc734f"},"effectiveDateTime":"2015-10-01T03:50:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"37de7bec-7868-8de9-718b-00cce6556714","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/e129a0ea-4c90-1471-d0b4-c32272eefb6e"},"context":{"reference":"Encounter/0368ecfa-5a96-cde7-f1b5-8d6d0b162f6c"},"effectiveDateTime":"2020-12-29T13:27:28-05:00","reasonReference":[{"reference":"Condition/a33ac6c5-cd6b-8557-b721-d9ee6b715649","display":"Gingivitis (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"c15f256a-66f0-e142-7451-3253070a019a","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/28a28108-e33e-b13a-dac3-87ce4bbc8b74"},"effectiveDateTime":"2015-10-04T06:26:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"cf87117e-9aea-0e52-1f93-c1e1866514c7","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/63fba401-f68c-4200-b375-b6fdb50ce4b6"},"effectiveDateTime":"2015-10-07T09:30:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"be35e958-e0a0-43d8-df04-735a7ab3be1f","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/f3fe8592-50e1-a2b0-98d6-8cb4e55a54df"},"effectiveDateTime":"2015-10-10T12:35:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"38ba65ff-612e-2caf-afa6-7fd0a161ee34","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/43cc58ed-fa24-3383-6af5-ec4d53b75e22"},"effectiveDateTime":"2015-10-13T14:37:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"3bab4f0a-0593-d62f-4c5f-36050c08263c","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/9be670b3-5e74-6e05-7d3e-25320431f4ae"},"effectiveDateTime":"2015-10-16T17:56:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"b0d4e9d4-af56-0039-3de7-6eb4dd1486a4","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/c10ba501-f610-f9af-78b8-8bb96523dba4"},"context":{"reference":"Encounter/a8f1ef38-95e3-019d-0755-3c8065362c65"},"effectiveDateTime":"2019-11-30T18:34:11-05:00","reasonReference":[{"reference":"Condition/80bf5f1f-b28c-1623-3a48-5fbb9b4e9405","display":"Gingivitis (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"26587167-55df-1ce0-c672-d3b277d129c8","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/4c105be2-9d08-8102-a198-53613502c425"},"effectiveDateTime":"2015-10-19T21:32:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"f4a4e798-8d51-349e-018d-87b32ff0d811","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/4d7c2fd6-d4c0-a8ec-cbfa-5e627487b640"},"effectiveDateTime":"2015-10-23T00:29:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"c5567a94-554a-bcd2-4e69-66ae268af298","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/e5c11457-e41f-4b9a-9220-c9163cb29014"},"effectiveDateTime":"2015-10-26T03:13:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"740a2b1b-0a1a-1a5e-9761-778d1702ba79","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/4d968e54-8493-e719-1e16-c16e161d3837"},"effectiveDateTime":"2015-10-29T06:27:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"1d9c8a39-6c2e-53ab-da1f-c4617307182a","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/c5e87935-b1e7-7403-bac4-8689a82c1357"},"effectiveDateTime":"2015-11-01T07:42:29-05:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"76cf9fb5-83c2-3ad3-b706-e55639ae54a4","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/e52d3849-f088-6024-4179-db8f2e2cf36c"},"effectiveDateTime":"2015-11-04T09:58:29-05:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"3e3b6c6d-2f1e-b5e5-fcc1-ed7e2f8e9612","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/c10ba501-f610-f9af-78b8-8bb96523dba4"},"context":{"reference":"Encounter/6885c30a-f49f-338f-406e-bfdcbbda1bbb"},"effectiveDateTime":"2020-01-04T18:00:10-05:00","reasonReference":[{"reference":"Condition/80bf5f1f-b28c-1623-3a48-5fbb9b4e9405","display":"Gingivitis (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"43d505b2-051a-d9c0-90a2-d473a22edd3c","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/cf890e59-5b58-6adc-4988-8ea61fccee63"},"effectiveDateTime":"2015-11-07T12:03:29-05:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"8a3d51b8-55ba-343b-ca75-981fe8a64e0c","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/fd077b27-ea39-40d6-5fc3-c91e767a2065"},"effectiveDateTime":"2015-11-10T15:33:29-05:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"21002c2d-c7df-d34f-6bce-a04c983bce85","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/e129a0ea-4c90-1471-d0b4-c32272eefb6e"},"context":{"reference":"Encounter/1b50f11b-ab88-b1fe-879e-ccbb8964fd31"},"effectiveDateTime":"2021-02-23T10:14:02-05:00","reasonCode":[{"coding":[{"system":"http://snomed.info/sct","code":"103697008","display":"Patient referral for dental care (procedure)"}],"text":"Patient referral for dental care (procedure)"}]}
{"resourceType":"MedicationAdministration","id":"19cdbc4f-bb4e-0ac2-30ac-ffbd54a104b2","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/c10ba501-f610-f9af-78b8-8bb96523dba4"},"context":{"reference":"Encounter/9141ed88-4487-6f61-1399-e4e57ef716c9"},"effectiveDateTime":"2020-05-23T19:20:46-04:00","reasonCode":[{"coding":[{"system":"http://snomed.info/sct","code":"103697008","display":"Patient referral for dental care (procedure)"}],"text":"Patient referral for dental care (procedure)"}]}
{"resourceType":"MedicationAdministration","id":"703e19b7-4c35-8569-9845-70b380d208a3","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/516239b8-cda9-cd0c-ef90-b59594abdca5"},"effectiveDateTime":"2015-11-25T19:55:29-05:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"703d1b20-46f1-04df-9c90-e353e9717b53","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/7e2442f6-e597-96b3-77ad-f448ed900adf"},"effectiveDateTime":"2015-11-28T23:46:29-05:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"cdb56e49-21c4-b577-6c77-0b5d258060f5","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/70a2b73a-0fb4-f1ab-5809-9cb4d157c1e8"},"effectiveDateTime":"2015-12-02T02:42:29-05:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"2bb33b49-b257-9e8e-3289-2d569af7bd9a","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/8bdb73c9-632e-feb0-8d9b-3829307d89a1"},"effectiveDateTime":"2015-12-16T19:20:29-05:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"c6f1fe84-83b3-fe85-9a15-a5a106ee268d","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/f1de4e44-211c-bcc4-454f-d070c184c6de"},"effectiveDateTime":"2015-12-19T22:31:29-05:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"36fa9a70-d47e-a953-1e1b-68fad6778506","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/3d81c660-56b6-916e-0aeb-8847bedd9eb3"},"effectiveDateTime":"2015-12-23T02:27:29-05:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"3c39e90a-06f9-9a2f-238c-d3c50d6dea3f","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/82c7b6d2-c5e0-f39e-f77c-78be03d0fb37"},"effectiveDateTime":"2015-12-26T06:05:29-05:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"8e36497a-c313-431d-fcf7-e68ec7151521","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/47bd41ee-6ee0-7664-85dc-c3cd73acb30f"},"effectiveDateTime":"2015-12-29T08:33:29-05:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"05551c0a-8815-bd44-6c9a-1d0d04d670f4","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/948b2f99-bb52-f6f1-dbda-b3973b4a0f6e"},"effectiveDateTime":"2016-01-01T12:19:29-05:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"ba31c022-4f4c-73be-3538-34725f94a84c","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/17ef6def-6523-0f30-408f-936448c8106d"},"effectiveDateTime":"2016-01-04T15:50:29-05:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"5ba4fceb-672a-1944-a7d4-1db9f12c2648","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/dedbb031-8484-dc7c-0d99-3ca1e408b02b"},"effectiveDateTime":"2016-01-07T18:14:29-05:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"3ce07f81-03f9-3332-fe7d-938525fbe100","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/50b72919-6d88-ff58-7715-9c9c8cdf55fc"},"effectiveDateTime":"2016-01-10T20:35:29-05:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"e52a173a-66e3-9d50-2925-1daeb6f445a3","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/a0d1b475-2cc0-1fe4-9d17-112e677e93f6"},"effectiveDateTime":"2016-01-13T23:48:29-05:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"bdf7ed10-eaa6-ee11-7f95-01151cdaa8b0","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/5cea8f34-cbce-9ac6-d991-b115182df1a8"},"effectiveDateTime":"2016-01-17T03:30:29-05:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"02e04273-e1b7-de51-eefa-13b4255aa558","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/f916dae3-d507-bf5d-2e05-ee240d6ef9e6"},"effectiveDateTime":"2016-01-20T05:48:29-05:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"228fd917-4dc2-3064-62d3-fd9daaae4a35","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/8071cd74-0e7f-06df-d5ce-2c86fd710e16"},"effectiveDateTime":"2016-01-23T09:23:29-05:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"8d9aa54b-4d9f-428f-df62-d8edce288c2f","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/5375f765-5623-19e3-6989-02038dece5e4"},"effectiveDateTime":"2016-01-26T12:07:29-05:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"8c148be5-ffe9-e3b1-d951-0f2027f28869","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/dc425c1c-ac7d-e2e3-e2df-64d602b95a1e"},"effectiveDateTime":"2016-01-29T15:14:29-05:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"5e948bb1-b729-e609-bab1-0eebdf329b0d","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/2f230c3b-b0e8-f141-ac5d-5b44bfa948bb"},"effectiveDateTime":"2016-02-01T19:11:29-05:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"3179ddf2-ef8a-8ab6-b206-2c73b352be58","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/1b045740-0308-ad59-6640-a40c5c21bda1"},"effectiveDateTime":"2016-02-04T21:14:29-05:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"cdb5968a-25b5-9536-cc77-339e2a1ffa9f","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/6d145da1-31f4-18fd-0715-d0baff877ab2"},"effectiveDateTime":"2016-02-07T23:16:29-05:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"a23a351f-0499-6f21-3627-db9111820f45","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/e3b6e144-c2c6-baba-30b4-ecedbbc24d81"},"effectiveDateTime":"2016-02-11T02:43:29-05:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"89f3dc8a-2336-3c9e-de7a-0a5256d8bd2d","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/d5879d3d-0415-bf24-8e5a-d6eb52dee2e6"},"effectiveDateTime":"2016-02-14T06:41:29-05:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"d06c437b-e2ec-0e37-207e-4e81fc2714ac","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/94452536-09a5-d71c-b9e7-ceeca388257a"},"effectiveDateTime":"2016-02-17T10:19:29-05:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"e46c8e91-de39-c707-3d33-8a519e954416","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/c10ba501-f610-f9af-78b8-8bb96523dba4"},"context":{"reference":"Encounter/063478bd-dbed-33bf-f8fa-d4d8cf96075c"},"effectiveDateTime":"2020-09-26T22:21:30-04:00","reasonReference":[{"reference":"Condition/80bf5f1f-b28c-1623-3a48-5fbb9b4e9405","display":"Gingivitis (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"7b6958b7-676d-de43-6d76-41578bc4e76c","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/0d2c756d-4f70-6b60-a855-a26ba49a9cda"},"effectiveDateTime":"2016-02-20T14:02:29-05:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"442fe5b0-f09a-c0eb-364d-d4728daec57e","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/14c998ab-06b7-6609-97e1-97bb5ddde15a"},"effectiveDateTime":"2016-02-23T17:13:29-05:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"e411cbc1-bb67-2282-7f0d-1a507d043687","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/32b50b70-d7e4-8468-334d-c2603e543388"},"effectiveDateTime":"2016-02-26T20:07:29-05:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"ebff5190-0aaf-2141-05d0-91da3b7aea2e","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/3bc20158-bf07-8dfc-bfc2-4f7a896bc991"},"effectiveDateTime":"2016-02-29T23:19:29-05:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"d21102d0-ab9a-3668-e615-add69338f805","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/e1f6ab2b-d861-8813-0a14-56c79dfa4775"},"effectiveDateTime":"2016-03-04T01:38:29-05:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"67c96379-ff5e-c2a5-8d61-5c0f716bab45","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/c94d3f95-77ca-534b-eff8-1d4bf798afb9"},"effectiveDateTime":"2016-03-07T03:57:29-05:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"b3777adf-fb06-15ae-508b-7f9af343d470","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/0d32e107-0bb7-feea-1b76-8b067530a1c1"},"effectiveDateTime":"2016-03-10T06:16:29-05:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"aaf707c6-413a-37d2-befb-cab475b8f96f","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/2d0bf59a-5527-3c45-dafc-3c624f5fba16"},"effectiveDateTime":"2016-03-13T09:28:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"03d91b33-31a7-e16d-d978-e366d4287ac8","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/4e86e491-48be-520c-2174-7cb562b66869"},"effectiveDateTime":"2016-03-16T11:28:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"b6baa7a4-8d70-5aa8-5ddb-762e8fd9ccfd","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/8de6ea95-f67f-3c6c-e8ab-c209c150c0ac"},"effectiveDateTime":"2016-03-19T14:15:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"3f2b6608-7a2b-0900-5296-c00df5317d50","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/ac2ed52c-e6d4-b2b6-1089-b0b994c35cca"},"effectiveDateTime":"2016-03-22T16:18:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"db74aba0-0b81-2987-77ce-cd1fd3b4cc08","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/4c545b58-0bac-8290-02e9-a5f6bd9dca2d"},"effectiveDateTime":"2016-03-25T18:40:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"36aaa243-7af2-bfb4-aae1-183d161826fa","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/e129a0ea-4c90-1471-d0b4-c32272eefb6e"},"context":{"reference":"Encounter/f056afc0-ca57-14d8-3ca8-4ec338967154"},"effectiveDateTime":"2021-07-27T11:49:14-04:00","reasonCode":[{"coding":[{"system":"http://snomed.info/sct","code":"103697008","display":"Patient referral for dental care (procedure)"}],"text":"Patient referral for dental care (procedure)"}]}
{"resourceType":"MedicationAdministration","id":"3f0be1b2-ee65-8273-104c-3060be216e8d","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/f51320c2-5729-d81b-bf7e-42089eca0816"},"effectiveDateTime":"2016-03-28T21:40:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"478510a7-c344-59c4-f7ec-55a90002edeb","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/b9fa4fc8-b503-c755-7b46-b5ef948af11f"},"effectiveDateTime":"2016-04-01T01:18:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"ba8e39e5-af86-25ae-ff8f-78a0b9b1d615","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/a2023535-2eeb-2f85-a26e-acdb6be53742"},"effectiveDateTime":"2016-04-04T03:21:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"cead1035-0cdc-fbbe-58af-91ac4a9c1c8d","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/120a973c-c789-07f6-59a7-b466ff7515fb"},"effectiveDateTime":"2016-04-07T06:00:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"ff200ff1-8a2c-f948-1fee-99f40fa85a28","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/88d915ad-4df1-9080-1f10-2e65a123da88"},"effectiveDateTime":"2016-04-10T08:52:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"e61d6a1d-e9f3-f62f-8331-6f30e9e654f1","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/54f29f0b-51b3-ac46-5247-306dc606d282"},"effectiveDateTime":"2016-04-13T11:46:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"3cab02c7-0640-c832-fe48-16cc21605960","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/6742dbbb-d95e-ae18-6f86-aa8332ef65ad"},"effectiveDateTime":"2016-04-16T15:29:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"39a07280-26fe-c8d2-8269-b893d7660dd3","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/3c69046d-74b6-aa3c-54f2-4b2398df205f"},"effectiveDateTime":"2016-04-19T18:15:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"d4f26384-fdb4-03bb-da1d-9e29fc75a0cf","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/e0e59537-37a0-a089-6874-5dc02c5006b2"},"effectiveDateTime":"2016-04-22T21:36:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"5c73959d-3eba-1f3a-5f0d-2b6695daedc4","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/d50fd7f9-c817-30f4-3c0d-ec493a24646e"},"effectiveDateTime":"2016-04-25T23:37:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"999f9450-d0b4-8658-c1aa-0af5d9b10992","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/adcbecbc-931f-19a4-cf6d-516d98ed9592"},"effectiveDateTime":"2016-04-29T03:36:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"dd9a0533-561a-a883-7a1d-3f5b60a13c39","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/4b4cf73b-ad2e-f097-e47d-46849008a07c"},"effectiveDateTime":"2016-05-02T05:51:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"218a262c-f367-f33a-7099-d69438694612","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/b3b95e37-b49c-e6b9-3987-bbbb1b75330f"},"effectiveDateTime":"2016-05-05T09:16:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"bd8045d4-3a54-7fa6-23ec-db7166287de3","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/e129a0ea-4c90-1471-d0b4-c32272eefb6e"},"context":{"reference":"Encounter/fbd7152a-7e63-62f6-0f7b-c003b6bb9ed9"},"effectiveDateTime":"2021-09-21T10:54:47-04:00","reasonCode":[{"coding":[{"system":"http://snomed.info/sct","code":"103697008","display":"Patient referral for dental care (procedure)"}],"text":"Patient referral for dental care (procedure)"}]}
{"resourceType":"MedicationAdministration","id":"f6ba7d1d-40e2-09be-fddb-4ba7438bb7dc","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/4b1f1bf2-6fa5-9960-c461-927ecd73e779"},"effectiveDateTime":"2016-05-08T11:39:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"f86dd18b-fc30-8564-0ddb-045e3736f9b5","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/b8a38e54-122d-7110-3af5-d1ee8db38b87"},"effectiveDateTime":"2016-05-11T13:39:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"d76c12b8-5678-7adb-ea92-59d925027d9b","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/3c091e0e-0069-bf5d-c34e-2e8d0510608f"},"effectiveDateTime":"2016-05-25T21:07:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"16ba5810-3875-0cf8-3ddb-269a3b392616","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/5c07e665-b546-feb2-d118-4ecde84d5567"},"effectiveDateTime":"2016-05-29T00:07:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"3dd08697-090d-3152-ff6d-9a9c994b5d60","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/976a21ca-a00b-332b-c68a-4bf6b80c2b4e"},"effectiveDateTime":"2016-06-01T03:07:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"a2ac21ca-4a46-b61a-6136-2c971e499648","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/c10ba501-f610-f9af-78b8-8bb96523dba4"},"context":{"reference":"Encounter/c576f5d4-e638-da4a-2aea-9fde18e772d8"},"effectiveDateTime":"2023-11-11T18:12:09-05:00","reasonReference":[{"reference":"Condition/80bf5f1f-b28c-1623-3a48-5fbb9b4e9405","display":"Gingivitis (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"5f4353c8-c23d-5a1d-d393-6a5a7a509523","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/9dc4801f-45d8-035e-e4d2-f64316091a6b"},"effectiveDateTime":"2016-06-08T23:16:49-04:00","reasonReference":[{"reference":"Condition/02a45867-628c-cf2b-d03a-9418bc51d591","display":"Gingivitis (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"275e11b8-3b0f-5b74-d7c5-56b9a898d19f","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/49675070-783a-6efe-6456-185223e6fa02"},"effectiveDateTime":"2016-06-15T20:25:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"6680433d-e73f-827e-37c0-9f20d0816e98","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/57c31ab1-9000-1303-26a0-2a902a1ef558"},"effectiveDateTime":"2016-06-18T23:18:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"f099f48a-0de1-6779-b4f0-b8524183e832","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/e443ce7e-472c-6c0e-61f0-7962aaf78059"},"effectiveDateTime":"2016-06-22T01:26:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"01e979f0-dbba-d39f-0ed2-1a1f4d759711","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/b29ed859-255b-1203-810d-c8e5041dcaca"},"effectiveDateTime":"2016-06-25T04:45:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"9a2acce9-d57e-a2a8-f3fe-ce9bef9d0971","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/e129a0ea-4c90-1471-d0b4-c32272eefb6e"},"context":{"reference":"Encounter/5baa856d-fdc3-385e-068b-e92e0e33ee3d"},"effectiveDateTime":"2021-11-23T09:56:30-05:00","reasonCode":[{"coding":[{"system":"http://snomed.info/sct","code":"103697008","display":"Patient referral for dental care (procedure)"}],"text":"Patient referral for dental care (procedure)"}]}
{"resourceType":"MedicationAdministration","id":"1c9c6783-537a-a30d-991f-a1ab5f2733af","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/f4593830-354b-44d5-a60f-86f44498f98e"},"effectiveDateTime":"2016-06-28T07:56:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"1baa3869-9e3c-2f8a-a3c8-fa06b2422db1","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/8c9eadbc-7b31-6f11-1a50-104c26c82682"},"effectiveDateTime":"2016-07-13T19:34:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"013e100e-bb28-6f3a-1b0f-506f1ffa1526","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/8948be83-e1a4-fb41-948a-0e61a4854c45"},"effectiveDateTime":"2016-07-16T23:30:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"190d85c3-b63b-1ae0-bb8e-478c09b8e313","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/be298df0-6980-f19a-e557-d08d1a6f94f2"},"effectiveDateTime":"2016-07-20T01:41:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"9b290b39-a0a6-7a2d-e1ce-d36d43273cf7","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/abc43f59-8143-9ea2-eb6c-c4ca104f45e9"},"effectiveDateTime":"2016-07-23T04:49:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"386a392e-77a4-f55b-6bf8-facb8bab13ce","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/3138505f-c896-30b1-3978-83607fdcd65c"},"effectiveDateTime":"2016-07-26T08:35:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"ce6e94e1-6df8-5c1e-dd3c-2795183cdf07","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/e129a0ea-4c90-1471-d0b4-c32272eefb6e"},"context":{"reference":"Encounter/fca129d1-4abf-72c8-afb0-f39e2671a625"},"effectiveDateTime":"2022-01-18T10:43:43-05:00","reasonReference":[{"reference":"Condition/a33ac6c5-cd6b-8557-b721-d9ee6b715649","display":"Gingivitis (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"fcda32f8-935f-be7d-4349-aa1961e9c191","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/6a5bb366-a0d6-1a70-09a1-d85ab9494bb3"},"effectiveDateTime":"2016-07-29T12:05:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"02d9a6be-2246-67ed-eef3-77fe852ef47e","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/9411ba1b-0871-14f7-fae3-5f6b1b1c9f1b"},"effectiveDateTime":"2016-08-01T14:30:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"689b1a26-5280-73c3-c84f-d52cc6d08c9d","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/ff3c527d-3e8d-2c7e-400a-6d4483677650"},"effectiveDateTime":"2016-08-04T17:37:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"e9b9a140-be21-3ca1-0918-9b8fdeefc6a5","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/ca64ad5d-2295-bf52-5c2b-90a5094d73d2"},"effectiveDateTime":"2016-08-07T21:34:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"5409b9e5-3a89-bf13-c6b8-7b824e9005d1","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/3c3df6de-8fb9-58e0-dc1a-9fd79472ad8d"},"effectiveDateTime":"2016-08-11T00:09:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"485afa1f-0ec9-b4b8-bf82-74911bb254ea","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/c7cba309-65de-9da0-737e-43b0b0271932"},"effectiveDateTime":"2016-08-14T04:07:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"a9969384-82f6-6c47-5790-1f6106309454","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/73e8e860-efc0-5a16-3dde-0afe157b3f36"},"effectiveDateTime":"2016-08-17T07:33:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"bed9dcc7-e579-c328-dfa8-66cb1505ab97","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/b562022b-ce5e-d94e-9c3b-e755e031737a"},"effectiveDateTime":"2016-08-20T11:06:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"37aef07c-0b5c-75e5-0492-b8c7d3901866","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/dc0e917c-897e-f3b1-31cd-fcf3793f10c9"},"effectiveDateTime":"2016-08-23T13:54:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"c3c2affb-9f45-0e04-c55e-766976f57549","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/fd967ad6-1fdd-924d-2b42-d4a8ee062156"},"effectiveDateTime":"2016-08-26T16:18:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"04b15c1c-1b62-1ec5-d392-f9fbe395c145","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/ce1ad3ee-02b7-22f6-ed2c-00078fd84d2c"},"effectiveDateTime":"2016-08-29T18:24:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"4e313f45-98ea-b843-ecde-b152818aec3b","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/e407c767-f46d-3266-a05e-ba220d061216"},"effectiveDateTime":"2016-09-01T21:13:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"915d85fb-5e5e-4613-d65f-27bc8f35f67a","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/db85f4a0-9a92-44b1-81e9-490946ce0959"},"effectiveDateTime":"2016-09-04T23:14:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"f2316ef3-d36b-4d23-5976-709799e204d4","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/9c17fa09-ab1e-c31d-b0bb-5f83440ada8d"},"effectiveDateTime":"2016-09-08T02:34:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"f1cdce3a-1090-88ad-64d2-ed262a61c917","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/a6fc02a4-8e68-37ca-8762-c1667ea4f538"},"effectiveDateTime":"2016-09-11T05:57:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"dd99e1ad-ec2f-795f-5a1d-1bd5f96e0a9b","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/dc46f2d4-b9a8-7c35-ba6e-aefc67a998a6"},"effectiveDateTime":"2016-09-14T09:24:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"f56f00b8-f8e5-cd23-5cb4-0262d26274d4","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/1c1b6abc-0f33-48a9-1f09-2ef634d7204c"},"effectiveDateTime":"2016-09-17T13:02:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"33d489fb-c6d9-dc05-7a51-0d35eee73ae3","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/0ca5aaaa-34b8-6a87-c7ab-0ab9f406a541"},"effectiveDateTime":"2016-09-20T15:56:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"fd36ee13-d00e-654b-03ab-3e2eadd43d85","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/b08ad3f1-95bf-a169-b6b8-bcc9dc6e0497"},"effectiveDateTime":"2016-09-23T18:35:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"a364a630-843c-3e1b-338f-24f2215044db","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/f564f15a-0da5-3467-816f-1a610dd26c1b"},"effectiveDateTime":"2016-09-26T22:16:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"63459cd4-81b0-d2f8-c939-5d2ffec65135","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/c10ba501-f610-f9af-78b8-8bb96523dba4"},"context":{"reference":"Encounter/277b87c9-b90a-9e28-943d-fa71df7a14bc"},"effectiveDateTime":"2024-08-17T22:00:44-04:00","reasonCode":[{"coding":[{"system":"http://snomed.info/sct","code":"103697008","display":"Patient referral for dental care (procedure)"}],"text":"Patient referral for dental care (procedure)"}]}
{"resourceType":"MedicationAdministration","id":"acc259bd-fc22-35a8-51ae-738f3c8eae5b","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/f6e17244-16c1-d0ed-8715-cee338d5f227"},"effectiveDateTime":"2016-09-30T00:39:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"5d99abcf-fe17-bd2e-7a1c-e5f80bb6ce16","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/f2b8500d-8955-9094-0177-2e80bad0c687"},"effectiveDateTime":"2016-10-03T03:07:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"00948b64-8b31-d1db-71b1-0e9eb33f8107","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/aa14d4f5-9868-6552-632e-9614c74c4962"},"effectiveDateTime":"2016-10-06T06:11:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"a0c746f6-c9db-1e67-40fe-440462cd2b50","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/d2f9bec5-95fe-9e44-25a7-20bbd1e6efc6"},"effectiveDateTime":"2016-10-09T09:10:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"cb3c8d93-7398-104d-5c86-6a16adc01e1d","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/f2e5fa96-5a4c-9919-f259-cb2fbdf0b717"},"effectiveDateTime":"2016-10-12T13:09:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"6b0df0b5-7e34-46d1-71fd-d046acf5e3e5","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/a0c41ce7-760d-0ebc-201c-0cdfae39467f"},"effectiveDateTime":"2016-10-15T16:33:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"51bcdc93-47e9-1b53-2318-b28f3f85210b","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/c10ba501-f610-f9af-78b8-8bb96523dba4"},"context":{"reference":"Encounter/e0c43157-aeca-333f-d461-95b5aff8d90c"},"effectiveDateTime":"2024-10-05T22:55:07-04:00","reasonReference":[{"reference":"Condition/80bf5f1f-b28c-1623-3a48-5fbb9b4e9405","display":"Gingivitis (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"3e00b8f6-b7ae-25e6-8302-76f6f8ddd64d","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/9993d1b9-7b23-51b6-0b2a-d61f5b646535"},"effectiveDateTime":"2016-10-18T20:20:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"831a4649-ead5-c221-dee9-f6b12fd78228","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/7dae9848-ca33-9c08-7b5c-12659208cec9"},"effectiveDateTime":"2016-10-21T23:56:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"bb1239a9-b0c6-25b8-0013-fbb68d0dd620","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/b1b5331a-e321-caec-6d24-418461d672b6"},"effectiveDateTime":"2016-10-25T03:18:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"bea4de34-7311-ceb8-df73-6837fb23c387","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/4320ac6a-cc43-2dc6-8533-75e6f8a2b81a"},"effectiveDateTime":"2016-10-28T05:18:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"7f7b8a0c-866e-2bed-5526-76e5b1a90f4e","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/e129a0ea-4c90-1471-d0b4-c32272eefb6e"},"context":{"reference":"Encounter/4efd92bf-5f0d-8f14-1586-893da21c0cbc"},"effectiveDateTime":"2022-04-26T12:07:45-04:00","reasonReference":[{"reference":"Condition/a33ac6c5-cd6b-8557-b721-d9ee6b715649","display":"Gingivitis (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"92528662-047f-1afc-34d3-6965fef8e330","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/51f65ed3-0f06-14ca-64d2-0ba915059a32"},"effectiveDateTime":"2016-10-31T07:43:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"7f6a6a45-e7d9-aacb-f177-52e620db9b63","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/9c2c5cd3-6ca2-a0b3-78f5-91f21ec19c18"},"effectiveDateTime":"2016-11-03T11:23:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"1d691b3b-8054-86a2-990c-e36f22d56bad","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/118866a2-052a-7adc-4ea9-946e6d92910e"},"effectiveDateTime":"2016-11-06T14:02:29-05:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"ba94deb5-85fc-bbf3-4498-76f6ed73dcc2","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/0d4762a2-273d-d2ee-5a13-b6218fe044e0"},"effectiveDateTime":"2016-11-09T18:01:29-05:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"1c9c0a81-737e-62aa-d91f-44a981ef4dcc","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/5577bf9b-bc69-c819-aa63-9f585b89fcaa"},"effectiveDateTime":"2016-11-12T20:06:29-05:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"7f69e424-d889-0953-f176-ccc5128c77e3","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/dfa9b698-9978-00c8-9962-b57df4fe2761"},"effectiveDateTime":"2016-11-15T22:23:29-05:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"09017ab4-0e4f-2b9d-24db-2d0a8439ee71","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/e129a0ea-4c90-1471-d0b4-c32272eefb6e"},"context":{"reference":"Encounter/3138b4a0-e1cd-f784-0a61-74ad14c4517f"},"effectiveDateTime":"2022-05-24T11:18:08-04:00","reasonCode":[{"coding":[{"system":"http://snomed.info/sct","code":"103697008","display":"Patient referral for dental care (procedure)"}],"text":"Patient referral for dental care (procedure)"}]}
{"resourceType":"MedicationAdministration","id":"0caddef0-46da-8bc5-decf-a0fff741d0c6","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/97f0afbd-9818-be0b-04a8-6f2b3e4d6762"},"effectiveDateTime":"2016-11-19T01:52:29-05:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"4e948ba9-b761-d2c9-2ff1-0ee3df7073da","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/bbbf5ccf-f596-3384-9d09-df63f8134faf"},"effectiveDateTime":"2016-11-22T04:29:29-05:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"89950828-7b08-bf36-7235-42ec92e33143","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/b7996ea9-7ac9-0813-2a13-62a287360549"},"effectiveDateTime":"2016-11-25T06:51:29-05:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"24ae8291-b61f-b0fd-0460-6eab87602705","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/0a1e21ec-7c1c-a1d7-5be3-3dc0d13d0666"},"effectiveDateTime":"2016-11-28T09:14:29-05:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"fb66f6ed-e1d5-3d9a-084f-972925f4f90d","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/66ef1496-0c69-da91-de21-10d9a2be727c"},"effectiveDateTime":"2016-12-01T12:01:29-05:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"00a78313-fe31-d62f-9dbb-8a848f7894f0","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/3df2772b-96f4-dd87-b463-2740901ca60d"},"effectiveDateTime":"2016-12-04T15:04:29-05:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"cd6fcd91-ddd8-3c39-e253-6a1518004b2a","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/700e44af-fd5e-4959-3eeb-8863b64b0f72"},"effectiveDateTime":"2016-12-07T17:23:29-05:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"5c996c87-937c-c2ec-d91c-a6afa27e1538","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/7d043688-6fd5-2a2d-efc5-583c604ebb4d"},"effectiveDateTime":"2016-12-10T21:04:29-05:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"20d2bcd6-8003-7a7b-f213-356279d86694","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/cbd9728e-3f20-7880-3d1d-331895796647"},"effectiveDateTime":"2016-12-14T00:27:29-05:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"5c3190f0-0b8a-7ac6-4e4b-691bd3be1d47","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/6b429c72-5c36-222a-625b-63c6deb235c2"},"effectiveDateTime":"2016-12-17T03:34:29-05:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"76fa8be1-e815-30c7-561b-5a6bebe1a154","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/361c5685-1677-3210-90c7-c49215c1a2cf"},"effectiveDateTime":"2016-12-20T06:48:29-05:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"221efac8-02c2-8b17-9c2c-e852eedc5c57","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/12909d19-6a84-3143-12ca-fcd96b581a9c"},"effectiveDateTime":"2016-12-23T09:17:29-05:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"0c2309e0-fdb2-d56b-e09c-52301e815f6e","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/828d6a61-1a8d-8231-3538-fb14ef021cbf"},"effectiveDateTime":"2016-12-26T12:34:29-05:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"5caa1353-be13-cfdb-5025-19c80e329401","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/97125989-1931-9e51-95e0-44516e80caf5"},"effectiveDateTime":"2016-12-29T15:58:29-05:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"34a92ebc-77c9-db3e-9956-1b22354e72f1","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/e129a0ea-4c90-1471-d0b4-c32272eefb6e"},"context":{"reference":"Encounter/69079b12-6ba4-67b3-eaf4-0a1ef4b939ba"},"effectiveDateTime":"2022-07-19T11:30:48-04:00","reasonCode":[{"coding":[{"system":"http://snomed.info/sct","code":"103697008","display":"Patient referral for dental care (procedure)"}],"text":"Patient referral for dental care (procedure)"}]}
{"resourceType":"MedicationAdministration","id":"f1ec02fc-999b-ad39-0bbd-43782b605426","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/00f9eb30-9577-7479-9d8d-e004a948cf8b"},"effectiveDateTime":"2017-01-01T19:13:29-05:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"c9c73b9c-05db-1c91-6a05-44390bcd297a","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/4c6b59ea-fea0-d71b-e98f-c501d715d86a"},"effectiveDateTime":"2017-01-04T21:28:29-05:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"d75b28f0-0607-5987-384d-35d8a645a2f2","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/e015d30f-9727-62a7-5e0c-dca135f33a7e"},"effectiveDateTime":"2017-01-08T00:58:29-05:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"aa0a9a22-8976-76f3-f584-1528fdc69638","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/879d8a08-ab5a-7ad3-7c41-15868b4d8f32"},"effectiveDateTime":"2017-01-11T04:54:29-05:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"ec2fa15f-3d94-e1a3-fbe2-6738da181bcb","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/d6ff1040-a4b5-2735-9bd0-d82125e40d1b"},"effectiveDateTime":"2017-01-14T08:03:29-05:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"63b11b49-2f58-0568-5594-e37cd1d90197","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/69552328-0ad3-13ef-470e-c8c04ee4ba59"},"effectiveDateTime":"2017-01-17T11:22:29-05:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"c3be3b4b-7277-0e21-463f-2d585b174d6e","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/73ce9ab6-a404-9ab6-d015-786cc8f4c5ea"},"effectiveDateTime":"2017-01-20T14:50:29-05:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"8d243a33-e46d-ee52-1fd7-eceb44b2fd20","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/e129a0ea-4c90-1471-d0b4-c32272eefb6e"},"context":{"reference":"Encounter/c9ebc844-09b8-c975-1d67-ca3a59f4043d"},"effectiveDateTime":"2022-08-16T11:34:07-04:00","reasonReference":[{"reference":"Condition/a33ac6c5-cd6b-8557-b721-d9ee6b715649","display":"Gingivitis (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"df1a464a-8eda-3f80-5c95-f6b1d3dc3be7","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/008cbf2b-3a85-c3ee-bff7-fb916b931c7f"},"effectiveDateTime":"2017-01-23T17:45:29-05:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"a4899a25-05f3-33b8-d3c1-952b7a43539e","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/84a893a9-9595-c710-2d11-8458fd3099dc"},"effectiveDateTime":"2017-01-26T19:48:29-05:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"59cc3e37-9a3d-bb3b-426c-7e439d672d48","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/6b0f4874-ab93-7f1e-5b1d-64f6fed2bc16"},"effectiveDateTime":"2017-01-29T21:57:29-05:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"70985c65-a08f-0b04-1319-62072a9ad338","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/58bc626f-3a23-77ff-e062-a5892ee479c6"},"effectiveDateTime":"2017-02-15T19:50:29-05:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"3df39ca7-8e68-cda8-f213-2e36bd36605b","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/e129a0ea-4c90-1471-d0b4-c32272eefb6e"},"context":{"reference":"Encounter/bad96c3e-a60b-6e39-bc1a-ec5fac00b8be"},"effectiveDateTime":"2022-09-20T10:52:41-04:00","reasonReference":[{"reference":"Condition/a33ac6c5-cd6b-8557-b721-d9ee6b715649","display":"Gingivitis (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"fd322efe-626b-a19a-0a1a-cf400c05b30d","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/a082ecff-64ce-c859-689b-85c499585b13"},"effectiveDateTime":"2017-02-18T23:49:29-05:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"ee34e7ad-0b0e-a78b-8cf6-84c1134bf982","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/e00af0fe-15e2-c828-3fca-e47d445b927c"},"effectiveDateTime":"2017-02-22T03:30:29-05:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"47349d53-c29a-d04c-f79b-e255d3f01d3f","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/ebf8e45c-16e1-f7ee-cc33-654e697d55f2"},"effectiveDateTime":"2017-02-25T06:11:29-05:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"d2158c18-a054-3b30-fbf2-0f52c864d5c8","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/997486e9-fafa-2c0d-34e2-9d1650bd886b"},"effectiveDateTime":"2017-02-28T08:25:29-05:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"dfe5a775-3eba-1df8-e410-471b85daec82","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/bf8550ea-cb8d-2a93-21af-1d6fb31478e1"},"effectiveDateTime":"2017-03-03T10:31:29-05:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"46bb1d1f-43e3-84bf-e5db-eba948122f2b","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/67be6f69-ddaf-fd67-ca1f-8bf10112f76f"},"effectiveDateTime":"2017-03-06T13:52:29-05:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"fb96d04f-6a71-e341-1568-10d7db4f762e","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/63d2423f-b22f-ef6c-824f-1c727443657a"},"effectiveDateTime":"2017-03-22T19:45:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"b71921b4-0b4e-efc2-c8fb-c855d3829243","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/f98d9e77-79f7-b843-264d-37432b7d0141"},"effectiveDateTime":"2017-03-25T22:35:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"6185d8a2-139a-51f1-e298-bdfa4b628593","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/7f1277f1-0c0d-0d43-a056-b41cd7b80c89"},"effectiveDateTime":"2017-03-29T01:56:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"4c42c884-bf1c-dc1f-c092-eb79b3201725","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/2a5dee2d-fd9d-63a7-90f5-759e0dc081a9"},"effectiveDateTime":"2017-04-12T20:47:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"aaac1270-3aa8-74df-0027-18e48acb89c7","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/72fa4888-a45f-7bdd-3aea-716e3589b89f"},"effectiveDateTime":"2017-04-15T23:14:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"b4363e19-87fe-2d8d-ee5e-4fb3f8fb8a10","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/677b6d82-91ae-059e-f019-157b7d6a54a3"},"effectiveDateTime":"2017-04-19T01:45:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"00075124-7264-e0f5-cf0d-40d4d9a9e331","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/8b60c53c-b2cd-bd3f-ba64-dd8ecfcc0047"},"effectiveDateTime":"2017-05-03T20:04:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"d2df1a25-bb66-5b63-5b5b-d52c2fb67f51","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/83e58d31-34f6-a812-da3e-8ced86df2ab0"},"effectiveDateTime":"2017-05-07T00:01:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"7fc97946-2a47-47e5-0303-a1583134cae2","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/723026b9-78a7-175c-40df-83a6b3f88099"},"effectiveDateTime":"2017-05-10T03:20:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"7ec37896-1d47-46a5-01fd-a0a893d43a22","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/fdc8f42c-3a3d-28cd-6879-7c1b0246bc46"},"effectiveDateTime":"2017-05-31T19:32:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"7b717f1e-b6c3-1484-ed7e-67bf00dce5b8","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/ccd4d49c-b58d-7696-2014-2cea9389b9fa"},"effectiveDateTime":"2017-06-03T21:39:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"273bb63a-15eb-952e-da3d-8b262fbcd5c2","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/71979afa-d2bf-b80c-24bf-89aa6c591c33"},"effectiveDateTime":"2017-06-06T23:51:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"579a9edd-b5a8-0ab7-2624-a38753ae91d8","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/e7054018-7532-2a09-d55a-599648f6bec2"},"effectiveDateTime":"2017-06-10T02:51:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"1b8f3d72-4460-d3b6-e3c2-dff36fc6f6e3","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/6ebc593d-a260-2df3-800d-9543bf89bf14"},"effectiveDateTime":"2017-06-13T05:01:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"f3d489fc-8bc1-d89a-3911-0d36b3d49f3e","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/68e64391-9c5c-65e5-473e-8658bf578c3f"},"effectiveDateTime":"2017-06-16T08:46:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"ff0ba563-a1db-08cb-057f-f5894f849745","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/2a531733-ec59-248f-4427-9d7b4e9149bb"},"effectiveDateTime":"2017-06-19T12:14:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"967cbd3b-1ef9-db2f-9b36-76caa61aa9b9","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/dd803ff5-e3a0-311c-affd-e5ad308e48fa"},"effectiveDateTime":"2017-06-22T15:07:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"de90151c-a624-ba89-1232-964c1899c252","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/ed7b5083-cf0e-5410-4ea6-45f03e30d9cf"},"effectiveDateTime":"2017-06-25T18:52:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"da500cf8-c328-2289-0df2-8e2937d99052","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/5252749b-2c77-d105-300a-ecba037f4c88"},"effectiveDateTime":"2017-06-28T22:05:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"472576c9-7563-bb41-2fc5-c327b4aead4e","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/73a649f3-ae75-3b32-7247-ba19d6f89cb3"},"effectiveDateTime":"2017-07-02T01:54:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"5896cc92-b6aa-0f8d-d9d5-4915f0d222b4","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/995d360f-d8c7-a201-81a6-b912287f9d82"},"effectiveDateTime":"2017-07-05T04:12:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"f8be2f9b-fc28-8b39-128f-7038b3a9d426","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/b459b31f-04bb-a86f-17d7-3c27f33a5728"},"effectiveDateTime":"2017-07-26T19:31:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"91de9a21-b96f-a397-0df8-15282dbfcae6","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/c4f6260e-3f3f-eb11-3c99-9ab0d37bc458"},"effectiveDateTime":"2017-07-29T23:30:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"fa2edd1f-19ee-224b-00a3-2d46886a5f45","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/faa6856e-5120-1775-e35f-ef151d0dacbf"},"effectiveDateTime":"2017-08-02T02:04:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"44a066fc-1b5d-cf74-84d3-e04be39171f5","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/2decdda7-c00f-3d05-34ec-89eb1c9006dd"},"effectiveDateTime":"2017-08-16T20:08:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"eb451c73-3d3d-ea27-aef5-83b83fc0504f","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/78904b7f-49b4-c825-7d0f-80ad3a52700f"},"effectiveDateTime":"2017-08-19T22:35:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"6f7abbe0-bdb7-24c5-7859-5f57de85aeca","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/2ea74a52-37a5-9849-7de6-9fe408fc42d4"},"effectiveDateTime":"2017-08-23T02:29:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"09911e44-36a5-2e9a-3d33-9f91ef0a9662","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/708a54b1-d8f4-7f88-8623-5a6efbc119f7"},"effectiveDateTime":"2017-09-27T20:12:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"35b22665-42b2-f391-2169-d6cc87b59106","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/7b800289-4831-992b-1d4a-bc14930d40fb"},"effectiveDateTime":"2017-09-30T23:22:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"b79d8170-26dc-ea52-5715-4bcbd7442f55","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/710bbd45-082f-849f-3cdc-030a3882adbd"},"effectiveDateTime":"2017-10-04T02:21:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"31343282-02aa-c7ac-db70-bd2eeec498ec","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/3ff8aefa-b6ff-d484-e707-1a48e839e720"},"effectiveDateTime":"2017-10-18T19:43:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"708ff538-02c5-f339-1b4d-96c4eedfc47a","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/9c2ef2bc-6b01-cdbc-9392-6f1ddfbc70e0"},"effectiveDateTime":"2017-10-21T22:55:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"b7a8f46a-0e0b-24af-86b4-08de1b065afa","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/e129a0ea-4c90-1471-d0b4-c32272eefb6e"},"context":{"reference":"Encounter/1e1be2a0-05b1-e7e4-5525-0b476cb97b83"},"effectiveDateTime":"2023-09-19T11:57:02-04:00","reasonReference":[{"reference":"Condition/a33ac6c5-cd6b-8557-b721-d9ee6b715649","display":"Gingivitis (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"1fb87aa5-e239-3d30-0bc3-66bfb379e870","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/fdec506c-d798-8f62-839e-bf3aa923cfb4"},"effectiveDateTime":"2017-10-25T02:49:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"80345cbd-b90e-fde4-036e-84d3314469e1","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/98ed8ed2-92ba-5afe-d9ca-65d97903684c"},"effectiveDateTime":"2017-10-28T06:24:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"47791bb1-c18d-c904-f7e0-60b47294b353","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/b464c026-f8bc-5b24-6d7c-1ca13e2b9622"},"effectiveDateTime":"2017-10-31T09:00:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"9b254cd3-9eb8-0211-6ed5-b418a16b106e","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/df4644aa-5e2c-7b05-e07c-a87e90f5b447"},"effectiveDateTime":"2017-11-03T12:39:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"8bba3b4e-b20f-e77e-2ba9-ad5b9ab03e20","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/21ea9384-0025-42c6-23fc-d9db3ecd9c16"},"effectiveDateTime":"2017-11-06T14:01:29-05:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"89dbd1ad-79ba-26cf-ca89-96a55aa640a0","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/f61f38ae-0d57-0ad5-6fc0-9cef6a1a378e"},"effectiveDateTime":"2017-11-09T17:35:29-05:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"cdba3332-1db2-c078-d89e-9dbb1c745d8c","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/e527761b-13a2-b651-130d-fe184033ad93"},"effectiveDateTime":"2017-11-12T21:08:29-05:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"be74be59-e894-8df8-df43-485f5ed632f7","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/e0011d46-5c6e-2af2-f103-ee802c17d6d7"},"effectiveDateTime":"2017-11-16T00:36:29-05:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"b394e631-05b9-08fe-4678-24f2a2cd13f3","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/ee46a229-fe91-b3f9-28bb-a7d1d1383030"},"effectiveDateTime":"2017-11-19T03:44:29-05:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"9b021d5b-94f7-0aed-3d83-7cf2c0f2d321","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/ec77afdc-a233-5010-c75f-670a6c2a09d1"},"effectiveDateTime":"2017-11-22T07:42:29-05:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"0f462762-3b54-aabb-1411-dfa0fcf1bec6","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/44c85b6e-4182-399d-2b11-dcb21cfbdae6"},"effectiveDateTime":"2017-11-25T10:56:29-05:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"dd9a5e1b-5c32-8fa0-fa1d-9843724c5efb","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/9dd3bc30-695c-5873-652b-e5ef1a3d5a9f"},"effectiveDateTime":"2017-11-28T14:31:29-05:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"be148267-288f-8280-8f55-35a6e2e26e9a","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/2f84c45c-7cdb-58fa-3cbe-532299402a5c"},"effectiveDateTime":"2017-12-13T18:45:29-05:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"82624692-ea8e-87e5-5361-f6fa2f9156ec","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/7fd17a84-7feb-2a6a-769d-6622e5cf9402"},"effectiveDateTime":"2017-12-16T22:28:29-05:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"9f2df2c3-96ea-6543-0672-f594a71ff4f4","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/9bdb907e-1b7b-807f-bc8f-7cdd825bc5bf"},"effectiveDateTime":"2017-12-20T02:24:29-05:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"e0c25f9e-e9cf-d06f-caae-79702a8495a2","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/b20dd1bf-d553-b408-acd6-abcfe854743c"},"effectiveDateTime":"2017-12-23T05:38:29-05:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"a3259005-2c3a-4afc-4ed5-f74a2f0f6391","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/4ccf3bc3-474b-b7ed-ca3c-6c6c5688ac48"},"effectiveDateTime":"2017-12-26T08:45:29-05:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"3cbf650c-2eae-5232-fe5c-79178b2fce80","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/0cf18aa9-8fa0-b56d-bb50-ffa3ef329451"},"effectiveDateTime":"2017-12-29T12:27:29-05:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"1312bd18-7e34-2d87-1e77-5e339cf5ca9b","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/39bd01eb-b47d-7487-051c-e65b2f59b2e2"},"effectiveDateTime":"2018-01-01T16:10:29-05:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"1ad7cb0f-7b64-f056-ad8b-8fce36c2ef23","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/e129a0ea-4c90-1471-d0b4-c32272eefb6e"},"context":{"reference":"Encounter/6e4b280a-c0eb-5a82-2e0d-1268ec78e0a3"},"effectiveDateTime":"2023-11-07T13:07:38-05:00","reasonCode":[{"coding":[{"system":"http://snomed.info/sct","code":"103697008","display":"Patient referral for dental care (procedure)"}],"text":"Patient referral for dental care (procedure)"}]}
{"resourceType":"MedicationAdministration","id":"f6fa798b-9f85-bde2-ee1b-4815a54cdaea","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/03aec6fa-5ba6-914a-b60c-8d82728ef698"},"effectiveDateTime":"2018-01-17T19:53:29-05:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"fd357556-e9bd-a19a-0a1e-15b39c2f8a0d","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/41a22bf7-2d94-3de9-ee7f-75ca4a8c5164"},"effectiveDateTime":"2018-01-20T23:11:29-05:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"a5227a8b-f5d6-cede-907b-66a5c71788c2","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/0129a706-55ec-036f-ec73-891d103e03a7"},"effectiveDateTime":"2018-01-24T01:11:29-05:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"23870701-d31a-36df-3792-b99ce008f87c","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/4a300b53-c8f0-facb-762e-d0139e5ebbcb"},"effectiveDateTime":"2018-01-31T22:58:01-05:00","reasonReference":[{"reference":"Condition/02a45867-628c-cf2b-d03a-9418bc51d591","display":"Gingivitis (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"cefe8f1b-fab7-ffd7-8b41-2130e6d1d118","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/3f1e26aa-e9cb-f12b-d52f-08d70f55c9c5"},"effectiveDateTime":"2018-02-07T18:35:29-05:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"27a50b19-4fa1-b755-5548-d34cf22330dd","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/aa70c4f4-7d88-339f-0f02-2adcc1bb31ee"},"effectiveDateTime":"2018-02-10T22:02:29-05:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"83aee19c-36ef-8281-54ef-9ee1b5326e9b","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/ff1d4ebf-18dc-765d-bdb9-3b8a37bd5423"},"effectiveDateTime":"2018-02-14T01:25:29-05:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"cacd271a-539b-7fc0-e7e7-1f364ed1ca8f","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/e129a0ea-4c90-1471-d0b4-c32272eefb6e"},"context":{"reference":"Encounter/2301a583-629c-bca7-1d7a-4b07892f6838"},"effectiveDateTime":"2024-01-09T10:31:06-05:00","reasonReference":[{"reference":"Condition/a33ac6c5-cd6b-8557-b721-d9ee6b715649","display":"Gingivitis (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"dbf96d8f-9989-7a68-ad3a-2d34166c6682","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/9e1e3d14-d316-3edf-06e5-c1b2c86da0df"},"effectiveDateTime":"2018-02-28T19:01:29-05:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"5c990c68-71cf-3ee9-391c-469089d3d06c","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/60d1ae75-4666-5eed-06c0-ab1afd83a3a2"},"effectiveDateTime":"2018-03-03T21:37:29-05:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"e66484ed-a9d7-3939-0035-c5ae5081dc26","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/67c416a2-012c-a2dc-959a-3c19d225ddc7"},"effectiveDateTime":"2018-03-07T01:25:29-05:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"c5da4655-5c5f-0bfb-55a6-f6bca1621393","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/e26a39ea-8a1b-cca3-f732-31d8ab0aadc2"},"effectiveDateTime":"2018-03-14T20:23:10-04:00","reasonCode":[{"coding":[{"system":"http://snomed.info/sct","code":"103697008","display":"Patient referral for dental care (procedure)"}],"text":"Patient referral for dental care (procedure)"}]}
{"resourceType":"MedicationAdministration","id":"9be50379-faa6-e91c-5eea-80cae6c0ba5d","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/9dd92d57-1928-d5eb-2798-6f176e9ba31b"},"effectiveDateTime":"2018-03-21T19:55:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"a7670159-32ea-0e1d-f797-e32109651491","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/6a4f061d-a48d-1f00-1757-d0dd4a0d1a7a"},"effectiveDateTime":"2018-03-24T23:26:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"f64ec642-1280-bb8f-fe67-b42e2c51fc53","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/7a0b8a40-8f0b-6ae2-2b83-83c72cdec443"},"effectiveDateTime":"2018-03-28T02:34:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"5a473426-7cdb-1378-faa9-78333acd2060","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/d595ca79-8bc4-2863-9f5d-de4cf2549429"},"effectiveDateTime":"2018-03-31T05:08:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"ea1cad37-bdd6-2a89-1dbf-2ec1cd3d2a52","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/9f56bd17-dc10-c401-ae23-709669df270b"},"effectiveDateTime":"2018-04-03T07:28:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"fea419ce-187f-b6b8-1f72-a3d444b63ec0","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/819ed320-74ad-16c5-86fb-3faa3c80ff21"},"effectiveDateTime":"2018-04-06T09:31:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"26e9b914-968b-cf0c-2db8-7ab1aa982f6f","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/4ac6c96a-05b0-3c9e-f8b6-b8dee6718e68"},"effectiveDateTime":"2018-04-09T11:43:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"2773f0bb-f270-6454-d7db-35bf0c8d643b","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/6d9827f5-9f5a-27d7-875d-22147fcef775"},"effectiveDateTime":"2018-04-12T14:54:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"4b9ca124-9019-2af3-70be-d4d4f75e2e0f","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/28d147ad-eae2-3560-2f9d-9fb4149a02eb"},"effectiveDateTime":"2018-04-15T18:39:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"e7528413-571c-9af7-b5dc-8a4fa8b87218","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/d97ba800-6845-bb5a-5d53-3b7fbc140480"},"effectiveDateTime":"2018-04-18T21:45:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"f87855ce-73df-21b8-98dc-5bc088d12ea1","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/123b4e5b-3757-6ede-1915-886ab0153a49"},"effectiveDateTime":"2018-04-22T01:18:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"7b643ea8-8e15-6465-ed71-2748f25b09d9","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/9f827437-b2a9-67d6-c390-fcd2f6c6b9e8"},"effectiveDateTime":"2018-04-25T03:31:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"b0e0a340-02be-69e6-79eb-638deed83b27","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/a7043cd1-eb6c-5f82-3483-039be3dfaeeb"},"effectiveDateTime":"2018-04-28T05:46:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"f306da47-7cb6-30de-427b-b36117db9874","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/e129a0ea-4c90-1471-d0b4-c32272eefb6e"},"context":{"reference":"Encounter/c324faee-de1a-0cb3-8a5b-a01d4e38cb17"},"effectiveDateTime":"2024-04-02T11:39:51-04:00","reasonCode":[{"coding":[{"system":"http://snomed.info/sct","code":"103697008","display":"Patient referral for dental care (procedure)"}],"text":"Patient referral for dental care (procedure)"}]}
{"resourceType":"MedicationAdministration","id":"f986088a-3612-beda-10bf-345269b5406e","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/024fc3ec-902d-89b4-d9d9-78a0bae77281"},"effectiveDateTime":"2018-05-01T08:50:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"48aa12fc-5956-e22f-1065-1970a989e4c1","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/fd40f288-9150-12e3-e393-92d34e924b97"},"effectiveDateTime":"2018-05-16T20:53:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"0979de59-8874-8746-3193-6f92edb10a80","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/9c7f20c3-8298-88ec-8fd8-f6adbc3c68f4"},"effectiveDateTime":"2018-05-19T23:10:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"24f9e020-34b4-867b-4d13-818109d109b5","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/4cf5d0fa-e463-982a-cad7-8e31f05ec762"},"effectiveDateTime":"2018-05-23T02:27:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"6d8820e1-cef9-3191-7403-814c3e1a001b","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/135d5b5e-64ae-bc34-0076-494ab67308bb"},"effectiveDateTime":"2018-06-06T21:14:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"05949a23-110b-8f51-3328-d529855bc34c","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/25ad498b-b79f-0aea-822a-c97c3172e695"},"effectiveDateTime":"2018-06-10T00:11:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"2d4a39c8-82ec-f9c1-4138-fb6596fa009b","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/548ce934-9e9b-43cf-31fd-d2c1a927ed76"},"effectiveDateTime":"2018-06-13T03:17:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"169b516d-99cf-dd24-7de0-54b14ebce8d4","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/823cc7e3-ccde-3c44-75e3-088fe2c7ea5c"},"effectiveDateTime":"2018-06-16T05:37:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"f6fa7f32-e47f-273c-ce1b-4dbceb0a8cfc","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/806e491d-d065-b035-f8a1-2c43735a9e49"},"effectiveDateTime":"2018-06-19T07:53:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"3fabfdb7-9925-ac8e-79d4-17f51cfce911","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/bd09bddd-7645-a8e8-6f1f-00599baa62da"},"effectiveDateTime":"2018-06-22T10:06:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"bc64fcc7-2161-89a0-f6cc-1d95ab681d11","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/c566948f-8fbf-f43e-394c-2c6f7816b35b"},"effectiveDateTime":"2018-06-25T13:51:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"e447d874-ac16-9ab7-b2d1-df0c21aeb9d8","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/3f5bd27b-ac57-7ed8-8ec2-bbd1a53c5718"},"effectiveDateTime":"2018-06-28T16:44:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"7b6c7722-4735-15c6-6d79-5fc2b0ecb8cd","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/47c85cd6-fa62-4b5e-e7fe-9b8993918123"},"effectiveDateTime":"2018-07-01T19:38:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"694d02a2-c369-8269-3a8d-d6920a056e83","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/16d30152-a578-4401-3fc9-6df762c48477"},"effectiveDateTime":"2018-07-04T22:12:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"46bb1d55-a6dd-431f-75db-ebdfad80ba99","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/01e4345a-ed59-9809-864f-07718ef60b02"},"effectiveDateTime":"2018-07-08T00:34:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"2adf1d15-61ea-10b5-7b14-58da7ea51729","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/c54c25a9-4681-6c02-2717-2132e8a9550b"},"effectiveDateTime":"2018-07-11T03:13:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"7fcb0c7c-6e2c-fb94-09d1-c6e5b3c41c63","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/c692e50c-31fc-ba5a-9e74-4db80ad0d65d"},"effectiveDateTime":"2018-07-25T20:17:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"8a2a1906-8ccb-8608-9a25-1f7add017996","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/a89a9710-9d7c-8778-ee93-edbe9f02680d"},"effectiveDateTime":"2018-07-28T23:28:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"66b796b9-0526-224d-7d1e-6012ed0344ec","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/e129a0ea-4c90-1471-d0b4-c32272eefb6e"},"context":{"reference":"Encounter/3ffb30a7-3c0b-6828-c2c9-f89027e63dfa"},"effectiveDateTime":"2024-08-06T13:29:13-04:00","reasonReference":[{"reference":"Condition/a33ac6c5-cd6b-8557-b721-d9ee6b715649","display":"Gingivitis (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"9116b984-ff54-8380-fd3d-9b53f1616c20","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/1b39de8a-9570-15c0-3f0e-2c4c74137dd1"},"effectiveDateTime":"2018-08-01T01:46:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"f4a00e38-431a-8689-2842-8fe9de2dae52","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/6e2b57e8-7e9b-6a3e-579c-d94b0a3f5d65"},"effectiveDateTime":"2018-08-04T04:12:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"1d85f4f1-cd1a-f5b0-ba9a-028699d63471","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/69954599-b4c6-cbbb-e79f-4cd566243e77"},"effectiveDateTime":"2018-08-07T06:20:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"f18acb44-3af9-0a3f-6952-fee6bcaca1e6","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/759f70db-e18f-bc4e-9182-2ca04b1665ff"},"effectiveDateTime":"2018-08-10T08:20:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"003af5e5-5724-d16c-03a4-282e36d538b1","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/e09c16d3-86e5-3904-c73f-277e1abdc899"},"effectiveDateTime":"2018-08-13T11:20:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"a901c1b8-9066-45a0-ee05-2ced256df607","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/b851fce3-afcc-d406-055b-c51e31cc10c4"},"effectiveDateTime":"2018-08-16T14:14:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"0dbcbd1b-036d-778e-b53a-050d105617fb","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/c25be2c4-1dff-16ce-2418-5e77a1fcb839"},"effectiveDateTime":"2018-08-19T17:52:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"e411126e-c99c-fbef-6e17-f0e4589c1cbe","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/a6ca5208-fafa-a65f-167e-ceea6590dbba"},"effectiveDateTime":"2018-08-22T20:16:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"baf3ecdd-72ec-0e24-0b2b-00ca24a71499","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/f571eea2-1124-6879-53cf-e175280674ef"},"effectiveDateTime":"2018-08-25T23:25:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"6bb76473-1b87-8ab7-3a41-6b599e2b41d8","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/e9fd28db-419b-98eb-4e3d-4aa3868bbcb5"},"effectiveDateTime":"2018-08-29T02:21:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"587f46b3-4540-7b84-a0c5-70cb1ef2d1fe","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/e129a0ea-4c90-1471-d0b4-c32272eefb6e"},"context":{"reference":"Encounter/879a64c4-0eea-b376-9b01-604fb8433545"},"effectiveDateTime":"2024-10-08T11:15:18-04:00","reasonCode":[{"coding":[{"system":"http://snomed.info/sct","code":"103697008","display":"Patient referral for dental care (procedure)"}],"text":"Patient referral for dental care (procedure)"}]}
{"resourceType":"MedicationAdministration","id":"34b27a8d-b39a-ed95-d801-66a784dbccc3","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/2b0539b5-bff4-5895-7ff5-323ff0bb8449"},"effectiveDateTime":"2018-09-12T19:33:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"229ddb35-7bf3-0ace-c51f-9a970e4ed301","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/8e24325d-85f3-3410-f9dc-3b84fa28a3a0"},"effectiveDateTime":"2018-09-15T23:22:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"3e90c538-46c1-5eb3-bf5d-13e7f728a3b6","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/30a9429e-0842-eac0-d55e-e09e8f930e7b"},"effectiveDateTime":"2018-09-19T03:16:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"8a4a2633-27e8-3b3e-632d-d69a6cebc57f","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/ffe39405-3a54-51f2-469a-86fb67e6b1f5"},"effectiveDateTime":"2018-10-03T19:47:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"4faec7a8-8a82-9328-c84e-7b0d37776be1","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/e129a0ea-4c90-1471-d0b4-c32272eefb6e"},"context":{"reference":"Encounter/9cb5cea2-54b9-5472-6ce2-ec4ef7e34b4b"},"effectiveDateTime":"2024-11-05T10:59:14-05:00","reasonCode":[{"coding":[{"system":"http://snomed.info/sct","code":"103697008","display":"Patient referral for dental care (procedure)"}],"text":"Patient referral for dental care (procedure)"}]}
{"resourceType":"MedicationAdministration","id":"cfac1399-d950-ca2c-92e7-1a0e29898e03","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/af4f68c4-325c-5ce6-f2b6-9cae3466c012"},"effectiveDateTime":"2018-10-06T21:51:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"2767af54-f49a-6eb4-d7ce-f45882d97747","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/57f56d9d-3c38-9a6c-fb4c-f30fcccec402"},"effectiveDateTime":"2018-10-10T00:39:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"0b916bb7-5be9-4916-d3c5-0e39240b704f","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/4545baad-db30-5b04-a5d5-d64205fe6b4e"},"effectiveDateTime":"2018-10-13T03:59:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"1c5b330e-75cd-f9c5-2d4d-3ff716404369","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/8003dab5-83b9-1053-f96e-72092db659c4"},"effectiveDateTime":"2018-10-16T07:50:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"d53dde41-bbb9-26a6-2679-bc407d563ab5","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/715b33cc-455e-e496-9ee0-577930328895"},"effectiveDateTime":"2018-10-19T10:40:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"99c4f0aa-41dd-826f-6b05-d63f93206e89","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/8ad2b8a5-9506-3ea8-0356-e3d6b67b652b"},"effectiveDateTime":"2018-10-22T14:09:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"a254899e-0805-c7c1-ef31-0cd830228ab6","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/c30991f9-2cbc-58d8-ff34-abfd8231e8cd"},"effectiveDateTime":"2018-10-25T18:05:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"976d7cef-e70e-b5af-3481-8b5976577471","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/7f6b042a-6302-b6cd-af21-27f13adb3923"},"effectiveDateTime":"2018-10-28T21:24:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"16aa4627-5607-8737-f585-f68e9b0b23a3","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/15dc8e1a-e16c-c9c9-303b-da658f7d43df"},"effectiveDateTime":"2018-11-01T01:17:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"bd111f81-bc59-829d-36b5-88a07df696ac","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/f91b3d08-2668-fbf8-a634-e7f6efb06a3a"},"effectiveDateTime":"2018-11-04T02:18:29-05:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"3e5f2b63-bc11-1fd9-85d1-384c5c852cd4","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/61d7e49e-62be-46ee-1e11-83fc5f9d15a5"},"effectiveDateTime":"2018-11-07T04:41:29-05:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"53457231-46c4-2b6b-7ef5-d9764a669641","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/781a325c-8de9-b521-8929-289f51f93680"},"effectiveDateTime":"2018-11-10T07:41:29-05:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"ed9d0924-299a-3ef3-5bc7-08d490df4298","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/9093aa85-153d-0c98-2fa8-9ce5509f3203"},"effectiveDateTime":"2018-11-13T10:44:29-05:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"b7a07ef6-3c95-bc65-d4d3-fe139918f68d","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/0d3e545e-b051-730b-f5d3-a4e97bf4f243"},"effectiveDateTime":"2018-11-16T13:33:29-05:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"0bb7733a-384a-814a-d3eb-15bc0c8649ad","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/250e4508-07ea-0d9c-b15c-c63fc656b708"},"effectiveDateTime":"2018-11-19T17:14:29-05:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"8f51b83c-b500-bf35-77f2-2d8c36333142","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/97489354-8170-c628-e9d8-895ccf759fa8"},"effectiveDateTime":"2018-11-22T20:27:29-05:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"f8ffc1ae-de33-18c2-07b1-cc6aecf4b5d7","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/c592888d-a814-e5ed-10ae-7a7c04113db4"},"effectiveDateTime":"2018-11-25T23:59:29-05:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"fcc5598c-04d5-02e3-e532-58470b49531e","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/3585edb0-f067-bc7a-3447-7122878733ae"},"effectiveDateTime":"2018-11-29T03:09:29-05:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"14280d93-cb3c-89ed-4625-4a170564a771","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/c52a4bcd-41ea-0cdb-7bb9-3e43e9b3e450"},"effectiveDateTime":"2018-12-02T05:38:29-05:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"a8c5c941-0af4-8887-d0e3-5dae9c510bc1","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/5eaa0514-4c90-1cb4-1c8d-678110324574"},"effectiveDateTime":"2018-12-05T09:17:29-05:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"6600afd0-95ec-1112-b63b-f8ea1da71786","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/be20ba2d-fde2-5d27-e11c-df3536b6c1ef"},"effectiveDateTime":"2018-12-08T12:25:29-05:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"4e35d4c0-0826-d9a7-2cf7-71d417011675","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/c83862df-6eb7-8ac0-b19c-63ac923edbfb"},"effectiveDateTime":"2018-12-11T14:38:29-05:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"62c24b41-c4b0-ea3e-8fae-6513059f0ed1","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/7a68e7d3-a563-0295-64cb-4b6464e7afab"},"effectiveDateTime":"2018-12-14T17:39:29-05:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"7b706ff7-3e2d-c7c8-ed7d-5897b580c8c0","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/d0587c66-08c9-2ed5-b5a2-2a8a181692c8"},"effectiveDateTime":"2018-12-17T21:03:29-05:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"19187b60-fdcb-006a-9244-ab401e998a71","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/f2e9291c-9f8b-7554-37b7-05e1137be5b9"},"effectiveDateTime":"2018-12-20T23:20:29-05:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"03a77c36-c143-6d8f-3dcf-9a2b62844a12","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/ada9f1ff-97c1-9db7-9ca4-e9bf4a679ada"},"effectiveDateTime":"2018-12-24T01:37:29-05:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"7b72dd50-fe66-b05c-ed7f-c5f176792700","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/fad7b84e-ac5f-addf-92d9-a71d321fb5bb"},"effectiveDateTime":"2018-12-27T04:07:29-05:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"7b338d92-fb8d-49ea-479f-8a1635b567ff","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/6410ed23-fa76-24e4-6fa2-828e778c3e40"},"effectiveDateTime":"2018-12-30T07:32:29-05:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"172a38d5-9eb8-273a-6828-fa72b2c739aa","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/22fef114-ab82-d4a2-56e5-cf7f5dd4efde"},"effectiveDateTime":"2019-01-02T10:28:29-05:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"8d228484-8385-048f-c21a-1ba106bf2cad","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/fe51e7bd-d470-0cf2-b4d5-eef56c4e1648"},"effectiveDateTime":"2019-01-05T13:27:29-05:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"1b9b7636-4429-f166-e3cf-18b8287922b5","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/ae517168-4c13-b100-54b1-b54017aebcb0"},"effectiveDateTime":"2019-01-08T15:56:29-05:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"27f345d6-0f24-eb4c-2bbd-eb8de6d55291","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/37965ac0-9dc5-e784-ba43-6c7d4fbf141f"},"effectiveDateTime":"2019-01-11T19:34:29-05:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"2763b779-3d12-ae34-d7ca-fc7d09c0a5a3","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/c6984637-56d5-6542-8b27-6474cb0cf05f"},"effectiveDateTime":"2019-01-14T23:20:29-05:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"7cfc15f1-ff89-f325-0036-3e1074ea3002","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/d23a8dd1-893e-39d4-8f18-94373b5970dc"},"effectiveDateTime":"2019-01-18T01:37:29-05:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"85b1b760-fdcc-1ddf-2702-02d81e9aa7e7","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/56081b51-547b-f9fe-bd2e-0a742d7b4f42"},"effectiveDateTime":"2019-01-21T03:37:29-05:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"6dafc1d8-26d4-dcc1-490c-13f3d73c21c5","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/2128130e-f152-53d0-b142-b288b574e9c2"},"effectiveDateTime":"2019-02-06T18:41:29-05:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"c8e71edd-c450-5ab7-9771-2698865b59d8","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/5c17d7c1-f045-86da-a591-84e4733c1861"},"effectiveDateTime":"2019-02-09T21:56:29-05:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"e6bab8fe-8c74-547f-cddb-878894332a03","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/c55415d8-3273-2764-1dd8-dcf88a63450b"},"effectiveDateTime":"2019-02-13T01:55:29-05:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"803b08ad-b142-35e4-0375-30ccf89da2e1","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/5a8b836e-f564-e337-b597-029bf949d763"},"effectiveDateTime":"2019-02-27T20:12:29-05:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"161da009-fd98-0724-3575-0cedda1b414c","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/8acd7c84-1d1e-ea1f-dd0c-d03ce16689ec"},"effectiveDateTime":"2019-03-02T23:05:29-05:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"00b8f65d-3f25-0190-04a5-ec569ed568d5","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/8a2b85f1-e968-6d70-28ac-ee16fbe17bc2"},"effectiveDateTime":"2019-03-06T02:52:29-05:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"8d8aa4db-c638-3156-1a52-d87e48312708","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/f77abd6f-1dfe-e957-377b-112753525bc4"},"effectiveDateTime":"2019-03-13T20:44:47-04:00","reasonReference":[{"reference":"Condition/1ed2f4d9-019c-c9e8-ffb5-98e1a2ca86a1","display":"Awaiting transplantation of kidney (situation)"}]}
{"resourceType":"MedicationAdministration","id":"f2886bed-b3d2-c539-0c59-aceb4fe1e026","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/8e340a3e-a2ea-1ad0-695a-d9184a2611f1"},"effectiveDateTime":"2019-03-20T21:13:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"90ac128f-cc84-12fb-a767-19041cc39a7f","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/930c1bfa-b8b5-54e7-41c6-af6b6ad94c1d"},"effectiveDateTime":"2019-03-24T00:57:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"c3d2c2d6-96b1-826d-9513-c1763a6f6e87","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/8009bc3a-187b-2104-50b1-f915e4b0fe74"},"effectiveDateTime":"2019-03-27T04:26:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"7a1483f0-bd75-be72-6fd2-7045de44487a","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"108515","display":"1 ML tacrolimus 5 MG/ML Injection"}],"text":"1 ML tacrolimus 5 MG/ML Injection"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/e7dda76c-b4bb-c984-def2-120cfa7347c6"},"effectiveDateTime":"2019-03-27T18:28:52-04:00","reasonReference":[{"reference":"Condition/1ed2f4d9-019c-c9e8-ffb5-98e1a2ca86a1","display":"Awaiting transplantation of kidney (situation)"}]}
{"resourceType":"MedicationAdministration","id":"c49194c8-46b7-dab4-c01e-0614f71f1fb8","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"108515","display":"1 ML tacrolimus 5 MG/ML Injection"}],"text":"1 ML tacrolimus 5 MG/ML Injection"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/e7dda76c-b4bb-c984-def2-120cfa7347c6"},"effectiveDateTime":"2019-03-28T19:44:46-04:00","reasonReference":[{"reference":"Condition/d1ba0d14-feff-ef47-a40f-4f85b59d0df1","display":"History of renal transplant (situation)"}]}
{"resourceType":"MedicationAdministration","id":"2771dac7-f331-9354-d7d9-1fcbef66cca2","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"108515","display":"1 ML tacrolimus 5 MG/ML Injection"}],"text":"1 ML tacrolimus 5 MG/ML Injection"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/e7dda76c-b4bb-c984-def2-120cfa7347c6"},"effectiveDateTime":"2019-03-29T20:19:36-04:00","reasonReference":[{"reference":"Condition/d1ba0d14-feff-ef47-a40f-4f85b59d0df1","display":"History of renal transplant (situation)"}]}
{"resourceType":"MedicationAdministration","id":"d0ba606f-977c-7f2c-a4a6-7a40d87bb6d1","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"108515","display":"1 ML tacrolimus 5 MG/ML Injection"}],"text":"1 ML tacrolimus 5 MG/ML Injection"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/e7dda76c-b4bb-c984-def2-120cfa7347c6"},"effectiveDateTime":"2019-03-30T20:59:25-04:00","reasonReference":[{"reference":"Condition/d1ba0d14-feff-ef47-a40f-4f85b59d0df1","display":"History of renal transplant (situation)"}]}
{"resourceType":"MedicationAdministration","id":"73aa1424-4de6-ffff-78b5-1a989e26d876","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"108515","display":"1 ML tacrolimus 5 MG/ML Injection"}],"text":"1 ML tacrolimus 5 MG/ML Injection"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/e7dda76c-b4bb-c984-def2-120cfa7347c6"},"effectiveDateTime":"2019-03-31T21:34:58-04:00","reasonReference":[{"reference":"Condition/d1ba0d14-feff-ef47-a40f-4f85b59d0df1","display":"History of renal transplant (situation)"}]}
{"resourceType":"MedicationAdministration","id":"3c3d1b10-a96a-562f-d951-2b32735e74f0","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/2db8428d-21dc-6abe-6b3e-d920cb2b5f13"},"effectiveDateTime":"2019-04-17T20:38:29-04:00","reasonReference":[{"reference":"Condition/ff5041d1-1ff2-f07c-f09c-0cb95ef04148","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"3e48ef42-2376-dd92-ffe6-03525709d018","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"108515","display":"1 ML tacrolimus 5 MG/ML Injection"}],"text":"1 ML tacrolimus 5 MG/ML Injection"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/275a676c-ea64-382e-cb37-939f1c68ae45"},"effectiveDateTime":"2019-04-24T18:24:39-04:00","reasonReference":[{"reference":"Condition/d1ba0d14-feff-ef47-a40f-4f85b59d0df1","display":"History of renal transplant (situation)"}]}
{"resourceType":"MedicationAdministration","id":"98889339-f56c-0d29-e8c9-aa4a1317139d","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"108515","display":"1 ML tacrolimus 5 MG/ML Injection"}],"text":"1 ML tacrolimus 5 MG/ML Injection"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/cd6af657-4345-f287-b456-899cdb5d2aa6"},"effectiveDateTime":"2019-05-01T19:58:12-04:00","reasonReference":[{"reference":"Condition/d1ba0d14-feff-ef47-a40f-4f85b59d0df1","display":"History of renal transplant (situation)"}]}
{"resourceType":"MedicationAdministration","id":"d9004153-5e33-5f42-e958-30bea4f4fc56","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"108515","display":"1 ML tacrolimus 5 MG/ML Injection"}],"text":"1 ML tacrolimus 5 MG/ML Injection"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/c55466dd-7052-74ab-2624-78a411961dfe"},"effectiveDateTime":"2019-05-08T21:19:19-04:00","reasonReference":[{"reference":"Condition/d1ba0d14-feff-ef47-a40f-4f85b59d0df1","display":"History of renal transplant (situation)"}]}
{"resourceType":"MedicationAdministration","id":"bb5f2ab6-66a1-9145-1ed1-379f0724e21d","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"108515","display":"1 ML tacrolimus 5 MG/ML Injection"}],"text":"1 ML tacrolimus 5 MG/ML Injection"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/efc04ec2-1785-e24b-d020-ea6434f7f07c"},"effectiveDateTime":"2019-05-15T22:40:41-04:00","reasonReference":[{"reference":"Condition/d1ba0d14-feff-ef47-a40f-4f85b59d0df1","display":"History of renal transplant (situation)"}]}
{"resourceType":"MedicationAdministration","id":"52891b34-bbba-c309-be4b-e3685e3cd293","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"108515","display":"1 ML tacrolimus 5 MG/ML Injection"}],"text":"1 ML tacrolimus 5 MG/ML Injection"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/a8b0cb57-33cf-da31-e15e-b5967a3f533a"},"effectiveDateTime":"2019-05-23T00:30:19-04:00","reasonReference":[{"reference":"Condition/d1ba0d14-feff-ef47-a40f-4f85b59d0df1","display":"History of renal transplant (situation)"}]}
{"resourceType":"MedicationAdministration","id":"099ab5f4-691f-d042-05e2-e996eb4816a2","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/8e59c385-779d-c390-4d44-c37e6632fb71"},"context":{"reference":"Encounter/dd653b87-f9ef-fd79-e4ea-84b7be7c33b6"},"effectiveDateTime":"2019-08-07T20:49:14-04:00","reasonReference":[{"reference":"Condition/02a45867-628c-cf2b-d03a-9418bc51d591","display":"Gingivitis (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"867d0e16-f6df-549e-a4f1-6290e075c303","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/045fe36c-9ca9-dcc5-10f4-d0582540f9ed"},"context":{"reference":"Encounter/aa18ac22-859b-388b-055b-395ccac65d96"},"effectiveDateTime":"1998-05-06T20:24:10-04:00","reasonCode":[{"coding":[{"system":"http://snomed.info/sct","code":"103697008","display":"Patient referral for dental care (procedure)"}],"text":"Patient referral for dental care (procedure)"}]}
{"resourceType":"MedicationAdministration","id":"337991b2-7cc7-4f5a-a1de-bf13f8711cf0","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/045fe36c-9ca9-dcc5-10f4-d0582540f9ed"},"context":{"reference":"Encounter/d631620b-ff16-89c9-bfe2-63b86ac2186a"},"effectiveDateTime":"2002-05-29T20:07:51-04:00","reasonCode":[{"coding":[{"system":"http://snomed.info/sct","code":"103697008","display":"Patient referral for dental care (procedure)"}],"text":"Patient referral for dental care (procedure)"}]}
{"resourceType":"MedicationAdministration","id":"f4aefed3-e966-fe65-a879-752da2fbc372","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1719286","display":"10 ML Furosemide 10 MG/ML Injection"}],"text":"10 ML Furosemide 10 MG/ML Injection"},"subject":{"reference":"Patient/045fe36c-9ca9-dcc5-10f4-d0582540f9ed"},"context":{"reference":"Encounter/39822efb-c733-f358-7357-d9f26a8beb80"},"effectiveDateTime":"2003-06-19T18:00:59-04:00","reasonReference":[{"reference":"Condition/7a742d9d-db39-09f6-4660-784e7f144c0a","display":"Chronic congestive heart failure (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"45df25e0-678c-510d-6993-72cd1aff7a97","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1719286","display":"10 ML Furosemide 10 MG/ML Injection"}],"text":"10 ML Furosemide 10 MG/ML Injection"},"subject":{"reference":"Patient/045fe36c-9ca9-dcc5-10f4-d0582540f9ed"},"context":{"reference":"Encounter/39822efb-c733-f358-7357-d9f26a8beb80"},"effectiveDateTime":"2003-06-20T06:00:59-04:00","reasonReference":[{"reference":"Condition/7a742d9d-db39-09f6-4660-784e7f144c0a","display":"Chronic congestive heart failure (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"84d6a08b-fb0f-ba66-1d79-809c49daf199","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1719286","display":"10 ML Furosemide 10 MG/ML Injection"}],"text":"10 ML Furosemide 10 MG/ML Injection"},"subject":{"reference":"Patient/045fe36c-9ca9-dcc5-10f4-d0582540f9ed"},"context":{"reference":"Encounter/39822efb-c733-f358-7357-d9f26a8beb80"},"effectiveDateTime":"2003-06-20T18:00:59-04:00","reasonReference":[{"reference":"Condition/7a742d9d-db39-09f6-4660-784e7f144c0a","display":"Chronic congestive heart failure (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"e64d552d-530d-3553-89d2-30fc1e4467ec","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1719286","display":"10 ML Furosemide 10 MG/ML Injection"}],"text":"10 ML Furosemide 10 MG/ML Injection"},"subject":{"reference":"Patient/045fe36c-9ca9-dcc5-10f4-d0582540f9ed"},"context":{"reference":"Encounter/39822efb-c733-f358-7357-d9f26a8beb80"},"effectiveDateTime":"2003-06-21T06:00:59-04:00","reasonReference":[{"reference":"Condition/7a742d9d-db39-09f6-4660-784e7f144c0a","display":"Chronic congestive heart failure (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"56e7aec2-60d7-9a1d-1c08-fbfcd73153b2","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1719286","display":"10 ML Furosemide 10 MG/ML Injection"}],"text":"10 ML Furosemide 10 MG/ML Injection"},"subject":{"reference":"Patient/045fe36c-9ca9-dcc5-10f4-d0582540f9ed"},"context":{"reference":"Encounter/39822efb-c733-f358-7357-d9f26a8beb80"},"effectiveDateTime":"2003-06-21T18:00:59-04:00","reasonReference":[{"reference":"Condition/7a742d9d-db39-09f6-4660-784e7f144c0a","display":"Chronic congestive heart failure (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"6c10c573-f3e6-c4fe-0287-1f2d88abeb72","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1719286","display":"10 ML Furosemide 10 MG/ML Injection"}],"text":"10 ML Furosemide 10 MG/ML Injection"},"subject":{"reference":"Patient/045fe36c-9ca9-dcc5-10f4-d0582540f9ed"},"context":{"reference":"Encounter/39822efb-c733-f358-7357-d9f26a8beb80"},"effectiveDateTime":"2003-06-22T06:00:59-04:00","reasonReference":[{"reference":"Condition/7a742d9d-db39-09f6-4660-784e7f144c0a","display":"Chronic congestive heart failure (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"b9ddbb78-deda-6576-8d3e-382ca5341f0b","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/045fe36c-9ca9-dcc5-10f4-d0582540f9ed"},"context":{"reference":"Encounter/9dba68dd-2899-b28c-785a-0fc77aa066b5"},"effectiveDateTime":"2004-06-09T20:34:28-04:00","reasonCode":[{"coding":[{"system":"http://snomed.info/sct","code":"103697008","display":"Patient referral for dental care (procedure)"}],"text":"Patient referral for dental care (procedure)"}]}
{"resourceType":"MedicationAdministration","id":"c44a00d4-7b39-1396-a28d-072e34cde73e","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1719286","display":"10 ML Furosemide 10 MG/ML Injection"}],"text":"10 ML Furosemide 10 MG/ML Injection"},"subject":{"reference":"Patient/045fe36c-9ca9-dcc5-10f4-d0582540f9ed"},"context":{"reference":"Encounter/ce380e90-b0ee-fe59-1e92-ecb7d8597227"},"effectiveDateTime":"2004-06-16T18:54:16-04:00","reasonReference":[{"reference":"Condition/7a742d9d-db39-09f6-4660-784e7f144c0a","display":"Chronic congestive heart failure (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"c5a589db-f6df-7d90-fa90-cb03b875ebf5","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1719286","display":"10 ML Furosemide 10 MG/ML Injection"}],"text":"10 ML Furosemide 10 MG/ML Injection"},"subject":{"reference":"Patient/045fe36c-9ca9-dcc5-10f4-d0582540f9ed"},"context":{"reference":"Encounter/ce380e90-b0ee-fe59-1e92-ecb7d8597227"},"effectiveDateTime":"2004-06-17T06:54:16-04:00","reasonReference":[{"reference":"Condition/7a742d9d-db39-09f6-4660-784e7f144c0a","display":"Chronic congestive heart failure (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"a48d3fe7-a64e-4db9-ba0a-c2148318b792","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1719286","display":"10 ML Furosemide 10 MG/ML Injection"}],"text":"10 ML Furosemide 10 MG/ML Injection"},"subject":{"reference":"Patient/045fe36c-9ca9-dcc5-10f4-d0582540f9ed"},"context":{"reference":"Encounter/ce380e90-b0ee-fe59-1e92-ecb7d8597227"},"effectiveDateTime":"2004-06-17T18:54:16-04:00","reasonReference":[{"reference":"Condition/7a742d9d-db39-09f6-4660-784e7f144c0a","display":"Chronic congestive heart failure (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"0711a6d3-6d72-e34a-6c46-94a7c33479b8","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1719286","display":"10 ML Furosemide 10 MG/ML Injection"}],"text":"10 ML Furosemide 10 MG/ML Injection"},"subject":{"reference":"Patient/045fe36c-9ca9-dcc5-10f4-d0582540f9ed"},"context":{"reference":"Encounter/ce380e90-b0ee-fe59-1e92-ecb7d8597227"},"effectiveDateTime":"2004-06-18T06:54:16-04:00","reasonReference":[{"reference":"Condition/7a742d9d-db39-09f6-4660-784e7f144c0a","display":"Chronic congestive heart failure (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"acf23fe7-87c6-036a-e8cb-c21464906d48","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1719286","display":"10 ML Furosemide 10 MG/ML Injection"}],"text":"10 ML Furosemide 10 MG/ML Injection"},"subject":{"reference":"Patient/045fe36c-9ca9-dcc5-10f4-d0582540f9ed"},"context":{"reference":"Encounter/ce380e90-b0ee-fe59-1e92-ecb7d8597227"},"effectiveDateTime":"2004-06-18T18:54:16-04:00","reasonReference":[{"reference":"Condition/7a742d9d-db39-09f6-4660-784e7f144c0a","display":"Chronic congestive heart failure (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"e886e15b-fc1f-2d5e-f009-0e38c6890e2d","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1719286","display":"10 ML Furosemide 10 MG/ML Injection"}],"text":"10 ML Furosemide 10 MG/ML Injection"},"subject":{"reference":"Patient/045fe36c-9ca9-dcc5-10f4-d0582540f9ed"},"context":{"reference":"Encounter/ce380e90-b0ee-fe59-1e92-ecb7d8597227"},"effectiveDateTime":"2004-06-19T06:54:16-04:00","reasonReference":[{"reference":"Condition/7a742d9d-db39-09f6-4660-784e7f144c0a","display":"Chronic congestive heart failure (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"dd10bee8-45ba-9ceb-3f46-4115228506cf","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1719286","display":"10 ML Furosemide 10 MG/ML Injection"}],"text":"10 ML Furosemide 10 MG/ML Injection"},"subject":{"reference":"Patient/045fe36c-9ca9-dcc5-10f4-d0582540f9ed"},"context":{"reference":"Encounter/ce380e90-b0ee-fe59-1e92-ecb7d8597227"},"effectiveDateTime":"2004-06-19T18:54:16-04:00","reasonReference":[{"reference":"Condition/7a742d9d-db39-09f6-4660-784e7f144c0a","display":"Chronic congestive heart failure (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"d33900f5-7ae6-de98-9da2-e6eade690b75","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1719286","display":"10 ML Furosemide 10 MG/ML Injection"}],"text":"10 ML Furosemide 10 MG/ML Injection"},"subject":{"reference":"Patient/045fe36c-9ca9-dcc5-10f4-d0582540f9ed"},"context":{"reference":"Encounter/ce380e90-b0ee-fe59-1e92-ecb7d8597227"},"effectiveDateTime":"2004-06-20T06:54:16-04:00","reasonReference":[{"reference":"Condition/7a742d9d-db39-09f6-4660-784e7f144c0a","display":"Chronic congestive heart failure (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"6e5c7b63-5728-c0ca-27f1-4f34684bc724","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1719286","display":"10 ML Furosemide 10 MG/ML Injection"}],"text":"10 ML Furosemide 10 MG/ML Injection"},"subject":{"reference":"Patient/045fe36c-9ca9-dcc5-10f4-d0582540f9ed"},"context":{"reference":"Encounter/ce380e90-b0ee-fe59-1e92-ecb7d8597227"},"effectiveDateTime":"2004-06-20T18:54:16-04:00","reasonReference":[{"reference":"Condition/7a742d9d-db39-09f6-4660-784e7f144c0a","display":"Chronic congestive heart failure (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"5222e39f-2810-86aa-31e4-7a0d8d457c38","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1719286","display":"10 ML Furosemide 10 MG/ML Injection"}],"text":"10 ML Furosemide 10 MG/ML Injection"},"subject":{"reference":"Patient/045fe36c-9ca9-dcc5-10f4-d0582540f9ed"},"context":{"reference":"Encounter/ce380e90-b0ee-fe59-1e92-ecb7d8597227"},"effectiveDateTime":"2004-06-21T06:54:16-04:00","reasonReference":[{"reference":"Condition/7a742d9d-db39-09f6-4660-784e7f144c0a","display":"Chronic congestive heart failure (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"3740db6a-4c8f-1536-1d94-64a0979aae9d","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/045fe36c-9ca9-dcc5-10f4-d0582540f9ed"},"context":{"reference":"Encounter/1dcbeb14-5925-4342-b06c-4e6ced003033"},"effectiveDateTime":"2005-06-15T20:21:02-04:00","reasonCode":[{"coding":[{"system":"http://snomed.info/sct","code":"103697008","display":"Patient referral for dental care (procedure)"}],"text":"Patient referral for dental care (procedure)"}]}
{"resourceType":"MedicationAdministration","id":"edce8bc1-c4b5-2079-d044-1250b16893a3","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/045fe36c-9ca9-dcc5-10f4-d0582540f9ed"},"context":{"reference":"Encounter/d6cf8411-8241-8064-92b0-c4158e20fe31"},"effectiveDateTime":"2006-06-21T20:22:03-04:00","reasonReference":[{"reference":"Condition/a8ba2967-59db-75c1-e52d-1b0935c5fc73","display":"Gingivitis (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"d20bc0bc-deda-d8b5-d235-63f63534924a","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/045fe36c-9ca9-dcc5-10f4-d0582540f9ed"},"context":{"reference":"Encounter/1f96caf6-006a-8e31-968b-772208a84953"},"effectiveDateTime":"2007-06-28T00:18:41-04:00","reasonCode":[{"coding":[{"system":"http://snomed.info/sct","code":"103697008","display":"Patient referral for dental care (procedure)"}],"text":"Patient referral for dental care (procedure)"}]}
{"resourceType":"MedicationAdministration","id":"d019c9d2-fbb9-1199-02ba-c87037abdcd1","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1719286","display":"10 ML Furosemide 10 MG/ML Injection"}],"text":"10 ML Furosemide 10 MG/ML Injection"},"subject":{"reference":"Patient/045fe36c-9ca9-dcc5-10f4-d0582540f9ed"},"context":{"reference":"Encounter/e3fcb589-2a0f-8258-42dd-8a52d533697e"},"effectiveDateTime":"2008-01-07T16:38:29-05:00","reasonReference":[{"reference":"Condition/7a742d9d-db39-09f6-4660-784e7f144c0a","display":"Chronic congestive heart failure (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"92483d72-ef8d-28a2-f7e3-d6c36f2e2c5b","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1719286","display":"10 ML Furosemide 10 MG/ML Injection"}],"text":"10 ML Furosemide 10 MG/ML Injection"},"subject":{"reference":"Patient/045fe36c-9ca9-dcc5-10f4-d0582540f9ed"},"context":{"reference":"Encounter/e3fcb589-2a0f-8258-42dd-8a52d533697e"},"effectiveDateTime":"2008-01-08T04:38:29-05:00","reasonReference":[{"reference":"Condition/7a742d9d-db39-09f6-4660-784e7f144c0a","display":"Chronic congestive heart failure (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"5576bcdc-56a4-72d8-7f86-bb4985d1264b","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1719286","display":"10 ML Furosemide 10 MG/ML Injection"}],"text":"10 ML Furosemide 10 MG/ML Injection"},"subject":{"reference":"Patient/045fe36c-9ca9-dcc5-10f4-d0582540f9ed"},"context":{"reference":"Encounter/e3fcb589-2a0f-8258-42dd-8a52d533697e"},"effectiveDateTime":"2008-01-08T16:38:29-05:00","reasonReference":[{"reference":"Condition/7a742d9d-db39-09f6-4660-784e7f144c0a","display":"Chronic congestive heart failure (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"34cad8c3-20b2-6c5a-74ed-c05fd3803902","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1719286","display":"10 ML Furosemide 10 MG/ML Injection"}],"text":"10 ML Furosemide 10 MG/ML Injection"},"subject":{"reference":"Patient/045fe36c-9ca9-dcc5-10f4-d0582540f9ed"},"context":{"reference":"Encounter/e3fcb589-2a0f-8258-42dd-8a52d533697e"},"effectiveDateTime":"2008-01-09T04:38:29-05:00","reasonReference":[{"reference":"Condition/7a742d9d-db39-09f6-4660-784e7f144c0a","display":"Chronic congestive heart failure (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"ac64455b-a033-12d4-134a-997bc640512e","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1719286","display":"10 ML Furosemide 10 MG/ML Injection"}],"text":"10 ML Furosemide 10 MG/ML Injection"},"subject":{"reference":"Patient/045fe36c-9ca9-dcc5-10f4-d0582540f9ed"},"context":{"reference":"Encounter/e3fcb589-2a0f-8258-42dd-8a52d533697e"},"effectiveDateTime":"2008-01-09T16:38:29-05:00","reasonReference":[{"reference":"Condition/7a742d9d-db39-09f6-4660-784e7f144c0a","display":"Chronic congestive heart failure (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"760dfdb2-a716-5fe5-52d8-81b9fbec2a12","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1719286","display":"10 ML Furosemide 10 MG/ML Injection"}],"text":"10 ML Furosemide 10 MG/ML Injection"},"subject":{"reference":"Patient/045fe36c-9ca9-dcc5-10f4-d0582540f9ed"},"context":{"reference":"Encounter/e3fcb589-2a0f-8258-42dd-8a52d533697e"},"effectiveDateTime":"2008-01-10T04:38:29-05:00","reasonReference":[{"reference":"Condition/7a742d9d-db39-09f6-4660-784e7f144c0a","display":"Chronic congestive heart failure (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"1f262d41-867d-1527-057a-4d90c69b6e8e","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1719286","display":"10 ML Furosemide 10 MG/ML Injection"}],"text":"10 ML Furosemide 10 MG/ML Injection"},"subject":{"reference":"Patient/045fe36c-9ca9-dcc5-10f4-d0582540f9ed"},"context":{"reference":"Encounter/e3fcb589-2a0f-8258-42dd-8a52d533697e"},"effectiveDateTime":"2008-01-10T16:38:29-05:00","reasonReference":[{"reference":"Condition/7a742d9d-db39-09f6-4660-784e7f144c0a","display":"Chronic congestive heart failure (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"66f11245-b555-c7cd-3363-dd7ce7f6caec","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1719286","display":"10 ML Furosemide 10 MG/ML Injection"}],"text":"10 ML Furosemide 10 MG/ML Injection"},"subject":{"reference":"Patient/045fe36c-9ca9-dcc5-10f4-d0582540f9ed"},"context":{"reference":"Encounter/e3fcb589-2a0f-8258-42dd-8a52d533697e"},"effectiveDateTime":"2008-01-11T04:38:29-05:00","reasonReference":[{"reference":"Condition/7a742d9d-db39-09f6-4660-784e7f144c0a","display":"Chronic congestive heart failure (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"724dae80-224f-03e2-d7e9-47d0a430cfdb","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1719286","display":"10 ML Furosemide 10 MG/ML Injection"}],"text":"10 ML Furosemide 10 MG/ML Injection"},"subject":{"reference":"Patient/045fe36c-9ca9-dcc5-10f4-d0582540f9ed"},"context":{"reference":"Encounter/e3fcb589-2a0f-8258-42dd-8a52d533697e"},"effectiveDateTime":"2008-01-11T16:38:29-05:00","reasonReference":[{"reference":"Condition/7a742d9d-db39-09f6-4660-784e7f144c0a","display":"Chronic congestive heart failure (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"a50ede01-b0bb-8499-1838-ee4836f2b14d","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1719286","display":"10 ML Furosemide 10 MG/ML Injection"}],"text":"10 ML Furosemide 10 MG/ML Injection"},"subject":{"reference":"Patient/045fe36c-9ca9-dcc5-10f4-d0582540f9ed"},"context":{"reference":"Encounter/e3fcb589-2a0f-8258-42dd-8a52d533697e"},"effectiveDateTime":"2008-01-12T04:38:29-05:00","reasonReference":[{"reference":"Condition/7a742d9d-db39-09f6-4660-784e7f144c0a","display":"Chronic congestive heart failure (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"14894310-d459-d345-dfc0-75b1d9670237","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1719286","display":"10 ML Furosemide 10 MG/ML Injection"}],"text":"10 ML Furosemide 10 MG/ML Injection"},"subject":{"reference":"Patient/045fe36c-9ca9-dcc5-10f4-d0582540f9ed"},"context":{"reference":"Encounter/e3fcb589-2a0f-8258-42dd-8a52d533697e"},"effectiveDateTime":"2008-01-12T16:38:29-05:00","reasonReference":[{"reference":"Condition/7a742d9d-db39-09f6-4660-784e7f144c0a","display":"Chronic congestive heart failure (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"8eb46c2d-f58f-9d1b-df37-452b2ef538b4","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1719286","display":"10 ML Furosemide 10 MG/ML Injection"}],"text":"10 ML Furosemide 10 MG/ML Injection"},"subject":{"reference":"Patient/045fe36c-9ca9-dcc5-10f4-d0582540f9ed"},"context":{"reference":"Encounter/e3fcb589-2a0f-8258-42dd-8a52d533697e"},"effectiveDateTime":"2008-01-13T04:38:29-05:00","reasonReference":[{"reference":"Condition/7a742d9d-db39-09f6-4660-784e7f144c0a","display":"Chronic congestive heart failure (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"879d10e0-5d08-2bdc-ed09-700d107b55ec","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1719286","display":"10 ML Furosemide 10 MG/ML Injection"}],"text":"10 ML Furosemide 10 MG/ML Injection"},"subject":{"reference":"Patient/045fe36c-9ca9-dcc5-10f4-d0582540f9ed"},"context":{"reference":"Encounter/e3fcb589-2a0f-8258-42dd-8a52d533697e"},"effectiveDateTime":"2008-01-13T16:38:29-05:00","reasonReference":[{"reference":"Condition/7a742d9d-db39-09f6-4660-784e7f144c0a","display":"Chronic congestive heart failure (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"475149f2-c375-69af-151d-f2348259c652","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1719286","display":"10 ML Furosemide 10 MG/ML Injection"}],"text":"10 ML Furosemide 10 MG/ML Injection"},"subject":{"reference":"Patient/045fe36c-9ca9-dcc5-10f4-d0582540f9ed"},"context":{"reference":"Encounter/e3fcb589-2a0f-8258-42dd-8a52d533697e"},"effectiveDateTime":"2008-01-14T04:38:29-05:00","reasonReference":[{"reference":"Condition/7a742d9d-db39-09f6-4660-784e7f144c0a","display":"Chronic congestive heart failure (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"4c28f1e0-64c6-a604-f014-f6ed1839d01b","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1719286","display":"10 ML Furosemide 10 MG/ML Injection"}],"text":"10 ML Furosemide 10 MG/ML Injection"},"subject":{"reference":"Patient/045fe36c-9ca9-dcc5-10f4-d0582540f9ed"},"context":{"reference":"Encounter/0f3a3215-5df8-a8d4-256c-fde57cb300d2"},"effectiveDateTime":"2008-04-12T18:17:20-04:00","reasonReference":[{"reference":"Condition/7a742d9d-db39-09f6-4660-784e7f144c0a","display":"Chronic congestive heart failure (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"6de588a0-e8f7-0d33-5439-b7fd5a71269a","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1719286","display":"10 ML Furosemide 10 MG/ML Injection"}],"text":"10 ML Furosemide 10 MG/ML Injection"},"subject":{"reference":"Patient/045fe36c-9ca9-dcc5-10f4-d0582540f9ed"},"context":{"reference":"Encounter/0f3a3215-5df8-a8d4-256c-fde57cb300d2"},"effectiveDateTime":"2008-04-13T06:17:20-04:00","reasonReference":[{"reference":"Condition/7a742d9d-db39-09f6-4660-784e7f144c0a","display":"Chronic congestive heart failure (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"9cbec6d8-652b-c5bd-e8cb-afdd7b16d623","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/166b7045-4a5c-8acc-e071-a1d0f9ea9d71"},"effectiveDateTime":"1981-12-16T19:07:46-05:00","reasonReference":[{"reference":"Condition/a0459caf-d2a8-b21d-a670-295542b8699f","display":"Gingivitis (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"fe0f5ac7-b76e-b2c3-645b-6b6c1eebe7d4","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/2668b6d3-5d1e-6271-f428-18723abf304a"},"effectiveDateTime":"1986-01-08T22:26:28-05:00","reasonReference":[{"reference":"Condition/a0459caf-d2a8-b21d-a670-295542b8699f","display":"Gingivitis (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"fafb8401-3d48-7ba7-0160-450ca4611a37","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/433d630d-c33c-fcc4-f874-0c0abda5450b"},"effectiveDateTime":"1986-02-05T22:59:36-05:00","reasonReference":[{"reference":"Condition/a0459caf-d2a8-b21d-a670-295542b8699f","display":"Gingivitis (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"6ac9a061-e644-b4b8-aee3-33662ca6b54c","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/f8df4233-637c-140f-57e0-adc8113667f0"},"effectiveDateTime":"1986-07-09T22:15:12-04:00","reasonCode":[{"coding":[{"system":"http://snomed.info/sct","code":"103697008","display":"Patient referral for dental care (procedure)"}],"text":"Patient referral for dental care (procedure)"}]}
{"resourceType":"MedicationAdministration","id":"2a85beac-4b18-3bab-c2a9-f739fed61c77","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/4eaa6de2-03e6-9729-4b20-90c69e5d9a4d"},"effectiveDateTime":"1987-08-15T20:59:02-04:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"b8db11cf-5430-7569-dac0-15b64536da2a","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/9ac2f1d8-86d3-6b68-2470-98417a252c65"},"effectiveDateTime":"1987-08-19T00:55:02-04:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"0d154ce0-b432-eb9e-5596-98dfd07484ce","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/fcc8ef64-e716-53bd-46b7-66ee37d7c99e"},"effectiveDateTime":"1987-08-22T03:53:02-04:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"67d908bf-252f-b41b-cc9a-2ae46b48a521","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/38d9971f-8202-b578-9189-d9c9c16c30b8"},"effectiveDateTime":"1987-08-25T06:39:02-04:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"1ba9ef49-ac1b-b957-284f-4d56759dfde2","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/70fb169f-6feb-211d-43b2-93b3961187b7"},"effectiveDateTime":"1987-08-28T09:48:02-04:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"62cf2460-a2d4-bccc-26e8-b7652c6a68c8","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/e827ff62-4e78-cd72-f8f2-9b4d8afdd420"},"effectiveDateTime":"1987-08-31T12:07:02-04:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"057e6464-d791-daee-2b87-7892fe6b5321","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/be1d0a36-cd1f-6c30-d555-f041cd06ab18"},"effectiveDateTime":"1987-09-03T15:30:02-04:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"6ad843e1-3814-dc6a-2ef1-d6e5c2ad5748","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/1661dc46-e5c3-dca1-344e-955b5eee84b6"},"effectiveDateTime":"1987-09-06T18:53:02-04:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"dc3dbdba-f298-3b99-7462-168a7a3e1c66","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/ceea8a65-6fb7-ee7a-b595-34c2e727f360"},"effectiveDateTime":"1987-09-09T22:18:02-04:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"88c572f4-6411-6410-0bd5-d940763fd0a5","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/d775dd3d-fc19-b3c8-b968-501f356860fd"},"effectiveDateTime":"1987-09-13T01:34:02-04:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"3e861687-8145-c6c9-70f7-1cec4268cdc0","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/e27d3d3e-7ab6-99e3-7be6-3142408ac893"},"effectiveDateTime":"1987-09-16T04:33:02-04:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"01defa91-4325-84c0-6212-b21475861653","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/b75930ad-64e6-c13b-760a-7fefd5b790e3"},"effectiveDateTime":"1987-09-19T06:37:02-04:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"8f42f623-b90c-5e25-ad30-272a1dcd816c","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/360e4eeb-5720-878c-416e-359b5e5aa8a2"},"effectiveDateTime":"1987-09-22T10:02:02-04:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"1fc89da2-20a5-cd32-bb4f-2d663a38d1bf","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/c6eb4a69-e8cd-7fba-1b0a-a9adc891c8bc"},"effectiveDateTime":"1987-09-25T12:03:02-04:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"a36336e4-7c9f-aa5b-0efb-25f4e2ebbc94","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/e0ac6d8c-2631-4241-1110-8b89b243665d"},"effectiveDateTime":"1987-09-28T14:15:02-04:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"2ba74e38-c104-8e2a-fce8-2c198d9cb29e","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/dabd4641-a8d5-de32-2bbc-94a6f2e47c47"},"effectiveDateTime":"1987-10-01T16:23:02-04:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"6a8615dd-dd21-37a5-c877-1c429e44fe99","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/923b2847-9bc6-20bc-ae0a-430f409c2589"},"effectiveDateTime":"1987-10-04T19:55:02-04:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"f5c17019-4250-b84b-260a-69de2adcf9e5","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/f9726809-010f-9c7b-9115-4dfc64fbc38d"},"effectiveDateTime":"1987-10-07T22:46:02-04:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"1e605b5a-3f94-1cc7-5823-80d272ba25e7","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/a33f5476-beea-a52f-8436-45f95ca28a26"},"effectiveDateTime":"1987-10-11T01:40:02-04:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"a70f2fb4-7551-747c-cfed-3c7df799c2a0","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/417ef978-4bd2-e078-606e-a4ef28b0d173"},"effectiveDateTime":"1987-10-14T03:53:02-04:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"7c74579b-8021-87c0-dd06-7b560c590af2","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/7ff508ca-a5f0-a4a1-7713-8a74f2152528"},"effectiveDateTime":"1987-10-17T07:21:02-04:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"985a9ebb-6422-0c8a-d1d2-d1e16d454825","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/657ff53e-cd84-e469-7656-5604d7988741"},"effectiveDateTime":"1987-10-20T09:54:02-04:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"19d4609b-fd96-0bbf-aac1-7261de62a3e3","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/7935989b-8a76-ed2c-0145-d1f1adba93dc"},"effectiveDateTime":"1987-10-23T12:22:02-04:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"05c03c6c-d62c-dc3b-2a68-3b44073340fc","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/183e678d-1bd8-e4c1-6157-15743e3e3362"},"effectiveDateTime":"1987-10-26T15:18:02-05:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"7ebc4300-9f25-a852-01ee-a3930328cf2a","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/bda4a6b9-b157-d425-eede-77c59ab02080"},"effectiveDateTime":"1987-10-29T17:56:02-05:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"a82a4791-a804-f84a-4aee-6124ac9897c3","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/c8befad4-4c4c-5faf-de70-e6ea6cf91065"},"effectiveDateTime":"1987-11-01T20:08:02-05:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"ed5d7404-3e85-5ea1-06f0-78985fa75d66","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/f1d84c0c-2072-6a16-4702-7d2ca3f98307"},"effectiveDateTime":"1987-11-04T23:40:02-05:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"3e77aee4-3fed-3799-c167-b9f4a63949eb","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/fe8539f2-2f20-35e6-2417-6d92f4e9e5c7"},"effectiveDateTime":"1987-11-08T02:00:02-05:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"48013213-385c-e281-db05-c7352138a69a","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/c649a2f8-df5c-628f-8dbf-d99076471894"},"effectiveDateTime":"1987-11-11T05:15:02-05:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"03321d64-0911-7991-6c46-46d50f763ab6","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/05cd818b-ccbf-16d5-5b7f-5a3908eeef86"},"effectiveDateTime":"1987-11-14T09:13:02-05:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"c6041236-bd1c-9fbb-ec75-189b7e422948","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/df9911f1-3c16-60c6-0ae4-816d36dd0bb0"},"effectiveDateTime":"1987-11-17T12:53:02-05:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"3d857c30-947c-3232-a7b5-c8722dac7b9c","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/7f75d032-2568-08c3-a365-b1bc39505f51"},"effectiveDateTime":"1987-11-20T15:42:02-05:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"e75fbcb1-1f8b-5051-4ed9-c8f2b8bb99c4","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/2b47a110-9eb0-ee57-d910-fb47bb884014"},"effectiveDateTime":"1987-11-23T18:10:02-05:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"80727796-fc4b-5692-03a4-d829f130556a","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/9755c57e-c0f0-0b47-e04e-3e9cdc70873e"},"effectiveDateTime":"1987-11-26T21:08:02-05:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"836f1527-8362-8618-e402-1a4d949a094a","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/ee38bd8f-3973-8db5-8518-fdb5331937c6"},"effectiveDateTime":"1987-11-30T00:53:02-05:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"c986ab6a-469b-c509-1bf7-80e279c1ce3b","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/db18d3b7-082c-d47c-e956-3336b8cc8b2a"},"effectiveDateTime":"1987-12-03T03:28:02-05:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"5056ef4f-d5b8-e8a3-0dc8-cd5c9f3b3538","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/df935332-9147-0a1d-859d-be4b7fc74272"},"effectiveDateTime":"1987-12-06T06:11:02-05:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"7037f688-952a-42a5-74d1-a087dcee5c38","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/2fb48749-fed8-7353-910b-03c2ee58bac6"},"effectiveDateTime":"1987-12-09T09:03:02-05:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"e61a5c4a-34f0-b6b4-1663-fedcebdcf84e","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/9bf6cbcf-ba13-143e-d7a3-c8569159d069"},"effectiveDateTime":"1987-12-12T11:08:02-05:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"f86aa419-aacd-3bff-f9e2-d73fb4028d32","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/e33eeed1-a645-2fba-e5a1-08652c8407bb"},"effectiveDateTime":"1987-12-15T13:22:02-05:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"bcd9ccc1-4ad9-eb00-e2e3-0313fbd36333","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/ebee30ad-0486-703b-5021-4868e6232a53"},"effectiveDateTime":"1987-12-18T16:22:02-05:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"3cd137a3-20a9-ae08-7e6a-67ecdb59cb94","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/d1e4fbb1-334a-c7af-04b0-aaece2ca1077"},"effectiveDateTime":"1987-12-21T19:54:02-05:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"41447426-b746-4c86-7c8c-652d1c077391","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/530cb947-4887-9687-d1fa-a9fa5ef94a25"},"effectiveDateTime":"1987-12-24T23:35:02-05:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"e5170d7f-b9f9-5052-09fc-6fe417da1ceb","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/8efacb06-f2fa-1e1d-219b-584764501dd6"},"effectiveDateTime":"1987-12-28T01:47:02-05:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"2ddabae9-bc37-5a8e-603b-4ed58079ea11","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/9c015211-21ff-8eb5-e556-eebd22be50e4"},"effectiveDateTime":"1988-01-13T19:38:29-05:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"cec28c87-89b0-99f7-92b2-0fb9ea4495ac","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/929e5d04-c757-6d6d-243f-e724f0c260b2"},"effectiveDateTime":"1988-01-16T21:55:29-05:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"78073cb1-44c8-8577-6a3f-d4f2ddf8cf7d","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/911b52a3-a59d-504a-a66a-1ddaf93e2fc2"},"effectiveDateTime":"1988-01-20T01:21:29-05:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"21fab1fb-9823-34a4-85db-7e93bd2a3a5b","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/5f6589ff-a353-c915-f850-d84fdfac5df3"},"effectiveDateTime":"1988-01-23T04:50:29-05:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"7ef4edc0-8a13-1511-0227-4e54b6282fa1","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/5d5e09d0-4e19-61f3-4df8-21195c5e7555"},"effectiveDateTime":"1988-01-26T07:22:29-05:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"8de34f4a-5f22-2d31-9285-2f020ea646c4","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/12eecd26-d442-44da-9886-85693e5f4fd9"},"effectiveDateTime":"1988-01-29T09:23:29-05:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"b8c5eaa5-a872-f866-86a3-6ebf3b779ac5","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/90c60cde-a6ee-7ffa-fe9d-98facdd15ed8"},"effectiveDateTime":"1988-02-01T11:25:29-05:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"3db94934-4257-ab28-7f52-797e7036d640","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/7a0042ff-de31-9992-e909-7a102f1f59f9"},"effectiveDateTime":"1988-02-04T13:29:29-05:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"399beb3e-4608-4bf6-5b64-e3716c1192b4","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/dbd85cf3-f6c7-064c-0473-5629b65063df"},"effectiveDateTime":"1988-02-07T16:42:29-05:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"f131fc0a-25ed-3169-2458-0551e7e58862","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/9e7601e4-5f50-d7ea-57bc-e3c6e20acb5b"},"effectiveDateTime":"1988-02-10T20:23:29-05:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"82491015-d2db-c5a6-ce5b-a19bf265d60c","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/c55fa4ed-3f51-8ac1-1be1-0006c729f86a"},"effectiveDateTime":"1988-02-13T23:16:29-05:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"e71c13cd-e29b-ef21-f782-5fe076201ed7","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/eec3ab84-81f2-6b0b-09ef-c0a63460f7d1"},"effectiveDateTime":"1988-02-17T01:33:29-05:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"3d7be292-6423-90bc-c6d3-66abf728361e","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/544054e4-debc-1c5f-ae65-d371a09bac79"},"effectiveDateTime":"1988-02-20T04:59:29-05:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"85ab879b-d8b1-daf2-abb4-d3615306d325","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/2f0165c5-66ba-c614-1120-49053c6f6638"},"effectiveDateTime":"1988-02-23T07:40:29-05:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"482a474c-6117-14c0-06ae-60df65bd7877","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/68e4519a-75d2-310a-acc1-5785f3d97512"},"effectiveDateTime":"1988-02-26T10:48:29-05:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"ac266d16-7a39-5872-d15d-89e67e1a250a","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/53ee9e3a-4713-3cd8-b1f6-8ae6aea37ce4"},"effectiveDateTime":"1988-02-29T13:18:29-05:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"30e53d95-7297-8625-bef5-a3e185351387","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/91357e7e-b3c5-7108-980e-52a913c95155"},"effectiveDateTime":"1988-03-03T15:43:29-05:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"1a603a47-081d-1437-c1a8-7be038679291","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/9be433e7-3f9f-5c17-516b-20133124953d"},"effectiveDateTime":"1988-03-06T19:38:29-05:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"9fb03d20-05d5-bf53-e4ec-1dec9dfb0289","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/338779a6-91d9-b231-3df4-111f183c54ac"},"effectiveDateTime":"1988-03-09T22:51:29-05:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"e3c8799a-44a7-62e3-4a14-8c3de1be44f4","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/08159e0d-edac-e4be-957b-8c8584121f5e"},"effectiveDateTime":"1988-03-13T01:42:29-05:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"78f12dd8-bc10-f0e5-0f82-de40fdaa2130","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/f5557e68-0139-592b-e6c1-6862ab22a36e"},"effectiveDateTime":"1988-03-16T05:20:29-05:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"c380b89c-3bdd-7525-a808-fa356c2813b5","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/a0373255-892b-8960-878b-c4439848c88f"},"effectiveDateTime":"1988-03-19T07:50:29-05:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"b8fa7625-ffbd-d16b-5b90-972c647efc06","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/f0b95373-abb2-88b3-d0a6-01cf27f71a14"},"effectiveDateTime":"1988-03-22T11:18:29-05:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"d052cdf8-c989-bf19-2434-d1d99621e471","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/ff09b9d7-4dec-4aaa-0634-e812e812e3e7"},"effectiveDateTime":"1988-03-25T13:50:29-05:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"62dd4d8e-a2ef-4362-e6f6-e0934e5a1814","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/a6dac107-4c1e-45fb-1d61-9787f141c393"},"effectiveDateTime":"1988-03-28T16:36:29-05:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"1bf3cec4-5093-ca12-c44f-18d4b6dfdcc1","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/80576c5e-ba7c-ecde-d2ce-d4f464de5d44"},"effectiveDateTime":"1988-03-31T18:44:29-05:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"3a1c3a93-a53b-18ab-b4e1-2a16d79bae38","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/f82517db-19bd-76f2-b420-4852c694a606"},"effectiveDateTime":"1988-04-03T23:19:29-04:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"685aa7ab-e9a2-bd8e-dd52-dad1f2fc994b","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/5766ecb4-105c-d992-2622-0f7b3c6e868f"},"effectiveDateTime":"1988-04-07T03:04:29-04:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"2f653117-71b8-16bc-ed71-fa99c870205b","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/b4ba2ec5-e00b-fa03-5403-1f01c953d61e"},"effectiveDateTime":"1988-04-10T06:55:29-04:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"1dc84220-743b-9990-5028-d7dea1bce913","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/dbb19ffb-e79a-68ae-a125-6efb09e53d43"},"effectiveDateTime":"1988-04-13T10:16:29-04:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"6c6ac79a-31f0-b206-6f62-fac03b4d999f","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/f22d9008-1515-7853-6560-1aeae89dcaec"},"effectiveDateTime":"1988-04-16T14:13:29-04:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"a9d03ccf-06ff-c1a7-cdec-1d9b9f253953","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/002bb13d-7c21-143b-0f7d-ec59c1000d8b"},"effectiveDateTime":"1988-04-19T17:47:29-04:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"d2c8662d-378f-1619-5520-21d2cd4d22e3","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/36964ad0-b787-95ee-847a-11aff135f07b"},"effectiveDateTime":"1988-04-22T21:23:29-04:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"fc5fc7f1-4d04-eea7-02c4-891d4aa2c347","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/0278265d-34e3-a724-5758-9427998009b8"},"effectiveDateTime":"1988-04-25T23:28:29-04:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"ef38afb1-b676-4aa1-08cb-b4622c2fbd26","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/36c959ac-77b9-2ed6-cc5d-27c3192c1c0e"},"effectiveDateTime":"1988-04-29T01:36:29-04:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"f4835175-889b-6f34-be05-a9f0a3dd2d41","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/1e49c9b9-b2fb-deb1-5150-ddc76dea711c"},"effectiveDateTime":"1988-05-02T04:27:29-04:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"a4b57674-9f84-7994-3cf7-0fa4ea9be0af","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/db004eab-3da9-efe0-8697-94c4223b7164"},"effectiveDateTime":"1988-05-05T07:09:29-04:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"bb99a43c-32c6-0bca-7cc6-21bf1e27122f","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/f8da0f2c-59f9-bc2b-e64a-4f3f0678ba00"},"effectiveDateTime":"1988-05-08T09:29:29-04:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"6ae266fe-2612-e97e-eefb-fa02d88a5549","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/b29c8c30-f544-6a12-f512-b6b72a81b376"},"effectiveDateTime":"1988-05-11T12:51:29-04:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"ac66d16a-5283-361f-1127-fe2817a09726","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/b0c1ca0e-ea94-438e-557e-b5cc46a265bc"},"effectiveDateTime":"1988-05-14T15:13:29-04:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"e183ea96-6be8-c558-e83a-6eaffeed78d0","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/79d1c18e-65ab-c5c3-90ab-d227335bb1c1"},"effectiveDateTime":"1988-05-17T18:20:29-04:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"5f4beee4-483f-2516-3c51-fcf4ae8b37e6","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/60afff2d-3159-86f4-5e3f-58f10ddd0574"},"effectiveDateTime":"1988-05-20T20:27:29-04:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"4dceba52-7f58-3b80-e5f4-5e0d05141c4c","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/c9abdd85-3402-97c8-384a-bb6b3214d35c"},"effectiveDateTime":"1988-05-23T23:03:29-04:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"02428b8d-bdf5-7338-cbc4-e609b7293144","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/4d7f1f03-fcd9-82f0-fa61-0d69d7b494a1"},"effectiveDateTime":"1988-05-27T01:59:29-04:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"506d16b0-6d10-37b1-80b8-6e460a98794a","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/b381e7a9-6d53-c653-1066-7f032a791f13"},"effectiveDateTime":"1988-05-30T05:22:29-04:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"9c01c44a-cc64-341e-00c2-f1c912831525","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/30c00f66-82b1-dd7d-ba60-37e739be5d15"},"effectiveDateTime":"1988-06-02T07:47:29-04:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"d3c45032-6a39-f9a9-f978-26068e1ac641","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/bf89961c-ff45-9737-599a-248aa853a20f"},"effectiveDateTime":"1988-06-05T11:18:29-04:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"8ed2320f-6310-37bb-bf1d-a1c351987954","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/16195075-e588-cc1a-ac13-e958bca40d21"},"effectiveDateTime":"1988-06-08T14:10:29-04:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"c748f30e-db4c-e946-3644-1481d3800f50","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/5f748b4b-b1e2-c815-bc04-b915ade1c1d3"},"effectiveDateTime":"1988-06-11T18:05:29-04:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"5e3eb9aa-199c-34c5-5b62-242e332f397d","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/9ffc698a-6e5d-393e-0b28-73ca1ce91e67"},"effectiveDateTime":"1988-06-14T20:24:29-04:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"c60dea9e-b5c7-d737-0058-6eb848cc8fb6","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/48f952c7-ee95-8662-3424-78d186bad29a"},"effectiveDateTime":"1988-06-17T23:36:29-04:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"4a22576b-94f2-5d61-13a6-70fe99ab5cd7","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/452028fd-e1d8-66db-ebcb-fc9bf5734aca"},"effectiveDateTime":"1988-06-21T02:53:29-04:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"9e25cf6a-101e-1bf0-9bed-866243442563","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/8d664dc3-fd71-22b4-a165-4e526e9cc088"},"effectiveDateTime":"1988-06-24T05:07:29-04:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"e61e1669-4cd8-0caf-7f4e-620941fc74f1","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/1d0e5503-845a-36c5-e560-d8bf6213c685"},"effectiveDateTime":"1988-06-27T07:56:29-04:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"94828c07-a393-13ac-16df-cc9071512076","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/4ee2b555-9954-ce6e-f09a-bf4711cc0bce"},"effectiveDateTime":"1988-06-30T11:31:29-04:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"7fcddd0e-4f1c-3191-0300-3da5af38f881","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/057b4d6c-dfd6-96db-3603-3b8e8ce04cff"},"effectiveDateTime":"1988-07-03T13:59:29-04:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"51688759-5631-58cf-8048-b4397737bd90","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/d53d8da2-8e86-3bc6-f150-a3d9e551ed1e"},"effectiveDateTime":"1988-07-06T16:26:29-04:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"85004f6a-0f99-77f0-89ab-626242bf8168","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/2fecad67-7a9b-5240-6134-625372f9cb0a"},"effectiveDateTime":"1988-07-09T19:57:29-04:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"2e4e7992-8613-d87e-72a8-c915b874700e","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/9c909b29-1e8c-88fe-43fd-a930a6d81f55"},"effectiveDateTime":"1988-07-12T22:24:29-04:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"7d3829ea-35f1-86d1-006a-8a81d66dcbc1","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/6464150e-5f7b-1c1c-398b-b1f23338174d"},"effectiveDateTime":"1988-07-16T01:59:29-04:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"1631cf64-ce09-5112-7738-3425fd6a2c73","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/73ca0ab9-0c04-39e6-7140-9442e2e75262"},"effectiveDateTime":"1988-07-19T04:17:29-04:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"c0b372a6-7422-e274-53b8-30aaa7f7668e","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/d7330d4b-cb76-a2d2-bfec-c80958e6ba68"},"effectiveDateTime":"1988-07-22T07:18:29-04:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"ece635a2-d233-1159-200c-3f1fdc61f052","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/863b9267-27c5-e8d9-6771-92d759751962"},"effectiveDateTime":"1988-07-25T10:23:29-04:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"910ff3bd-acc4-c16b-a40c-0abf76d527b7","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/5a8947f8-feab-c0f5-544f-7b243e98200a"},"effectiveDateTime":"1988-07-28T13:20:29-04:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"f51937f2-81ae-3d6a-e600-f38204e09e02","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/76fb4a11-ab17-8d41-7983-c4cd1415e932"},"effectiveDateTime":"1988-07-31T16:46:29-04:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"299a422f-c4e9-4c30-c2ca-8e3046166471","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/79bf8b69-dbfc-345e-fc6c-0e89bc21de17"},"effectiveDateTime":"1988-08-03T19:49:29-04:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"ce2259c4-465a-695d-d7a3-6c5241529c83","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/269f4c63-a43f-4734-f7ed-b8c0198c730d"},"effectiveDateTime":"1988-08-06T23:05:29-04:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"4ec3ea95-9983-66a3-630a-6eaf2c8827ac","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/3fb7fdf2-bb33-efd9-5395-dff4ef0f2a1b"},"effectiveDateTime":"1988-08-10T01:32:29-04:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"97f07a64-05fb-733c-fa73-f1050c60346c","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/aa57ec7b-4832-a91d-4a7f-f335382ef169"},"effectiveDateTime":"1988-08-13T04:40:29-04:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"6badb092-b362-75c2-ccb3-9380f16f3f44","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/d344b300-8963-6379-d266-7d22136a0e24"},"effectiveDateTime":"1988-08-16T08:14:29-04:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"3f125f22-bbe7-03f4-1fde-f748d04ab588","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/ee0973f6-948d-5175-9099-c6cf2ecd49f1"},"effectiveDateTime":"1988-08-19T11:12:29-04:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"d42a5329-b245-8650-a9ae-6cbcb7089285","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/b926f0cf-7cc4-e203-9eb1-9df6e49af9f7"},"effectiveDateTime":"1988-08-22T13:37:29-04:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"b1c89519-62b8-df69-7554-554ce6d2726e","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/a8fc1ab1-d3ab-4109-af81-945a5f4a430f"},"effectiveDateTime":"1988-08-25T15:55:29-04:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"6ad39c9e-c571-7eb4-eeed-2fa3897ee843","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/a50f26be-8a09-ae99-37b6-2881b4e9a371"},"effectiveDateTime":"1988-08-28T19:27:29-04:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"184c43a4-d4b3-f342-6495-3f5adcf58c72","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/07568139-3072-2754-5a5e-7a79c9c617a0"},"effectiveDateTime":"1988-08-31T23:22:29-04:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"3c7b367e-3389-a288-7e14-66ca84a8a0e0","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/2fd23a9f-66f6-fb91-8f5d-62b0f8ce6bfe"},"effectiveDateTime":"1988-09-04T03:13:29-04:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"26571cb1-c5eb-e579-372d-84f35f1c31d2","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/2fe01b03-7379-dd6d-c3bf-1e9dac2d8cdf"},"effectiveDateTime":"1988-09-07T05:16:29-04:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"3c256698-19f9-b07f-6255-ecbdcdda7d17","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/c6ac62e4-85ca-c41c-39b1-2c4e153f5a89"},"effectiveDateTime":"1988-09-10T07:40:29-04:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"805a9afb-8ca3-1787-2552-ce21963038ba","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/f92de1bb-198a-14fa-4af1-786acfbf44c4"},"effectiveDateTime":"1988-09-13T10:08:29-04:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"5dbc5531-8b93-1467-e01f-de9877512130","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/7491eb2e-393e-3ef1-86cc-e599d8101b7f"},"effectiveDateTime":"1988-09-16T13:59:29-04:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"162f39fd-e6b8-e719-347e-57abf71f332c","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/55f1c259-dc3b-398b-1735-e0247f907e90"},"effectiveDateTime":"1988-09-19T17:07:29-04:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"58cce098-9d03-e5f7-a4e0-00e622c1f65d","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/debc30f0-281e-e659-a130-b2dbd2002039"},"effectiveDateTime":"1988-09-22T19:27:29-04:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"3987bcb1-2474-184c-84b6-34f2bda464d5","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/d867979d-9209-7ac9-4210-30dbfb46feb9"},"effectiveDateTime":"1988-09-25T22:47:29-04:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"9635babc-5165-bc42-373c-1f7d83ab0497","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/f9d1cd74-1058-bac0-3f5a-876441c0f92a"},"effectiveDateTime":"1988-09-29T01:36:29-04:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"42e0c3c4-2a97-9766-dc13-69d4fa1ac9c6","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/70178180-9113-f0de-b433-3b68c471a30e"},"effectiveDateTime":"1988-10-02T04:12:29-04:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"62db6b2d-0460-2152-e6f4-fe31ce76e53b","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/5a072e02-e17a-d12c-354e-d5cbfcb26bb2"},"effectiveDateTime":"1988-10-05T07:41:29-04:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"2f7071fb-31c7-6e8f-6d7d-3b7d97125f44","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/69c9d761-9c50-b45e-be83-665452e50b5b"},"effectiveDateTime":"1988-10-08T09:44:29-04:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"5f2243d8-bc1b-e3ea-1090-de20fdb51437","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/25409b01-945e-088f-20f7-676fbd122040"},"effectiveDateTime":"1988-10-11T12:54:29-04:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"37f77628-42fa-99a2-8a7e-572ea7bbcc88","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/b3951364-5086-2aa3-7b1f-20aef92cd959"},"effectiveDateTime":"1988-10-14T16:51:29-04:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"e1d6b3c6-9342-3559-14fc-bd5ec771b052","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/a482bacb-813e-c593-713c-577131f6dbda"},"effectiveDateTime":"1988-10-17T19:53:29-04:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"3e34c9d1-1218-0568-7fcd-fa1ddbdd3ec0","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/5d3ca6f4-2b17-c8b1-817b-f2cf819d5e9f"},"effectiveDateTime":"1988-10-20T23:45:29-04:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"f1030926-eb41-daf8-170c-a3614afcd32c","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/c875389b-e0b7-d8fa-f655-fe7f95e682ea"},"effectiveDateTime":"1988-10-24T02:49:29-04:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"5f80ef4f-0e3b-f19d-dac3-ad5bd7be586c","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/a36d5835-cb68-6cab-4f9e-8ac08066a46c"},"effectiveDateTime":"1988-10-27T06:25:29-04:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"dce8f858-ff42-ea75-6fed-c677bbbe6e8f","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/e13cc213-e180-0977-c6b0-3bbd1406117d"},"effectiveDateTime":"1988-10-30T07:51:29-05:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"b6d09dc8-8ce2-8507-176a-71c78c32083a","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/5a418b83-0d46-28ec-a093-0271dc21b629"},"effectiveDateTime":"1988-11-02T11:08:29-05:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"02836676-b360-10f9-6a14-3acb716cda7b","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/8bee8cd1-48d6-b63d-f136-9ab0a9d45db7"},"effectiveDateTime":"1988-11-05T14:41:29-05:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"dbe61430-b35e-a312-43b7-654f716b6c95","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/3e6e44ea-929b-7c3f-855e-8eebab296066"},"effectiveDateTime":"1988-11-08T17:49:29-05:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"95e34d7a-5122-3b34-9ab3-6f4162a654c7","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/e6fa6919-79be-e572-c5a5-893510f1364b"},"effectiveDateTime":"1988-11-11T19:53:29-05:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"20f921d3-5c8f-1ccb-a361-73d87acd2994","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/a2690bbd-5596-af0b-4ffe-53ab258d421f"},"effectiveDateTime":"1988-11-14T23:46:29-05:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"d3818a13-1fd0-925e-6331-0d45806ab6fe","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/a050d8c1-16f6-dc32-a1d4-23ffb7772ac5"},"effectiveDateTime":"1988-11-18T02:53:29-05:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"29c252dc-fb8f-14fa-ac2b-2596194d21c3","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/a88bfed8-9741-924b-c897-3ce107467492"},"effectiveDateTime":"1988-11-21T05:43:29-05:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"3e70d082-2ba9-7804-1f3d-68a8bce1df90","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/8d04c497-e95b-3623-b345-fd1932b1a31d"},"effectiveDateTime":"1988-11-24T09:13:29-05:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"11fae889-a822-f057-1ddb-b521ceb82679","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/28dc56d0-42a1-4092-d830-79f143ae7d20"},"effectiveDateTime":"1988-11-27T11:37:29-05:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"899a6c4c-fe47-15aa-791d-9ead98ac0b90","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/9379bcf7-be01-c6bb-bcb1-1242bc3b2cd2"},"effectiveDateTime":"1988-11-30T14:43:29-05:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"ae465bc7-365a-60fd-b7ed-aff529529423","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/844e599f-6562-eb2b-e5c3-e29673031107"},"effectiveDateTime":"1988-12-03T18:41:29-05:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"cfe0f919-84e4-f4d6-e331-a74dc6f55b22","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/00d30955-e299-4c41-900e-1a1229ff09b5"},"effectiveDateTime":"1988-12-06T22:06:29-05:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"e5e587cd-d385-daea-0bef-3124eec2d31e","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/4d21a404-b30c-4f88-392d-b861a97c7e38"},"effectiveDateTime":"1988-12-10T00:40:29-05:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"9c2a50a1-2e38-100c-58ae-6a34330d3cfa","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/dfecc9aa-985b-f0bf-62a3-d12a3185358b"},"effectiveDateTime":"1988-12-13T04:02:29-05:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"15803896-ba06-3746-b5c8-7a2fea539222","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/7bee1fb9-37bd-6e1b-2cc6-9681e9023e6f"},"effectiveDateTime":"1988-12-16T07:06:29-05:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"eb9e68ac-701b-7498-e3d1-8eb61c76ec71","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/8e4aa204-484f-0d19-3ec1-f74f8ef98821"},"effectiveDateTime":"1988-12-19T09:38:29-05:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"4102134e-cc5b-e5a3-8d15-6e06a8a5f609","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/fb51fea3-9c42-7d4c-5f69-3861b4121b18"},"effectiveDateTime":"1988-12-22T12:20:29-05:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"2f710bd3-b1d6-2b7f-ed7d-d5561d6d4f97","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/9a19f35a-bf6f-3724-3436-df9121432231"},"effectiveDateTime":"1988-12-25T15:05:29-05:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"69013f11-e346-0fa1-2a37-2ab0e4671606","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/50fa669a-f1ad-f6cb-5c74-745dda60e7cc"},"effectiveDateTime":"1988-12-28T17:46:29-05:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"4087ef45-7655-9914-52df-2d523fd8052b","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/74b9a86e-350a-1b33-89f4-e97f421f35bb"},"effectiveDateTime":"1988-12-31T20:08:29-05:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"ab3abfc1-cccb-1637-77d2-e68750447a18","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/e646411d-27d5-9caf-653a-e0d07e26f5b6"},"effectiveDateTime":"1989-01-04T00:02:29-05:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"6adf3cee-e670-fe4e-eef8-cff3c18365d2","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/dc77d48b-e83d-c6bd-f2b6-d6fd97d9bcbd"},"effectiveDateTime":"1989-01-18T19:22:29-05:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"31235864-0758-5864-15b6-0a050dbd199b","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/74e33936-22a0-bca8-a590-d25b5628e23f"},"effectiveDateTime":"1989-01-21T21:52:29-05:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"98c18cb3-c1d2-1de4-39b1-0fe6226da04c","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/e3b6d09a-6bb7-4516-2b79-7c5a8046b47c"},"effectiveDateTime":"1989-01-25T00:59:29-05:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"3fc28c3e-6102-dee3-7432-0f70c19e7145","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/506da937-742e-4525-e50f-ccf81dd58ab9"},"effectiveDateTime":"1989-01-28T03:27:29-05:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"977af352-0d0d-7c34-1cea-315ed68feabe","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/0e22a6d3-90c2-f68d-d8d2-92fe8b90d371"},"effectiveDateTime":"1989-01-31T06:00:29-05:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"cdc6b99a-4591-b619-3287-f0ff79f35720","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/0a87ae04-8284-3b89-397a-4c37ec2d8220"},"effectiveDateTime":"1989-02-03T09:36:29-05:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"40b7bfa8-ba39-4706-67a8-6ca1fe1a139e","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/ba73862a-a59d-8696-8347-0f0ff6364145"},"effectiveDateTime":"1989-02-06T12:38:29-05:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"2f71e4f7-a218-681b-6d7e-ae7a1163fdb7","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/63d4fe5c-304c-fbac-8983-2c9f45328182"},"effectiveDateTime":"1989-02-09T16:06:29-05:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"b84c1384-74b2-7481-063d-9b4f7cf40db2","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/569f67ee-66ee-c8f9-8e72-4ea02e348e58"},"effectiveDateTime":"1989-02-12T19:26:29-05:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"43428df8-da35-5424-0d5a-89d9a6cd7b21","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/8730ff6e-a079-a077-fa4e-0758042a488f"},"effectiveDateTime":"1989-02-15T22:27:29-05:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"458b7dd3-6ab2-fc86-25a4-fbf8eecc8f8b","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/75d75af4-d30c-213f-8542-f72c192e539f"},"effectiveDateTime":"1989-02-19T01:09:29-05:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"099974f6-045e-cb16-d91c-a756a071ed30","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/ce00aaeb-10c3-3795-8d4d-0591f59f192f"},"effectiveDateTime":"1989-02-22T03:28:29-05:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"907595bb-fd4c-83b1-9939-8cffde191bd8","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/d352d0c9-6743-04bf-5007-7cb7dda8d27d"},"effectiveDateTime":"1989-02-25T05:42:29-05:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"6adbaf53-0525-9232-eef5-4257e6bd9c78","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/fcb02a92-8841-bef5-f087-1ee5771ccf2c"},"effectiveDateTime":"1989-02-28T08:00:29-05:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"676f7ee4-340f-65e2-c4db-b0f49a5b796a","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/ba979094-ed42-6827-7835-d8d7ac3eb002"},"effectiveDateTime":"1989-03-03T10:10:29-05:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"84b476fd-d052-1d1a-1cf6-102e1e7bb26a","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/00d47c5c-eec2-ccbd-9b9b-582463f67236"},"effectiveDateTime":"1989-03-06T13:53:29-05:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"c0c1c6a9-6a21-daf5-e6cb-8cdf2c34d328","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/c7e1dc40-e487-eadc-3eb6-3b28ec311dc8"},"effectiveDateTime":"1989-03-09T17:21:29-05:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"71907ed3-49f9-c19e-98ad-61171dda8e36","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/0b1112eb-7abe-d235-43bd-f7e1cc0ed4f4"},"effectiveDateTime":"1989-03-12T20:44:29-05:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"107990ee-bcc6-0d05-d1b2-97f258e71369","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/c120bb3c-2191-45bb-8f09-600e6ebdc19b"},"effectiveDateTime":"1989-03-15T23:10:29-05:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"8f74d109-7121-3421-f436-0a304c985527","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/e5924930-adf2-0e76-ef42-fff7fc950963"},"effectiveDateTime":"1989-03-19T01:22:29-05:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"99a52acf-1198-bff1-2746-670d1e624264","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/71137f82-15c5-b0b0-246d-fe1d0fceed30"},"effectiveDateTime":"1989-03-22T03:50:29-05:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"02d187b1-1745-dae9-28db-52ea21dad31c","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/9c45783b-d779-ebfa-2290-233cb95dc338"},"effectiveDateTime":"1989-03-25T07:08:29-05:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"20869cb1-8453-f45b-e5af-d4f31d8442bc","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/5a6e913a-c480-ce1c-2abf-2c8630801d27"},"effectiveDateTime":"1989-03-28T09:35:29-05:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"fbae0db4-5b8d-82a5-0212-ceee02ce3d05","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/74ddc809-6aa0-d014-b3d0-5213b77f200b"},"effectiveDateTime":"1989-03-31T12:33:29-05:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"f496f1aa-1c17-6004-13a2-6e2e35aa64ec","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/5ec96a1c-f8e5-3d33-8471-1bbaa5d7a79b"},"effectiveDateTime":"1989-04-03T17:18:29-04:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"b89b3528-ae38-3b37-50c2-7220995c1c04","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/641c3875-ca08-c01f-3837-cc28d852f71f"},"effectiveDateTime":"1989-04-06T19:50:29-04:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"498f2597-98f0-36a7-79dd-a791ff687840","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/977948d0-d890-3387-328d-468cd3f62619"},"effectiveDateTime":"1989-04-09T22:47:29-04:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"ce51d621-a997-dd4e-6b65-cea9d91b0faf","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/4d3c28d7-7f02-2274-8e5c-10ce6b143150"},"effectiveDateTime":"1989-04-13T01:25:29-04:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"a4b5672f-c668-2e98-8cf7-006014fa51ce","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/70dea457-6bbc-f037-7a07-4a83db4706d1"},"effectiveDateTime":"1989-04-16T05:24:29-04:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"e5ef9f6a-1611-fdcc-298a-6462493807a0","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/f1dea6e5-9aab-97cd-091c-9b7d8822b748"},"effectiveDateTime":"1989-04-19T07:44:29-04:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"62cce519-1449-db09-88d6-b95e679ed33c","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/e102eb4f-1610-c04b-a70d-679b281d6bc8"},"effectiveDateTime":"1989-04-22T10:48:29-04:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"d40038de-2840-43b6-4e58-7a77588eedfe","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/7c375820-56d6-4852-b93a-3667b9b1a5fc"},"effectiveDateTime":"1989-04-25T14:25:29-04:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"31a06ec4-431a-970f-c782-a0d4a966aabb","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/b3a400b4-bf88-f96a-f5f5-ab2aec04d326"},"effectiveDateTime":"1989-04-28T17:34:29-04:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"c8c6c898-1929-eae3-2f12-dc46b29a88f4","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/4c370b8d-100a-06bc-1a41-800b1b71af4d"},"effectiveDateTime":"1989-05-01T20:39:29-04:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"168c3ec4-2b39-48c8-b199-3cd491855c78","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/e273ff24-1b80-1647-3272-f94609b3e436"},"effectiveDateTime":"1989-05-04T23:27:29-04:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"b5431fd9-e8d0-37e9-e591-ea3e5d787982","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/22056590-3a2a-7eab-73fe-09d9e4a9da6d"},"effectiveDateTime":"1989-05-08T01:44:29-04:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"9ccb7a60-aa98-c1f8-3a70-795fda1bf459","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/45835eb9-d928-5998-04b9-23d3983ed4c3"},"effectiveDateTime":"1989-05-11T05:17:29-04:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"c6bfc292-db6e-d799-a20e-d7e7d3a1fda3","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/bf9d226c-6e71-9443-3e70-74b7131ce3a2"},"effectiveDateTime":"1989-05-14T07:36:29-04:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"100f2659-b391-964d-ff4d-33233608aa19","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/9efef942-c146-0a1d-4c20-2aa2f282538c"},"effectiveDateTime":"1989-05-17T10:12:29-04:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"846abb44-728b-3459-dd62-ee6a7c688737","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/b0c6e366-707d-d3d8-f9a9-04aec265e4cc"},"effectiveDateTime":"1989-05-20T13:50:29-04:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"843975aa-2468-2266-af2d-5f2e3dfb2755","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/8f3ad172-ac83-a02b-1ee6-adac98b64f5c"},"effectiveDateTime":"1989-05-23T17:17:29-04:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"f4894284-838f-a2a1-0e1c-477430084926","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/11e2e9a6-757b-936d-5355-b18d2882d3f5"},"effectiveDateTime":"1989-05-26T20:44:29-04:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"bc875baa-1155-63a5-e97d-132e2ae86895","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/2de83fc1-643b-c0ea-c376-b2a9e52e0e34"},"effectiveDateTime":"1989-05-29T23:35:29-04:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"2c04f624-b299-e96e-d773-572b175b2599","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/c4d798d4-0c45-0a3a-a16a-1c798940d3ac"},"effectiveDateTime":"1989-06-02T03:09:29-04:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"00d33319-a000-1526-0737-f455ec0cb2c7","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/e049d133-df12-c4ea-f110-0b66cdff668d"},"effectiveDateTime":"1989-06-05T06:36:29-04:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"8af3ea94-1179-b7ca-6dc0-6eada47ea97b","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/8f5aa412-c2f9-6b2d-2bf4-e80c86532d48"},"effectiveDateTime":"1989-06-08T09:34:29-04:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"df0f30bc-7a11-7f7a-88cd-3d85fc8a97f7","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/c44c2edc-b779-e21b-a621-a735851581d9"},"effectiveDateTime":"1989-06-11T12:11:29-04:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"c75669b2-c782-bb11-d7bc-b5c6924f7273","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/f77af803-bd91-ac49-fb8a-b87f2a99aa8c"},"effectiveDateTime":"1989-06-14T16:02:29-04:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"618ff86d-e9fa-0bc8-8929-9d1835dad860","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/a3e82aad-f138-977a-e24b-895f1204ed59"},"effectiveDateTime":"1989-06-17T19:25:29-04:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"6606121b-9335-d7e8-d167-18805472c52e","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/d4625886-189a-2320-0bca-9b58295c3de6"},"effectiveDateTime":"1989-06-20T22:17:29-04:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"2c2a4fd7-f4f8-5ed7-91ae-696af9ec936d","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/97eca007-034b-3a38-f904-e6b151cd4e98"},"effectiveDateTime":"1989-06-24T00:33:29-04:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"a0b77a92-2ea2-5f0c-4a79-4a156102fda3","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/52b1d5d8-8473-6b0a-66f1-54954138b25c"},"effectiveDateTime":"1989-06-27T03:32:29-04:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"2f14ff7b-ece4-c86f-42e9-d87d2af52ebb","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/02c4d009-7713-5663-a024-2f235714baeb"},"effectiveDateTime":"1989-06-30T06:39:29-04:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"728615bc-a811-5d1a-3e67-1c21694ecaf0","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/65d94830-4f2b-4cf2-5d7f-7ba58791d4d5"},"effectiveDateTime":"1989-07-03T09:51:29-04:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"2f6ce304-822b-941d-6d79-ac86fd471060","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/ec5c094f-09c8-2f73-ea4b-1f00eed8223a"},"effectiveDateTime":"1989-07-06T12:12:29-04:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"cb218fc8-f2e0-4ac3-316d-a3a3d1a108d4","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/d0c98745-6a5f-8adc-3edf-1c8dc4267b9a"},"effectiveDateTime":"1989-07-09T15:11:29-04:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"d1428d5b-62b1-617b-c87c-80b5e6caf480","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/5815dcfe-6ffc-9063-86a4-7af3a49451ee"},"effectiveDateTime":"1989-07-12T19:04:29-04:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"5ec7c66e-1e5f-c8e5-c891-d6d46a73a7ce","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/2c3f4773-4279-def4-2625-06f78e6f8a7e"},"effectiveDateTime":"1989-07-15T21:52:29-04:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"f951e922-c2ee-4952-061b-6b9edfb53f91","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/5d21d2ed-beed-49e0-75ca-3c9e7873105b"},"effectiveDateTime":"1989-07-18T23:58:29-04:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"6d3d65b3-be8e-361e-d1fe-a3e28a8b9724","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/d6c01e09-421f-715f-87d3-f69e3c020b53"},"effectiveDateTime":"1989-07-22T03:29:29-04:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"09c5e2a5-7135-729e-2bfc-66bf043a6bda","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/41102123-e6a8-d658-1ae4-df26ebe885c9"},"effectiveDateTime":"1989-07-25T06:36:29-04:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"a214baa0-8fa2-8847-02b3-f245ddb20b7a","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/44c9133f-bec1-ec82-7c3e-de4a887fb792"},"effectiveDateTime":"1989-07-28T09:46:29-04:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"e751713b-15be-fdd1-f7b7-bd4efeb735ff","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/df682f36-8d06-270c-73ac-5b9fc8080258"},"effectiveDateTime":"1989-07-31T12:51:29-04:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"385aa1d5-7787-84e2-3152-d4fb817d03cd","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/b0bad71f-51ce-f1ec-2db9-60e0093ec4e2"},"effectiveDateTime":"1989-08-03T16:14:29-04:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"ae861665-f3d5-ebf5-05e7-1ccab514bbd5","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/5ec94689-14f6-07bc-5ee8-536025438055"},"effectiveDateTime":"1989-08-06T18:49:29-04:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"fdd50082-2998-584e-0a9e-830009af320d","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/3b4df310-64ae-dbc7-9b94-5a1e9abea8be"},"effectiveDateTime":"1989-08-09T21:47:29-04:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"d0c54e1e-2bc9-9d5e-cad5-b46a3fba9c25","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/ae1ccd3e-8194-140b-981b-1e4c4a23dedd"},"effectiveDateTime":"1989-08-13T00:04:29-04:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"fe4e6d94-6393-9625-04b3-2ed393735805","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/ca5234bb-2749-f702-7a29-299ca962b43f"},"effectiveDateTime":"1989-08-16T02:31:29-04:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"37028860-0e93-2066-b981-27ae52d12d2f","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/d0d01c94-50b8-4428-35da-4cde790a6791"},"effectiveDateTime":"1989-08-19T04:34:29-04:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"08e5798e-0b5d-8d76-eef5-dfda1f548d85","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/caeb1036-ce95-66b5-904a-890cff46425d"},"effectiveDateTime":"1989-08-22T07:57:29-04:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"180189b4-f370-952b-27d1-0ce754105d72","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/ffebdd1b-cf7e-bb6a-3615-594f5ebc4b3f"},"effectiveDateTime":"1989-08-25T11:48:29-04:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"f4f9edf9-0edb-ab94-0b90-c9d9db73d38b","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/42993ebd-737f-3b88-9bc5-da65a723e671"},"effectiveDateTime":"1989-08-28T14:43:29-04:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"f2dc732d-2496-733f-bc5e-f2cecc8cb14c","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/232d27ed-1762-fa4b-c907-e680af863c35"},"effectiveDateTime":"1989-08-31T17:34:29-04:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"6fad7b6e-eb52-f8e1-6f32-bcd3e3861eeb","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/d17eb799-8d0b-f159-06c5-94f3467fdca3"},"effectiveDateTime":"1989-09-03T19:44:29-04:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"977b5cb2-3889-784b-e459-a4f3d1b9c84f","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/b415b70b-e737-ab49-f39e-af1f6b0eac4f"},"effectiveDateTime":"1989-09-06T23:34:29-04:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"3ec762d5-2e5a-5125-48c8-ebdf9752844b","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/7f13378a-9fd8-eba1-6867-2ac9cb5302dc"},"effectiveDateTime":"1989-09-10T01:58:29-04:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"a21ff142-49f9-ba31-ca2a-22419dda86c9","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/83296efa-2050-9286-d100-e3f2ef368cd2"},"effectiveDateTime":"1989-09-13T05:28:29-04:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"b59e7a8d-7ed0-45f7-8236-a29baa1b31d8","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/3ab75dcd-19d6-868b-27cb-dd9536be7d88"},"effectiveDateTime":"1989-09-16T07:37:29-04:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"523ab93c-ac26-6ac6-0e1b-85d4d4388fad","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/98a35025-c317-6753-ad2b-72e0ed44217f"},"effectiveDateTime":"1989-09-19T09:43:29-04:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"4df0d867-c26a-7a00-57f6-61101162ad26","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/9a67eaa6-c1b6-2f30-2dec-7e7fbffe0839"},"effectiveDateTime":"1989-09-22T12:07:29-04:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"c42a5572-6678-8ca9-a8ae-6f056b7bd282","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/57042c2c-03a9-c324-8a09-0b5f2eb1a174"},"effectiveDateTime":"1989-09-25T15:34:29-04:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"55fffc6c-8cda-8d4a-ec8b-dd392502ab88","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/a87815c1-8a29-9886-f568-1c540426205e"},"effectiveDateTime":"1989-09-28T19:17:29-04:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"75087f0b-5761-8632-d5a9-085395310964","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/032f0f74-9a9f-1208-321b-65f0abf7b779"},"effectiveDateTime":"1989-10-01T23:16:29-04:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"307f2b7c-3d62-f671-56d9-7cc01e2f8e99","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/ac2d7003-c720-d252-4261-c0d54eac3be8"},"effectiveDateTime":"1989-10-05T02:26:29-04:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"62d132ba-c3ea-6a5c-e6ea-c5bfc935f6fd","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/a793b8d9-e897-3546-5be1-66ea3ed8801b"},"effectiveDateTime":"1989-10-08T05:09:29-04:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"64364189-043f-576f-2c77-dab9549c25c6","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/1374dc52-2b7a-d806-43b8-969984e0b231"},"effectiveDateTime":"1989-10-11T08:30:29-04:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"90221104-32b4-e283-2327-1750703a669d","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/aa5c6c39-41b8-6c7a-ab3c-9b62ee878862"},"effectiveDateTime":"1989-10-14T10:41:29-04:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"f60f2804-3b08-875b-13cd-34cdbd8bee48","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/49613d51-080d-ca6a-0d47-8ad5b5b62016"},"effectiveDateTime":"1989-10-17T14:11:29-04:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"ef2cc7e6-3800-caa9-08bf-cced86d9ed2e","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/51743169-39d2-8c65-f288-1eb4aa875f71"},"effectiveDateTime":"1989-10-20T17:20:29-04:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"8b5b410b-fde6-3436-c9ce-9fa7deb2cc5e","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/88fa3a07-cfda-8a08-44f0-48009967ef20"},"effectiveDateTime":"1989-10-23T19:39:29-04:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"941171cc-fcc4-b742-a832-ae5aeed51d8e","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/1df00cc5-debf-0fc3-e9ba-e3499d56841e"},"effectiveDateTime":"1989-10-26T22:38:29-04:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"8238bc3d-af59-244f-06a0-6b8eed65edd2","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/f808ae36-3473-5b60-3193-111940fad78c"},"effectiveDateTime":"1989-10-30T00:20:29-05:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"b114ddd3-08b9-1e62-588d-87911582a0e7","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/81e18a3c-4144-4ea0-0ba7-b88b0328a2bc"},"effectiveDateTime":"1989-11-02T02:39:29-05:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"c4b52082-2578-437f-ccf6-b9b276154ae0","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/a1c5c0a1-ad8c-128b-9fb8-a30d3ea494c2"},"effectiveDateTime":"1989-11-05T06:06:29-05:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"ceb38793-328d-dace-f4bd-9c367860d301","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/69481550-3931-f4fa-665e-1fa4df2d4bce"},"effectiveDateTime":"1989-11-08T09:21:29-05:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"c99bda26-d21d-c161-f91f-0c87737809f4","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/5f5d4ed5-d979-3154-7286-d66cac473dd4"},"effectiveDateTime":"1989-11-11T12:17:29-05:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"67663046-4a58-8c2f-0096-80fb8678c471","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/5ef412bd-85f7-00c4-1cfd-f2d57ec85c0c"},"effectiveDateTime":"1989-11-14T15:43:29-05:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"e9eb639d-f3d1-daef-0ff5-7b4462a2d323","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/53c3bfd4-9581-6a6f-0e6f-091164531867"},"effectiveDateTime":"1989-11-17T17:58:29-05:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"f2667287-62a6-90b2-febb-534be6c023b7","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/f944f099-bcc5-5010-866e-c4437699fc41"},"effectiveDateTime":"1989-11-20T21:30:29-05:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"08861731-6381-43d2-07e7-1d9624c47990","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/a72a4950-b230-5efb-de85-4a6166cb030e"},"effectiveDateTime":"1989-11-24T01:17:29-05:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"9dd6e5b0-6564-b61c-0298-290682be9723","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/8992612d-a397-f35e-13c9-97725a42ed6b"},"effectiveDateTime":"1989-11-27T04:43:29-05:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"1bfdd1b8-b35e-2722-a2ea-6840f16af0a4","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/ee41828c-47c7-bdb2-4273-18ab79d01cf3"},"effectiveDateTime":"1989-11-30T07:42:29-05:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"31ffc8cd-febb-c5ae-7e14-02370e7dd614","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/b6a832f4-f643-0246-2b5d-f717768157a4"},"effectiveDateTime":"1989-12-03T10:54:29-05:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"690d136a-2d2a-bf09-1bed-42626050c927","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/ed92a584-1322-c88d-3220-ce4368e07d31"},"effectiveDateTime":"1989-12-06T12:59:29-05:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"7e403950-7640-43c9-2c88-7ae9a6913954","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/f3591d7e-ee32-6bf7-31b4-5b5074f5ef9c"},"effectiveDateTime":"1989-12-09T15:06:29-05:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"499ada83-ee56-2761-d91e-0ce490512c54","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/d23e366e-ca61-1a50-e627-369f32bd0c34"},"effectiveDateTime":"1989-12-12T17:22:29-05:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"84dd74fb-8970-b68a-b52e-7a905b98f823","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/f2a98457-00e6-9703-01da-e57cbb649896"},"effectiveDateTime":"1989-12-15T20:36:29-05:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"c46abab6-078a-763e-6f62-eddc11ac2b15","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/cd865a6c-36fd-e82e-4421-ecb787eafcdd"},"effectiveDateTime":"1989-12-18T23:49:29-05:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"f23b115f-7829-8707-fe1b-ddf7a0b46403","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/a0847385-abac-6ca8-0d69-b6decf834271"},"effectiveDateTime":"1989-12-22T03:05:29-05:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"803f7a92-3da4-c2e1-3282-ea157005651d","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/9f87744f-5557-0633-e157-5e1df423f24d"},"effectiveDateTime":"1989-12-25T06:47:29-05:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"ea217637-e169-598d-1c82-1883d2000911","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/897a5a6c-8218-b4d0-6d4a-e7a89fc141e3"},"effectiveDateTime":"1989-12-28T10:29:29-05:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"127b422f-e58d-ac2f-abab-935deb9d8470","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/bf3aa7ff-9770-00ea-2fa7-0f427433c7a2"},"effectiveDateTime":"1989-12-31T13:33:29-05:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"bb78aa68-4d2a-3f46-c08c-0aac8cae58d9","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/62d1769b-4e21-be6f-19c3-ddba75c1a5f4"},"effectiveDateTime":"1990-01-03T16:03:29-05:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"bcf2ed88-4d9e-24c8-fe8c-1dd98ba271a0","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/6deb8f39-bb77-9791-2ff0-1f78674994b2"},"effectiveDateTime":"1990-01-06T18:37:29-05:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"3195fdf8-6c81-9487-41f1-a9d93919bd2a","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/a805dfe4-03f9-44d9-cb45-a1e14d71148f"},"effectiveDateTime":"1990-01-09T22:13:29-05:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"fa192c77-2e4a-b41b-5eda-7228e6591522","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/86c8d310-d01c-8f8e-f2c3-bf2004e846c3"},"effectiveDateTime":"1990-01-24T19:13:29-05:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"032ddd5b-f52f-c253-0ff7-5fe799a07f11","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/45069a98-879c-5a61-eaeb-b91dea752002"},"effectiveDateTime":"1990-01-27T22:57:29-05:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"52d9cdf8-ce9d-d190-9605-f1d99b35fa4e","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/2ab12b6e-88a0-69ca-ec8b-391098a1c527"},"effectiveDateTime":"1990-01-31T01:14:29-05:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"591e6a38-bb49-6de4-ddb2-11d0fce29e35","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/80add0a5-db67-c7f9-ce1b-d6424882adef"},"effectiveDateTime":"1990-02-03T04:17:29-05:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"f20611c0-de35-d6a6-df27-18259f7c08f3","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/6feb66a2-c8f7-5cc8-3d63-4c5018a279ed"},"effectiveDateTime":"1990-02-06T06:50:29-05:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"3e1f2feb-1f2e-9fe8-7fb8-603cb3e26460","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/f13e8893-e1a6-0e2a-1ee3-6df2d86d1149"},"effectiveDateTime":"1990-02-09T10:35:29-05:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"e2c76b16-24c4-d9d7-f72e-96176ed54023","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/51c98f5e-8555-93a1-0cf1-7722dc6794f2"},"effectiveDateTime":"1990-02-12T12:52:29-05:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"02076ebc-50f1-7a53-0ed0-f1497629a211","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/9bbe85d5-2fbc-908b-2db6-d6be847681b8"},"effectiveDateTime":"1990-02-15T15:15:29-05:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"0dbc0a23-cff5-eae4-33c6-3fbab262e317","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/cd0cdf69-46c9-2b14-674d-acdcb994ae89"},"effectiveDateTime":"1990-02-18T18:24:29-05:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"84347678-7322-b594-ec76-0fa8c4d78568","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/456aaa0c-d6fd-7f91-d22a-8049801c3cb3"},"effectiveDateTime":"1990-02-21T21:52:29-05:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"e9c94a46-38fa-4559-1cef-547dd5fe4c52","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/c6d41a2d-1e6e-23c9-8f21-28e766774c5d"},"effectiveDateTime":"1990-02-25T01:19:29-05:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"9a428b63-bcb8-a998-1f52-0e961d5c3392","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/7ac3b3db-6296-5360-9217-0394b7c8443a"},"effectiveDateTime":"1990-02-28T04:38:29-05:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"9e52c486-cd81-95f7-6aea-ed6d5b0279d8","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/894b099d-675a-3452-2b91-abaa12be9671"},"effectiveDateTime":"1990-03-03T08:18:29-05:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"60e52286-a95e-2132-eef5-88d2bdd36f9f","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/5b9d548f-f465-3c18-697e-302a4b0a53bb"},"effectiveDateTime":"1990-03-06T11:59:29-05:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"1a7c4df8-b44c-1190-baca-c1d980e43a7e","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/b5f5fa0c-053b-d24d-9918-dd7003aa1ccb"},"effectiveDateTime":"1990-03-09T14:48:29-05:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"020b52f1-308f-b96a-3531-5d2dd7538862","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/7a372587-b9d3-5480-99b7-14459c119b09"},"effectiveDateTime":"1990-03-12T16:59:29-05:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"5a3209b1-ff22-2df0-5f50-df4fbea64783","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/e88987c4-1013-13c7-8b07-d64865f726e2"},"effectiveDateTime":"1990-03-15T20:51:29-05:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"8c5be291-4163-3224-479c-66aad4685179","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/4b23838e-0935-9227-865c-b31dd44c254e"},"effectiveDateTime":"1990-03-18T22:54:29-05:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"99a3ac86-562e-2c1d-e198-ebf4b73490de","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/2daa4de0-6608-d28b-8af8-5d2ee4047ce3"},"effectiveDateTime":"1990-03-22T01:37:29-05:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"043dc7cf-0542-5519-2f02-800d120bd7a9","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/2093598e-a0a4-0da4-12bb-f8feb493605c"},"effectiveDateTime":"1990-03-25T04:30:29-05:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"87132f69-c49c-0bad-f8d1-3c33472c7616","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/d65fdac1-2980-2658-5d79-7e3bea8dfe44"},"effectiveDateTime":"1990-03-28T06:39:29-05:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"de73a2d6-7f1a-7341-a7f6-3381864bb14e","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/e031fd1c-e2da-bb50-d802-2885917703ff"},"effectiveDateTime":"1990-03-31T09:56:29-05:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"eb000d11-1f33-cea1-0493-1232f6172626","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/ce3ac3bb-245b-654e-0277-98e061cdfe52"},"effectiveDateTime":"1990-04-03T13:59:29-04:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"277bc4bc-3d45-4474-3a2c-06181e11dc9d","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/fbf34eed-6a9b-47bb-b785-6ad07e84d74f"},"effectiveDateTime":"1990-04-06T16:03:29-04:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"2435d5d7-f72b-2856-cc77-6f0849587f44","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/4f5f5143-214e-fa08-61c3-903c33c40562"},"effectiveDateTime":"1990-04-09T18:16:29-04:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"d4828a93-20a8-b361-82b2-0dc5814d1e12","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/9afc82c6-9975-fbf5-9a25-9e2346a68cf9"},"effectiveDateTime":"1990-04-12T20:53:29-04:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"023a67be-19c1-1eaf-8e1b-345642dfc4eb","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/234a4d70-cc20-5474-8f8f-9b1d09e2ed1e"},"effectiveDateTime":"1990-04-15T23:01:29-04:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"24977ef1-8140-8c62-af14-21410472ed06","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/7007cecd-b951-6e6e-4b99-393daf93f31a"},"effectiveDateTime":"1990-04-19T01:04:29-04:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"f799f938-1ace-a8a9-112c-fe5cef815d2e","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/619c6a14-fcd5-da97-d5ee-3fcc5c680886"},"effectiveDateTime":"1990-04-22T04:06:29-04:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"28e55a34-459a-540a-32f5-c0805a2fa6d7","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/59dc5c69-703c-e07d-dfcd-6dfa453a5c78"},"effectiveDateTime":"1990-04-25T06:40:29-04:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"47f47426-c2c5-48c7-387b-d52d2786923c","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/e49a49a4-9f88-c0d6-e4ab-8f8175c70bc9"},"effectiveDateTime":"1990-04-28T08:41:29-04:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"f4733cb1-3d58-db7c-444d-04f2d6892de2","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/141b94d7-2d42-b138-79f9-c02cdd9f33f0"},"effectiveDateTime":"1990-05-01T11:58:29-04:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"97c332c2-3a39-3a3d-c0f9-de97a61a06d5","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/12602f2e-1a3a-6fa8-9a84-515c722203bc"},"effectiveDateTime":"1990-05-04T14:49:29-04:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"3ca6c122-3054-1788-7e3f-f174a5ccc0c0","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/dc4ab74f-34d1-6d66-6e50-11859e68efdb"},"effectiveDateTime":"1990-05-07T18:35:29-04:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"bd33f143-7fd1-4548-fecd-2195fd573dd0","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/164efa03-323b-cbbc-e938-69b4319861d1"},"effectiveDateTime":"1990-05-10T21:38:29-04:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"eca20cf0-478f-1555-6f36-39364bcd221f","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/6684fc68-ee05-6eff-1643-c3433d450007"},"effectiveDateTime":"1990-05-14T00:18:29-04:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"4404fb84-372a-29bd-492d-d3944aae4350","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/068c65f3-7147-caa0-e3e7-b305610e38c3"},"effectiveDateTime":"1990-05-17T02:35:29-04:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"6fa1652f-01cf-f637-3c39-8e79d3f4ba18","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/db57c69d-29f6-15b5-ac69-ac2bdcf7e202"},"effectiveDateTime":"1990-05-20T06:26:29-04:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"2a83d15b-83b9-6f3a-f406-664855bbad46","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/5476f090-39e0-266b-156e-4e67c5bacb4a"},"effectiveDateTime":"1990-05-23T08:38:29-04:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"71132e94-0dab-d49c-f851-3b5d904101b7","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/43641759-ffcb-fdeb-5b3d-6d7d7847a876"},"effectiveDateTime":"1990-05-26T11:32:29-04:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"20e9544b-fdb4-90aa-77c5-234fde8128d3","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/96d7c205-4f32-fa89-0465-ec58ee48200f"},"effectiveDateTime":"1990-05-29T14:50:29-04:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"c8682c9e-af60-f3d6-5e16-c1e66d6dbd59","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/5c522f02-3bff-9117-db36-1c73d99265e2"},"effectiveDateTime":"1990-06-01T18:23:29-04:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"023a6fc8-2b34-d870-9e1b-3c605493d48d","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/51e3fd67-f1d7-a15a-907d-dbfd8deca829"},"effectiveDateTime":"1990-06-04T22:19:29-04:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"56b51a88-65d0-3813-8707-e07c160879ac","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/afb11b08-70d3-feeb-1b79-6ed7a571dbc0"},"effectiveDateTime":"1990-06-08T00:43:29-04:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"143276d0-2c74-e7ce-b538-db9177acef75","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/a33f7d12-b2f9-1941-f122-2db359caf7c6"},"effectiveDateTime":"1990-06-11T03:48:29-04:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"5cb605dd-7a39-5c23-8621-0711761a28bb","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/963a8326-f34c-c2bd-a850-a9c330ce069e"},"effectiveDateTime":"1990-06-14T06:23:29-04:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"1d428b05-32c0-a1aa-26b2-0e3793665db8","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/93fbd72e-9c8c-4a91-889d-c2393ba8af86"},"effectiveDateTime":"1990-06-17T09:07:29-04:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"9f418b44-6718-7b43-1c11-0e76c7be476e","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/0355aaf3-e365-b998-fed8-850dd8318272"},"effectiveDateTime":"1990-06-20T12:12:29-04:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"92642fd5-de5a-5825-9cc1-f31fe9528b4b","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/be49fbba-cbb4-fff6-d93c-a72e91c7ddb0"},"effectiveDateTime":"1990-06-23T14:57:29-04:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"316351a4-8a76-e26a-c468-810612be6683","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/7b30f08c-8394-0db6-7b1e-a775fac50ced"},"effectiveDateTime":"1990-06-26T17:27:29-04:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"3dd1ba23-2045-ee28-7f6a-ea761e755ee0","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/537778df-9c20-daf8-af9a-5f176e95f681"},"effectiveDateTime":"1990-06-29T20:51:29-04:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"eb9a4ab7-b356-2faf-83cb-e026f162f932","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/1f45bd88-2806-176e-7139-b77435dda955"},"effectiveDateTime":"1990-07-02T23:32:29-04:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"fc253e44-46be-a6a5-0289-ff907f5d8fc5","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/4be1e3b1-372f-b847-e40f-25b25b7fed32"},"effectiveDateTime":"1990-07-06T01:42:29-04:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"505a8f84-62c7-2c58-4b52-c2aa6d29f3a9","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/25d1ec2c-5cc1-40f6-41a8-5779357a8162"},"effectiveDateTime":"1990-07-09T04:57:29-04:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"a061e29d-4b57-a2b9-5813-66b6de5cd49d","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/9f5c4f5e-8c88-660c-8e17-10a8a46812e0"},"effectiveDateTime":"1990-07-12T07:33:29-04:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"8e1c7f35-c6fc-2c29-57a8-dbabd762783e","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/067f4645-6274-a7a3-cf80-d0ceff04b87d"},"effectiveDateTime":"1990-07-15T09:45:29-04:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"274e9df8-9797-1823-46e9-c9d9642f41ba","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/8f0a5a82-a9c2-9899-9a8f-43fd301fa618"},"effectiveDateTime":"1990-07-18T12:49:29-04:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"d2de1625-2a96-fd4d-794a-9b0c3a1a2fae","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/2296369d-fbd9-ce2d-e493-53831b2729b3"},"effectiveDateTime":"1990-07-21T15:30:29-04:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"bceaa12a-5e53-08c8-fe83-d17d9c8c5d70","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/f2be975f-a7c8-27a1-5c2f-c8d7ca5a94d5"},"effectiveDateTime":"1990-07-24T17:44:29-04:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"b0e541ad-cbe1-9a85-0af5-a7f9e0b33155","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/2fb66cc3-61b3-814e-417e-0cb508293632"},"effectiveDateTime":"1990-07-27T21:32:29-04:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"740038dd-7642-2fc9-3188-7a76a6957e40","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/6df0e1bf-9b4c-a681-9c5b-54ceb996bff8"},"effectiveDateTime":"1990-07-31T01:06:29-04:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"0febdc3d-263d-cc30-a91c-2f9393674471","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/d6d739d6-e2e6-0b65-2e8b-463f804f4846"},"effectiveDateTime":"1990-08-03T03:19:29-04:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"e531c4cd-09ed-2569-1857-cf38da9bce62","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/a62511c0-b32d-18f1-fe8a-8b37da6f7bc2"},"effectiveDateTime":"1990-08-06T06:46:29-04:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"afe22435-d505-3420-14a3-71cfe57f9527","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/e8a68224-0d1b-843c-2eae-38ff99ad7502"},"effectiveDateTime":"1990-08-09T09:17:29-04:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"9672117e-8071-6f3a-5ff4-acf35c71ad47","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/07ac623f-af5f-fc59-8d0e-b659049e8d5f"},"effectiveDateTime":"1990-08-12T12:42:29-04:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"98b55295-e712-7e5c-7659-3b17f778ca71","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/dc4c0d16-c98f-584e-0cba-678f6937fb91"},"effectiveDateTime":"1990-08-15T14:50:29-04:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"4c110016-eb5d-9954-bbe1-4ca5e390bf5e","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/de56d107-44a6-60df-98d6-e572d8b0b9dd"},"effectiveDateTime":"1990-08-18T16:55:29-04:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"42fd8338-3b3c-7cf4-c98d-ac307cd5ad47","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/f8a6b2f0-2728-3653-17bb-9278aa0d284f"},"effectiveDateTime":"1990-08-21T19:59:29-04:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"feaa5dab-d53d-b052-0b73-e04849d8e191","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/f2393b36-62a0-1b1c-0503-64378bda40d2"},"effectiveDateTime":"1990-08-24T22:40:29-04:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"f1a3510d-af58-5738-8e57-f02f6d6520bb","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/a7a71cee-fcf9-0fb0-e8ee-8125f977ffa6"},"effectiveDateTime":"1990-08-28T01:15:29-04:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"2eadea9f-9a0a-a5e7-9918-6eb92d0fdfcf","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/34e2876b-9094-de16-74cd-cbfd5d3c1b91"},"effectiveDateTime":"1990-08-31T03:20:29-04:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"a75c010d-a122-b41b-0c1d-4fa7b48dd522","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/578b9030-9f7d-cc72-c7ba-25189e4c2c86"},"effectiveDateTime":"1990-09-03T05:50:29-04:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"fd4ca8b4-591a-98a5-03b1-6a0313616c45","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/68cb44cb-2862-2726-3297-05a027053f3b"},"effectiveDateTime":"1990-09-06T08:52:29-04:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"c4225599-57c3-b98e-2fa6-6f2c5cff2519","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/8c30a4ed-cd7b-b8ea-e040-4a110a1da4c4"},"effectiveDateTime":"1990-09-09T12:51:29-04:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"9d364abc-bf45-9637-69ce-749c286ea218","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/0cbbaed0-e99a-7044-ee1a-87f37c48d35a"},"effectiveDateTime":"1990-09-12T16:21:29-04:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"423a3600-e3c4-09a0-5e1b-02990da78089","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/91ce7926-96c2-2ab1-aa57-413f96f8a398"},"effectiveDateTime":"1990-09-15T19:55:29-04:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"7ed6fe20-a2da-c112-0209-5ec840b2cdc2","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/e1dc7576-8685-c940-34e2-c4b045a6819f"},"effectiveDateTime":"1990-09-18T22:25:29-04:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"39b84a95-ae50-3851-6a0c-2190638879ea","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/cdd21200-4057-d369-0609-e81bc49bb1a9"},"effectiveDateTime":"1990-09-22T01:31:29-04:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"e1711f63-f4b2-db8d-3550-3aa25cf474be","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/b4aede94-f8e2-d556-af6e-770bb6ffc422"},"effectiveDateTime":"1990-09-25T05:16:29-04:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"252bbe38-52f3-10b8-ad16-8a191f8b3aab","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/8d773a2f-0929-129e-c4a7-5e349a771bb3"},"effectiveDateTime":"1990-09-28T07:25:29-04:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"292766c4-63c6-ea12-e958-38d4ca12ff0d","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/a7e7d37e-659c-2350-998a-da518f6818e3"},"effectiveDateTime":"1990-10-01T09:26:29-04:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"326de321-1e8d-4c30-cb9e-37183133c471","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/505bc89a-36c1-9035-74b7-789337e18495"},"effectiveDateTime":"1990-10-04T12:39:29-04:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"6ae19a1d-96d1-2ebe-eefb-2d22d6c17df9","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/85747d3f-20b2-c77c-9fc7-bbbee69b5362"},"effectiveDateTime":"1990-10-07T14:43:29-04:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"2f81e29e-5a1d-b1d1-4cb8-66b7ed22f243","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/cd87afa6-b52f-87b8-4a46-d16036025c80"},"effectiveDateTime":"1990-10-10T18:20:29-04:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"7108f472-765a-63d0-7b8a-d797ad5296f6","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/60154f5b-e345-82ab-119c-f3d5872186f6"},"effectiveDateTime":"1990-10-13T20:35:29-04:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"e72d383c-e0bc-8d41-f793-8451e68892bf","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/c19113f4-b941-3a78-a81d-7a5a4890917d"},"effectiveDateTime":"1990-10-16T23:59:29-04:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"96379567-75d4-51e0-f73d-fa28c65178e5","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/e5c0cbf7-62d6-4f87-c9e3-85eb38fc73ad"},"effectiveDateTime":"1990-10-20T03:29:29-04:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"855abcb0-f77a-7d73-dce0-94f290aad19a","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/ee1e1a09-e025-d043-e139-a0647e32c833"},"effectiveDateTime":"1990-10-23T06:33:29-04:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"bd563d19-10e1-84d4-1dfe-9bae8bd10807","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/5258ad24-a07f-c782-d5f2-e4e289db272a"},"effectiveDateTime":"1990-10-26T08:39:29-04:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"e96f69a0-562f-8d94-3a4d-00c1f735f256","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/8f28930d-7c0a-a50d-f423-63362305332b"},"effectiveDateTime":"1990-10-29T11:12:29-05:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"f51b2f94-f432-b68f-495a-a1c24c744fc0","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/345249b8-a508-6c49-d7ba-9681974331ad"},"effectiveDateTime":"1990-11-01T14:13:29-05:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"62bb23a2-14d4-7cf2-dbf5-32262e678236","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/2199e707-f9d0-95c9-2641-aba02b68360e"},"effectiveDateTime":"1990-11-04T18:00:29-05:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"d0132638-03d2-db98-e651-3301867558e5","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/1136aa96-0570-3e64-bedb-a3c0e7edfc63"},"effectiveDateTime":"1990-11-07T21:22:29-05:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"542aabaa-0f92-20d7-ce1c-f12e2925261c","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/914e7390-c1f0-49ed-7f15-fc70ae767745"},"effectiveDateTime":"1990-11-10T23:33:29-05:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"f1dac7ba-f7eb-c5c7-3def-dfa9f8edd62e","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/a642e115-746f-df75-2c2a-21b505a8410c"},"effectiveDateTime":"1990-11-14T03:10:29-05:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"2afd3993-00f3-1c6b-d0dd-c9163353c53a","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/54248160-97b6-61d5-5f79-13fb0f469518"},"effectiveDateTime":"1990-11-17T06:34:29-05:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"70b34a78-5793-15d5-f356-c91ec6d1229e","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/cb5156a3-c764-4d30-0d7b-f4cfef984710"},"effectiveDateTime":"1990-11-20T09:12:29-05:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"d62027e1-1cdf-0ae3-3c6c-3cff17b048f4","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/db1082d9-8641-ae5a-6125-da65088c8331"},"effectiveDateTime":"1990-11-23T12:35:29-05:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"6b99e298-8283-72a3-287c-66b21588baa4","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/c08183aa-bc34-0835-e2b5-bcbd5851a4e9"},"effectiveDateTime":"1990-11-26T16:20:29-05:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"dbcbc09d-091f-6a8c-d3fe-e6a79a22d779","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/e66dacbd-7f6d-bf50-765d-0531acfca74b"},"effectiveDateTime":"1990-11-29T19:28:29-05:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"fe053893-0b57-f852-0ace-bb378bb6f791","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/7b48e44b-3534-cb37-41cc-4a8e79c608e0"},"effectiveDateTime":"1990-12-02T21:28:29-05:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"c997eb1e-3dcf-6f71-d232-e35163da0274","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/42d11549-0aee-f5cf-dc6e-47fe0d5a814b"},"effectiveDateTime":"1990-12-06T00:29:29-05:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"92427625-b96d-199f-1643-972c1e2e6c20","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/c65419bc-79a8-129a-5636-7a9b318315c6"},"effectiveDateTime":"1990-12-09T03:22:29-05:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"15c0909b-fd95-793d-69e0-a58fde621167","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/336da4c1-65d4-47c9-e3e8-9899330a0d52"},"effectiveDateTime":"1990-12-12T07:04:29-05:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"ebccae11-09ae-2f0c-e3ff-d41b9fb8c893","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/e5e00f4c-5a43-d886-ce8c-0a63e0fba42f"},"effectiveDateTime":"1990-12-15T10:23:29-05:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"dca0b96f-c7b5-7aab-c968-fb08f80a331a","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/0ec2430c-4061-4b00-8743-1e08b2cc8e4e"},"effectiveDateTime":"1990-12-18T13:54:29-05:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"6ac0b8f9-6149-6dd2-6978-fa92919e2e46","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/0411fb4d-9ce0-578f-561a-f123b9b164d5"},"effectiveDateTime":"1990-12-21T16:39:29-05:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"4a2ab7e8-304a-ea6f-dd30-04716a236e88","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/46932a92-b3b0-04e1-9727-ddb9b9d8a6b6"},"effectiveDateTime":"1990-12-24T20:22:29-05:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"2d86aa20-ef92-25f8-fa1e-d489416821d8","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/f44f62ab-6b9e-b0c1-c847-36ad2798b3c4"},"effectiveDateTime":"1990-12-27T23:31:29-05:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"fe9c1168-ec93-1c77-8142-d6ab32512941","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/3181df42-a494-45b3-b294-7ba838ce1ae4"},"effectiveDateTime":"1990-12-31T02:15:29-05:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"fa52ef66-5293-2250-7cf9-f51a65d12f1a","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/4affa2c9-d234-add6-311a-8837b82080e3"},"effectiveDateTime":"1991-01-03T05:20:29-05:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"9037eb21-8b19-ccbe-545e-e354b12469d9","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/f258df93-a1b3-c15e-86c5-ddadedf3561e"},"effectiveDateTime":"1991-01-06T09:03:29-05:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"11641166-f163-c5e5-5d79-4d9b743dd64b","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/ce58fd5a-d65f-741f-5d11-2a99f59e5b36"},"effectiveDateTime":"1991-01-09T11:28:29-05:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"ca9ac3f2-8196-fc1c-bc3b-430204c95cc6","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/b1dcae59-57fe-8dce-ec1b-6246cd412ffc"},"effectiveDateTime":"1991-01-12T13:58:29-05:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"a23a990c-d52f-4a66-6e1b-65a4ffafab72","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/d3dfb173-5bdc-faec-a6ce-500ae5eb3097"},"effectiveDateTime":"1991-01-15T16:01:29-05:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"a8c56115-e9ca-2a21-3ad5-c761ff1415eb","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/a71961ff-4d12-1ce7-3a29-c62a16067cf9"},"effectiveDateTime":"1991-01-30T18:50:29-05:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"4a9ba7b6-58ac-c88c-3a1e-da17030c6098","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/1965f222-5ff9-b205-5ae4-77b8d35e3353"},"effectiveDateTime":"1991-02-02T22:27:29-05:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"b0df3a93-42aa-4af0-57a2-ea16750af560","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/62c001c4-049c-da4c-4089-b6dc0a5afe28"},"effectiveDateTime":"1991-02-06T01:17:29-05:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"247b6058-3c5f-849f-645e-5b707df8b4f4","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/20cf9554-6356-4826-7cb8-57018234e87f"},"effectiveDateTime":"1991-02-09T04:25:29-05:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"4494f990-f3c7-ea36-4d72-4914262894c6","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/27b39f10-8c73-a042-3114-93502901d0d2"},"effectiveDateTime":"1991-02-12T08:12:29-05:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"dbc461d9-c6c1-e4fc-d3f7-87e470c4e9cf","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/afec6d27-4de0-446e-f03e-c392f2ed0a0a"},"effectiveDateTime":"1991-02-15T11:29:29-05:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"577d1b05-6ac6-1314-ad00-297eeedfa619","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/07e8c5fd-d3ac-c547-f73c-82c6dab05064"},"effectiveDateTime":"1991-02-18T14:57:29-05:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"a2ca09b2-83e9-3620-6332-5342071b96cb","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/626c50d1-8961-d725-8c46-0f58b44e9256"},"effectiveDateTime":"1991-02-21T17:38:29-05:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"7ecc58d4-bd7d-b052-01fe-b97f8de52142","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/8a5937ce-4578-3db3-be9f-31cebcf572be"},"effectiveDateTime":"1991-02-24T20:11:29-05:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"4f08f34d-5db1-7c32-f0bd-315a273427b3","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/1528c0f8-7840-12b0-8a81-01d1682e61ec"},"effectiveDateTime":"1991-02-27T22:46:29-05:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"e68f8df8-df7f-268a-08b2-09d9ac175147","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/61ebd1e8-5063-078d-eb0a-bdcefbd4ccf6"},"effectiveDateTime":"1991-03-03T01:55:29-05:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"8ab1ce72-eb73-add1-3abb-5fd9e3a6d3dc","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/934e5c03-463d-06fc-72ef-713f59b9c787"},"effectiveDateTime":"1991-03-06T04:47:29-05:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"958418cd-b484-4179-1ba5-1f3275da6289","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/dfe10b47-e7ac-17d6-2d27-191d9dfe7f6c"},"effectiveDateTime":"1991-03-09T07:02:29-05:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"dba699ac-461c-00a8-d3d9-bfb6f824d5d9","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/77af82f4-38e9-d9c9-853e-534f71183f37"},"effectiveDateTime":"1991-03-12T09:42:29-05:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"a4283bd3-0524-d4eb-66e8-f81111ee5798","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/253f8998-1198-fc19-9a2a-13404ae9e513"},"effectiveDateTime":"1991-03-15T12:54:29-05:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"cfc28c47-8ae2-e5b7-26d2-0f79eb8e26a8","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/0be4706d-f180-404a-dd25-05e3bba88d9d"},"effectiveDateTime":"1991-03-18T16:38:29-05:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"f8a51568-b418-2d4e-056e-9815f885ef0d","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/bc05c56d-64dd-4ec5-7e18-5ddd7b5890aa"},"effectiveDateTime":"1991-03-21T19:59:29-05:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"3eeb9231-a61f-2c2f-d81b-e7e24a4e7470","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/23e12b2b-bbbf-aba5-4c3f-97cc8331e62c"},"effectiveDateTime":"1991-03-24T23:22:29-05:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"e94deae6-68c3-56a9-02e0-f041f28a562e","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/b7e5c963-16ad-9e5f-d0d4-b28f39e3684a"},"effectiveDateTime":"1991-03-28T01:39:29-05:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"62cf7390-d155-59ac-e6e9-06962d5e7171","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/11472cdd-a0fb-1378-e190-5bacb799fe3b"},"effectiveDateTime":"1991-03-31T03:49:29-05:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"23fffc71-e9eb-1d10-fb83-dd3e8216016a","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/14bb13ab-e988-5b53-e3b0-1997797b7801"},"effectiveDateTime":"1991-04-03T07:42:29-05:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"3ca82aa9-0e86-b908-7e41-5afedf5688a0","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/b604998b-055a-43f4-d41c-d8a5179d2580"},"effectiveDateTime":"1991-04-06T11:13:29-05:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"c72f7199-ca32-fcc1-d795-bdaf406625cb","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/5c485993-04f9-41fc-e81c-7fc14597874c"},"effectiveDateTime":"1991-04-09T14:40:29-04:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"10c5595e-2f44-fd5e-76d5-bfaa44bd365f","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/5eb0485c-d346-e8b3-c9ba-7e67ffe08583"},"effectiveDateTime":"1991-04-12T18:05:29-04:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"c79685d5-467a-3319-d7fc-d1eac0bb56cb","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/ef9cd424-e9f2-e162-425d-c3101e392d0a"},"effectiveDateTime":"1991-04-15T21:50:29-04:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"76df4793-44e4-ec7b-8c5b-91c3a2f552c7","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/4691e7b2-d698-88ad-cc9b-87da5f3c7cc8"},"effectiveDateTime":"1991-04-19T01:43:29-04:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"202a4cc1-3fe6-338c-5cae-66544545c762","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/a42c5d7a-65cc-9da8-c6a1-9792559b3a58"},"effectiveDateTime":"1991-04-22T05:02:29-04:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"7df59f2e-5360-1551-0127-ffda56216d81","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/8b84c011-c7a0-6cfc-1a37-8e5f9c410ba8"},"effectiveDateTime":"1991-04-25T08:53:29-04:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"4517db1d-d434-0f05-9b21-4d37ec75a835","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/e54aeba0-9e95-58ed-99ed-6131bfd7eb57"},"effectiveDateTime":"1991-04-28T12:05:29-04:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"dd6dd32d-91cc-1569-1093-ddefc44c7062","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/7633a857-324e-a227-d76c-135862c03c28"},"effectiveDateTime":"1991-05-01T15:53:29-04:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"69a7e660-ccc8-9818-1f25-f6c718de1e86","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/1547f44e-2545-bb14-c472-a517bf805bea"},"effectiveDateTime":"1991-05-04T19:43:29-04:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"fdeabae4-303c-2a25-044f-7c3cb7541245","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/85932295-b33f-da9e-10d9-256b27945bdd"},"effectiveDateTime":"1991-05-07T22:50:29-04:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"93a5bd5c-fd2a-4223-9908-5b8345ae5bb6","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/b0aa004d-90c1-94fd-15c3-1e841813bda1"},"effectiveDateTime":"1991-05-11T02:26:29-04:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"37647871-82af-c076-9b2e-d18105e22122","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/849d8697-38f8-4cc1-b09e-f98db1c78e63"},"effectiveDateTime":"1991-05-14T05:06:29-04:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"41c70ee4-55c2-b8e0-c38c-60f4bc0ece6e","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/a6d4e67b-8509-0990-00b1-aee25c90de54"},"effectiveDateTime":"1991-05-17T08:54:29-04:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"689c0af7-4293-231d-eb4e-1b2c8a512fe6","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/d1e759fa-d72f-73f1-66ea-10eb3911eee1"},"effectiveDateTime":"1991-05-20T11:27:29-04:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"53a2bdb0-0b22-2eca-5907-5e052fa6485d","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/bfca55eb-ae97-fd1f-dc15-027efa6125a6"},"effectiveDateTime":"1991-05-23T13:58:29-04:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"35f342f8-3abc-00ce-881b-68607c553124","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/4ee26bd1-7307-5451-cd97-7d89f315907f"},"effectiveDateTime":"1991-05-26T17:48:29-04:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"b5ecc3e0-c610-e27a-48f2-2bc370136694","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/55dff692-c223-0b53-b08a-657adbd7f1bf"},"effectiveDateTime":"1991-06-12T20:00:29-04:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"2f6cd5f4-888c-705d-ed79-9f773cbe19df","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/1b967f55-e9a4-1e52-2d39-b705ccb2d8a1"},"effectiveDateTime":"1991-06-15T22:57:29-04:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"d8effd06-9cd2-204a-ed83-ddd334fd676d","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/4eed4d51-c55f-2f31-f313-67c6671ee119"},"effectiveDateTime":"1991-06-19T02:08:29-04:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"696398a6-3b22-31b6-6ecf-fc13a9a64b49","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/f4db9c4e-714a-a65f-234d-54ce20f37125"},"effectiveDateTime":"1991-07-10T19:32:29-04:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"0b219563-cfe5-895a-3e47-a03d9aa59a52","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/308b2c8a-fd0a-3999-879c-6b50692c8d2b"},"effectiveDateTime":"1991-07-13T23:14:29-04:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"2ddf7df8-6022-9c25-6281-21d92cbac790","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/6cdabff5-8226-9d43-23e9-76c3023d40cc"},"effectiveDateTime":"1991-07-17T02:30:29-04:00","reasonReference":[{"reference":"Condition/9a44af1f-85ef-55b5-b3b8-ffc90771da8f","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"50ab7c36-c647-7335-1a2e-32f82e74d142","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1665060","display":"cefazolin 2000 MG Injection"}],"text":"cefazolin 2000 MG Injection"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/8d4d3f9f-0644-d05e-a8b7-ed3fefcb2306"},"effectiveDateTime":"1991-07-17T18:57:22-04:00"}
{"resourceType":"MedicationAdministration","id":"8c4c55bf-8bf0-b6da-bca3-2dec919cf873","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1659263","display":"1 ML heparin sodium, porcine 5000 UNT/ML Injection"}],"text":"1 ML heparin sodium, porcine 5000 UNT/ML Injection"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/8d4d3f9f-0644-d05e-a8b7-ed3fefcb2306"},"effectiveDateTime":"1991-07-17T18:57:22-04:00"}
{"resourceType":"MedicationAdministration","id":"ff1b0505-8ea3-aab3-dfe7-9d30faba2d89","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1796676","display":"25 ML protamine sulfate (USP) 10 MG/ML Injection"}],"text":"25 ML protamine sulfate (USP) 10 MG/ML Injection"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/8d4d3f9f-0644-d05e-a8b7-ed3fefcb2306"},"effectiveDateTime":"1991-07-17T18:57:22-04:00"}
{"resourceType":"MedicationAdministration","id":"66ad7645-6ac5-b897-d432-9c482edf4b9c","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1740467","display":"2 ML Ondansetron 2 MG/ML Injection"}],"text":"2 ML Ondansetron 2 MG/ML Injection"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/8d4d3f9f-0644-d05e-a8b7-ed3fefcb2306"},"effectiveDateTime":"1991-07-17T20:18:58-04:00"}
{"resourceType":"MedicationAdministration","id":"c785e509-8e0e-36f9-d7ec-311f4422cf04","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"311700","display":"Midazolam 1 MG/ML Injectable Solution"}],"text":"Midazolam 1 MG/ML Injectable Solution"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/8d4d3f9f-0644-d05e-a8b7-ed3fefcb2306"},"effectiveDateTime":"1991-07-17T20:18:58-04:00"}
{"resourceType":"MedicationAdministration","id":"de4da866-6996-79b2-8bfe-4d26c119ac13","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1808217","display":"100 ML Propofol 10 MG/ML Injection"}],"text":"100 ML Propofol 10 MG/ML Injection"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/8d4d3f9f-0644-d05e-a8b7-ed3fefcb2306"},"effectiveDateTime":"1991-07-17T20:18:58-04:00"}
{"resourceType":"MedicationAdministration","id":"7a144088-8e66-598e-ac74-ee393326b111","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1234995","display":"Rocuronium bromide 10 MG/ML Injectable Solution"}],"text":"Rocuronium bromide 10 MG/ML Injectable Solution"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/8d4d3f9f-0644-d05e-a8b7-ed3fefcb2306"},"effectiveDateTime":"1991-07-17T20:18:58-04:00"}
{"resourceType":"MedicationAdministration","id":"9d262155-332a-33df-a293-a67b35ee4d72","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"542347","display":"isoflurane 99.9 % Inhalation Solution"}],"text":"isoflurane 99.9 % Inhalation Solution"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/8d4d3f9f-0644-d05e-a8b7-ed3fefcb2306"},"effectiveDateTime":"1991-07-17T20:18:58-04:00"}
{"resourceType":"MedicationAdministration","id":"757d1381-5d74-8caf-0ead-6a59afd4b8f1","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1723208","display":"10 ML Alfentanil 0.5 MG/ML Injection"}],"text":"10 ML Alfentanil 0.5 MG/ML Injection"},"subject":{"reference":"Patient/ea844c14-eee1-9d1b-42d4-741a87fef173"},"context":{"reference":"Encounter/8d4d3f9f-0644-d05e-a8b7-ed3fefcb2306"},"effectiveDateTime":"1991-07-17T20:18:58-04:00"}
{"resourceType":"MedicationAdministration","id":"97fd8850-0192-5d90-df86-40c2819dd821","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/748c8dde-685c-a40a-d99b-6d7816a1f362"},"context":{"reference":"Encounter/2ba1bae2-c25d-64f5-5cee-e263993c6734"},"effectiveDateTime":"2015-10-14T20:46:54-04:00","reasonReference":[{"reference":"Condition/f91d6aed-db72-788c-684c-d6fdfae18ad1","display":"Gingivitis (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"12eb018e-73cc-c0b8-271c-5370a1eabbba","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/748c8dde-685c-a40a-d99b-6d7816a1f362"},"context":{"reference":"Encounter/1015caba-63a4-ab8f-8d16-adf7e5932d61"},"effectiveDateTime":"2018-09-26T22:44:48-04:00","reasonReference":[{"reference":"Condition/f91d6aed-db72-788c-684c-d6fdfae18ad1","display":"Gingivitis (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"e4dc0dbe-8540-5d05-02fe-efa85852a9f2","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/748c8dde-685c-a40a-d99b-6d7816a1f362"},"context":{"reference":"Encounter/4890c175-9c9a-554f-0771-e61963ed5135"},"effectiveDateTime":"2020-02-12T19:03:03-05:00","reasonCode":[{"coding":[{"system":"http://snomed.info/sct","code":"103697008","display":"Patient referral for dental care (procedure)"}],"text":"Patient referral for dental care (procedure)"}]}
{"resourceType":"MedicationAdministration","id":"eb810e52-c4e4-bf8e-a2d2-f080e3d9d2f7","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/748c8dde-685c-a40a-d99b-6d7816a1f362"},"context":{"reference":"Encounter/ed66f85f-f8c8-8911-eed8-da812b1f6c35"},"effectiveDateTime":"2020-11-11T20:08:44-05:00","reasonCode":[{"coding":[{"system":"http://snomed.info/sct","code":"103697008","display":"Patient referral for dental care (procedure)"}],"text":"Patient referral for dental care (procedure)"}]}
{"resourceType":"MedicationAdministration","id":"55c58890-d7b3-bd40-a0ae-79a7e7428af9","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/748c8dde-685c-a40a-d99b-6d7816a1f362"},"context":{"reference":"Encounter/ed573f2e-a5ee-3743-7a61-81c1ca103f07"},"effectiveDateTime":"2021-03-17T19:23:09-04:00","reasonCode":[{"coding":[{"system":"http://snomed.info/sct","code":"103697008","display":"Patient referral for dental care (procedure)"}],"text":"Patient referral for dental care (procedure)"}]}
{"resourceType":"MedicationAdministration","id":"18155864-baf6-0fce-004a-aee4c5325592","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/748c8dde-685c-a40a-d99b-6d7816a1f362"},"context":{"reference":"Encounter/c9683e7a-8894-9740-b5b5-a7ddf1175171"},"effectiveDateTime":"2021-07-07T20:11:02-04:00","reasonCode":[{"coding":[{"system":"http://snomed.info/sct","code":"103697008","display":"Patient referral for dental care (procedure)"}],"text":"Patient referral for dental care (procedure)"}]}
{"resourceType":"MedicationAdministration","id":"29dc95dc-3dea-8b39-9b37-dd64f6681014","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/748c8dde-685c-a40a-d99b-6d7816a1f362"},"context":{"reference":"Encounter/7902f524-13a1-83ed-f9a8-262946389179"},"effectiveDateTime":"2021-10-13T20:32:07-04:00","reasonCode":[{"coding":[{"system":"http://snomed.info/sct","code":"103697008","display":"Patient referral for dental care (procedure)"}],"text":"Patient referral for dental care (procedure)"}]}
{"resourceType":"MedicationAdministration","id":"22121a11-ee23-fd31-979f-76ac7d356e31","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/748c8dde-685c-a40a-d99b-6d7816a1f362"},"context":{"reference":"Encounter/9bf7ee0f-bba6-2c24-02ff-25a95492707f"},"effectiveDateTime":"2023-04-05T20:07:16-04:00","reasonCode":[{"coding":[{"system":"http://snomed.info/sct","code":"103697008","display":"Patient referral for dental care (procedure)"}],"text":"Patient referral for dental care (procedure)"}]}
{"resourceType":"MedicationAdministration","id":"81397a8c-3369-8c01-726c-6ed0d72de842","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/748c8dde-685c-a40a-d99b-6d7816a1f362"},"context":{"reference":"Encounter/b5a2c0e6-5ba1-f12e-54a1-056b64c9a3d8"},"effectiveDateTime":"2024-02-28T20:00:26-05:00","reasonCode":[{"coding":[{"system":"http://snomed.info/sct","code":"103697008","display":"Patient referral for dental care (procedure)"}],"text":"Patient referral for dental care (procedure)"}]}
{"resourceType":"MedicationAdministration","id":"eec3f5e3-1924-1a0e-b73f-c0722a951e2d","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/748c8dde-685c-a40a-d99b-6d7816a1f362"},"context":{"reference":"Encounter/7ebf8e55-26cc-4335-f5f9-1d849cdd2f4b"},"effectiveDateTime":"2024-04-03T19:44:48-04:00","reasonCode":[{"coding":[{"system":"http://snomed.info/sct","code":"103697008","display":"Patient referral for dental care (procedure)"}],"text":"Patient referral for dental care (procedure)"}]}
{"resourceType":"MedicationAdministration","id":"ad9f7280-875a-7d65-d206-76d269889e06","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/748c8dde-685c-a40a-d99b-6d7816a1f362"},"context":{"reference":"Encounter/af27de2d-e7e3-4bcc-44c6-642d215a3a10"},"effectiveDateTime":"2024-07-03T20:05:18-04:00","reasonReference":[{"reference":"Condition/f91d6aed-db72-788c-684c-d6fdfae18ad1","display":"Gingivitis (disorder)"}]}
